Contents I: Cardiovascular Section System Chapterl.Embryology. C h a p t e rH2i.s t o l o g y
.....5 .......13
Chapte...
136 downloads
1115 Views
51MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
Contents I: Cardiovascular Section System Chapterl.Embryology. C h a p t e rH2i.s t o l o g y
.....5 .......13
Chapter5.Anatomy....
....19
Chapter4.Physiology,.
.,..51
C h a p t e rP5a. t h o l o g y . . .
....87
Chapter 6. Pharmacology
. .123
Section ll: Respiratory System C h a p t e rEl .m b r y o l o g y C h a p t e rHZi.s t o l o g y C h a p t e rASn.a t o m y . . . .
....141 ......143 ...147
C h a p t e rP4h. y s i o l o g y
.....157
C h a p t e rP5a. t h o l o g y . .
....185
6. Pharmacology Chapter
. . .217
lll: Rena/Urinary Section System l. Embryology . Chapter C h a p t e rH 2 i.s t o l o g y
...227 ......231
iliiitical
vii
Chapter5.Anatomy
......239
Chapter4.Physiology..
...241
Chapter 5. Pathology ...
. . .257
Chapter 6. Pharmacology
. . 281
Section lV:Hematologi{Lymphoreticular System C h a p t le. rH i s t o l o g y
......289
Chapter 2.Anatomy
. . . . . .297
ChapterS.Physiology..
...299
C h a p t e rP4a. t h o l o g y . . .
...303
Chapter 5. Pharmacology
. .327
Section V:Nervous System Chapterl.Embryology. Chapter2. Histology: NerveTissue
.....339
Chapter 5.Histology: Sensory Organs
. .345
Chapter4. Neuroanatomy: lntroduction ,..
...355
Chapter 5.Divisions oftheNervous Sy$em
. . . 559
Chapter 6.Meninges, Ventricular System, andCerebrospinal Fluid 7.Cross Chapter Anatomy oftheSpinal Cord.
viii
ilitstical
...335
. . . . . 561 . . . . . .367
Chapter 8.Spinal Regulation ofSkeletal Muscle Activity Cord
, , . .375
Chapter 9.Functional Anatomy andLesions oftheSpinal Cord.
. .379
Chapter 10.TheAutonomic Nervous Sy$em
. . 389
Chapter ll. ThePeripheral Nervous System
. . .395
B r a iSnt e m C h a p t le2r. T h e
.....401
i ael r v e s C h a p t lesr. C r a n N
......413
Nerves andCranial oftheBrain Stem 14.Lesions Chapter
. .431
Formation 15.Reticular Chapter
. .435
16.TheVestibular System Chapter 17.TheAuditory System Chapter
. . . . .439 . .443
Cerebellum C h a p t le8r. T h e
.....447
19.TheVisual System Chapter
. . .453
Chapter20.TheDiencephalon..
......459
21.TheThalamus Chapter
. . 461
22.TheHypothalamus Chapter
. . 465
.. andSubthalamus 25.TheEpithalamus Chapter
. . .471
24.TheLimbic System Chapter
. . .473
25.TheMotorSystem Chapter
. . .479
.. Hemispheres Anatomy oftheCerebral 25.Cross Chapter
. . . . .483
Cortex 27.TheCerebral Chapter
. .491
to theBrain 28.BloodSupply Chapter
. . 501
Chapter2g.Physiology.
...507
C h a p t e r 5P0a. t h o l o g y . .
...555
. . . 585 Nervous System theAutonomic Drugs Affecting 51.Pharmacology: Chapter Nervous System. . . . . 607 Affecting theCentral Drugs Chapter 52.Pharmacology: Drugs Psychoactive 53.Pharmacology: Chapter lndex
. . . . .643 ....653
ifitshical
ix
I SECTION
System Cardlovascular
Embryology Cardiovascular Allof these andlymphatic vessels. Thecardiovascular system consists of theheart, bloodvessels, isoutlined inthischapter. arederived frommesoderm;their development structures
PRIMITIVE VASCULAR SYSTEM A. Blood islands. During the third week of development, mesenchymal cells associatedwith the yolk sac,chorion, and connecting stalk form clusters called blood islands, which acquire lumina and fuse to form endothelium-lined capillary plexuses.Peripheral cells of the islands become angioblasts that give rise to the endothelial cells of the vessels,whereas centrally located cells become embryonic hemoblasts that give rise to primitive blood cells. 1. Certain capillaries enlargeto form the major blood vessels:vitellinevessels are formed in the yolk sacwall and umbilical vesselsare formed in the vascular chorion. 2. Extraembryonic blood vessels join with intraembryonic blood vesselsformed from splanchnic mesoderm and the primitive vascular systemis established. B. Hematopoiesis first occurs within the islands of the yolk sac.Later, blood cells are formed in the liver (1-7 months), spleen and lymphatic organs (2-4 months), and bone marrow (after 4 months).
Cardiovascular System
PRIMITIVE HEART TUBE FORMATION The pericardial cavity of the coelom lies cephalic to the buccopharyngeal membrane and neural plate in the embryonic disk Mesenchymeclusters in this region form a pair of endothelium-lined heart tubes on either side of the midline. With transversefolding of the embryonic disk, thesetubes fuse to form the single median primitive heart tube. A. Rotation. Cephalocaudal folding of the embryonic disk causesthe pericardial cavity and heart tube to rotate 180' along a transverseaxis and become located ventral to the foregut and caudal to the buccopharyngealmembrane. 1. The heart tube bulges into the pericardial cavity and becomestransiently suspendedfrom its dorsal wall by the dorsal mesocardium. 2.1\e mesoderm adjacent to the heart tube thickens to form the epimyocardial mantle; mantle cells differentiate into muscle cells of the myocardium and mesothelial cells of the epicardium. B. Early differentiation. The cephalic,or arterial, end of the heart tube is continuous with the aortic sac,while the caudal, or venous,end receivesthe vitelline veins from the yolk sac,the umbilical veins from the placenta,and the common cardinal veins from the body wall. The heart tube expands and differentiates to form, in a cephalocaudal direction, the bulbus cordis, primitive ventricle, primitive atrium, and sinus yenosus. 1. The aortic arches connect the truncus to the paired dorsal aortae, which arise from the aortic sacand lie dorsolateral to the foregut. 2. The distal portion of the bulbus, the truncus arteriosus, becomesthe proximal part of the aorta and pulmonary artery. 3. The sinus venosus eventually forms a major part of the wall of the right atrium and the coronary sinus. C. Loop formation. Becausethe bulbus cordis and the ventricular parts of the heart grow more rapidly than the pericardial caviry elongation of the heart tube is accomplishedby the formation of a dorsoventral cardiac loop, which has its convexity directed anteriorly and to the right. 1. In the resulting S-shapedheart, the expanding atrium lies cranial to the ventricle and bulbus cordis, on either side of the truncus arteriosus, and the passagebetween the atrium and ventricle narrows to form the atrioventricular canal. 2. Thesechangesin position are accompaniedby a caudal migration of the pericardium and heart tube from the level of the third and fourth somites to the level of the seventeenthto the rwentiethsomites(FigureI-1-1).
Embryology
Aorticsac ' Truncusarteriosus -----l. r'r r
I"
-' ' ,
l,
"l
Ventricle
Sinusvenosus
Homsof sinusvenosus
Umbilicalvein
Commoncardinalvein ( r. o-
Vitellinevein (1.o.,
.-
1't"
Aorticsac n,
',
.:
.p...
,
,\ i.
I I
Ventricle
;.i
I
Sinusvenosus
c
Hornsof sinusvenosus Aorticsac
Rightatrium
D
Leftatrium
Ventricle
Figure l-1-1.Bending of the endocardial heart tube in the pericardium.
SEPTUM FORMATION A. Primitive atrium 1. At the end of the fourth week, the septum primum grows from the roof of the primitive atrium towards two mesenchymal cushions, the endocardial (atrioventricular; AV) cushions, which appear in the ventral and dorsal walls of the AV canal. a. The transient opening between the septum primum and endocardial cushions is known as the interatrial foramen primum. b. The endocardial cushions gradually extend along the edge of the primum, thereby obliterating the foramen primum.
-a
o, 38
r\ "'
It
"
System Cardiovascular
c. Prior to its closure,the central portion of the septum primum perforatesto form the interatrial foramen secundum, which insures free blood flow from the right to left primitive atrium. 2. As the sinus venosusbecomesincorporated into the right atrium, the septum secundum grows from the ventral cranial wall of the atrium towards the endocardial cushions. a. The lower edgeof the septum secundumenclosesthe foramen secundum in the septum primum but does not extend firlly towards the endocardialcushions.The opening it leavesbetween the right and left primitive atria is known as the foramen ovale. b. The upper part of the septum primum disappears,but the lower part becomesthe valve of the foramen ovale, which allows blood from the vena cava to pass from the right to left atrium. B. Primitive ventricles
^,-{ rj
-,r1. .,.r r
1. The ventricle beginsto dilate by the end of the fourth week. 2. The expanding walls of the apposing ventricles approach each other medially and fu1e to form the muscular interventricular septum. 3. The interventricular foramen, which lies between the muscular interventricular septum and the endocardialcushionsand permits communication betweenthe two ventricles,is eventually closedby the membranous interventricular septum. C. Ttuncus arteriosus. During the fifth week, the right superior and left inferior bulbar ridges appearin the cephalicportion of ttre truncus arteriosus. 1. The right superiorbulbar ridge grows distally to the left, and the left inferior bulbar ridge grows distally to the right. 2. The bulbar ridges twist around each other and fuse to form the aorticopulmonary septum, which divides the truncus arteriosusinto aortic and pulmonary passages.
VALVES OFCARDIAC FORMATION A. Aortic and pulmonic valves 1. The semilunar valves of the aorta and pulmonary arteries develop following the formation of the aorticopulmonary septum. 2. Three swellingsof endothelium-coveredloose connectivetissue form at the orifices of both the aorta and pulmonary artery. These swellingsbecome hollowed at their uPper surfacesto form semilunar valves. B. Atrioventricular (AV) valves 1. The AVvalves form after the endocardialcushionsfuse. 2. Each atrioventricular orifice becomessurrounded by endocardium-coveredconnective tissueswellings,which hollow on their ventricular surfacesto form valves. a. Two valve leaflets, the bicuspid (mitral) valve, are formed in the left atrioventricular canal. b. Three valve leaflets, the tricuspid valve,are formed in the right atrioventricular canal. 3. The valvesremain connectedto papillary musclesin the wall of the ventricle by meansof chordae tendinae.
6
Embryology
ARTERIAT SYSTEM A. Formation of the aortic arch arteries 1. The aortic arch arteriesarise during the fourth week from the aortic sac,the most distal part of the truncus arteriosus. 2. Eachof the six pairs of arteriesis embeddedin the mesenchymeof its correspondingpharyngeal arch and terminatesin the paired dorsal aortae. 3. The dorsal aortae fuse by the fifth week to form the descendingthoracic aorta and the abdominal aorta with branchesto the embryo, yolk sac (vitelline arteries),and allantois (umbilical arteries).
Flashbackto GeneralPrinciples Nowmaybea goodtimeto review thepharyngeal arches andtheirderivatives inthe lastEmbryology chapter of Book2 Ceneral Principles ftolumell). a o(" ( o <( - I ( ' ?
B. Aortic arch derivatives 1. First aortic arch. The persisting portion becomes the maxillary artery, which supplies the derivatives of the first pharyngeal arch. 2. Second aortic arch. The persisting portion becomes the hyoid artery and stapedial artery, which supply derivatives of the secondpharyngeal arch. 3. Thhd aortic arch. It gives rise to the common carotid artery and the first part of the internal carotid artery (the remainder is formed from the cranial portion of the dorsal aorta); the externalcarotid artery branchesfrom this arch. 4. Fourth aortic arch. The left side forms part of the arch of the aorta betweenthe left common carotid and left subclavianarteries.The right side forms the proximalportion of the right subclavian artery (distal portion is formed from the right dorsal aorta and the seventh intersegmentalartery). 5. Fifth aortic arch. It involutes and disappears. 6. Sixth aortic arch. This is the "pulmonary arch." a. The proximal portions become the proximal left and right pulmonary arteries. b. The right distal portion degenerates.
l''' ;:,":'l
'ri-
\{
'
:
'..",,4,'i-.j't
t^,..!. ,-.,
^
1.,. ,
.
n
,
.
_
t
4 '
Aorticarchderivatives: . Maxillary = lstarch artery . tlyg!{{.ry= 2ndarch t_t .,;] ' Stapedial = 2ndarch* artery - -] . Common artery carotid I z. , 3rdarch './,'
n t/\'
|i'' ''
/
C. Developmental changesin the aortic arch system 1. There is obliteration of the carotid duct, the portion of the dorsal aorta betweenthe third and fourth arches.
. Aortic = 4tharch( --: , dICh P.: el . I +.ri ', . Proximal rightsubclavian ,t,' = 4tharch'' r'' i' . * '{; . artery ''^''e''""' ' Proximal pulmonary a r t e r i e s = 6 t h a ir(c"h' ' r6 I
" : ,
i-'r
i-
. Ductus = 6tharch ( +" arteriosus ' r-. ('' .
2. Disappearanceof the right dorsal aorta occurs betweenthe origin of the seventhintersegmental artery and the junction with the left dorsal aorta.
..i /\
f't,t.
--l
".l
"
-
.
v
D. Branches of the dorsal aortae 1. Dorsal intersegmental arteries (30 pairs) arise from each side of the fused dorsal aortae from the baseof the skull to the sacrum.
'
rt
',"; . Proximal internal carotid' , 'r = 3rdarch artery d,',
. . r ' a ' . , \
c. The left distal portion becomesthe ductus arteriosus.
Jc.g',,."
", , t In a Nutshell, ,-';:'';'-;\',r;)'.
,J '
lAr
)rt',,
rr "!:!-_l__:"t -r ., -;i ,r,l
a. Dorsal ramus suppliesthe spinal cord, meninges,skin, and musculatureof the back. Longitudinal anastomosesgive rise to vertebral arteries,which fuse with the single basilar artery. The basilar artery fuses with the internal carotid artery to form the cerebralarterial circle (of Willis). b. Ventral ramus. Each fuseswith its partner at the ventral body wall, giving rise to the intercostal,limb, and lumbar arteries.
,i;r ^
-.'j -.t
r," ..r rr
[ 't'.r.) ',
27? -.. n
j (,
,l j
,
(
0 f
: ,i
,).'
r n,, .,'-
1'r:t tr',-
:u
6'
l"'
7
!
System Cardiovascular
2. Laterulsplanchnic arteries arise from each side of the dorsal aorta. They supply intermediate mesodermand derivativesand give rise to renal, suprarenal,phrenic, and testicular or ovarian arteries. 3. Ventral splanchnic arteries
;rtfl
+
a. Vitelline arteries originate asa number of paired vesselsrunning to the yolk sac.They eventually fuse to form the celiac artery to the foregut, superior mesenteric artery to the midgut, and inferior mesentericartery to the hindgut.
vii( i I
b. Umbitical arteries originate as paired ventral branchesto the placentain association with the allantois. ( 1) During the fourth week,eachartery becomesconnectedwith the dorsal aorta via the common iliac artery. ri"'
(2) After birth, the umbilical arteriesgive rise to the internal iliac arteries,proximally, and the medial umbilical ligaments,distally.
VENOUS SYSTEM At five weeks,the embryo has three major pairs of veins. A. Viteltine (omphalomesenteric)veins drain the yolk sacand carryblood around the duodenum and through the septum transversumto the sinusvenosus. l. The vitelline veins cephalicto the liver becomethe hepatocardiacchannels,which enter the sinusvenosuswith the right channelbecoming the first segmentof the inferior vena cava. 2. Caudal to the liver, the vitelline veins anastomoseand atrophy to form the singlehepatic portal vein of the portal systemthat drains the viscera. B. Umbilical veins. After atrophy of the right vein and the left vein proximal to the liver, the remaining left vein carriesblood from the placentato the liver. 1. The ductus venosus, a direct connection through the liver to the right hepatocardiac channel,is formed. This preventsdepletion of oxygenand nutrient-rich blood in the hepatic sinusoids.
Bridgeto Anatomy is Theligamentum venosum remnant ofthe thefibrous ductus venosus. lt runsina of fissure onthevisceral surface theliverandisattached onone endtotheleftbranch ofthe portalvein andontheother venacava. endtotheinferior Theligamentum teresisthe fibrous remnant ofthe in umbilical vein.lt islocated thefreemargin ofthe falciform ligament. 8
2. After birth, the ductus venosusbecomesobliteratedand is fibrosedto form the ligamentum venosum. The left umbilical vein forms a similar ligament, the ligamentum teres, in the free margin of the falciform ligament. C. Cardinal veins 1. The anterior cardinal veins drain the cephalicend of the embryo, and the posterior cardinal veins drain the caudalend of the embryo. Thesejoin to form the common cardinal veins,which enter the horns of the sinus venosus. 2. By the seventhweek, the subcardinalveins, which drain the kidneys, the sacrocardinal veins, which drain the lower extremities,and the supracardinalveins, which drain the body wall via intercostalveins,are formed. 3. The vena cava system is formed by anastomosesbetweenthe right and left sidesof the cardinal systemsuch that blood from the left is channeledto the right side. a. Anastomosisbetweenthe anterior cardinal veins forms the left brachiocephalicvein during the eighth week. b. The superior vena cava is formed from the proximal right anterior cardinal vein and the right common cardinal vein.
Embryology
c. Anastomosisbetweenthe sacrocardinalveins forms the left common iliac vein. The right sacrocardinalvein becomesthe sacrocardinalsegmentof the inferior vena cava. 4. The fourth to eleventh right intercostal veins empty into the right supracardinal vein, which joins the posterior cardinal vein to form the azygosvein. The fourth to seventhleft intercostal veins enter the left supracardinal vein (hemiazygosvein), which empties into the azygosvein.
LYMPHATICS Development of this systemparallelsthat of the veins.It beginswith six primary lymph sacs, which later form a network of lymphatic vessels.Aggregatesof lymphatic tissue, or lymph nodes,form in this network shortly before or after birth.
CIRCUTATION OFBLOOD A. Fetal pattern (Figure I-I-2) 1. In the fetus, blood is oxygenatedat the placenta and travels via the umbilical vein, most of it bypassingthe liver through the ductus venosus, to the inferior vena cava. a. There,it mixes with deoxygenatedblood from the lower body and hepaticportal system and, subsequently,entersthe right atrium. b. The valve at the orifice of the inferior vena cava directs most of the flow out of the right atrium, through the foramen ovale,into the left atrium. c. From the left atrium, the oxygenatedblood, plus some deoxygenatedblood from the lungs, passesinto the left ventricle and, hence,into the ascendingaorta toward the brain, heart, and upper extremities. 2. Deoxygenatedblood from the head and upper extremitiesreturns to the right atrium via the superior vena cava,and passesthrough the tricuspid valveto the right ventricle.From there, most of it is short-circuited awayfrom the inactive lungs by the ductus arteriosus into the descendingaorta to supply the trunk and lower extremities. 3. Since the right ventricle must pump blood againstthe relatively high resistanceof the unexpandedlungs and through the ductus to the generalcirculation, pressureon the right side of the heart is greater than on the left. Thus, prior to birth, the thickness of the right ventricle wall is similar to that of the left. 4. Blood in the aorta travels to the placentavia the umbilical arteries,which now arise from the internal iliac arteries. B. Changesat birth. Cessationof placental blood flow at birth and an increasein flow through the lungs causethe pressurein the right atrium to decrease,while that in the left rises.As a result, the septum primum is apposedto the septum secundum,and the foramen ovale is closed functionally. Fusion occurs in about one year.
System Grdiovascular
Ductus arteriosus
Superior vena cava Foramen ovale In fe ri o r vena cava Portalvein
U mbi l i cal vei n
TO, U mb i l i c a l cord
Shunts in bold
Rightand left umbilicalarteries
JO,
Figure l-1-2.Fetal circulation.
ITAIMATFORMATIONS CONGEN A. Tetralogy of Fallot is a common abnormaliry which consistsof pulmonary stenosis,right ventricular hypertrophy (secondaryto pulmonary stenosis),interventricular septal defect, and an overridingaorta.
ln a Nutshell Tetralogy of Fallot . Pulmonary stenosis . Right ventricular (RVH) hypertrophy . Interventricular septal defect . Overriding aorta
1. It is a result of asymmetricaldevelopmentof the truncus arteriosusseptumto form a very small pulmonary artery and a very large aorta. Unoxygenatedblood is shuntedto the left side and blood flows from both right and left ventricles into the enlarged aorta with little reachingthe lungs. 2. This abnormaliry,compatiblewith life, is the most important causeof neonatalryanosis. B. Transposition of the great vesselsis an anomaly in which the aorta emergesfrom the right ventricle and the pulmonary artery from the left ventricle. It is thought to be due to failure of the bulbar septum to spiral. C. Patent ductus arteriosus is a failure of anatomic obliteration that allows orygenated blood from the aorta to be shuntedback into the pulmonary artery. D. Atrial septal defects (ASD) are the failure of the septaprimum and secundum to form. The most common form is a patent foramen ovale,resulting from incompleteadhesionbetween the septum primum and septum secundum.
t0
Embryology
E. Ventricular septal defects (VSD) are usually due to malformation of the membranous interventricular septum. F. Persistent truncus arteriosus is a failure of the partitioning of the truncus arteriosus into the aorta and pulmonary artery. G. Pulmonar'' valvular atresia is an unequal division of the truncus arteriosus such that the pulmonary trunk has no lumen or orifice at the level of the pulmonary valve.
Bddget9 Patrology These congenital abnormalities andmore arediscussed in detailin theCardiovascular Pathology chapter.
H. Aortic coarctation is a narrowing of the aorta just above or below the ductus arteriosus.
tl
Histology Cardiovascular Thecardiovascular isa closed, fortheseparate system doublepathway circulation of bloodto the lungsandtheperipheral tissue. lt consists of a four-chambered heartanda system of vessels for (arteries (veins) delivery andcapillaries) andsubsequent return ofthebloodto theheart. This chapter willreview thedifferent tissue typesfoundin eachof thesecomponents, andhowthese tissues fortheirspecific arespecialized functions.
MUSCTE CARDIAC CEttS A. Cardiac muscle cells are elongated,branching fibers that exhibit transversebanding patterns like that of skeletalmuscle. 1. They possessone or two centrally placednuclei. 2. Individual cells are surrounded by a delicate connectivetissue containing an abundant capillary network. 3. Cardiac myofibers are joined together by extensive junctional structures called intercalated disks. 4. Unlike skeletalmuscle, cardiac muscle cells are electrically coupled to each other through gap junctions located in the disks. B. Cardiac muscle sarcomeres are similar to those found in skeletalmuscle. Their filaments, however,are not segregatedinto discretemyofibrils but are found in continuous fields that are partially divided by portions of sarcoplasm.Actin filaments attach to the intercalateddisks at the ends of the cells. C. Control of cardiac muscle. Cardiac muscle does not require neural input for activation, but its activity is modulated by the sympathetic and parasympatheticdivisions of the autonomic nervous system(ANS). 1. Specializedmuscle cells in the right atrium, the sinoatrial (SA) node, spontaneously depolarize rhythmically to initiate each heart beat. 2. Electricalcoupling via gapjunctions at the intercalateddiskscausesdepolarization,which is initiated at the SA node and spreadsthrough the atria. a. The impulse reachesthe atrioventricular (AV) node and is delayedthere for approximately 0.1 seconds. b. From the AV node, specializedconduction fibers in the bundle of His and its branches transmit the impulse to the ventricular muscle.
t5
System Cardiovascular
3. The large-diameterconducting fibers are modified muscle cells called Purkinje fibers, which have few myofibrils and abundant sarcoplasm containing mitochondria and glycogen.
HEART The heart is a muscular organ, composedprimarily of cardiacmuscle tissue,which contracts rhythmically to pump blood throughout the body. A. Structure of the heart wall. The walls of the heart are constructed in layersthat are similar to those of the major blood vessels.
In a Nubhell + outside lnside Endocardium + myocardium -+ epicardium
1. Endocardium is the innermost layer of the heart and is lined with endothelium. Veins, nerves,and components of the impulse conducting systemare presentin the subendocardial connective tissue layer. 2. Myocardium is composedof branching, anastomoticcardiac myocytesattachedto one another by intercalated disks. Most of these cells are involved in the pumping function of the heart; others are specializedfor the control of rhythmicity (impulse conducting system) or secretion(myocardialendocrine cells). 3. Epicardium is a serousmembrane that forms the viscerallining of the pericardium. Its externaimesothelium is supported by a loose connectivetissuesubepicardiallayer. B. Cardiac skeleton is composedmainly of denseconnectivetissueand consistsof the annuli fibrosi, the trigonum fibrosum, and the septum membranaceum. C. Cardiac valvesare composedof densefibrous tissuecoveredby endothelium.
ln a Nutshell Venacavae + RA+ tricuspid valve+ RV+ pulmonic valve + pulmonary artery+lungs+pulmonary vein+ LA+ mitralvalve-> LV+ aorticvalve+ aorta
1. Unidirectional flow is maintained from the: a. Right atrium to the right ventricle (tricuspid valve) b. Right ventricle to the pulmonary artery (pulmonic semilunar valve) c. Left atrium to the left ventricle (mitral/bicuspid valve) d. Left ventricle to the aorta (aortic semilunar valve) 2. Tricuspid and mitral valves are attached to papillary muscles by cords of fibrous connectivetissue(chordaetendineae)and prevent reflux of blood into the atria during ventricular contraction (systole). 3. Semilunar valves (aortic and pulmonic) prevent reflux of blood back into the ventricles during ventricular relaxation (diastole). D. Impulse conducting system of the heart consists of specialized cardiac myorytes that are characterizedbyautomaticity and rhythmicity (i.e.,they are independentof nervous stimulation and possessthe ability to initiate heart beats).Thesespecializedcellsare located in the sinoatrial (SA) node (pacemaker),internodal tracts,atrioventricular (AV) node,AV bundle (of His), left and right bundle branches,and numerous smaller branchesto the left and right ventricular walls (Figure I-2-l).Impulse conducting myocytesare in electricalcontact with eachother and with normal contractile myocftes via communicating (gup) junctions. Specializedwide-diameter impulse conducting cells (Purkinje myocytes), with greatly reduced myofilament components,are well adaptedto increaseconduction velocity. They rapidly deliver the wave of depolarization to ventricular myocytes.
t4
Histology
In a Nubhell Conduction Pathway SAnode (located nearSVCin RA)
Atrioventricularnode (AV node)
I V
Left atrium
\ Sinoatrial node
AVnode I
I
(SA node)
Bundle of His ,/\
His bundle
Leftventricle
Rightatrium *';:,+
Bundle branches
Rightventricle
r\
Rbundle branch
rl vv Purkinje system
Lbundle branch Purkinje sy$em
lnferior vena cava Purkinje fibers
Figure l-2-l.lmpulse-conducting system of the heart.
E. Myocardial endocrine cells are also specializedmyocytes found mainly in the atria. These cellscontain numerous secretorygranules,which contain atrial natriureticpeptides (ANP). When releasedinto the blood, thesehormones play rolesin the regulation of blood pressure and blood volume.
ARTERIES
Note There arethreetypesof heart cells: . Contractile . lmpulse conducting (Purkinje) . Endocrine (ANP)
Arteries are classifiedaccording to their size,the appearanceof their tunica media, or their major function. A. Large elastic conducting arteries include the aorta and its large branches.Unstained, they appearyellow due to their high content of elastin. 1. The tunica intirna is composed of endothelium and a thin subjacent connective tissue layer.An internal elastic membrane marks the boundary between the intima and media. 2. The tunica media is extremely thick in large arteries and consistsof circularly organized, fenestratedsheetsof elastictissuewith interspersedsmooth muscle cells.Thesecells are responsiblefor producing elastin and other extracellularmatrix components.The outermost elastin sheet is considered as the external elastic membrane, which marks the boundary between the media and the tunica adventitia. 3. The tunica adventitia is a longitudinally oriented collection of collagenousbundles and delicate elasticfibers with associatedfibroblasts. Large blood vesselshavetheir own blood
In a Nubhell -+ outside lnside Intima+ media-+ adventitia
Note Vasa vasorum isLatinfor "vessels of thevessel."
t5
Cardiovascular System
supply (vasavasorum), which consistsof small vesselsthat branch profusely in the walls of larger arteries and veins. B. Muscular distributing arteries are medium-sized vesselsthat are characterizedby their predominance of circularly arranged smooth muscle cells in the media interspersedwith a few elastin components.Up to 40 layersof smooth muscle may occur. Both internal and external elastic limiting membranes are clearly demonstrated.The intima is thinner than that of the large arteries. C. Arterioles are the smallestcomponents of the arterial tree. Generally,any artery lessthan 0.5 mm in diameter is consideredto be a small artery or arteriole.A subendotheliallayer and the internal elasticmembrane may be present in the largestof thesevesselsbut are absentin the smaller ones.The media is composedof severalsmooth muscle cell layers,and the adventitia is poorly developed.An external elasticmembrane is absent.
CAPITTARIES Capillaries are thin-walled, narrow-diameter, low-pressure vesselsthat generally permit easy diffi.rsion acrosstheir walls. Most capillaries have a cross-sectionaldiameter of 7-12 pm. They are composed of a simple layer of endothelium, which is the lining of the entire vascular system,and an underlying basallamina. They are attachedto the surrounding tissuesby a delicate reticulum of collagen.Associatedwith thesevesselsat various points along their length are specializedcells called pericytes. These cells, enclosedwithin their own basal lamina, which is continuous with that of the endothelium,contain contractileproteins and thus maybe involved in the control of capillary dynamics. They may also serve as stem cells at times of vascular repair. Capillaries are generally divided into three types, according to the structure of their endothelial cell walls. A. Continuous (muscular, somatic) capillaries are formed by a single uninterrupted layer of endothelialcellsrolled up into the shapeof a tube and can be found in locationssuch asconnectivetissue,muscle,and nerve. B. Fenestrated (visceral) capillaries are characterizedby the presenceof pores in the endothelial cell wall. The pores are coveredby a thin diaphragm (exceptin the glomeruli of the kidney) and are usually encounteredin tissueswhere rapid substanceinterchangeoccurs (e.g.,kidney, intestine,endocrine glands).
Note . Morethan700/o of total bloodvolume isfoundin thevenous system atany onetime. . Return bloodflowto the heartisaidedbytheaction and ofsmooth muscle special unidirectional valves inthewallsofveins themselves, aswellasbythe action ofadjacent skeletal muscles.
t6
C. Sinusoidal capillaries can be found in the liver, hematopoietic and lymphopoietic organs, and in certain endocrine glands.Thesetubes with discontinuous endothelial walls have a larger diameter than other capillaries(up to 40 pm), exhibit irregular cross-sectionalprofiles, have more tortuous paths, and often lack a continuous basallamina. Cells with phagocytic activity (macrophages)are presentwithin, or just subjacentto, the endothelium.
VEINS Veins are low-pressurevesselsthat have larger lumina and thinner walls than arteries.In general, veins have more collagenousconnective tissue and less muscle and elastic tissue than their arterial counterparts.Although the walls of veins usually exhibit the three layersdescribedabove, they are much less distinct than those of the arteries. Unlike arteries, veins contain one-lrray valves composedof extensionsof the intima that prevent reflux of blood a\ ray from the heart. Veins can be divided into small veins or venules,medium veins, and large veins. A. Venules are the smallest veins, ranging in diameter from approximately 15-20 pm (postcapillary venules) up to 7-2 mm (small veins). The walls of the smaller of these are structurally and functionally like those of the capillaries; they consist of an endothelium
Histology
surrounded by delicate collagen fibers and some pericytes. In those vesselsof increased diameter, circularly arranged smooth muscle cells occur surrounding the intima layer, but unlike in the small arteries, these cells are loosely woven and widely spaced.Venules are important in inflammation becausetheir endothelialcellsare sensitiveto histamine released by local mast cells.This causesendothelial cells to contract and separatefrom each other, exposing a naked basement membrane. Neutrophils stick to the exposed collagen and extravasate(i.e.,move out into the connectivetissue).Histamine also causeslocal arterioles to relax, affectinga rise in venouspressureand increasedleaking of fluid. This producesthe classicsignsof inflammation: redness,heat, and swelling. B. Medium veins in the range of t-9 mm in diameter have a well-developed intima, a media consisting of connective tissue and loosely organized smooth muscle, and an adventitia (usually the thickestlayer) composedof collagenbundles,elasticfibers,and smooth muscle cells oriented along the longitudinal axis of the vessel.Venous valvesare sheet-like outfoldings of endothelium and underlying connectivetissue that form flaps to permit unidirectional flow of blood.
Note Themajorityof veins(withthe exception ofthemaintrunks) aresmall ormedium-sized.
Note . Artery-media is thickest layer . Vein-adventitia is thickest layer
C. Large veins, such as the external iliac, hepatic portal, and vena cavae,are the major conduits of return toward the heart. The intima is similar to that of medium veins.Although a network of elasticfibers may occur at the boundary betweenthe intima and media, a typical internal elasticmembrane as seenin arteriesis not present.A tunica media may or may not be present.If present,smooth muscle cellsare most often circularly arranged.The adventitia is the thickestlayer of the wall and consistsof elasticfibers and longitudinal bundles of collagen.In the vena cava,this layer also containswell-developedbundles of longitudinally oriented smooth muscle.
TYMPHATIC VESSETS Lymphatic vesselsare discussedin the Histology chapter of the Heme/Lymph Systemsection in this book.
t7
Anatomy Cardiovascular portion cavity known asthemediastinum. This inthemiddle ofthethoracic Theheartislocated anatomy thestructures located in themediastinum aswellasthegross of the chapter willreview andazygos vein. andthebranches inferior venacava, heartitself oftheabdominal aorta,
MEDIASTINUM Located between the pleural cavities,the mediastinum is divided into inferior and superior parts by a plane passingfrom the sternalangle anteriorly,to the intervertebraldisc betweenT4 and T5 posteriorly. The inferior mediastinum is classicallysubdivided into middle, anterior, and posterior parts (FiguresI-3-1 andl-3-2). A. Middle mediastinum. This sectioncontainsthe pericardium, phrenic nerves,and heart. 1. Pericardium is the outer fibrous sac; it is lined by a double-layeredserousmembrane that enclosesthe pericardial cavity betweenits parietal and viscerallayers. a. Transversepericardial sinus is a spaceposterior to the ascendingaorta and pulmonary trunk and anterior to the superior vena cava. b. Oblique pericardial sinus is a blind, inverted,U-shapedspaceposterior to the heart and bounded by reflection of serouspericardium around the eight vesselsentering and leaving the heart. 2. Phrenicnerves a. Phrenic neryesarisefrom the ventral primary rami of cervicalnerves3, 4, and 5. b. They are the sole motor supply of the diaphragm and convey sensoryinformation from the central portion of both the superior and inferior portions of the diaphragm. c. Both phrenic nerves passthrough the middle mediastinum lateral to fibrous pericardium and anterior to the root of the lung. 3. The heart (discussedseparatelybelow)
ClinicalCorrelate
isa lifeCardiac tamponade resulting threaten ingcondition in compression oftheheart of dueto anaccumulation fluidinthepericardial excess cavity. Thefluidmustbe bypericardiocentesis removed to relieve thepressure. is Pericardiocentesis performed byinserting a needle theskinand through tissues along subcutaneous theunderside ofthexiphoid process, inward and directed toward thepericardial upward, the sac(alternatively, pericardial saccanbe approached fromthe angles, xiphocostal orthrough space). thefifthleftintercostal Withdrawal of evena small offluidcanrestore amount in many function cardiac cases. Caremustbetakento access thepericardium to the"barearea" through avoid violation ofthe pleura. costal
t9
System Cardiovascular
Anterior
Figure l-3-1. Divisions of the mediastinum.
Mnemonic
B. Anteriormediastinum. This section contains fat and areolartissue.
C3,C4,andC5keepthe alive! diaphragm
C. Posterior mediastinum. This section contains many of the samestructuresas the superior mediastinum. 1. Thoracic (desceneg) aorta
Mnemonic Thefourbirdsin thethoracic caSe: . Va-goose . Azy-goose . Esopha-goose . Thoracic duck
20
a. The most important branchesof the thoracic aorta are the bronchial, esophageal, and posterior intercostalarteries. b. It terminatesat vertebrallevel T12, where it passesthrough the aortic orifice between the two crura of the diaphragm. 2. Esophagus a. The esophagusis related anteriorly to the anterior esophagealplexus,which is derived mainly from the left vagus.
Anatomy
\
a tr
\, !
I
Aortic valve
Pulmonary valve
J
;
t I
t,
Tricuspid Mitral valve valve
Figure l-3-2.Surface landmarks and auscultation points.
b. The esophagusis related posteriorly to the posterior esophagealplexus, which is derived mainly from the right vagus. c. The esophagusterminates at vertebral level T10 by passingthrough the esophageal hiatus in the right crus of the diaphragm. 3 . Thoracic duct a. The thoracic duct lies betweenthe esophagusand the thoracic aorta. b. It arisqsfrom the cisterna chyli in the abdomen at vertebral level L1-L2 and entersthe thorax through the aortic orifice of the diaphragm.
Mnemonic "LARP" Esophagus: (leftanterior, rightposterior)
4. Azygous systemof veins (Figure I-3-3) a. The posterior thoracic and abdominal walls are drained by the arygossystemof veins. b. The azygous vefn may arise from the posterior aspectof the inferior vena cavain the abdomen; the hemiarygos vein often arisesfrom the left renal vein. Theseveins often ascend to the thorax throug\ the aortic orifice of the diaphragm. Alternativgly, the arygosand hemiarygos veins may arise from the ascendinglumbar veins and ascend behind the diaphragm. c. The azygosveintermillqtes by arching over the root of the right lung to empty into the superior vena cava. d. It receivesblood djlgctly from the right posterior intgrcostal veins and indiregtly via the left-sided tributaries of the hemiarygos and accessoryhemiarygosveins and the left posterior intercostalveins.
2l
Cardiovascutar System
Ir , , .
Superior venacava
Leftsuperior intercostaf vein
Accessory hemiazygos vein Hemiazygos vein
Inferior vena cava Ascending lumbarvein
Figure l-g_9.The azygos
system of veins.
5. Sympathetic trunks a' The sympathetic trunks are located paravertebra[y, just outside the posterior stinum.
media-
"fJ::i',:Tril:i.f::"'fji:':ffi
::.#:#.h:*':,pregangrionicsympathetic mediallv *" posterior runningbr.n.i., of thesympatherijl;,i,lrll meairrti'um ", D superior,il"$::SffiJH:,,'"T*:n contains manvstru*ures, someof whicharearso l. Thymus (or remains) 2. Superiorvenacaya
" ffi:'ffi',T#l:dffi:1,?ffiX*lffitheright sternocostar junction bythe union 22
Anatomy I
la'
I t
Left vagus nerve (X) Right vagus nerve (X) Rightsubclavian artery and vein
l;
Right brachiocephalic vein Brachiocephalic artery
Rightphrenic nerve
'' t,.'...' ," "',--.
Left vein brachiocephalic Left phrenicnerve
Superior venacava
Figure l-3-4. Structures of the superior mediastinum.
Bridgeto Embryology b. It returns blood from the head, neck, and upper extremities to the right atrium of the heart. 3. Arch of aorta a. The aortic arch begins and ends at the level of the sternal angle. b. There are three branches:the brachiocephalic trunk, the left common carotid artery, and the left subclavian artery. +. Right and left vagus nerves contribute to the pulmonary and cardiac plexuses. a.@rvegivesrisetotherightrecurrentlaryngealnerve(intherootof the neck), which passesunder the righf subClavianartery to ascend in the groove between the esophagusand the trachea to reach the larynx. b. The left vagus nerve gives rise to the left recurrent laryngeal nerve, which passes under the aortic arch and ligamentum arteriosum to ascendto the larynx (ligamentum arteriosum).
lqryUqql nerve -gb!tqgUtrent "recurs" around thederivative ofthefou4lfaodicareh (proximal portion ofsubclavian grtery); re_current'tecurs" left around thederivative ofthe sixt!-ggrtrc arch(igamentum arteriosr,rm), ClinicalCorrelate Hoarseness asa result of compromise oftheleft nerve recurrent laryngeal may pressure indicate froman aortic aneurysm.
2t
Grdiovascular System
ClinicalCorrelate Therightprimarybronchus is straighter andwiderthanthe left;aspirated objecbtherefore lodgemorefrequently inthe rightbronchus thanin theleft.
Superior Mediastinum (remains) Thymus SVC Aortic arch Vagus nerves Trachea Bophagus
Thoracic duct InferiorMediastinum
rv\ Anterior Fatand areolar tissue
|
a. The tracheaext€ndsftom the levelofthe cricoid cartilage(vertebrallevelC6) to bifurcation (behindthe sternalangle)to form the primary bronchi. b. At the bifurcation is a ridge calledthe carina whosernucosais very sensitiveto external stimuli.
6. Esophagus a. The esophagusextendsfrom the level of the cricoid cartilage(vertebrallevel C6) and passesthrough the esophagealhiatus of the diaphragm (Tt0).
In a Nutshell
/
5. Trachea
\
Middle Posterigt Pericardium Descending Heart aorta Phrenic Esophagus nerves Thoracic duct Azygos system Thoracic splanchnic
u"ffil:'*" and Denvatives: anterior and posterior esophagal plexuses, left recunent laryngeal nerve
b. It lies to the right of the thoracic duct in the superior mediastinum. 7. Thoracic duct a. The thoracic duct is the largest lymphatic channel in the body. b. It returns lymph to the venous circulation at the junction of the left internal jugular vein and the left subclavianvein (beginning of left brachiocephalictrunk).
THEHEART A. Borders of the heart 1. The right border is formed by the right atrium. 2. The inferior border is formed by the right ventricle and the apex of the left ventricle. 3. The left border is formed by the left ventricle and the auricle of the left atrium. 4. The superior border is formed by the right and left auriclesplus the conus arteriosusof the right ventricle. 5. The apexis the tip of the left ventricle. 6. The baseis oppositethe apex,formed mainly by the surfacewhere pulmonary veins enter the heart (left atrium) and by part of the right atrium. B. Surface projections of the heart may be traced on the anterior chestwall. 1. The right border extends from the margin of the third right costal cartilage to the sixth right costalcartilagejust to the right of the sternum. 2. The inferior border extendsfrom the sixth right costalcartilage to the fifth left intercostal spaceat the midclavicular line. 3. The left border extendsfrom the fifth left intercostalspaceto the secondleft costalcartilage. 4. The superior border extendsfrom the inferior margin of the secondleft costalcartilage to the superior margin of the third right costalcartilage.
24
Anatomy
ClinicalConelate Ligamentum arteriosum
Valve
Leftpulmonaryartery
Right pulmonary
Pulmonary trunk
artery
Left atrium
Right pulmonary
Pulmonary L 2nd intercostal space Aortic
R2nd interco$al space
Mitral
L 5th intercostal space
Tricuspid
Xiphisternal function
Left pulmonary veins
verns
Left ventricle Right
atrium
Areaof Auscultation
Right ventricle Figure l-3-5. Sternocostal view of the heart.
C. Chambers of the heart 1. Right atrium receivesvenous blood from the entire body with the exception of blood from the pulmonary veins. a. Auricle is derived from the fetal atrium; it has rough myocardium known as musculi pectinati. b. Sinus venarum is the smooth-walled portion of the atrium, which receivesblood from the superior and inferior venaecavae. c. Crista terminalis is the vertical ridge that separatesthe smooth from the rough portion of the right atrium; it extends longitudinally from the superior vena cava to the inferior vena cava. d. In the fetus, the fossa ovalis was the foramen ovale, an opening in the interatrial septum to allow blood entering the right atrium from the inferior vena cava to passdirectly to the left side of the heart. e. Right atrioventricular (AV), or tricuspid, valve communicates with the right ventricle. 2. Right ventricle receivesblood from the right atrium via the tricuspid valve; outflow is to the pulmonary trunk via the pulmonary semilunar valve. a. Trabeculae carneae are ridges of myocardium in the ventricular wall.
ClinicalCorelate Themostexposed chamber fromananteriorprojection is right the ventricle. Thisisthe mostfrequently chamber damaged infrontal trauma, i.e.,stabwound.
Flashback to Embryology venarum Thesinus is derived fromthefetalsinus venosus, which isdiscussed intheCardiovascular Embryology chapter.
b. Papillary muscles project into the cavity of the ventricle and attach to cuspsof the AV valve by strands of chordae tendineae.
25
Cardiovascular System
c. Chordae tendineae pull cuspsof the valve together during contraction of the ventricle.
ClinicalCorrelate Mitralvalveinsufficiency leads to a backup of bloodin the leftatrium; theresultant enlargement ofthischamber mayexertpressure onthe esophagus. Symptoms of dysphagia, therefore, may indicate a problem withthe functioning ofthemitral valve.
Ftashback to Embryology
d. Infundibulum valve.
is the smooth area of the right ventricle leading to the pulmonary
3. Left atrium receivesoxygenatedblood from the lungs via the pulmonary veins. a. There are four openings for the upper right and left and the lower right and left pulmonary veins. b. The left AV orifice is guarded by the mitral (bicuspid) valve; it allows oxygenated blood to passfrom the left atrium to the left ventricle. 4. Leftventricle. Blood enters from the left atrium through the mitral valve and is pumped out to the aorta through the aortic semilunar valve. a. Tiabeculae carneae. The myocardium is normally three times thicker than that of the right ventricle. b. Papillary muscles, usually two large ones, are each attached by chordae tendineae to both cuspsof the bicuspid valve.
Theaortic ve$ibule and c. Aortic vestibule leadsto the aortic semilunar valve and ascendingaorta; right and left infundibulum oftheright coronary arteries originate from the right and left aortic sinusesat the root of the ventricle arederived fromthe ascendingaorta. fetalbulbus cordis, asdiscussed D. Arterial supply of the heart intheCardiovascular Embryology chapter. 1. Right coronary artery
Bridgeto Physiology Thecoronary arteries fillduring diastole.
a. The right coronary artery arisesfrom the ascendingaorta and runs in the coronary (AV) sulcus. b. The right coronary artery suppliesthe right atrium, the right ventricle, the sinoatrial (SA) and AV nodes,and parts of the left atrium and left ventricle. c. Important branches are the SA nodal artery, the a-v nodal arte\, the right marginal artery and the posterior interventricular artery. 2. Left coronary arter'' a. The left coronary artery arisesfrom the ascendingaorta. It divides into two branches, the anterior interventricular (left anterior descending) artery and the circumflex artery. b. The left coronary artery supplies most of the left ventricle, the left atrium, and the interventricular septum. E. Venous drainage of the heart l. Coronary sinus is the main vein of the coronary circulation; it travels in the posterior coronary sulcus.It drains to an opening in the right atrium. 2. Greatcardiac vein travels in the anterior interventricular sulcus. It is the main tributarv of the coronary sinus. 3. Middle cardiac vein travels in the posterior interventricular sulcus.It joins the coronary sinus. 4. Venae cordis minimae (thebesian veins) and anterior cardiac veins open directly to the chambers of the heart.
26
Anatomy
F. Conducting system of the heart (seeFigure I-2- 1) 1. SA node a. The SA node initiates the impulse for contraction of heart muscle (and is therefore termed the "pacemaker"of the heart). It is located at the superior end of the crista terminalis, where the superior vena cavaenters the right atrium. b. The SA node is supplied by the SA nodal branch of the right coronary artery.
Bridgeto Physiology
c. Impulse production is speededup by sympatheticnervousstimulation; it is slowedby parasympathetic(vagal) stimulation.
Astheimpulse travels through theAVnode,it slovrs. This corresponds to thePRinterval onanelectrocardiogram.
2. Nl node receivesimpulses from the SA node. The AV node is located in the interatrial septum near the opening of the coronary sinus. 3. Bundle of His originatesin the AV node. It distributesto the right and left ventricles. a. In the right ventricle, the moderator band (septomarginaltrabecula) contains the right bundle branch. b. Impulses passfrom the right and left bundle branchesto the papillary musclesand ventricular myocardium. G. Innervation. The cardiac plexus is a combination of sympathetic and parasympathetic (vagal) fibers. Sympathetic stimulation increasesthe heart rate; parasympatheticstimulation slowsthe heart rate.
BRANCHES OFTHEABDOMINAI AORTA AND INFERIOR VENA CAVA A. The abdominal aorta first passesthrough the aortic orifice of the diaphragm at vertebral level T12 (Figure I-3-6). It ends atL4, where it forms the paired common iliac arteriesand single small median sacralartery. The branchesof the abdominal aorta include the following: 1. Three visceral unpaired branches a. Celiactrunk b. Superior mesentericartery c. Inferior mesentericartery 2. Three visceral paired branches a. Renalarteries b. Suprarenalarteries c. Gonadal arteries 3. Five paired parietal branches a. Inferior phrenic arteries b. Four pairs of lumbar arteries c. A fifth pair of lumbar arteriesarisefrom the median sacralartery. B. The inferior vena cava begins at vertebral level L5 from the joining of the two common iliac veins. It terminates in the right atrium after passing through the caval orifice of the diaphragm at vertebrallevel T8. 1. The azygosvein interconnectsthe superior and inferior venaecavae.It drains the posterior intercostalveins of the thoracic wall and the posterior abdominal wall.
27
Grdiovascutar System
2' The renal veins lie superficial to the corresponding arteries. The left renal is longer becauseit must cross the aorta and vertebral column to reach the inferior vena cava. 3' Right gonadal vein is a direct tributary of the inferior vena cava.(The left gonadal drains to the left renal vein.) 4' Right suprarenal vein is a direct tributary of the inferior vena cava.(The left suprarenal drains to the left renal vein.) 5. The lumbar veins drain the posterior abdominal wall. 6. The inferior phrenic veins drain the diaphragm. 7' The hepatic veins open into the inferior vena cava just before it passesthrough the diaphragm. They return blood from the liver to the systemiccirculation.
fnferiorphrenic--'
Superiormesenteric
Gonadal Lumbars
Mediansacral
Commoniliac
Internaliliac Externaliliac
Figure l-3-0. Branching of the abdominal aorta. C' Azygosvein arisesin the abdomen, usually from the inferior vena cavaor ascendinglumbar vein' It ascendsto the posterior mediastinum and terminates in the superior vena cavajust before the superior vena cavaenters the pericardium. 1' The hemiazygos vein drains the lower left inferior posterior intercostal veins (T9-T12). It joins the azygosvein.
28
Anatomy
2. The accessoryhemiazygos vein receivesblood from the left posterior intercostal veins from T5 to T8. It joins the azygosvein.
Left suprarenalvein
suprarenal vein Right renal vein Right gonadalvein
Left renal vein Left gonadalvein
Figurel-3-7.Inferiorvenacava(lVC)and tributaries.
29
Physiology Cardiovascular q6tem,consi$ing Thecardiovascular functions oftheheartandvessels, inthedistribution of essential fromthetissues. sub$ances tothetissues andtheremoval byproducts ln addition, of metabolic the provides for homeo$atic including bod support mechanisms, temperature regulation, humoral l6tem communication, andadju$ment oftheoxygen andnutrient supply. Thischapter willreview thebasic processes functions and associated withthedifferent components ofthecardiovascular system.
MYOCARDIAT ETECTROPHYSIOTOGY A. Anatomyof the conduction system (Figure I-4-l)
Superior i venacava\-\- i -\ Sinoatrialnode (SA node)
Atrioventricularnode (AV node)
Pulmonary veins His bundle Left ventricle
Rightatrium
Bundle branches
Rightventricle Inferior _/-' vena cava' : Purkinje fibers
Figure l4-1.The cardiac conduction system.
5l
Cardiovascular System
1. The electrical impulse that depolarizes the heart normally originates in the sinoatrial (SA) node, a spindle-shapedstructure 10-20 mm long and,2-3 mm wide, located at the junction of the superior vena cavaand right atrium, 1 mm below the epicardial surface. a. The SA node is richly innervated with postganglionic sympathetic (adrenergic) and parasympathetic(cholinergic) nerve terminals. b. Sympathetic stimulation produces acceleration of the SA node discharge rate, while parasympathetic stimulation slows it down. 2. The depolarizing impulse travels from the SA node concentrically through the atrial myocardium, eventually reaching the atrioventricular (AV) node, which lies just beneath the right atrial endocardium,anterior to the ostium of the coronary sinus. 3. In the AV node, the impulse is conducted very slowly, delaying the impulse and allowing atrial contraction to be completed before ventricular depolarization and ventricular contraction begin. a. The AV node has a rich supply of sympathetic and parasympathetic fibers. b. Parasympatheticstimulation slows AV conduction and prolongs AV nodal refractoriness,while sympathetic stimulation speedsAV conduction and shortensrefractoriness. 4. From the AV node, the depolarizing impulse enters the His bundle, where conduction becomesrapid again. 5. The His bundle penetratesthe interatrial septum, and after approximately I cm it divides into a right bundle branch (RBB) and a left bundle branch (tBB), which also conduct rapidly. a. The RBB is a relatively thin bundle that travels along the endocardial surface of the right side of the interventricular septum. b. The LBB is a thicker bundle that travelsalong the endocardialsurfaceof the left side of the interventricular septum. After approximately I to 2 cm, the LBB divides into a thin left anterior division and a broad left posterior division. 6. The RBB and the divisions of the LBB arborize into a fine network of Purkinje fibers, which also conduct rapidly. The Purkinje fibers penetrate the ventricular myocardium and function to depolarize the ventricular muscle cells. 7- The term His-Purkinje system or ventricular conduction system is used to describethe His bundle, bundle branches,and Purkinje fibers together. It consistsprimarily of rapidly conducting cells called Purkinje cells.
In a Nutshell NormalCardiac Conduction -+ -> SAnode atrialmuscle AVnode+ Hisbundle and bundle branches + Purkinje fibers + ventricular muscle
B. Electrophysiologic categories of cardiac cells 1. Cardiac cellscan be divided into two electrophysiologiccategories: a. Fast fibers: atrial and ventricular muscle cells,Purkinje cellsof the His-Purkinje system b. Slow fibers: SA node, AV node 2. Fast fiber versus slow fiber terminology is based primarily on the velocity at which the electricalimpulse is conducted. C. Basic cellular electrophysiology 1. The phospholipid bilayer of the myocardial cell membrane, particularly its hydrophobic core' servesasan insulator that allows the cell to maintain a potential differencebetweenits interior and its exterior. This potential differenceis generatedby:
t2
Physiology
a. Net movement of ions (i.e., electrical current) across the cell membrane through transmembrane protein "openings" in the phospholipid bilayer, called channels. Channelsare usually selectivefor a specific ion (Na*, K*, Ca2*,or Cl-) and are controlled by protein gates,whose conformation (open or closed) may depend on the potential difference acrossthe cell membrane. b. Exchange of ions along their concentration gradients via protein transmembrane transport systems c. Active transport of ions against their electrochemical energy gradients by special transmembranepumps, which may be electrogenic(i.e., effect net chargemovement acrossthe membrane) 2. Adjacent myocardial cells are connectedend-to-end by a thickened portion of the cell membrane, called the intercalated disk. The nexus, or gap junction, is a region in the intercalated disk that provides a low-resistanceelectrical connection and allows movement of ions betweenadjacentcells. D. Resting membrane potential (RMP). The RMP is -90 mV in fast fibers (atrial and ventricular musclecells,Purkinje cells)and {0 to-7O mV in slowfibers (SA node,AV node), with the inside of the cell being negativewith respectto the outside. 1. Two characteristicsof resting cardiaccellsare important for establishingthe RMP: a. Differences in composition between the extracellular fluid (ECF; often abbreviated as o = outside) and intracellular fluid (ICF; often abbreviatedas i = inside): most importantly [K*], >> [Kn]. and [Na+]">> [Na*J,. b. The selectivepermeability of the cell membrane: most importantly, the K+ permeability (P") >> Na* permeability (P*"). 2. Given thesetwo characteristics,the RMP originatesas follows: a. Due to the high P*, K+ movesfrom ICF to ECF along its concentrationgradient,leaving an excessof anions (many of which are too large to diffirse out of the cell along with K+) in the ICF and creating a negative transmembrane potential (TMP). This negativeTMP tends to slow the further efflux of K+. b. If the cell were permeable only to K+, an equilibriurn would be establishedin which the negative TMP created by K* efflux would exactly balance the tendency of K+ to leavethe cell along its concentration gradient. The negativeTMP at equilibrium would then equal the K+ equilibrium potential (V*), as calculated by the Nernst equation for K+: V r = 6 1 .5l o g ([K+ ]./[K + ],)mV c. However, due to the small P*u,Na+ moves from ECF to ICF along its concentration and electrical gradients,making the actud RMP lessnegativethan V* and allowing for a continued small K+ efflux. Thus, at the RMR there is a small outward K+ current balancedby a small inward Na+ current. d. Slow fibers have a somewhat greater PN"/PKratio than fast fibers and therefore a less negativeRMP. 3. The RMP can be changedby: a. Changes in the K+ concentration gradient. For example, a decrease in the K+ concentration gradient decreasesthe tendency of K+ to leavethe cell along its concentration gradient, resulting in a less negative RMP. (1) Hyperkalemia (increased[K"].) reducesthe magnitude of the gradient.
,,
System Cardiovascular
(2) Myocardial injury or ischemia can result in a local decreasein the magnitude of the gradient. b. Changes in the ionic permeabilities. For example, an increase in K" permeability increasesthe tendencyof K* to leavethe cell along its concentration gradient, resulting in a more negative RMP. Acerylcholine hyperpolarizes cardiac cells by this mechanism. E. Cardiac action potentials (APs). When a resting cardiac cell is depolarized to a certain critical potential, the threshold potential, an AP is initiated. The APs in fast fibers (fast responseAPs) differ from the APs in slow fibers (slow responseAPs) (Fig:ureI-4-2, Thble
r_4_1):
20 0 o -20 = o -40 = -60 -80 -100
20 0 a -20 = o -40 = -60 -80 -100 0,1 0.2 Seconds
0.3
0.1 0.2 Seconds
0.3
Figurel-4-2.Fastresponseand slow responsecardiacactionpotentials.
Thble I-4-f . Comparison of fast and slow response cardiac action potentials. Parameter
Fast ResponseAP
Slow ResponseAP
Resting membrane potential (RMP)
-90 mV
-60 to -70 mV
Threshold potential
-60 to -70mv
-30 to -40mV
Rapid inward Na+ current 100-130mV 200-1,000mV/sec
Slow inward Ca2+ current 35-75 mY 1-10 mV/sec
0.3-3.0 m/sec
0.01-0.10m/sec
Phase0 Primary current Amplitude Slope Conduction velocity
1. Fast responseAPs. The fast responseAP can be divided into four phases(Figure l-4-3, Table I-4-2), which are causedby passiveion fluxes along their establishedchemical and electrical gradients,primarily through ion-specific channels. The rapid, spike-like depolarization (phase0) is followed by a gradual repolarization (phasesf to 3) back to the RMP (which is commonly referredto asphase4).
,4
Physiology
?able l-4-2. The phasesof the fast response action potential. Phase
Description
0
Rapid depolarization,which determinesconduction velocity of action potential
1
Early repolarization
2
Plateau
3
Late repolarization
4
Resting potential
Nrc'hcLcx
{< c[tex '*[trl,r Ca
K "llt'.^
g E
Figure l-4-3. Conductances of Na+,Ca2*,and K+ during the phases of the fast response action potential.
a. Phase 0 is causedby an increasein Na* permeability, or conductance,resulting in a Na* influx that depolarizes the cell to = +20 mV. This increasein Na* permeability can be attributed to the activation of the voltage-gatedNa* channels, which are rapidly activated when the fast fiber is suddenly depolarized to its threshold potential. The Na* influx is termed the rapid inward Na* current. (1) The Na* channelscan be blocked pharmacologicallyby the classI antiarrhythmic drugs, such as procainamide, quinidine, and lidocaine. (2) The Na* channelsare inactivated if the RMP becomesless negative (e.g.,due to hyperkalemia, myocardial injury or ischemia) or if the fast fiber is gradually (rather than suddenly) depolarized to its threshold potential. b. Phase l, the initial repolarization phase,is especiallyprominent in Purkinje fibers. It is causedby the termination of the rapid inward Na* current, due to inactivation of the Na* channels (thus, the phase0 depolarization approaches,but never reaches,the Na+ equilibrium potential of +40 mV), a transient efflux of K+, and possibly a transient influx of Cl-.
Bridgeto Pharmacology These drugsarereviewed in detailin theCardiovascular Pharmacology chapter.
55
Cardiovascular System
Note Inatrial andventricular phase muscle, 2 Caz* isresponsible fortriggering therelease of largeramounts of Ca2*from reticulum thesarcoplasmic (Ca2*-induced Ca2*release).
c. Phase2,the plateau, is the longest phaseof the AP and is characterizedby an increase in Ca2*permeability, resulting in a Caz+influx. This influx of Ca2ndoes not causethe transmembrane potential to become more positive becausethe K* permeability, which decreasedduring phase0, is sufficiently large to allow K* efflux. This increasein Ca2* permeability can be attributed to the activation of the voltage-gated L-type 662* channels, which are slowly activated when the fast fiber is depolarized to a transmembrane potential of = -60 to -70 mV (i.e., the activation of the Ca2+channels actually begins during phase 0, but since the activation is slow, the Ca2+influx is delayed).The Ca2*influx during phase2 is termed the slow inward Ca2*current. (1) The Ca2* channels can be blocked pharmacologically by the Ca2* channel blockers, such asverapamil and diltiazem. (2) Caz*influx through the Ca2*channels is increasedby sympathetic stimulation (B, receptors)and inhibited by parasympatheticstimulation (M, receptors). (3) The phase2 Caz*influx is responsiblefor triggering the releaseof larger amounts of Ca2*from the SR (Cah-induced Cah release). d. Phase3, the final repolarization phase,is causedby the termination of the slow inward Ca2*current, due to the inactivation of the Ca2*channels,and an increasedK* efflux, due to the return of K* permeability to its high resting value. At the end of phase 3, the potential returns to the RMP (i.e., the hyperpolarization seen at the end of the nerve AP is not observed). The phase 3 slope is an important determinant of the action potential duration (APD), i.e., the width of the AP (phases0 through 3). (1) The typical APD in cardiaccellsis 200 to 300 msec,markedly longer than the I to 2 msecAPD observedin nerve and skeletalmuscle. (2) Purkinie fibers havethe longestAPDs, while atrial muscle fibers havethe shortestAPDs. (3) The APD varies with the heart rate: the faster the rate, the shorter the APD. (a) The APD varies with the temperature hypothermia increasesthe APD. 2. Slow responseAPs. The major differencesbetween fast responseAPs and slow response APs are summarized in Thble I-4-1. The most significant differencesinvolve phase 0: a. The phase0 slope and amplitude are reduced in slow fibers. b. Phase0 depolarization is accomplishedby the slow inward Ca2*current (rather than the rapid inward Na* current) in slow fibers. In fact, slow response APs can be observedin fast fibers if the rapid inward Na* current is blocked by inactivating the Na* channels. Such inactivation can be achievedpharmacologically(procainamide, quinidine,lidocaine) or by making the RMP lessnegative(hyperkalemia,myocardial injury or ischemia). The conduction velocity refers to the speed of impulse propagation and is determined by various characteristics of the cell and also by the phase 0 slope and amplitude. 1. A decreasein fiber diameter increasesthe resistanceto current flow and slows conduction. The siow conduction observedin the AV node can be attributed in part to the small diameter of AV nodal cells. 2. A decreasein contractile protein content reduces the resistanceto current flow and speeds conduction. The rapid conduction observed in the Purkinje cells of the HisPurkinje systemcan be attributed in part to a reduced contractile protein content. 3. A decreasein electrical resistance of junctions between adjacent cells speedsconduction. The rapid conduction observedin the Purkinje cells of the His-Purkinje systemcan be attributed in part to their long,low resistancenexus (gap) junctions.
56
Physiology
4. Conduction velocity is directly proportional to the phase 0 slope and amplitude. Thus, conduction velocity in fast fibers is markedly greater than that in slow fibers (Table I-a-l); in fact,the fast fiber-slow fiber terminology wasoriginally developedto emphasize this difference in conduction velocity. G. Excitability refersto the ability of cardiac cellsto respond normally to electrical stimulation. During the AP, cardiaccellsare refractory to excitation,i.e.,they cannot be excitedby electrical stimulation in the normal way. The effective refractory period (ERP) is the interval during which a propagatedAP cannot be elicited, no matter how strong the depolarizing stimulus.The relative refractoryperiod (RRP) is the interval during which a propagatedAP may be elicited,but only if the depolarizingstimulus is strongerthan is neededto initiate an AP when the excitability is normal (Figure I-4-4).
In a Nubhell Conduction Velocities > Purkinje fibers> ventricles AVnode
1. In fast fibers, the ERP starts at the beginning of phase0 and typically lastsuntil repolarization reachesa transmembranepotential of = -50 mV. The RRP startsat the end of the ERP and typically lastsuntil the end of phase3. As repolarizationproceedsduring phase 3, increasingnumbers of Na* channelshaverecoveredand are readyto be reactivatedby the next stimulus. Thus, the later the cell is stimulated in the RRP,the greaterthe phase0 slope and amplitude, and hence conduction velocity, of the resulting AP. Conduction velocity is constantand maximal once the cell is completelyrepolarized.
Fast response
40
Slow response 2
0 I
E*o =
-80 -'120 ttl
0 A
100 200 300 Time(msec)
0 B
100 200 Time (msec)
Figure l-4-4. Refractory periods in fast and slow fibers. (ERP = effectiverefractoryperiod;RRP = relativerefractoryperiod.)
2. ln slowfibers, the ERPis much longer than in fast fibers and typically extendsbeyond phase 3, i.e.,evenwhen the slow fiber is completelyrepolarized,it may not be ableto respondnormally to electrical stimulation. Thus, the RRP extendsinto phase4. Theselong refractory periods account for the increasedlikelihood of conduction blocks in slow fibers (e.g.,the AV node). H. Automaticity refers to the ability of some cardiac cells to automatically depolarize toward thresholdduring phase4. Suchcellsdo not exhibit a constantRMR but insteaddisplaygradual phase4 depolarization (Figure I-4-5). 1. Automaticity normally occurs in the cells of the SA node, AV node, and His-Purkinje system. The mechanism for automaticity involvesa gradual increasein Na* influx during phasea (the pacemakercurrent), due to the activation of a specialpopulation of Na* channels;in the SA node and AV node, a gradual increasein Ca2*influx and a gradual decreasein K* eflux are important.
Note Automaticity isdefined asa gradual depolarization phase during 4.
17
Cardiovascular System
In a Nutshell Pacemaker Cells . SAnode . AVnode . Purkinje fibers > rate AV SA rate> Purkinje rate
2. If phase4 depolarization is not interrupted before the threshold is reached,an AP will be initiated spontaneously. Thus, cells that possessautomaticity can function as pacemakers, i.e.,sourcesof APs that can propagatethrough the remaining myocardialtissue. Normally, the SA node is the dominant pacemaker becauseit depolarizes more rapidly and becauseof what is known as overdrive suppression, the slowing of other pacemakers roughly in proportion to the duration and rate of stimulation of the dominant pacemaker (e.g.,the fasterthe SA node dischargerate, the slower the rate of the AV node and His-Purkinje system pacemakers).Clinically, the use of percutaneouspacemakersto terminate arrhythmias takesadvantageof overdrive suppression. 3. The pacemaker firing rate, and therefore the heart rate, is determined by: a. The rate of phase4 depolarization,i.e.,the phase4 slope. (1) Sympathetic stimulatiot (F, receptors) and fever increasethe phase 4 slope, thereby increasingthe heart rate (Figure I-4-5). (2) Parasympatheticstimulation (M, receptors)and hypothermia decreasethe phase 4 slope,there\ decreasingthe heart rate (Figure I-4-5). b. The threshold potential c. The transmembrane potential at the start of phase4 (maximum diastolic potential). Parasympatheticstimulation causeshyperpolarization of the cell membrane, i.e., a more negative maximum diastolic potential, which contributes to its abiliry to decreasethe heart rate (Figure I-4-5).
mV
t
Sympathetic stimulation
mV
Figure l-4-5. Automaticity in SA nodal cells, illustrating the effect of sympathetic and parasympatheticstimulation on heart rate.
MYOCARDIAL CONTRACTION Note T tubules facilitate action potential transmission intotheinterior ofthefiber. Theyarewelldeveloped intheventricles.
58
A. Mechanism of excitation-contraction coupling. As in skeletal muscle, Ca2+ions mediate myocardial excitation-contraction coupling. 1. During phase 2 of the action potential, Ca2nions enter the cell through voltage-gated L-type Ca2*channels (slow inward Ca2*current). At the Z line of each sarcomere,the sarcolemma invaginates to form the system of T tubules, thus ensuring that the action potential spreadsinto the interior of the myocardial fiber. 2. Although the Ca2*ions that enter the cell during phase2 are not sufficient to activatethe contractile mechanism of the myocardial cell, their entry causesthe releaseof a much
Physiology
larger number of Ca2*ions from the sarcoplasmic reticulum (SR), an intracellular Ca2* storage reservoir that consists of a network of anastomosingtubular structures surrounding each myofibril. This Ca2*-induced Ca2*release provides a sufficient amount of Ca2*to initiate contraction. a. Sac-like cisternae, or lateral sacs,of the SR are found adjacent to the T tubules and surfacesarcolemma. b. The Ca2*ions entering during phase2 releaseCa2*from the SR by binding to Ca2+ releasechannels (also known as ryanodine receptors) on the cisternaeof the SR. 3. The amount of Caznreleasedfrom the SR, and hence the number of activatedcontractile sites and the force generatedby the contraction, is determined by the amount of extracellular Ca2*entering the cell during phase2, the time that has elapsedsincethe previous action potential (which, in turn, determineswhether the Ca2*releasechannelshave recovered their ability to respond to Ca2*),and the sizeof the SR Ca2*stores. 4. The amount of extracellular Ca2nentering the cell during phase2 is directly proportional to the: a. ExtracellularCa2*concentration b. Number of open Ca2*channels c. Duration of the action potential d. Number of action potentials 5. Sympathetic stimulation (p, receptors) and p-receptor agonists increasethe force of myocardial contraction by increasingthe probability that a given Ca2*channel is open, thereby increasing Ca2*influx. B. Mechanism of myocardial contraction I. Caz*binds to troponin C, causing the troponin complex to undergo a conformational change,which in turn causestropomyosin to move deeperinto the groove betweenthe two actin strandsof the thin filament. 2. The movement of tropomyosin into the grooveuncoversthe myosin binding siteson the actin strands, allowing the myosin headsto bind to the thin filament. 3. The myosin headundergoesa changein shape,which causesthe myosin head to move the thin filament (power stroke),thereby shorteningthe sarcomere. C. Mechanism of myocardial relaxation 1. The influx of extracellularCa2*stopsat the end of phase2 of the action potential. reducing the intracellular Ca2*con2. The SR actively accumulatesCa2*via a Ca2*-ATPase, centration and removing Ca2*from troponin. 3. The regulatory proteins troponin and tropomyosin now assume their inhibitory conformation, preventing cross-bridging between actin and myosin and resulting in myocardial relaxation. D. Differences between cardiac and skeletal muscle contraction 1. Prolongedtetanic contraction, possiblein skeletalmuscle,cannot occur in the myocardium, becausethe efifectiverefractory period of the myocardial fiber extendsbeyond phase 2 of the action potential; thus, relaxation is part of the contractile rycle triggeredby each action potential.
T9
Cardiovascular System
In a Nutshell . Skeletal muscle: changes in contractile forcearedueto changes inthenumber of fibersactivated . Cardiac muscle: changes in forcearedueto contractile inconFactility changes offiben
2. Forceofcontraction a. In skeletalmuscle, each activated fiber generatesa maximum force and any variation in the total force generatedby the skeletalmuscle is therefore due to changesin the number of fibers activated. b. In cardiacmuscle,all fibers are activatedwith eachcontraction; any variation in the force of contraction is therefore due to changesin the contractile properties,or contractility, of the individual fibers rather than to changesin the number of fibers activated.
THECARDIAC CYCTE The concurrent electricaland mechanicaleventsoccurring during the cardiacrycle are shown in Figure l-4-6 (the Wiggers diagram). In the following description of the cardiac rycle, the eventson the left side of the heart will be emphasized. A. Atrial systole ( 150 milliseconds). The atria contract,accomplishingthe final = 20o/oof ventricular filling (atrial kick) (Figure l-4-7). 1. On the ECG, the P wave (atrial depolarization) startsjust before the beginning of atrial systole,triggering atrial muscle contraction. 2. Left atrial pressure increasesasthe left atrium contracts,causingthe a wave. 3. Left ventricular pressure increases,paralleling the a wave,but remains below left atrial pressure. Thus, the pressuregradient for ventricular filling is maintained. The left ventricular pressureat the end of atrial systolerepresentsthe left ventricular end-diastolic pressure. 4. Leftventricular volume increases= 20o/oto its maximum value during the cardiac rycle (= 120 ml), the end-fiastolic volume. Left atrial volume falls. 5. The fourth heart sound (Sn)occurs during atrial systole,but typically is audible only in pathologicalconditions that result in a more forceful atrial systole(e.9.,a reduction in left ventricular compliancedue to hypertrophy or infarction).
40
Physiology
lso. Filling Atrial lso. Ejection systole Vol. Rapid RedrcecVol, Rapid Reduced Col RIX R ,B\
Q
---_r{
120
b
6;100
I
,
I
I
E g80 E = o
ECG
-....E
- Left ventr'icular presriure
Aortic pressure
$60
(L
40
Atrial p ressure I
" t , " I" f ' f
20
8 4oo-J-
c-' . . X
a
500-1
t t
o
a
i
\-V a
! zoo-lP 1oo f roo-J€ 80 sJ
l \
^.'(
Mitral Aortic Tricuspid PulmonaryI
1t
,,i,
lntri,:ularoutflow
f-:\
l_ 4th
i4,
\I
. a ' \
E soo-l€rzo
\ t
(
Ar Jtr
2nd I
Left ventricular volume Atrial volume
'\--
Heart sounds
3rd
E Open valves I Closed valves
I 0 . 1 5 0.06 0 . 1 1 0 . 1 7 ).0t 0 . 1 1
0.20
Time (sec) Figure l-4-6. Concurrent electrical and mechanical events during the cardiac cycle.
4l
Cardiovascular System
Figure l-4-7. Atrial systole. B. Ventricular systole(300 milliseconds). The contraction of the ventriclescanbe divided into threephases: 1. Isovolumetric contraction (50 milliseconds).The left ventricle contracts at a constant volume,sinceboth the mitral and aortic valvesare closed(FigureI-4-S).
Figure l-4-8. lsovolumetric contraction. On the ECG, the QRS complex (ventricular depolarization) starts just before the beginning of isovolumetric contraction, triggering ventricular muscle contraction. b. Left ventricular pressure rises above the left atrial pressure,closing the mitral valve; in fact, mitral valve closure defines the beginning of isovolumetric contraction. Left ventricular pressurecontinuesto rise at an increasinglyrapid rate until aortic pressure is reached. Note that mitral valve closure occurs very shortly before tricuspid valve closure. c . Left atrial pressure increasestransientlydue to the bulging of the mitral valveinto the
left atrium at the beginning of isovolumetric contraction, causingthe c wave.
42
Physiology
d. teft ventricular volume remains constant at its maximum value (end-diastolic volume); isovolumetric contraction causesonly a shape change and a rise in left ventricular pressure.
I
L .
r.i+
. . t t t
e. The first heart sound (S,) coincideswith AV valve closure (mitral, then tricuspid). S, is the loudest and longestheart sound and can continue into early ejection. 2. Rapidventricular ejection (100 milliseconds). The aortic valve is open and most of ejection occurs (Figure I-4-9).
('z
-- t
Figure l-4-9. Rapid ventricular ejection. a. Left ventricular pressure rises above the aortic pressure,opening the aortic valve; in fact, aortic valve opening defines the beginning of ventricular ejection. Left ventricular pressurecontinuesto rise at a slower rate until maximum left ventricular pressure(= 120 mm Hg) is reached. Note that aortic valve opening occurs after pulmonic valveopening; thus, isovolumetric contraction is longer in the left ventricle.
. r-P
b. t€ft ventricular pressure decreasesrapidly, then more slowly. c. Aortic pressure risesrapidly, sincethe rapid ejection of blood into the aorta exceeds the drainageof blood into the peripheral arteries.
.
ft.>(t
''
g-
f-,i,..r'
a .,'
d. Left atrial volume begins to increaseas the left atrium is refilled by the pulmonary veins whiie the mitral vaive is closed,causingthe v wave.
--y
tso '-
':r , r_
['r/-'
Jft
'.-' ,-
'tt,
e. On the ECG, the isoelectricST segmentand the beginning of the T wave (ventricular r epolarization) are recorded. 3. Reducedejection (150 milliseconds). Ventricular ejection slows. a. Left ventricular pressure decreasesdue to relaxation of the left ventricular muscle until aortic pressureis reached. b. Left ventricular volume decreasesmore slowly, reaching its minimum value (= 40 ml), the end-systolic volume. c. Aortic pressure decreasesbecausethe drainageof blood into the peripheral arteries exceedsthe ejection of blood into the aorta.
4t
I
System Grdiovascular
d. teft atrial pressure continues to increasedue to continued refilling of the left atrium, increasingthe magnitude of the v wave. e. On the ECG, the end of the T wave is recorded. t 1 ' t . 1 . , ' i i, ' . t ' 1 ( r I
, 5.r'' i 1
I
, !\t
'
(i
L ' ( t J f r r ' r r
I
C. Ventricular diastole (duration dependson heart rate). The relaxation of the ventricles can be divided into four phases. 1. Isovolumetric relaxation (50 milliseconds). The ventricle relaxesat a constant volume, sinceboth the mitral and aortic valvesare closed(Figure I-4-10).
Figure l-4-10. lsovolumetric relaxation.
a. Ieft ventricular pressure falls below aortic pressure,resulting in closure of the aortic valve; in fact, aortic valve closure defines the beginning of isovolumetric relaxation. Left ventricular pressurecontinues to fall, due to the continued relaxation of the left ventricular muscle. Note that aortic valve closure precedespulmonic valve closure; thus, ventricular ejection is longer in the right ventricle. b. I€ft ventricular volume remains constant at its minimum value (end-systolicvolume). c. Aortic pressure shows a dip, the incisura, when the aortic valve closes,followed by a small pressureincrease. This is due to a short period of backward flow of blood immediately prior to aortic valve closure that is interrupted by the closure. d. Left atrial pressure continues to increasedue to continued refilling of the left atrium, reaching its maximum value, the peak of the v wave, at the end of this phase. e. The secondheart sound (Sr) coincideswith semilunar valve closure.Two S, sounds can be heard: aortic valve closure(4) followed by pulmonic valve closure(Pr). f. On the ECG, the beginning of the isoelectricTP segment is recorded.
2. Rapid ventricular filling (100 milliseconds).The mitral valve is open and most (= 80o/o) of ventricular filling occurs (Figure I-4-11).
u
Physiology
Figure l-4-11. Rapid ventricularfilling.
a. I,eft ventricular pressure falls below left atrial pressure,opening the mitral valve; in fact, mitrd valve opening definesthe beginning of ventricular filling. Left ventricular pressurecontinues to fall in parallel with left atrial pressure. b. I^eft ventricular volume increasesrapidly as the left ventricle fills. c. Ieft atrial pressure starts at the peak of the v wave,then falls as blood flows into the left ventricle (the y descent). Left atrial pressureremains above left ventricular pressure,maintaining a pressuregradient for ventricular filling. d. Aortic pressure decreasesslowly due to the drainage of blood into the peripleural arteries. e. The third heart sound (Sr) coincideswith rapid ventricular fillitg. S, can be a normal finding in children and young adults,but in adults over 30 to 35 yearsof age,it usually is audible only in pathologic conditions. f. On the ECG, the isoelectricTP segment is recorded. 3. Diastasis (duration dependson heart rate) is the period of slow ventricular filling.
In a Nutshell
a. Left ventricular pressure and left ventricular volume slowly increase,due to the slow filling. b. Left atrial pressure slowly increases,due to continued left atrial filling from the pulmonary veins. c. Aortic pressure decreasesslowly, due to the continued drainage of blood into the peripheral arteries. d. On the ECG, the end of the isoelectricTP segment is recorded. 4. Atrial systole. The rycle begins again.
Left MiFal Aortic \ftnthhr Vahe Valve Volume bo,ofum€fic closed closed <+ contaction Ejection
closed oPen
.,
lsorclume0ic closed closed <+ relaxation Venbicular open closed T filling
D. Normal pressures. Thble l-4-3 shows the normal pressuresin the right and left sidesof the heart.
45
Physiology
C. Third heart sound (Sr) 1. 53, or the ventricular gallop sound, is synchronous with rapid ventricular filling. S, *r,epresents vibiations of the left ventricular structures and bloildrnaiis as the iapid fiflow of blood is limited to the left ventricular diastolic expansion. 2. S, is a normal finding in children and young.adults.In 3{ults over 30 to 35 yearsof age, the presenceof an S, usually reflects significant global ventricular dysfunction and is frequently associatedwith ventricular dilatation and increa-sedleft ventricular end-diastolic volume and pressure. 3. S, may also be a sign of diastolic volume overload without significant abnormalities of systolic ventricular function. S, can, therefore, be present in mitral regurgitation, severe aneTrar or jhyrotoxicosis. D. Fourth heart sound (Sn) 1. 54,or the atrial gallop sound, is synchronouswith atrial systole. Sinceatrial contraction is requiied to generateSn,it is never heard in atrial fibrillation. 2. Sufrequently occurs in conditions associatedwith decreasedleft ventricular compliance, or i4-c1e_ased stiffness,such as systemichlryertension,aortic stenosis,idiopathic hypertrophic subaortic stenosis,acut6myocardialischemiaor infarction.
ClinicalCorrelate S,andSoarelow-frequency sounds andarebestheard withthebellof the placed stethoscope atthe leftventricular apexwiththe patient in theleftlateral position. decubitus
MURMURS A murmur is a sound associatedwith turbulent flow. Murmurs can occur when an excessof blood flows through a normal-sizedvalve(high output), when a normal amount of blood flows through a small or stenotic valve,or when blood leaksbackrvardsthrough a regurgitant (incompetent) valve.Sometimesthey occur when blood flows through an inappropriate opening,asin septaldefects. A. Systolic murmurs can be divided into two categories:ejection murmurs and pansystolic (or holosystolic) murmurs. The intensity of systolic murmurs varies with respiration. Murmurs originating on the right side of the heart generally increasewith inspiration and those from the left side decreasewith inspiration becauseinspiration increasesvenous return. 1. An ejection murmur startsafter S,,crescendosto reacha peak in early or middle systole, and tapeTsto a closebefore Sr.
Bridgeto Pathology Valvular disease isdiscussed indetailintheCardiovascular Pathology chapter,
a. Ejection murmurs originate from the outflow tracts of the right and left ventricles. They can usually be well heard in the neck. b. Conditions usually associatedwith systolicejection murmurs are: (1) Valvular aortic stenosis (2) Idiopathic hypertrophic subaortic stenosis (3) Pulmonic stenosis (4) Atrial septaldefect c. The term functional or flow murmur is used to describe an ejection_murmur produced by increasedejection velocity acrossa normal aortic or pulmonic valve in various pathologically or physiologically altered states.This type of a murmur can be heard in -fevet anemia, during exercise,pregnancy,or in conditions in which stroke volume d itrge ie.g., bradycardiu,.o-plete heart block, aortic regurgitation).
47
Grdiovascular System
In a Nubhell . Systolic ejectionmurmurs - Aorticstenosis - Pulmonic stenosis - ASD . Pansystolic murmurs - Mitralregurgitation - Tricuspid regurgitation
-ry
. Diastolic murmurs - Aortic regurgitation - Pulmonic regurgitation - flitralstenosig - Tricuspid stenosis
2. A pansystolic murmur starts with S, and continues on through Sr.It is a longer -ur-u, and frequently obscuiesS, and Sr.The prominent gap betweenthe murmur and S, heard with ejection murmurs is not present. Conditions usually associatedwith pansystolic murmurs are: a. Mitral regurg{4ti_on b. Tiicuspid regurgitation c. Ventricular septaldefect (some of the loudest murmurs encountered) B. Diastolic murmurs also can be divided into two categories: regurgitant murmurs of aortic and pulmonic regurgitation and ventricular filling murmurs. 1. In aortic regurgitation, the murmur starts in early diastole,usually immediately after Sr. This murmur is typically_blowing,decrescendo,high-pitched, and pandiastolic and is best heard at the upper right sternal border with the patient leaning forward at full expiration 2. ln mitrd stenosis, the murmur is loudest when the flow across the mitral valve is maximal: during rapid filling in early diastole and then again during atrial systolein late diastole. It may be p.recededby an audible opening snap of the stiffened mitral valve and -followedby a loud S,.
Note Thecardiac indexisequal to thecardiac output divided bythebody's surface area. It represents cardiac outputnormalized for bod sizeandisuseful in comparing function cardiac of different individuals.
In a Nubhell
' S V =rn ft =EDV-ESV
. EF=ffx roovo (normal= 55-800/o)
(CO) GARD|AC OUTPUT Cardiac output is the volume of blood pumped by either of the ventriclesper minute. Cardiac output usually representsleft ventricular output, but in the absenceof pathologic intracardiac shunts, the outputs of both ventricles are obviously closely matched. The range of normal resting cardiac output is 4-8 liters/min, depending on body size,and it can increasefive or six times during exercise. A. Definitions 1. Stroke volume (SV) representsthe volume of blood pumped by the ventricle per beat. SV can be calculatedby dividing the CO by the heart rate or as the difference between ventricular end-diastolicvolume (EDV) and end-systolicvolume (ESV). In the absenceof pathologic intracardiac shunts and valvular regurgitation, the stroke volumes of both ventricles are closelymatched. If valvular regurgitation is present,the total stroke volumes of the two ventricles may differ greatly. 2. Ejection fraction (EF) representsthe fraction of the blood in the ventricle at the end of diastole that is ejected during systole.EF can be calculatedby dividing the SV by the ventricular EDV and is typicallyerpressedasa percent.The normal resting EF is 55 to 80o/o. a. If valvular regurgitation is present,a distinction must be made between the total, forward, and regurgitant EF: Total EF = forward EF + regurgitant EF b. Note that even when there are no pathologic intracardiac shunts or regurgitant valvular lesions,the EFs of the two ventricles may be different. c. Although EF is affectedby the ventricular preload and afterload, it is the best clinical index of myocardial contractility. B. Measuring cardiac output. The Fick oxFgen rnethod is based on the principle of the conservation of mass. Thus, the total uptake of oxygen by the lungs per minute must equal the product of the pulmonary blood flow per minute and the difference in the oxygen concentrations in pulmonary venous (systemic arterial) and pulmonary arterial (systemic mixed
48
Physiology
venous) blood. If there are no pathologic intracardiac shunts, the pulmonary blood flow equals systemicblood flow, and the Fick method allows the measurement of systemic cardiac output.
t.. "
./ :'
{
1. Since pulmonary venous blood cannot be easily sampled,the orygen concentration of systemic arterial blood is used in the calculation of cardiac output by the Fick method. Pulmonary arterial blood is also difficult to sample,but complete mixing of venous blood is accomplishedonly in the pulmonary artery. 2. Becausebronchial and thebesian(small cardiac) veins drain directly into the left ventricle (the physiologic intracardiac shunt), the orygen concentration of systemicarterial blood is generally 2 to 5o/olower than that of pulmonary venous blood. This results in a small and usually not clinically significant overestimation of the cardiac output. The total error of the Fick method is approximately 10olo.
t:'lf: i
3. The Fick method is most accuratewhen the cardiac output is low and the arteriovenous difference in orygen concentration is high.
DETERMINANTS OFCARDIAC PERFORMANCE The performance of the heart is determined by three factors: preload, afterload, and inotropic state (contractility). A. Preload. A fundamental property of cardiac muscle is that the force of contraction is determined by the initial stretch on the myocardial fibers, or preload. When applied to the whole heart, this relationship between the force of contraction and preload is referred to as the Starling law of the heart and is best illustrated by plotting ventricular peak systolic pressureas a function of ventricular end-diastolic volume (EDV), to give the peak systolic pressure-volume curve (Figure I-4-12).
ln a Nubhell Strengh of contraction isrelated to muscle fiberstretch.
Peak systolic pressure- volumecurue
o l
a o o (L
50 100 150 End-diastolic volume(ml) Figure a-4-1 2. Ventricular pressure-volume curves. 1. Note that the ventricularpeaksystolicpressurerisessharplyuntil the ventricularEDV becomesgreaterthan a certaincriticalvalue,and then plateaus.
49
System Cardiovascular
Note lengh Optimal sarcomere corresponds to optimal overlap ofthickandthin filamen6.
a. Ultrastructurally, the steeply ascendingportion of the peak systolic pressure-volume curve corresponds to increasesin the length of individual sarcomeresuntil the optimal overlap of the thick and thin filaments in the sarcomereis achieved,typically at a sarcomerelength of 2.0 to 2.2 p. b. In the intact heart, the myocardial fibers cannot be stretched much beyond the sarcomere length corresponding to optimal filament overlap, due to the extreme stiffnessof cardiac muscle at longer fiber lengths. This stiffiressis evident in the steep rise of the diastolic (resting) pressure-volume curve at high EDVs (Figure l-4-I2). c. The steeply ascendingportion of the peak systolic pressure-volumecurve can be attributed not only to optimization of the overlapof the thick and thin filaments,but also to an increasedaffinity of troponin C for Ca2+as sarcomerelength increases (length-dependent activation). 2. This "longer is stronger" property of cardiac muscle is important to the function of the intact heart becauseit provides a mechanism for adjusting the force developedduring contraction with the volume filling the ventricle just prior to the contraction (EDV). In effect, the greater the venous return to the heart, the greater the EDV which in turn increasesthe force of contraction, thereby increasing the cardiac output. 3. Becausethe aortic pressureis typically lower than the peak systolicpressurecorresponding to a given left ventricular EDV in normal cardiac contractions the peak systolic pressureis not attained. Instead, as soon as the left ventricular pressureexceedsthe aortic pressure,the aortic valveopensand blood is ejected. Thus, the cardiaccycleforms a loop on the pressure-volumegraph, calledthe PV loop (Figure I-4-13).
Peak systolic pressure- volumecurve
o
= (t, o o (L L
pressure- volumecurve ESV
EDV V ol ume
Figure l-4-13. A typical cardiac cycle illustrated as a PV loop on the pressure-volumegraph. (1 = isovolumetriccontraction; 2 = ventricularejection;3 - isovolumetricrelaxation;4 = ventricularfilling; EDV= end-diastolic volume;ESV = end-systolic volume.)
4 . PV loops can be usedto illustrate how an increasein preload (EDV) resultsin an increase in strokevolume (SV), a manifestationof Starling'slaw of the heart (Figure I-4-I4).
50
Physiology
Peak systolicpressurevolumecurve
Afterload (constant) Diastolicpressurevolumecurue
ESV
EDVI
EDVz
Figure l-4-14. The effect of changing preload (EDV)on SV.
5. The EDV is directly related to the duration of ventricular filling, the pressuregradient betweenthe atrium and the ventricle,the rate of venousreturn, the effectiveness of atrial contraction (the atrial kick), and the integrity of the AV valve. B. Afterload. The force of contraction is determined by the wall tension or pressurethat the ventricle must generateto ejectblood, commonly termed the afterload.The bestindex of left ventricular afterload is left ventricular systolic wall stress,but aortic pressure is a satisfactory index that is more readily measured.
Note lncreased heartratewill decrease diastolic filling timeandtherefore decrease EDVandSV.
1. PV loops can be used to illustrate how a decreasein afterload results in an increasein strokevolume (SV) becauseit is easierto ejectblood if the pressurethat the ventricle must developis reduced(FigureI-4-15).
Afterloadl Afterload2
ln a Nutshell ESV2 ESVI
EDV (constant)
Figure l'4-15. The effect of changing afterload on SV.
2. Mitral regurgitation,patent ductus arteriosus,septaldefects,and arteriovenousfistulaeall representconditions in which the left ventricular afterload is reduced,resulting in an increasedstroke volume. The inverse relationship between afterload and stroke volume provides the rationale for vasodilator therapy in congestiveheart failure.
3 . Systemichypertensionand aortic stenosisrepresentconditions in which the left ventricular afterload is increased.In theseconditions, the left ventricular and diastolic volume generallyincreases,which in many casesallows a normal or near normal stroke volume to be maintained.
. Preload = ventricular end (EDq= 1l0* diastolic volume muchbloodtheheartis receiving fromvenous system; howmuchit needs to pump. preload. Venodilators decrease . Afterload = aorticpressure; affected byhowmucharterial resistance theheartispumpingagainst. Vasodilators decrease afterload. . Stroke volumeisincreased by preload increasing or decreasingafterload.
5l
System Cardiovascular
C. Inotropic state (myocardial contractmat'). Cardiac performance is determined not only by the preload (or EDV) and afterload (or aortic pressure),but alsoby the degreeof activation of the fibers. In skeletal muscle, contractile force is regulated by varying the number of fibers that are completely activated.In cardiac muscle, contractile force is regulatedby varying the degree to which all fibers are activated. The term inotropic state, or myocardial contractility, is used to describe the degree to which the fibers are activated at a given preload and afterload. 1. The peak systolic pressure-volume curve can be used to illustrate the effect of changesin myocardial contractility on cardiac performance. Any agent or condition that shifts this curye upward and to the left (so that the same or greater peak systolic pressurecan now be generated at a smaller preload or EDV) is called a positive inotropic agent. Conversely,any agent or condition that shifts this curve downward and to the right is called a negative inotropic agent. For a given preload (EDV) and afterload, positive inotropic agentswill result in an increasedstrokevolume, while negativeinotropic agents will result in a decreasedstrokevolume (Figure I-4-16).
Peak systolic - volume curve 1 Afterload (constant)
Diastolic pressure- volume curve
ESV2 ESV
EDV(constant)
Figure l-4-16. Effect of changes in inotropic state (myocardial contractility) on the peak systolic pressure-volumecurve and the stroke volume.
2. Mechanisms for changesin inotropic state (contractility) a. Changes in troponin sensitivity to Ca2*.The binding affinity of troponin C for Ca2* can be influenced by mechanismsthat usually involve phosphorylation processes. Changesof this type permit the activation of more actin activesitesat lower intracellular concentrationsof Ca2*as a positive inotropic mechanism;the conversenegative inotropic potential is also present. b. Changesin Ca2*-inducedC,a2*release. A small amount of Caznentersthe myocardial cell during phase2 of the action potential,though not enough to initiate cardiacmusclecontraction. However,this phase2 Caz*influx causesthe releaseof a much larger amount of Ca2*from the sarcoplasmicreticulum (SR). The amount of Ca2*releasedfrom the SR, and hencethe force generatedby the contraction, is determinedby the amount of extracellular Ca2*entering the cell during phase2, the time that haselapsedsincethe previous action potential (which, in turn, determineswhetherthe Ca2*releasechannelshaverecovered their ability to respondto Ca2*),and the sizeof the SR Ca2+stores.
52
Physiology
c. Regulation of the sarcoplasmic reticulum Ca2*AIPase. The Ca2*releasedduring the activation process(and bound to troponin C) is removed from the cytoplasm and returned to storagesitesin the SR by the SR Ca2*ATPase. (1) This ATPaseconsumesapproximately20o/oof the heart's energy,or an amount about equal to that expendeddoing mechanicalwork, i.e.,pumping blood. (2) The rate of Ca2*uptake can be regulated,so that the rate of removal of cytoplasmic Ca2*can be adjusted. (3) This ATPaseis probably concentration-gradientdriven and may automatically operatefasterwhen more Ca2*is releasedfrom the SR. d. Changesin Na*-Ca2*exchange(the Ca2*turret pump). To prevent an increasingaccumulation of Caz*in the cell, the small amount of Ca}*that entersthe fiber during phase 2 of the action potential must be removed from the cytoplasm. This Ca2*removal is accomplishedprimarily by a passiveNa+-Ca2+ exchangemechanism,locatedin the sarcolemma in proximity to the activeNa*-K* ATPase. (1) The Na*-K+ATPasecorrectsthe minor Na* and K* concentration changesarising from the ion fluxesthat occursduring the action potential, by removing Na* from the cell and returning K* to the cell. (2) The Na* gradient createdby the Na*-K* AIPase drives the Na*-Ca2*exhange mechanism, which exchangesthree extracellular Nan ions for one intracellular Ca2*ion, thereby removing the small amount of Ca2*that entersthe cell during phase2 of the action potential. (3) Cardiac glycosides such as digitalis inhibit the Na*-K* AIPase, thereby decreasing the Na* gradient and inhibiting Na+-Ca2+ exchange. The intracellular Caz* concentration therefore rises slightly. 3. Positive inotropy is most commonly relatedto increasedavailabilityof intracellular Cazn. Positiveinotropic agentsinclude: a. Epinephrine, norepinephrine, and other B,-receptor agonists, which increase the probability that a given Ca2*channelis open, resultingin increasedCa2*influx during phase2 of the action potential. b. Increased concentration of extracellular Ca'*,which causesan increasein Ca2*influx during phase2. c. Cardiac glycosides such as digitalis, which inhibit the Na*-K* ATPase.Digitalis causes an increasedconcentration of intracellular Ca2*by reducing the Na* gradient that normally drivesthe passiveNa+-Ca2+ exchangemechanism.
Bridgeto Pharmacology glycosides Thecardiac havea positive inotropic effect.
d. Increasedheart rate, which increasesCaz*influx by increasingthe number of phase 2s per minute 4. Negative inotropy is most commonly relatedto decreasedavailabfity of intracellular Ca2*. Negativeinotropic agentsinclude: a. Ca2*channel blockers, such asverapamil and diltiazem b. Acidosis, which decreasesthe affinity of troponin C for Ca2n c. p,-Receptor antagonists, which decreasethe probability that a given Ca2*channel is open, decreasingCa2*influx d. Myocardial ischemia
55
Grdiovascular System
e. Alcohol f. Decreasedheart rate, which decreasesCa2*influx by decreasingthe number of phase 2s per minute g. Acetylcholine, which decreasesCa2*influx in the atria, but not in the ventricles D. Interactions between cardiac function and vascular function in regulating cardiac performance are best analyzedusing the cardiac ouput-venous return graph, on which the cardiac output curve and the venous return curve are plotted (Figure I-4-17). 1. Cardiac output curyes a. On the pressure-volumegraph (Figure I-4-I2), an index of performance (e.g.,peak systolicpressure)is plotted as a function of an index of filling (e.g.,EDV). Similarly, on the cardiac ouput curve, an index of performance, the cardiac output, is plotted as a function of an index of filling, the right atrial pressure(Figure I-4-l7A). b. Like the peak systolic pressure-volume curve, the cardiac output curve illustrates Starling'slaw of the heart.
21
.F 21
21
18 c
5ru
@ Inotropy,decreased afterload.or increased heart rate
d,lz :J
E
818
3.18 E >15 E
T
E rs o f
en o
Rtz g tt,
be
3 e c
o9 .o
E (UD
= Eo6
o
o
Inotropy,increased afterload, or decreased heart rate
A
024681012 Venousfillingpressure (mmHg)
B
o o
3
.q3 p
(! C)
024681012 Venous filling pre$sure (mm Hg)
C
024681012 Venous filling pressura (mm Hg)
Rr .^f, rat prtgg , Hez.^'!q9le*,irL; 1,^1 p, r i.,.
Figure l-4-17. The cardiac output-venous return graph. (A, cardiac output curve; B, venous return curve; C, interactionof cardiac output and venous return curves)
c. The cardiac output curve is shifted upward and leftward by positive inotropic agents, decreases in afterload,or increasesin heart rate, all of which increasethe cardiacoutput at a given right atrial pressure.Conversely,it is shifted downward and rightward by negative inotropic agents,increasesin afterload, or decreasesin heart rate, all of which decreasethe cardiac output at a given right atrial pressure. 2. Venous return curves a. On the venous return clrrve, the venous return (i.e., the flow of blood returning to the heart from the venous system) is plotted as a function of the right atrial pressure (Figure l-4-178). Note that in contrastto cardiacoutput, venousreturn decreases as venous filling pressure increases. The shape of the venous return curve can be explained as follows:
54
Physiology
(1) x-Intercept. If the heart were stopped,the venous return (and cardiacoutput) would equal zero and the pressurethroughout the entire cardiovascular system would be the same. Hence, the x-intercept, which is equal to the right atrial pressure when venous return = 0, is also equal to this uniform vascularpressure, commonly termed the mean systemic filling pressure (MSFP). The normal MSFP is = 7 mm Hg. (2) Downsloping region. If the heart now starts to pump, it removesblood from the venous system (and adds it to the arterial system), thereby lowering right atrial pressure(and increasingarterial pressure).The harder the heart pumps, the more it lowers the right atrial pressure on the filling side of the heart. A decreasein right atrial pressurefaciliatesvenous return to the heart; the lower the right atrial pressure,the greater the venous return. (3) Plateau. If the heart pumps hard enough, it eventually removesenough blood from the venous system to decreasethe right atrial pressureto zero (compared with atmospheric pressure). At a right atrial pressure of zero, any further increasein pumping tends to collapsethe venae cavae,and there will be no further increasesin venousreturn. b. The venous return curve is shifted upward and rightward by increasesin MSFP and downward and leftward by decreasesin MSFP. The MSFR in turn, is affected by changesin blood volume and vascularsmooth muscletone, commonly referredto as vasomotor tone (Figure I-4-l7B). (1) Blood volume. The MSFP representsthe uniform vascularpressuremeasured when the heart is stopped and therefore is increasedby expanding the blood volume (e.g.,blood transfusion) and decreasedby a loss of blood volume (e.g., hemorrhage). (2) Vasomotor tone. The MSFP is increased if the vesselwalls become stiffer (increasedvasomotor tone) but are filled with the same blood volume. The MSFP is decreasedif the vesselwalls become less stiff (decreasedvasomotor tone) with a constant blood volume. The MSFP is most sensitiveto changesin the stifftressof the veins,i.e., changesin venomotor tone becausethe veins contain = 75o/oof the total blood volume; making the arteries stiffer won't significantly affect the MSFP at a given blood volume. c. The venous return curve is rotated rightward, without changing MSFR by decreasesin vascular resistance and rotated leftward, without changing MSFP, by increasesin vascular resistance. ( 1) Many interventionsthat changevascularresistancealsochangeMSFP.For example, vasoconstrictordrugs generallyincreasevascular resistanceand venomotor tone; therefore,such a drug would causean upward and rightward shift and leftward rotation of the venousreturn curve. (2) A small number of interventions changevascularresistanceonly. For example, increasesin blood viscosityincreasevascularresistancewithout changingMSFP. A large but localized flow obstruction in a large vessel(e.g., a clot or tumor obstructing the vena cava) could increasevascular resistancewith only a negligible effect on MSFP.
3 . Interaction between the cardiac output curve and venous return curve. The cardiac output curve illustrates the relationship between cardiac output and venous fi.lling pressure in a given physiological state. The venous return curve illustrates the relationship between the venous return and venous filling pressure in a given physiologic state.
55
Cardiovascular System
Obviously, in a given physiologic state,the cardiac output must equal the venous return with a single venous filling pressureat steady state; these steady state values for cardiac output, venous return, and venous filling pressureare given by the intersection point of the cardiacoutput and venousreturn curvesfor that physiologicalstate(Figure I-4-l7C).
THEPERIPHERAT CIRCUTATION A. Hemodynamic parameters. Severalparameters are used to characterizethe flow of blood through the different parts of the circulatory system. 1. Blood flow (Q) is the volume of blood that passesa given point in the circulation per unit time (liters/min or mUmin). Blood flow may be laminar (in layeredstreamlines)or turbulent (chaotic). a. Laminar flow. Blood flows in concentric layerswithin the vessel,with the velocity of flow being zero at the vesselwall and maximal along its central axis. Becauseof the zero velocity layer, there is no friction at the vesselwall, only within the molecular structure of the blood. b. Turbulent flow. Blood flows chaotically in the vessel,continuously mixing. Flow tends to become turbulent when blood flows at high velociry passeshighly irregular surfaces,or makes a sharp turn. The tendency toward turbulent flow is expressedby the Reynold's number (RE): RE = vdp/r] where v is the mean velociry d is the tube diameter, p is the fluid densiry and 11is the fluid viscosity. (1) When RE is greaterthan 200, turbulent flow occurs at the branching points of blood vessels. (2) When RE exceeds2000, turbulent flow occurs even in the smooth portions of vessels,where laminar flow would normally occur. (3) The flow is alwaysturbulent in the proximal aorta and pulmonary artery but is almost never turbulent in small vessels. 2. Pressure(P) in the circulation is the force applied by the blood to a unit areaof the walls of the heart and blood vessels.A pressure gradient is required for flow to occur. a. Arterial pressure. In the arterial part of the circulation, blood pressurevaries during the cardiac rycle. ( 1) Systolic pressure is the peak pressureduring the cardiac cycle,occurring early in ventricular systole. (2) Diastolic pressure is the lowest pressure during the cardiac cycle. The arterial pressuredrops throughout ventricular diastoleand reachesits lowest value iust prior to the opening of the aortic valve. (3) PulsePressureis the differencebetweenthe systolicand diastolicpressures. b. Pressure waves are transmitted from the left ventricle to arteries down to the arterioles and capillaries.Pressurewavestravel fasterthan blood itself. The velocity of the pressurewaveincreasesin smaller and stiffer (e.g.,atherosclerotic)vessels. c. Shapeof the pressurecurve is alteredin certain pathologic states(Figure I-4-18). For example, in aortic stenosis,arterial pressurerises more slowly, and the pulse pressure is reduced.The shapeis a function of:
56
Physiology
( 1) Rate of rise of ventricular pressure. The faster the ventricle contracts, the steeper the rise in arterial pressure. (2) Stroke volume. The larger the stroke volume, the larger the increment of arterial volume and the larger and steeperthe rise in arterial pressure. (3) Arterial elasticity. The lesscompliant the arteries,the larger and steeperthe rise in arterial pressure for a given stroke volume; this is one of the reasonsblood pressurerises with age. (a) Blood viscosity. The higher the viscosity of the blood, the more difficult flow becomes,and the higher the pressurerequired to pump a given stroke volume. d. Mean arterial Pressure is the area under the arterial pressure curve for a single cardiac qcle, divided by the duration of the cycle.As long as the heart rate is between 60 and 100 beats/min, the mean arterial pressurecan be accurately approximated by the equation: P = ll3 systolicP + 213diastolic p.
In a ilrfthell = Meanarterial pressure + 2/J dia$olic. l/3 systolic
C',
r
E E
160
g 120 o o
$Bo 120
0.4
0.8
1.2 1.6 Seconds
2.0
2.4
Figure l-4-18. Normal and pathotogic aortic pressure curves. e. Indirect measurement of arterial blood pressure is routinely accomplished by the auscultatory method using a sphygmomanometer, a pneumatic device that allows a controlled occlusion of the underlying artery (usually the brachial artery). f. Direct measurement of arterial blood pressure involves the insertion of a needle or a plastic cannula into a large artery (usually, the radial or femoral artery); this cannula is connected via fluid-filled plastic tubing to an electronic transducer, which converts changesin pressureinto electricalsignalswhosemagnitude is proportional to the blood Pressure. g. fu the distance from the aortic valve increases,the peak systolic pressurein the large arteries becomesgreater,but the mean pressuredeclines becausethe pressureenergy is gradually dissipated by vascular resistance.The mean pressure drops slightly in smaller arteries, and then falls steeply acrossthe arterioles, the major site of vascular resistance.
57
Cardiovascular System
3. Resistance(R) representsthe viscous opposition to the flow of blood. a. Resistancecannot be measured directly, but for a given segment of the circulation, resistanceis defined as the ratio of the mean blood pressure gradient across that segmentto the mean blood flow through it:
Nole
R = AP/Q
A decrease invessel (e.g., diameter via atherosclerosis) can greatly increase resistance.
b. Resistanceis directly proportional to the length of the vesseland inversely proportional to the fourth power of the vesselradius. R = 8rlVnl where 4 is the viscosity of the blood, I is the length of the vessel,and r is the radius. This called Poisenille's law. Although strictly this equation applies only to laminar flow through a rigid blood vessel,it is useful for understanding the factors that affect the resistanceto blood flow. c. Viscositl' (n) is a measure of the resistanceof a fluid to flow. Among other factors (e.g.,temperatureand velocity of blood flow), the viscosityof blood is a function of:
Note ^ n: Q:
AP : e
8ql t t r o, therefore
APtrt{
8nl
Flowisdependent on. . Vessel (direct) diameter . Viscosity (inverse) . Vessel lengh(inverse)
(l) Hematocrit. Hematocrit is the most important determinant of viscosify;when the hematocrit is greaterthan 600lo(e.g.,in primary polycythemia), blood viscosity is more than twice its normal value (2) Concentration of proteins in plasma. For example,when there is marked overproduction of immunoglobulins in multiple myeloma or Waldenstrom's macroglobulinemia,blood viscositymay rise sharply. 4. Velocity (v) of blood flow in each part of the circulation is inversely related to its total cross-sectionalarea: v=Q/A The segmentof the circulation with the largesttotal cross-sectionalareais the capillarybed (2,500 cm'). Therefore, the velocity of blood flow in the capillaries is slower than anywhere elsein circulation, allowing adequatetime for transcapillary exchange. 5. Bernoulli's principle is basedon the observation that the total energy of laminar flow is constant anywherein the vessel.As the diameter and therefore cross-sectionalarea of the vesseldecreases,the velocirf of flow increases.A greater fraction of the fluid's energy therefore becomeskinetic energy,and the amount of energy availableto distend the vessel decreases,causing the transmural distending pressureto fall. B. Venous portion of the circulation. Compared with the arterial part of the circulation, the venous systemis characterizedby much lower pressuresand much higher compliances. The systemicveins return blood to the heart and serve as capacitance vessels,containing up to 75o/oof the systemicblood volume at rest. 1. Venous compliance is under the control of the sympathetic nervous system (cr receptors), with sympatheticstimulation resulting in a prompt increasein venous return. 2. Blood from all of the systemic veins returns to the right atrium. The mean right atrial pressure,also referred to as the central venous pressure, is normally 0 to 3 mm Hg. 3. Pressurein peripheral veins is greatly affectedby gravity, reaching 90 mm Hg in the lower extremities in the upright human. This is not usually a factor in the circulation of blood becausethe hydrostatic pressureadded to the venous blood is also added to the arterial side, and the gradient for circulation is unafifected.However, the venous side is very compliant, and sudden changesin position allow the blood in the peripheral veins to stretch
58
Physiology
the vesselwalls and transiently pool, thereby decreasingvenous return to the heart. Three main mechanismsare involved in maintaining venous blood flow toward the heart: a. Abdominothoracic pump of inspiration. When inspiration occurs, intrathoracic pressuredecreasesand abdominal pressureincreases,favoring the flow of blood from the abdominal vena cavainto the thoracic vena cava,and hence the heart. b. Musclepump of skeletal muscle aaivity. During activiry skeletalmuscle contraction causescompressionof thin-walled veins,preventingbackflow of blood and enhancing venousreturn. c. Venous valves allow venous blood to flow only toward the heart. If the pressureand volume in the venous side are sufficiently elevated,the vesselsmay become so dilated that the valveswill not reach acrossthe functional diameter of the vessels.Suchvenous dilation and valvular incompetencemay occur during prolonged upright posture or when the central venouspressureis elevated(e.g.,in right heart failure). 4. Becauseno valvesseparatethe right atrium from the venae cavae,the right atrial pressure wavescan be seenin the jugular vein, particularly when the right atrial pressures are elevated. a. Prominent cannon jugular venous a waves are present in patients with AV dissociation (e.g.,due to third-degreeAV block), and are causedby the right atrium contracting againsta closedtricuspid valve. b. Prominent v waves are present in patients with tricuspid regurgitation, representing transmitted right ventricular systolic pressures.
Note waves Cannon areseenin (complete) third-degree AVblock.
C. Microcirculation 1. Arterioles branch extensively,each supplying 10 to 100 capillaries. a. Arterioles have a circumferential continuous smooth muscle coat. b. In some tissues,the arterioles give rise to smaller metarterioles, which have smooth muscle fibers encircling them at various points. c. At the junction between an arteriole or metarteriole and capillary, a circumferential band of smooth muscle, the precapillary sphincter, can open or closethe entrance to the capillary, regulating the flow of blood into the capillary. d. The resistanceof arteriolesand metarteriolesaccountsfor approximatelyone-half of the resistanceof the entire systemic circulation; correspondingly, the pressure drop acrossthe arterioles and metarterioles is the largest of any type of vessel,decreasing from = 85 mm Hg at the arterial end to = 30 mm Hg at the capillary end. 2. The capillary wall consists of a single layer of endothelial cells, resting on a thin basement membrane.The capillary endothelialcellscan be: a. Continuous, as in skeletal muscle capillaries, allowing only smaller molecules (e.g., water, electrolytes,glucose) to travel acrossthe capillary wall b. Fenestrated, with perforations piercing the cytoplasm of endothelial cells, as in glomerular capillaries and capillaries of most endocrine organs, allowing larger molecules(e.g.,myoglobin, small peptides)to be transportedpassivelyacrossthe capillary wall c. Discontinuous, with large gaps between endothelial cells, as in hepatic sinusoids, allowing largeproteins (e.g.,albumin) to enter and leavethe capillaries(hepatic sinusoids also are fenestrated)
59
System Cardiovascular
3. Venules a. Postcapillaryvenules have no smooth muscle coat and allow some exchangebetween the blood and surrounding cells. b. Collecting venules have an incomplete muscle coat and drain the capillary system. c. Muscular venules contain a continuous smooth muscle coat and may serveas postcapillary resistancevesselsas well as active capacitancevessels. 4. Regulation of capillary blood flow. Contraction of the smooth muscle in the walls of arterioles and metarterioles can change the diameter of these vesselsand therefore the amount of blood flow to the correspondingcapillary bed. a. Nervous mechanisms. Arterioles are denselyinnervated by the sympathetic nervous system. (1) Stimulation of cr receptors resultsin arteriolar constriction. (2) Stimulation of p, receptors producesarteriolar dilatation. (3) Metarterioles and precapillary sphinctersare sparselyinnervated and therefore are primarily under the control of various local mediators. b. Localmechanisms.Variousfactorsrelatedto local tissuemetabolism (e.g.,phosphate, pH, K*, lactate, and ATP) can produce dilatation of metarterioles and precapillary sphincters,leading to an increasein blood flow through the appropriatecapillary bed. c. Humoral mechanisms. Chemical agents(such as angiotensin,bradykinin, serotonin, histamine,and various prostaglandins)can affect arteriolar smooth muscletone and, in some situations,capillary permeability. 5. Transcapillary exchange. The capillary bed is the site of nutritive exchangebetween the body's tissuesand blood. The capillary wall acts as a semipermeablemembrane, allowing water and small solute molecules to travel passivelyacrossthe capillary wall. a. The net flow of fluid across the capillary wall (Q) is governed by the Starling equation: Q=K[(P.-P,)-1n.-n,)J ( 1) The capillary filtration coefficient (K) is a measureof capillary permeability. (2) The capillary hydrostatic pressure (P.) dependson the hydrostatic pressuresin the feeding arteriole and draining vein and the precapillary and postcapillary resistances. P. is largeston the arteriolar end of the capillary (= 30 mm Hg) and decreases(to = 15 mm Hg) at the venous end. P. tends to drive fluid out of the capillary and into the interstitial space. (3) The interstitid fluidhydrostaticpressure (P,) dependson the stateof hydration (i.e., interstitial fluid volume) and tissue compliance.P, is difficult to measure directly,but its magnitude is thought to be small (= 2 mm Hg). (a) The capillary oncotic pressure (n.) is a function of the concentration of nondiffusible molecules in plasma,especiallyalbumin. n. keepsfluid in the capillary and averages28 mm Hg. (5) The interstitial fluid oncotic pressure (n,) is determined by the interstitial protein concentration.It is of small magnitude (= 5 mm Hg) and draws fluid out of the capillary and into the interstitial space. b. At the arteriolar end of the capillary, the pressuresdriving fluid out of the capillary (primarily P.) are greater than the pressureskeeping it in the capillary, resulting in a
60
Physiology
net outflow of fluid. At the venular end of the capillary P. is much lower and is exceededby the other pressurestending to pull fluid into the capillary (primarily n.), resulting in net inflow of fluid (Figure I-4-19). Net outflow normally exceedsnet inflow, and the excessfluid is returned to the intravascular spaceby the lymphatics.
ln a Nubhell . P,-drives fluidoutof capillaries . P,-drives fluidinto capillaries . n,-pullsfluidintocapillaries . lq-pullsfluidoutof capillaries
Figure l-4-19. Transcapillaryfluid flow. c. Small solutes (e.g.,ions, glucose,urea) are carried with the fluid flowing acrossthe capillary wall (bulk flow). d. Large molecules must be transported acrossthe capillary wall by membrane-bound carriersor by vesiculartransport.
Atthearteriolar end,P. dominates andthereisa net fluidoutflow intothe interstitial space. Atthe venular endofthecapillary, n, dominates andpullsthe fluidbackintothecapillary.
6. Lymphatics a. The lymphatic systemreturns excessfluid and solutesfrom the interstitial spaceto the intravascular space. (1) AX of the lyr,tph from the lower part of the body and from the left side of the head, left arm, and left chest drains into the thoracic duct, which empties into the venous system at the junction between the left internal jugular and subclavianveins.
Bridgeto Heme/Lymph Lymphatic vessels are discussed intheHeme/Lymph Histology chapter of thisbook.
(2) The ly*ph from the right side of the upper body drains into the right ly-ph duct, which empties into the venous system at the junction between the right internal jugular and subclavian veins. b. In any part of the body, ly-ph has the samecomposition asthe correspondinginterstitial fluid. On the average,lyotph contains 2 g protein per 100 ml fluid. Ly-ph protein concentration is higher in the lymphatics draining the gastrointestinaltract. c. The rate of lyotph flow is approximately 120 mUhr, most of it (approximately 100 mUhr) draining into the thoracic duct. Factorsthat increasethe rate of lymph flow are: (1) IncreasedP. (2) Decreasedn. (e.g.,hypoalbuminemia) (3) Increasedcapillary permeabiliry K (4) Increasedn, (5) Muscular activity d. When the net movement of fluid out of the capillaries exceedsthe maximum rate of lymphatic drainage in a particular area of the body, edema develops. D. Coronarycirculation. Under normal physiologic conditions, the contracting heart receives 60 to 90 ml of blood per minute per 100 g of myocardium, or approximately5o/oof the total cardiacoutput.
Bridgeto RenafUrinary Thepathophysiology of edema isdiscussed in detail intheRena[Urinary Physiology chapter ofthis book.
6l
Cardiovascular System
Flashback to Anatomy Youmaywantto takea few minutes to review the anatomy ofthecoronary arteries intheCardiovascular Anatomy chapter.
ln a Nutshell . Mostcoronary bloodflow occurs during diastole. . lncreased heartrate decreases diastole more thansystole andcan compromise coronary bloodflow.
I
l. Regulation of coronary blood flow. The flow through the coronary circulation, as through any vascular bed, dependson the perfusing pressure gradient and the vascular resistance. a. Perfusing pressure gradient. In the coronary circulation, the perfusing pressuregradient is the pressuregradient between the coronary arteries and the coronary sinus. (1) Coronary artery pressure. During systole, the coronary artery pressure is slightly below aortic pressurebecauseof the rapid flow past the coronary ostia (Bernoulli's principle). During diastole, if the aortic valve is competent,aortic diastolic pressureis transmitted into the coronary arteries without significant diminution. In conditions associatedwith decreaseddiastolic blood pressure (e.g.,aortic regurgitation, arteriovenousfistula), coronary blood flow may also be decreased. (2) Coronary sinus pressure. The pressure in the coronary sinus equals the right atrial pressureand varies little during the cardiac cycle relative to the changesin the coronary arterial pressure. b. Coronary vascular resistance (CVR) (1) Variations in CVR during the cardiac cycle. Becauseof high compressiveforces within the myocardium during systole,a large portion of intramyocardial (particularly endocardial) vesselsare collapsed shut, and the systolic CVR is high. Intramyocardial pressuredrops during diastole, allowing intramyocardial vessels to reopen, accounting for the much lower diastolic CVR. Consequently,a large proportion of coronary blood flow (particularly endocardial) occurs during diastole. Thchycardia, in addition to increasing myocardial oxygen demand, decreasesthe duration of diastole more than the duration of systole and may causea decreasein coronary blood flow. (2) Variations in CVR due to local metabolic factors. Severalmetabolic factors may have a role in regulating CVR via their effects on coronary vascular tone. For example, a reduction in intracellular AIP can activate the K^". channels in coronary vascular smooth muscle. The activation of these channels,in turn, resultsin K+ efflux,leading to hyperpolarization,smooth musclerelaxation,and a decreasein CVR. Under ischemic conditions, the nucleoside a@p,osine, a potent coronary vasodilator, may have a role in regulating CVR. The concentration of adenosine,a breakdown product of AIP metabolism, increaseswhen cardiac metabolic activity increases, and the resulting vasodilation (and decreasedCVR) ensuresthat coronary blood flow increasesto support this increasedmetabolic activity. Local metabolic factors also ensurethat changesin regional coronary blood flow resulting from fluctuations in systemicblood pressure are transitory, i.e., they account for the autoregulation of coronary blood flow. Only when the perfusion pressure falls below 50 mm Hg is coronary autoregulation lost, so that coronary blood flow becomespressure-dependent. Local metabolic factors also allow coronary flow to rise as much as four- to fivefold to match increasedmyocardialoxygendemand,e.g.,during exercise.
i' i
(3) Neural effects on CVR. The coronary arteries are richly innervated by the sympathetic nervous system.Stimulation of the coronary sympathetic fibers resultsin receptor-mediated vasoconstriction, but this effect normally is overridden by metabolic factors. Specifically,the increasedheart rate and inotropic statecaused by sympathetic stimulation result in an increasedproduction of vasodilator metabolites,and hence a decreasein CVR.
62
physiofogy (a) Pharmacologic effects on cvR. o-receptor agonists cause coronary vasocon-
:H::f;J'"T'il"'$,ffi
channel Lroir.".r, dipvridamore, andprostacycrin Bridgeto pharmacology .
2. Myocardial oxygen requirements and extraction a' under basalconditions, the contracting heart extractsmore than75o/oofarterial oxygen (arterial oxygen exrraction is only ,sii'irrthe rest of the iody). consequently, when myocardial oxygendemand "bo".rt rises,the h.*t.* increase its arteriar oxygenextracUy only a_smallamount, and most of the in Iol
Because nitrates and calcium-channel blockers cause coronary vasodilation, theyareusedin the treatment of angina.
(ttq Ihas tobematch ediv in.r.*.,i, .o,o,,"ry'lil:: TJIT::t* #fil ffnill vasodilation isnotpo-r-Jut., additionar
;;;;ur., in Mvo, may
tl$t."9tr,o.ffi;,:n
b' under normal' nonischemic conditions, fatry acids are the major myocardial €n€rgy ---r source' accounting for 700/o of myocardial consumption. carbohydrate metabolismvia the Krebs cycre "rr:: accountsfor most of the remaining MVor.
,!
i ^ t
i,
NEURAT CONTROT OFTHECIRCUTATION a' The autonomic nervous system pluy: a major role in controlling the circulation regulating the cardiac output, by vascular resistance,and venous capacitance.Neural
ct'
;:ff:l,T:*J:iil:j|,'ff:,1"Ti'krv ;;; po'",tulv,"l"*i"g rorrapid changes in
1. Role of the sympathetic nervous system a' Preganglionicfibers originate from cell bodiesin the intermediolateral columns in the thoracic and lumb", ,.!ior,, of the ,pirJ.o.d and ild; ;; sympatheticganglia. Postganglionictttu'o"'-innervate effector sites such as the heart and blood vessers. Preganglionic neurons release acetylcholine and- postganglionic neurons almost always releasenorepinephrine (exceptions: acetylcholi.rJ is i.l..r.d by sympathetic postganglionicneuronsin most sweatglandsand some skeletJmuscle blood vessers). b' The adrenalmedulla receives preganglionicsympatheticinnervation and respondsby secretingepinephrine (along with sm-all of norepinephrine) into the tion. circula"-o.r.rt,
t
cr,,G2'andB,receptors. Epinephrine srimutates ITtdtl.t:.li*:.stimulates o,, G, F,,
d' stimuration of the sympathetic nervous systemresurtsin: (1) constriction of skin and splanchnicvesselsvia cx,receptors (2) Dilatation of skeletal musclebrood vessers via B, receptors (3) Venoconstrictionvia clr receptors (4) Increasedheart rate' conduction velocify (particularly in the AV node), and inotropic statevia p, receptors 2. Role of the parasympathetic nervous system a' Parasympatheticoutflow to the heart originates in the dorsal motor vagarnucleus and nucleus ambiguus in the brain stem and is transmitted to the heart via the vagus nerye.
ff:3#H:6':
##'r:rotransmitter
in both preganglionic and postgangrionic
6t
J
Grdiovascular System
b. Stimulation of the vagus results in decreasedheart rate, AV node conduction velocity, and inotropic stateof atrial musclevia M, receptors. B. Baroreceptors are stretch receptorsthat provide afferent impulses to the cardiovascularcenters in the CNS. The baroreceptorsare situated in the carotid sinus and aortic arch (arterial baroreceptors) and in the heart and lungs (cardiopulmonarybaroreceptors). 1. Arterial baroreceptors a. The nerve endings in the arterial baroreceptorsare activated by stretching of the arterial wall secondaryto elevation of arterial pressure. (1) Afferent impulses from the carotid sinus travel in CN IX (glossopharyngeal nerve),while those from the aortic arch travel in CN X (vagusnerve). (2) The rate of firing of arterial baroreceptorsis affectedboth by the magnitude and rate of stretch; i.e., the rate of firing is affected by both the mean arterial pressure and the pulse pressure. b. The function of arterial baroreceptors is to reduce acute fluctuations in blood pressure. Arterial baroreceptorsdischargeat a baselinerate even when blood pressureis normal; the rate of firing varies slightly with normal pulsatile pressure,increasing in systoleand decreasingin diastole. (1) A decreasein systemic arterial pressure producesa decreasein baroreceptor firing, which leadsto an increasein sympathetic tone and a decreasein parasympathetic tone. This results in vasoconstriction and increased heart rate. (2) An increase in systemic arterial pressure stretchesthe arterial wall, resulting in an increasein the rate of baroreceptorfiring, which leadsto a decreasein sympathetic tone and an increasein parasympathetictone. This resultsin vasodilation and decreasedheart rate. The increasein arterial baroreceptor firing is also proportional to the rate of rise of the arterial pressure.
ln a Nutshell Baroreceptor Reflex . JBP+lsympathetic
(3) In normotensivesubjects,maximal arterial baroreceptorfiring occurs when the arterial pressureis = 180mm Hg. Arterial baroreceptorsensitivityis decreasedin exercise,hlpertension, heart failure, and with aging.
J parasympathetic . tBP+Jsympathetic t parasympathetic
2. Cardiopulmonary baroreceptors. The function of the cardiopulmonary baroreceptors is lessunderstood.The atrial receptors, located at the junction of the right atrium and the venae cavaeand of the left atrium and the pulmonary veins, are activatedby atrial filling and contraction.Activation of the atrial receptorsresultsin: a. Increasedheart rate (the Bainbridge reflex) r'
b. Increasedsecretionof atrial natriuretic factor (ANF), a polypeptide hormone that c. Decreasedsecretionof antidiuretic hormone (ADH) (also known asvasopressin),a polypeptide hormone that regulatesurine concentrationby its action on the kidney
ETECTROCARDIOGRAPHY Nole Traditionally, therehave notbeenthatmanyECC questions onStep 1 oftheUSMLE. il
A. Electrocardiography is a technique for studying the electrical potentials generatedby the heart during the cardiacrycle. In contrastto the electricalpotentials discussedearlier in the study of cardiac action potentials, which represent transmembrane potential differences, the electrical potentials studied in electrocardiography represent potential differences between specificpoints on the surfaceof the body. The electrocardiogram (ECG) represents a plot of thesepotential differences(y-axis) as a function of time (x-axis).
Physiology
1. In the absenceof electrical activity within the myocardium (e.g., asystoleor death) or skeletalmuscle (e.g.,absenceof voluntary contractions or shivering),the surfaceof the body is uniformly positive at all points, the potential difference befween any two points is zero, and the ECG records a flat line (isoelectric segment) along its baseline. 2. Once an action potential is generatedand depolarizationspreadsthrough the heart, distribution of electricalchargeon the surfaceof the body is no longer uniform, differences in electricalpotential are generatedbetweendistinct points on the skin, and a deflection is recordedon the ECG tracing. 3. The ECG is recordedon l-mm graph paper,with darker grid lines every 5 mm. a. On the 7-axis, a l-mm deflectioncorrespondsto a voltageof 0.1 mV. b. On the r-axis at a standardrecording speedof 25 mm of recording paper per second, each mm correspondsto a time interval of 0.04 seconds,so that the 5-mm grid lines indicate time intervals of 0.20 seconds. B. Electrocardiographic leads.An ECG consistsof 12leads,each of which recordsthe potential difference along an axis connecting two specific points on the surfaceof the body. Six of these leads record potential differencesalong axesin the frontal plane of the body and six record potential differencesalong axesin the transverse, or horizontal, plane of the body. By convention, a depolarization wave advancing toward the positive end of each axis is recordedas an upward deflection,while a depolarizationwave advancingtoward the negative end of eachaxis is recordedas a downward deflection. 1. The six frontal plane leads,or limb leads, can be subdivided into three bipolar leads (I,II, III) and three unipolar leads (aVR, aVL, aVF). The limb leadsrecord potential differences along the axesillustrated in Figure l- -2},using electrodesattachedto the arms and legs.
Note . Toward (+) endof leadaxis (+) + upstroke . Toward (-) endof leadaxis (-) + downstroke
aVR
1180'
+ +
Figure l-4-20. Orientations and polarities of axes of the limb leads.
a. The bipolar leads I,II, and III measurepotential differencesbetweenthe right arm (RA),left arm (LA), and left leg (LL): (1) Lead I recordsthe potential differencebetweenthe LA and RA and is positive at 0 and negativeat 180 degrees.
65
Cardiovascular System
(2) Lead II records the potential difference between the LL and RA and is positive at +60 and negativeat -120 degrees. (3) Lead III recordsthe potential differencebetweenthe LL and LA and is positive at +I20 and negativeat -60 degrees. b. The unipolar leads aVR, aVI" and aVF measurepotential differencesbetween eachlimb and an electricallyderived zero potential level,correspondingto the centerof the chest. (l) Lead aVR is positiveat -150 and negativeat +30 degrees. (2) Lead aVL is positiveat -30 and negativeat +150 degrees. (3) Lead aVF is positive at +90 and negativeat -90 degrees. 2. The six transverseplane leads,or precordialleads, designatedV, throughVu, record potential differencesalong the axesillustrated in Figwe l-4-21A. The precordial leadsmeasure potential differencesbetween each of six points on the chestwall (Figurel-4-2lB) and an electricallyderived zero potential level,correspondingto the center of the chest.
A
Figure l-4-21. A, orientations and polarities of axes of the precordial leads; B, electrode placement for the precordial leads: (V1: rightfourthintercostal space,V2: left fourth intercostalspace,V3: midway betweenV2 and V4, V4: left fifth intercostalspace at midclavicularline,V5: midwaybetween V4 and V6;V6: leftfifth intercostalspace at midaxillaryline)
C. Complexes and intervals on the ECG. A rypical ECG tracing recorded by one lead is illustrated in Figure l-4-22. Although depolarizationof the SA node initiates overall depolarization of the heart, this initial depolarizationis too small to be detectedby electrodeson the surfaceof the body and thereforeis not recordedon the ECG tracing.
66
Physiology
l)'f
0.2
0.4 Time(sec)
Figure a-4-22.Normal complexes and intervals on the ECG.
1 . The P wave representsthe depolarization of the atria. Normal P wavesare: a. No more than 2.5 mm (small boxes)in amplitude b. Gently rounded in contour c. No more than 0.10 secondsin duration d. Upright in leadsI, II, aVF,and Vn through Vu e. Inverted (negative)in lead aVR
2. The PR segment is measuredbetween the end of the P wave and the beginning of the QRS complex. It reflectsthe depolarization of the AV node, the bundle of His, bundle branches,and Purkinje fibers and is normally isoelectric, as thesedepolarizations are too small to be detectedby electrodeson the surfaceof the body. 3 . The 3&intsr*val is measured from the beginning of the P wave to the beginning of the QRS complex,i.e.,it includesthe P waveplus the PR segment.It reflectsthe time it takes for the depolarizingimpulse to travel from the SA node to the ventricles.The normal PR interval: a. Is 0.12to 0.20 secondsin duration F''\'1
'41
decreases(due to more rapid conduction b. Ygftglgtttt ]regt rate, e.9., the PR interval through aha-Avnode) at faster tates 4. The QRS complex, the most important component of the ECG, representsthe spread of depolarizationthrough the ventricles. a. The deflections in the QRS complex are labeled according to the following rules: (1) If the first deflection is downward (negative),it is a Qwave. (2) The first upward (positive) deflection is an R wave, regardlessof whether it is precededby u Q wave.Subsequentupward deflections are labeled successivelyR', R" , etc. (3) A downward deflection following an R wave is an Swave. Subsequentdownward deflectionsare labeledsuccessively S', S", etc.
67
Cardiovascular System
(4) If the complex consistsonly of a Q wave,it is described as a QS complex. (5) Uppercaseand lowercaseletters are used when labeling relatively large and small deflections, respectively. b. The normal width of the QRS complex, the QRS interval (or QRS duration), is less than 0.10 seconds.A QRS interval of 0.12 secondsor longer is clearly abnormal and can be causedby: ( 1) Marked slowing of action potential conduction through ventricular muscle, e.g., due to severehyperkalemia or quinidine or procainamide toxicity. (2) Asynchrony of ventricular depolarization, so that the ventricles no longer depoIarizr, almost simultaneously, e.g., due to bundle branch block or ectopic beats that originate in the ventricles, such as premature ventricular contractions. c. The normal sequenceof ventricular depolarization is as follows (Figure I-4-23):
S-A node A-V node
Figure 14-23. Normal sequence of ventricular depolarization.
ln a Nutshell Venfricular Depolarization ventricular free .$tuLwalls
68
(1) The interventricular septum depolarizes first, mainly from left to right because the Purkinje fibers that initiate septal depolarization arborlze from the LBB. Becausethe right side of the septum facessomewhat anteriorly as well as rightward, septaldepolarization spreadsin a generallyrightrvard and anterior direction. (2) The ventricular free walls depolarize next, from endocardium to epicardium becausethe bundle branchesrun along the endocardial surfaceof the ventricles. While the ventricular walls are depolarized approximately simultaneously, the left ventricular free wall is so much thicker than the right ventricular free wall that the electricalpotentials generatedby its depolarization almost totally mask the electrical potentials generatedby the depolarization of the right ventricular free wall. Sincethe left ventricular freewall facessomewhatposteriorly well asleftward, its depolarization spreadsin a leftward and posterior direction. "r The electricalpotentials generatedby Ieft ventricular free wall depolarization are normally the largest electrical potentials generated during the cardiac cycle and therefore are very important in determini.g the morphology of the QRS complex.
Physiology
d. The normal sequenceof ventricular depolarization is perhaps most clearly demonstratedby the QRS complexesin leadsV, and Vu. (1) LeadV, recordsa positivedeflectionwhen depolarizationspreadsanteriorly and a negativedeflectionwhen depolarizationspreadsposteriorly. LeadV, therefore will initially record a positive deflection (r wave), becauseseptaldepolarization spreadsanteriorly. Next, it will record a negativedeflection (Swave), becauseleft ventricular free wall depolarizationspreadsposteriorly. (Note that the electrical potentials generated during left ventricular free wall depolarization are larger than those generatedduring septaldepolarization.) (2) LeadVu recordsa positivedeflectionwhen depolarizationspreadsleftward and a negativedeflection when depolarization spreadsrightward. Lead Vu therefore will initially record a negativedeflection (q wave), becauseseptal depolarization spreadsrightward. Next, it will record a positivedeflection (Rwave), becauseleft ventricular free wall depolarization spreadsleftward. (3) Note that the QRS complex is predominantly negativein lead V, and predominantly positive in lead Vu; i.e., a transition from predominantly negativeQRS complexes to predominantly positive QRS complexes normally occurs when moving from right to left acrossthe precordium. Normally, the transition from negativeto positive is recordedin lead V, or Vn. (4) Note that a small r wave is recorded in lead V, and a large R wave is recorded in lead Vr; i.e., a gradual increasein r wave height normally occurs when moving from right to left acrossthe precordium (normal R wave progression). The largestR wave can be recordedin leadV4,Vs, or Vu. e. Mean frontal QRS axis. The electricalpotentials generatedduring ventricular depolarization produce the largestnet QRS amplitude in the ECG lead whose axis is parallel to the path of depolarization and the smallestnet QRS amplitude in the ECG lead whose axis is perpendicular to its path. To estimatethe net QRS amplitude in a particular lead, the magnitudesof the negativedeflectionsin the QRS complex are subtractedfrom the magnitudes of the positive deflections in the QRS complex. The axis of the limb lead that recordsthe largestnet QRS amplitude represents(at leastapproximately) the mean frontal QRS axis. If a limb lead recordsa net QRS amplitude of zero,the mean frontal QRS axis is perpendicular to the axis of that lead. The mean frontal QRS axis normally lies between-30 and +90 degrees. (1) If the mean frontal QRS axis is further leftward (i.e., more negativethan -30 degrees),abnormal lgft34l*deviation is present.Possiblecausesinclude left ventricular trlpe*qtrophy-andconduction tto.t in the anterior fascicle of ihe LBB (left anterior hemiblock). (2) If the mean frontal QRS axis is further rightward (i.e., more positive than +90 degrees),abnormal right axis deviation is present.Possiblecausesincludeljght ventricular-h)rpertrophy, conduction block in the posterior fascicle of the left The Q$S axis is normally bundle (left posterior hemiblock), and dextrocard_ia. hypertrophy of the right relative the because of deviatedto the right in neonates ventrjcle-. 5. The ST segment is measuredfrom the end of the QRScomplex to the beginning of the T wave.
vt
a. The _STsegmgntis normally isoelectric, correspond-ingtp,the part of the cardiac rycle wlrsn all gf1fu ve_ntricglg muscle cells are depolarized (p-!rar_s_e _2of the a,,cJ_io_n_p*oJenpoints on the surfaceof the body any two between _tiqD,so that the potential difference is zero.
69
Cardiovascular System
b. ST segmentelevation or depression can be seenin numerous pathologic conditions, including myocardial infarction and ischemia,ventricular hlpertrophy, bundle branch block, and electrolyteabnormalities. 6. The T wave representsthe electrical recovery,or repolarization, of the ventricles. a. Normal T waves are:
ln a Nutshell . PWqve =depolarization of atria . PRsegment = conduction through AVnodeandthe Purkinje system ' QRS = complex depolarization of ventricles ' Twave= repolarization ofventricles
(1) Upright in leads with QRS complexesthat are predominantly positive, and inverted (negative) in leads with QRS complexesthat are predominantly negative. However, in leads V, and V, the T wave may be upright even if the QRS complexesare predominantly negative. (2) Slightly rounded and slightly asymmetricalin shape. (3) Lessthan 5 mm in height in the limb leadsand lessthan 10 mm in height in the precordial leads. b. Unusually t"q_T waves ("tented T waves") can be seen in myocardij! ischemia, myocardial infarction, hyperkalemia, and cerebrovascularaccidents. c. Inverted (negative) T waves can be seenin numerous pathologic conditions, including ;yocardial infarction and ischemia, ventricular hypertrophy, bundle branch block,ind electrolyteabnormalities. 7. The QT interval is measuredfrom the beginning of the QRS complex to the end of the T wave;f.e.,liincludes the QRS complex,ST segment,and T wave. The QT interval: a. Varies with heart rate, so that a normal range can be specified only for the ratecorrected QT interval (QT.), defined as QT. : QT/VRR, where RR is the RR interval (seebelow). The normal QT. is 0.35 to 0.44 secondfin duration. b. Varieswith ageand sexof the patient c. Is prolongjd in congestiveheart failure (9HFJ, myocardial infarction, and hypocalcemia,and by quinldgre, procainamide,and triry_clicantldepre$a-lJs.Prolongationis co_ngenitalin some paiients, who are then at higEir risk for vCntricular tactiyatrtt@mias and sudden death. d. Is s"hortenedin hypercalcem.raand by digitalis 8. TbU wave is a small deflection that, when present,follows the T wave and has the same orientation as the T wave. Its magnitude is in hypokalemia. increased 9. The RRinterval is the time interval from the beginning of one QRS complex to the beginning of the next QRS complex and representsthe cardiac cycle length. If the RR interval is measuredin seconds,the heart rate = 60/RR.,Therefore,at a normal heart rate of 60 to 100/min, the RR interval is 0.6 to 1.0 seconds. n. \":+_4_9_Tus rhythm. Under normal conditions, the heart is depolarizedby impulses that o*rlginatein the SA node at a regular (or approximatelyregular) rate of 60 to 100/min and spreadto the remainder of the heart via the cardiacconduction system. This is callednormal sinus rtrythm. Three other sinus rhythms can be identified, which differ from normal sinusrhythm only in their rates;the impulsesstill originate normally in the SA node and are conductednormally to the remainder of the heart via the cardiacconduction system. l. In sinus tachycardia, the rate exceeds100/min. Sinus tachycardia is most commonly cauied by incieased syfrrpathetic stimulation of the heart, as in exercise,feve!, pain, and anterior myocardial infarction.
70
Physiology
2. In sinus bradycardia, the rate is less than 60/min. Sinus bradycardia can be causedby increised paiasymdthetic tone to the heart, as in some young healthy individuals (particularly well-trained athletes) and inferior myocardial infarction. It also can be seen in SA node dysfunction. 3. In sinus arrhythmiS, the rate is irregular, i.e., the_va4qtio" in thg RR interval exceeds0.16 seconds. The most common type of sinus arrhythmia is respirato_rysinusrrrhythmia, in which the rate-inc-r_eaqgs during inspiration a-nddecreasesduring expiration. E. Arrhythmias. The term arrhythmia refers to any cardiac rhythm other than normal sinus rhythm. The arrhythmias can be divided into disturbances of impulse conduction and disturbances of impulse origin.
Nole Arrhythmias aresometimes refened to asdysrhythmias.
* ARRHYTHMIAS l: DISTURBANCES OFIMPUTSE CONDUCTION
/ t--
Delaysor complete failure of conduction can occur in anypart of the cardiacconduction system, producing characteristicchangeson the ECG. The following discussionwill consider conduction disturbancesin the AV node (AV block) and bundle branches(bundle branch block).
L;
-_./ ' ,,.',.
A. AV block 1. First-degree AV block representsa delay in conduction of the impulse from the atria to the ventricles. This delay is most commonly due to abnormalities in the AV node and is reflectedby a prolonged PR interval, usually exceeding0.20 sec.First-degreeAV block may be due to a wide variety of-ggs_es,.including:
li.,t., 'z
)tQl r u /
''
'
7,4 F '-t f
a. lalasympathetic (vagal) stimulation b. Digitalis c. B-rec9-ptorantagonSJs d. Infiltrative or degenerativeconditions (amyloidosis,sarcoidosis,hemochromatosis, l""iil.r .Acification) e. Inflammatory processes(vual mJ.oc_arditis, ankylosing spondylitis, bacterial endo."rditis with myocardial abscess) f. Hypothyroidism g. Duchenne muscular dystropJry h. Congenital conduction systemabnormalities i. Isolated PR interval prolongation in otherwise healthy asymptomatic young adults, which is usually benign Second-degreeAV block representsan intermittent, usually periodic or cyclical,failure of conduction of the impulse from the atria to the ventricles.When the intermittent failure occurs in a regular pattern, it can be described by giving the ratio of the number of P waves (including the nonconducted P wave) to the number of QRS complexesper rycle (e.g.,3:2,4:3,2:l).Two typesof second-degree AV block can be identified: a. Wenckebach,or Mobitz Type I, second-degreeAV block ( 1) Mobitz Type I second-degreeAV block is characterizedon the ECG by (Figure I-4-24): (a) ryqg{ggliveprolongation of the PR interval before failure of AV conduction (i.e.,dropped QRS) occurs.
7l
System Cardiovascular
(b) Progressivediminution of the increment of PR interval prolongation before failure of AV conduction occurs. (c) Progressivediminution of the RR interval before failure of AV conduction occurs.
Progressively longerPR interval
/ P
Droppedbeat
P
P
J
Figure l-4-24. MobitzType lsecond-degree AV block.
(2) Mobitz Type I second-degreeAV block is usually du_eto a problem in the AV node; the tist of possibl. ."rrr., is identical to the list o? causesof first-degtie AV= block but should also include myocardial infarction, especiallyinferior myocard.1alinfarction. (a) Type I second-degreeAV block is usually_asymplom4lc, very rarely progressesto third-degree (complete) AV block, and therefore does not require prophylactic pacemakerinsertion. (b) If symptoms of decreasedcardiacoutput do occur,the patient may respond to atropine or isoproterenol. b. MobitzTlpe II second-degreeAVblock is characterizedon the ECG by a constant PRinterval before failure of AV conduction occurs (Figure I-4-25). The anatomic site of Mobitz Type II second-degreeAV block is almost alwaysbelow the AV node. Mobitz II block is frequently associatedwith bundle branch blocb it often progressesto third-degree(complete)AV block, and prophylactic pacing may be required.
Droppedbeat \ \ P
J\
P
P
I
P
\-
E.
t
Figure l-4-25. MobitzType ll second-degree AV block.
72
I
Physiology
c. In second-degreeAV block with 2:1 conduction, it is not possible to determine whether the block is Mobitz I or Mobitz II. In iqQrior myocardial infarction, Mobitz I is-Uqqfe-likely;in anterior my.ocardialinfarclion or in the pt.r.tt.e of bundle branch block, Mobitz is mgre likelylI 3. Third-degree (complete) AV block representsthe f4ilure of any impulses to be conducted frqm-Ue atrla,tq"the-ventrides. The yelqrcLeq,qrqdepolarized by an AV nodal or ventricular escaperhythm. Thus, third-degree AV block results in AV dissociation, i.e., the indgnendg3t{epolariiqtion of the atria and ventricles(Figure l-4-%).-
Figurel-4-26.Third-degree(complete)AV block.
a. Third-degree AV block must be differentiated from other causesof AV dissociati,on, with an ectopic junctional or ventricular escape such as marked sinuq-b_radyq4rdia pacemakerfiring at a rate faster than the SA node. b. Third-degreeAV block is manifestedby a slow ventricular rate,wi{e_pulsepressgle,a variablefirst heart sound, and prominent jugular venouspulsations,correspondingto right atrial contractions against a llosed tricuspid valve (cannon a waves). It may be causedby: (I) A utg.myocardialinfarction
(usuallyvalvular) tz) O_ry!99_t_95rg.ry (3) Degenerativeconduction systemdisease (+) C_9nggr1t{conduction systemabnormalities (5) Cardiomyopathy insertion to prec. Acquired third-degree AV block virtually dWgySr-e-quires-pacemaker vent CHF or shock secondaryto bradycardia and to prevent ventricular tachyarrhythis frequently asymptomatic, especiallyif the mias. Qo_"ggry!44_tr_4-4egfee,AV_block ventricular rate exceeds50/min. b. Bundle branch block representsfailure of conduction of the cardiac impulse through one of the bundle branches.Depolarization spreadsnormally through the other bundle branch, rapidly activating the corresponding ventricle. The affected ventricle is depolarized much more slowly. For example, in LBB blgck (LBBB), the right v_e_ntriql_q5&pq\,y_izedfirstand the leftventricle later,producing paradoxic4tsplitting of-the se.otrd heait ro.rttd. In the presenceof bundle branch block, the _QR!lnlerval is prolonged (to O.tZ secor longer). The QRS complexesin LBBB and RBBB have characteristic appearances(Figure l-4-27).
7t
System Cardiovascular
Lead I
LeadVu
Lead V.,
LBBB ) V
I
)
A\.,
\\
V
RBBB 1/]
U'-\
|\
/'
! U-.-
Figurel-4-27.TypicalORScomplexesin LBBBand RBBB.
t !
,t'.', \,r r-'
i..: / 1
I
r
(''
ll: DISTURBANCES OFIMPUISE ORIGIN . ARRHYTHMIAS In the disturbancesof impulse origin, the heart (or part of the heart) is depolarized by an impulse that originatesoutside of the SA node, i.e., an ectopic impulse. A beat resulting from an ectopic impulse is called an ectopicbeat. A. Escapebeats and rh)'thms. Under normal circumstances,pacemakercells outside of the SA node (e.g.,in the AV nodal area and His-Purkinje system)are latent: Becausetheir rate of depolarizationis slowerthan the rate of depolarizationof the SA node, they are depolarized by a SA nodal impulse before they can reach threshold and fire spontaneously. If, however, a SA nodal impulse fails to depolarize such pacemaker cells,they may reach threshold and produce an escapebeat or an escaperhythm. 1. Nodal or junctional escapebeats originate in the AV nodal area and reach the ventricles via the normal His-Purkinje system,producing a normal QRS complex. If SA nodal impulsesfail to depolarizethe AV nodal areafor a prolonged period, €.8.,in third-degree (complete) AV block located abovethe AV nodal pacemakers,junctional escaperhythm, typically at a rate of 45-60/min, will be seen. 2. Ventricular escape beats originate in an ectopic ventricular focus (generally in the Purkinje fibers) and produce an abnormal QRS complex that resemblesa PVC. If SA nodal impulsesfail to depolarizethETurkinje fibers for a prolonged period, e.g.,in thirddegree (complete) AV block located below the His bundle, ventricular escaperhythm, fyp,icallyat a rate of 3540lmin, will be seen. B. Supraventricular arrhythmias. Supraventricular arrhythmias originate abovethe ventricles and therefore are typically associatedwith normal QRS complexes. 1. A premature atrial contraction (PAC) occurs when an ectopic atrial pacemaker interrupts the underlying sinus rhythm by inserting an ectopicbeat before the next sinusbeat occurs. a. The P waveis usually abnormal in shapeand is thereforecalled a P'wave. b. The QRS complex is usually normal, but it may be abnormal (as a result of aberrant conduction of the premature atrial impulse) or even absent (if the AV node is still refractory from the precedingsinus beat), dependingon when the PAC occurs. c. PACs typically reset the SA node and are therefore followed by a noncompensatory Pause. d. PACsare usually benign.
74
Physiology
2. Wandering atrial pacemaker. The dominant pacemaker"wanders" from one atrial focus to another and in and out of the SA node. a. When the pacemakeris in the SA node, the P wave and PR interval are normal. Other P wavesare abnormal and vary in configuration; the correspondingPR intervals are usually longer. b. This arrhythmia is usually benign. (PSVT) is a_regulll:Igp-l9lll_9 to 250/min) 3. Paroxysmal suprave;tti;"1.;tachycardia arrhythmia _orry"1lglilgin the atria or AV node, often via a re-entry mechanism. divided into two a. AV nodal re_gntry (70o/oof all PSWs). The AV:n95!9-l!"pa_t_hologieally fun?lional pithways. The impulse proceedsantegradedown the slow pathway and retrograde back up the fast pathway in the majority of cases.The P wave is usually recorded simultaneously with the QRS complex; thus, a rapid ,.q,r.rr.. of normal QRS complextls ii typically seen on the ECG. This arrhythmia is frequently seen in older patients,of whom = 50o/ohave underlying heart disease. b. Atrid re-entry (I0o/oof all PSVTs).The re-entrant pathwayis in the atria. The P wave is recorded before the QRS complex. This arrhythmia is frequently associatedwith organic heart disease. c. Automatic atrial (5o/oof all PSVTs).Often, theseare not paroxysmal,lasting daysto years,and are resistantto treatment.The P wavehas an abnormal configuration. d. Treatment of the re-entry tnres of PSVTs includes stpport of blood pressurewith pressors(e.g.,norepinephrine) and maneuversto re-establish fl11rlgand,if necessary, normal sinus rhythm by interrupting the re-entry pathway: (1) IncreasingAV nodal refractorinesswith vagal maneuvers(e.g.,therelease_ofa Valsalva maneuver, carotid sinus massage),adg4-gqlng,9\.grt-acting acetylinhibitors (e.9.,edrophonium),9ig*i", y-.5rlgqf$ or p-receptor _ch9]!1eg19rase antagonists(e.g.,propranolol) (2)
-Cardioversion (3) Over{rive pacing (saferthan cardioversionif digoxin level is.bigh)
e. Following conversion of PSVT to normal sinus rhythm, the_-ECQ* mgy__qhow widespreadT wave inversion that may take 2 to 7 daysto resolve.It is usually a benign finding. 4. Atrialflutter is a regular,rapid (250 to 350/min) arrhythmia originating in the atria, often as a result of a wave of depolarizationthat propagatescontinuously within a closedcircuit (circus movement). On the ECG,atrial depolarizationis representedby flutterwaves (F waves), which typically have a "sawtooth" appearance, especiallyin leads II, III, and aVF.Becauseof the refractorinessof the AV node, a physiologicAV block is almost always present,and only one-half, or evenone-fourth, of the impulsesare conductedto the ventricles (2:l or 4:1 conduction). a. The degreeof AV block is decreased(i.e.,more of the atrial impulsesare conductedto the ventricles)by: (I) Sy_mpalhetic stimulation, €.g.,exercise (2) Accessorypathwaysbetween the atria and the ventricles,which rypically have shorter refractory periods than the AV node (3) Quini4ine, which slows impulse conduction in_atrial muscle and can lead to a "paradoxic" increasein the number of atrial impulses that passthrough the AV node to the ventricles. The anticholinergic (atropine-like) effectsof quinidine,
75
System Grdiovascular
which can decreaseAV nodal refractoriness,may also contribute to its ability to increasethe number of atrial impulses passingto the ventricles. b. The degreeof AV block is increased(i.e., fewer of the atrial impulses are conducted to the ventiiiles) b/_yagal maneuvers, digoxin, verapamil, and p-receptor antagonists (e.g.,propranolol). c. Atrial flutter should be suspectedwhenever an ECG shows a regular ventricular rate of 125to 150/min. If the patient does not have bruits on auscultation of the ;;bTra arteries,careful carotid sinus massagemay by increasingparasympatheticstimulation of the heart, result in a higher degree of AV block and may reveal the characteristic "sawtooth" pattern on the ECG (FigureI-4-28), which can otherwise be obscured by the QRS complexes.
Figure l-4-28. Atrial flutter.
(1) Atrid contractions are often ineffective in atrial flutter. Adequate cardiae-output .g" b. maintained only if the ventricular rate is sufficiently slow, i.e., if the degree of AV block is high enough. (2) Atrial flutter usually accompaniesorganic heart disease,such as coronary artery or valvular disease. d. The treatment_olatrial flutter should include: (1) Correction of fever, anemia, ischemia, pericarditis, electrolyte abnormalities, hlpovolemia, infections, hyperthyroidism, and valvular disease (2) Drugs and maneuvers that increaseAV block, as they may occasionally convert the rhythm to atrial fibrillation or normal sinus rhythm (3) Quinidine, but only after the AV node is blocked with digoxir_r propt_iiolol 9r (4) If necessary atrial pacing at l25o/oof the atrial rate for_3Q1gqgry\_ Spia (5) If necessarylow-voltage synchroniznd cardioversion 5. Atrial fibrillation is a common supraventricular arrhythmia (and one of the most common of all cardiac arrhythmias). In atrial fibrillation, randomly irregular, rapid (350__to 600/min) impulses from multiple atrial foci depolarize the atria. This chaotic atrial depo-larization is representedon the ECG by irregular, rapid, and continually varying undulations called fibrillatory waves (f waves), which are often most prominent in lead V Normal QRS complexesare recorded at irregularly irregular intervals, as the rapid atriai impulses are randomly conducted through the AV node.
76
Physiology
a. If the ventricula!_t4[e-js.over"200/minand the QRS complexesare abnormal, aberrant condiictio" accessorypathrvayshould be suspelied (e.g.,in Wolff-Parkinson"1" ""
M_t!ry.4fqqr.).
b. Atrial contraction is extremely ineffective in this arrhythmia. As a result, qtlg! fibrillation is usually associatedwith a fall in cardiac output, especiallyin patients who are elderly or-who hir," u noncompliant (stiff) left ventricle (e.g., due to ischemia or chronic hypertension). c. Tieatment of atrial fibrillation invovles the following: (t) Slqulthr-ventricular respensethrough administration of digo{in, a F-receptor antagonist,or yerapamil. (2) Conve_r!the pa!,ientto normal sinus rhythm. If the left atrium is large and the patient hasbeen in atrial fibrillation for a long time, a normal sinusrhythm may be difficult to maintain. The ventricular responseshould be slowed. (3) ,{nticoagulatethe patient iltbgre a{e no contraindicationsand if the atrial fibrillation has been presentfor more than two days. (a) Administer guinidile or procainamide; i! they are i-neffqc_tivg, e_lgctrical cardioversionshould be used. (5) MqLlLt4lItdigoxin plus quinidine or procainamide for 3 to 6 months after cardioversion. 6. Multifocal atrial tachycardia (MAI) is an irregular atrial rhythm in which impulses from multiple foci depolarizethe atria; however,the atrial rate (100 to 250/min) is slowerthan in atrial fibrillation. a. The diagnosticECG criteria (FigureI-4-29) for MAT are:the prese_nce of abnorm4l P waves(P'waves) of at leastthree different morphologies and an irregularly irregular rhythm.
P'waves
Figure 14-29. Murtifocaratriar tachycardia- onset in middre of rhythm strip. b. It is very important to distinguish MAT from wandering atrial pacemaker (a benign arrhythmia) and from atrial fibrillation (MAT does not respond to digoxin). MAT is an arrhythmia secondaryto serious, and not necessarilycardiac, disease.It is seen most commonly in COPD, postoperativesettings,and in elderly patientswith serious illnesses. c. The treatment MAT includes the improvement of the patient's underlying illness of -'- -:-'--(e.g.,correction of hypoxia, acidosis,fever,anemia), ayor.dalce_of aminophylline and sympathomimetics,and the useof verapamil.Note that cardioversionand digoxin are not indicated in the treatment of MAT.
77
Grdiovascular System
pace7. Acceleratedjunctionalrhythm.In acceleratedjunctional rhythm,Ulggally,latent regular, rate area depolarizes at a accelerated of 60 to 150/min. .T{.f_111!_:_AYlg,*al a. The P wavesare typically inverted and may precede,follow, or be hidden within the dnS ;oapieiCi-(Figure I-a-30). However, when the rate of the acceleratedpacemaker is closeto the rate of the SA node, the ectopic impulsesare often conductedto the ventricles only, while the atria remain under the control of the SA node; thus, acceleratedjunctional rhythm gan causeAV dissociation. b. Acceleratedjunctional rhythm is usually 4g._tg digoxin toxicity and may be clinically manifested first by the apparent "regularization" of the ventricular rate in atrial fibrillation. This arrhythmia may also be seenafteiin acute inferior myocirdial infarction. c. Treatment is often expectant;gg9y
should be withheld.
Figure l-4-30. Accelerated junctional rhythm.
C. Ventricular arrhythmias. Ventricular arrhythmias originate in the ventricles and therefore are associatedwith abnormal ("wide and bizarre") QRS complexes. 1. A premature ventricular contraction (PVC) occurs when an ectopic ventricular pacemaker inserts an ectopic beat before the next sinus beat occurs. The ectopic impulse spreadsthrough the ventricles via an abnormal route but is typically not conducted retrograde through the AV node to the atria. a. PVCsare representedon the ECG as shown in Figure l-4-31.
78
Physiology
Figure l-4-31. Premature ventricular contractions (PVCs) in a bigeminy pattern (i.e., each sinus beat is followed by a PVC).
(1) A "wide and bizarre" QRS complex,sincethe ectopicimpulse doesnot follow the normal rapid conduction systembut is conducted slowly through the ventricular myocardium (2) Large deflections in the QRS complex becausethe two ventricles do not depolarize simultaneously.Normally, the simultaneous opposing ventricular depolarizations partially canceleachother and reducethe sizeof the QRS deflections. (3) A compensatorypause following the PVC. The pause occurs because the AV node and/or ventriclesare refractory to the normal SA node impulse that immediately follows the PVC, but the next SA node impulse is conducted normally and produces a normal QRS complex. Thus, the underlyrng sinus rhythm is not disturbed. b. PVCs occur both in normal and in diseasedhearts. (1) In patients with normal hearts, PVCs are not associatedwith decreasedlife expectanry. (2) In patients with heart disease,PVCs may be a marker for a higher risk of other ventricular arrhythmias and sudden death. c. The use of antiarrhythmic drugs to treat PVCs has not been demonstratedto have a clear benefit, in part becausemost of thesedrugs haveproarrhythmic effects. Patients with symptomatic PVCs should be reassured;if necessary a B-receptor antagonist without intrinsic sympathomimetic activity (i.e.,without partial agonistactivity) can be administered. 2. Accelerated idioventricular rhythm (AIVR). In AIVR, a normally latent pacemaker in the ventricles depol arizesat a regular, acceleratedrate of 50 to 100/min. This arrhythmia is seen_mo_st commody _t" F&tr_or myocardial infarction ( Figure l- 4-32).
79
Cardiovascular System
vs
Figure l-4-32. Accelerated idioventricular rhythm.
a. The rate in AIVR is often similar to the sinus rate, so that the ECG may show fusion beats (i.e.,QRS complexesresulting from the simultaneousspreadof the ectopic and sinus impulses) at the onset and termination of AMR. b. If the patient is asymptomatic, no treatment is indicated; atropine may be used to increasethe sinus rate, while lidocaine may be usedto protect againstventricular tachycardia. 3 . Ventricular tachycardia (VT). In VT, ectopic impulsesoriginate in the ventricles at q rggf Iar, rapid rate of 1_00* to 250/min (Figure l-4-33).It is most frequently causedby a re-entry pechanism; in a smill minority of cases,it is causedby the fitiog of an ectopic focus. a. The ECG in VT shows: (l) "Wide and bizarre" QRS complexes,similar to PVCs (2) In some cases,evidencethat the SA node retains control of the atria (AV dissociation), such as fusion beatsand independentsinus P waves
Figure l-4-33. Ventricular tachycardia.
b. VT is usually associatedwith a decreasein cardiacoutput, due to decreasedtime for ventricular filling and absenceof an effective"atrial kick."
80
Physiology
c. Emergency treatment is alwaysindicated in sustained (more than 30 secondsduration) VT. Treatment includes: (1)
-Precordialthump
(2) C_ardiopulmonary.resuscitation (3 ) Synchronlzg{ cardioversion (4) Lidocaine (5) Procainamide
Nolc Torsades dePointes isa form of ventricular tachycardia in whichtheQRS amplitude andaxischange cyclically. It occurs mostcommonly in patients witha prolonged interval. QT
(6) Brerylium (7) B-recgptg*Lqntagonists d. Patients who have experienced repeated episodesof sustainedVT should be treated with an itpt."q{gtttqgt-ty.a_1dia pacemakeror sotalol. e. Patients who have experienced repeated episodesof nonsustained, symptomatic VT can be treatedwith F-receptorantagonists. f. Vag{mgreu_ve1q_hgye no effe-ct-o-n the rate of ventricular tachycardia. 4. Ventricular fibrillation. In ventricular fibrillation, ventricular depolarization is rapid and irregular, due to impulses originating tr multiql_e991opicventricular foci. a. Ventricular fibrillation can be triggered by a !VC- that occurs during the "vulnerable period" at the end of ventricular repolarization (the R-o4-T phenomenon). b. The ECG shows random electrical activity without recognizable QRS complexes (Figure l-434r. c. Emergency treatment of ventricular fibrillation includes: ( I ) Cardiopulmonary resuscitation (CPR) (2) Asynchronous defibrillation (3) Ep_ineph-rine and repeat defibrillation if necessary (4) Lidocaine (5) Procainamide d. Patientswho have experiencedrepeatedepisodesof ventricular fibrillation should be treated with an implanted defibrillator.
Figurel-4-34.Ventricularfibrillation.
8l
System Cardiovascular
(CHF) HEART FATTURE GoNGESTTVE Congestive heart failure may be defined as an inability of the heart to deliver a sufficient cardiac output to meet the metabolic demands of the peripheral tissues,despite normal or elevatedcardiac filling pressures. A. Pathophysiology 1. Initial causesof CHF a. Increased afterload, as in hypertension or aortic stenosis b. Increasedpreload, as with injudicious transfusionsor fluid infusions, or noniatrogenic accumulationof fluid volume (e.g.,due to renal disease) c. Severevalvular disease,which leads either to pressureor volume overloading of the ventricle(s) d. Chronic tachy- or bradyarrhythmias e. Impaired myocardial function (e.g., a large myocardial infarction, viral myocarditis, alcoholic or other cardiomyopathy) 2. Factors involved in the development of chronic CHF a. Sympathetic nervous system. Plasma norepinephrine concentration is commonly elevated in patients with CHR while myocardial tissue levels of catecholaminesare depleted.Systemicvasoconstrictionand tachycardiaare also common findings. b. Renin-angiotensin-aldosterone system. Plasma renin levels are elevated in some patients with CHF. c. Antidiuretic hormone. Antidiuretic hormone levelsare frequently elevatedin CHF. 3. Hemodynamic and hormonal factors contribute to sodium retention by the kidneys and developmentof peripheral and pulmonary edema,which characterizeadvancedforms of CHF. B. Symptoms
Clinical Conelate thedegree of Clinically, is oftenquantified orthopnea of intermsofthenumber pillows patient needs in the orderto sleepcomfortably "three-pillow (e.g., orthopnea").
1. Dyspnea refersto laboredbreathingand the sensationof shortnessof breath. In CHR the elevatedpulmonary capillary pressureand engorgement of the lungs with fluid increase the work of breathing, producing the sensation of effort characteristic of dyspnea. Dyspnea on exertion is usually one of the earliest symptoms of CHF. 2. Orthopnea is the sensation of dyspnea occurring while lying relatively flat in bed. Recumbencyresultsin a rise in the position of the diaphragm and a decreasein ventilatory reserve.More importantly, it causesincreasedvenous return from the dependent portions of the body, augmenting right ventricular output and further increasingpulmonary capillary pressure.Patientswith orthopnea report having to use additional pillows to sleepcomfortably. Orthopnea usually developsat a later stageof CHF than does exertional dyspnea. 3. Paroxysmal nocturnal dyspnea (PND). Patients with PND awake from sleep suddenly with a sensation of severebreathlessnessand gasp for air. They immediately sit up and PND has the same mechanism as may complain of cough as well as breathlessness. orthopnea.It may be a harbinger of impending acutepulmonary edema. a. Weight gain not explained by changesin diet or activity may be the earliest evidence of sodium and water retention associatedwith CHF. Approximately 10 lb of extracellular fluid accumulatesbefore it becomesevident as pitting edema.
82
Physiology
C. Signs l. Cardiac signs. Most patients with chronic CHF have an enlarged heart (cardiomegaly). Examples of relatively unusual conditions associatedwith CHF without cardiomegaly include restrictive cardiomyopathy and constrictive pericarditis. The heart appearslarge on the chestx-ray. The apical impulse is displacedlaterally and may be diffuse and boggy. fu S, gallop due to excessvenous return to the right atrium may be heard if left ventricular dilatation is severe. a. Cardiomegaly (eccentric or volume overload hypertrophy) involves volume overloading and dilatation of the ventricles. The ultrastructure of hlpertrophied fibers in this condition containsnormal distributions of myosin isomers. b. Concentric or pressure overload hlpertrophy is frequently not detectableon radiographs,but can be detectedon the ECG (increasedvoltage of the QRS complexes), which is usually quite sensitive to mass increasein the myocardium. The isomer of myosin produced in this type of hypertrophy is unusual and of a type with intrinsically slow myosin AIPase activity. 2. Vital signs a. Thchycardia is a common finding. Heart rate may be irregular, reflecting atrial fibrillation or frequent PVCs commonly associatedwith longstanding CHF. b. Arterial pressure may be high, normal, or, if cardiac failure is severe,low (shock). Pulsus alternans (variations in blood pressureassociatedwith alternating weak and strong left ventricular contractions) may be present if left ventricular dysfunction is very severe. c. Respiratory rate is commonly elevated. d. Temperature may be markedly below normal if the cardiac output is very low. 3. Pulmonary signs. Persistentlyelevatedpulmonary capillary pressuresresult in transudation of fluid from pulmonary capillaries into the interstitial spacesand, eventually, into the alveolar spaces.When the rate of transudation exceedsthe rate of absorption of the fluid by the pulmonary lymphatics, the accumulated edema results in pulmonary rales, initially heard only in the dependent portions of the lungs (i.e., the posterior bases). Severepulmonary edema may also be associatedwith wheezing secondary to bronchial wall edemaor bronchospasm. 4. Central venous pressure (CVP) is commonly elevated in patients with CHF. Increased CVP may be manifested by: a. |ugular venous distension. The peak of the maximum venous pulsation within the deep jugular venous systemis elevatedmore than 2 cm of vertical distance above the sternal angle when the patient lies in bed with the head elevatedto a 45-degreeangle. b. Positive Kussmaul sign. ]ugular venous pressureincreaseswith inspiration. c. Hepatojugular reflex. |ugular venous pressureincreasesmore than 2 cm after approximately 1 minute of heavy pressureexertedby the examiner's hands over the patient's abdomen while the patient breathesnormally. 5. Hepatomegaly. If right ventricular failure is present,the liver may become congestedand enlarged. The liver edge may be felt well below the costal margin and may be pulsatile if tricuspid regurgitation is present secondaryto right ventricular dilatation. Occassionally, CHF may produce splenomegaly as well as hepatomegaly.
8T
System Cardiovascular
6. Edema. Extracellular fluid initially accumulatesin the most dependent areas:in an ambulatory patient, the feet; in a bedridden patient, the lumbosacral area. a. Edema of CHF is characteristicallypitting: A finger applied against a bony structure produces a dimple or pit, which disappearsin 1 minute. b. Edema involving the entire body is referred to as anasarca. 7. Pleural effrrsions. Bilateral or right-sided unilateral pleural effirsions are common in patients with CHF. They are detectedby finding dullness to percussion in the lower lung fields and on chestx-rays. 8. Ascites. The transudation of fluid can result in its accumulation in the peritoneal caviry or ascites.Ascitesis usually seenin severebiventricular or right-sided heart tailure. 9. Cyanosis. Becausepatients with CHF have inappropriately low cardiac outputs, the flow through the capillarybeds is reducedand oxygenextraction is increased.The increasedconcentration of deorygenatedhemoglobin in the capillary beds results in a bluish hue of the skin, referred to ascyanosis.In contrast to cyanosiscausedby primary pulmonary diseases, the ryanosisof CHF is likely to remain unaffectedby the administration of oxygen. D. Classification of CHF 1. Clinically, CHF is usually classifiedby the severity of impairment of exerciseperformance according to the New York Heart Association Functional Classification: a. Class I: no limitations of activity; no symptoms with ordinary physical activity b. Class II: slight limitation of physical activity; symptoms with ordinary activity c. ClassIII: marked limitation of physicalactiviry; symptomswith lighter-than-ordinary activity d. ClassfV: symptoms presentat rest of circulatory impairment 2. Classificationbasedon more objectivemethods of assessment are also available.
In a Nutshell Strategiesfor TreatingCHF . Reduce (vasodilators) afterload . Reduce preload (diuretia) . Increase contractility (+ inotropes)
E. Principles of treatment. The initial efforts are understandably directed toward reversingthe existing initial causesof CHR such as surgical correction of aortic stenosisor treatment of hypertension, arrhythmias, or the causeof cardiomyopathy. If CHF persists,the goal of the therapy becomesimprovement of the patient's circulatory function. The mainstays of such therapy are: 1. Vasodilators (e.g.,captopril, hydralazine,nifedipine, nitroglycerine) to reduce left ventricular afterload 2. Diuretics (e.g., furosemide, thiazides) to reduce intravascular volume and ventricular preload 3. Positive inotropic agents (e.g.,digoxin, dobutamine) to improve ventricular contractility
84
Physiology
CARDIOVASCUTAR RESPONSE TOEXERCISE A. Definitions (Thble l-4-4) 1. Isotonic or dynamic exerciseis predominantly aerobic,is performed againsta constantload (isotonic), and involves rhythmic contractions of flexor and extensor muscle groups (dynamic). 2. Isometric or static exercise (i.e., weight lifting) refers to activity that is predominantly fueled by anaerobicbreakdown of glucoseto lactate,is performed at a relatively constant musclelength (isometric), and involvesminimal or no movement (static). ?able l-4-4. Overview of cardiovascular effects of exercise. Parameter
Isometric
Isotonic
Minimally increased
Markedly increased ,
Heart rate
Minimally increased
Markedly increased
Blood pressure
Moderately increased
, Systolicincreased, diastolic unchanged, and mean slightly increased
Cardiac index
Minimally increased
Markedly increased
Systemicvascular resistance
Relativelyunchanged
Markedly decreased
' Orygen consumption
I
B. Cardiovascular response to isotonic exercise 1. Initial anticipatory sympathetic outflow occurs even before exercisebegins, resulting in increasedheart rate, increasedcardiac output, and decreasedvenous compliance. 2. Shortly after the beginning of exercise,muscle blood flow increasesup to 15 times its resting value as a result of vasodilatation mediated by local factors such as hypoxia and changesin K*, H*, and AIP concentrations. 3. Circulating catecholaminesand direct sympathetic stimulation of the heart increasethe heart rate and the inotropic state. a. Early in exercise,increasedstroke volume is the most important adjustment. b. Later (beyond 50o/oof maximal work capacity), increased heart rate becomes more important in maintaining the cardiac output. c. At maximum exercisein well-conditioned individuals, cardiac output can be doubled by increasesin stroke volume and tripled by increasesin heart rate.
85
Cardiovascular Pathology
Cardiovascular disease affects a large segment ofthepopulation. Infact,atherosclerosis istheleading cause of deathintheUnited States. Because theeffects of cardiovascular disease arewidespread and potentially lethal, it isimportant to beableto identify themajorriskfactors foreachtypeof disease. Thischapter willfocus onthe$ructural andfunctional changes withdiseases thatoccur oftheheart andvessels, aswellasthemajorriskfactors associated witheachdisease entity. Notethatconduction abnormalities andarrhythmias werereviewed intheCardiovascular Physiology chapter.
CONGENITAL ABNORMATITIES OFTHEHEART A. Overview 1. Etiology a. During cardiacdevelopment,insults must occur before the end of week 16 (completion of heart development)in order for a congenitaldefectto occur. b. Chromosomal abnormalities (e.g.,trisomy 13, 18, 21) may lead to specific cardiac anomalies. c. Mendelian hereditary syndromes (e.g.,Marfan, Ehlers-Danlos) may also be associated with specificcardiacdefectsaswell aswith other developmentalanomalies. d. Environmental causes(e.g., maternal rubella, alcohol, smoking) may have variable effects,dependingon when and how severethe insult is to the mother and fetus. e. Up to 90o/oof congenitalheart diseaseis of unknown etiology. f. Cardiomegily, heart murmurs, and congestiveheart failure g. Chronic ryanosis,which will causepolycythemia, clubbing of fingers and toes, and hlpertrophic osteoarthropathy B. Acyanotic congenital heart disease (left-to-right shunts). In this disease,blood is abnormally shunted from the left to the right side of the heart. This causeschronic right heart failure and secondarypulmonary hypertension as a result of increasedpressureand flow. Right heart pressuremay eventuallyincreaseto becomegreaterthan left heart pressure,and the shunt will reverse,becoming a right-to-left shunt that resultsin late onset ryanosis.
GliniCal COrfelate
1. Ventricular septal defect (VSD) is an abnormal communication betweenventricles,usually at the membranousinterventricular septum.The clinical significancedependson the volume of the shunt. It is often associatedwith other defects.
Someof the loudest murmursareVSDs.
87
System Cardiovascular
Ostium primum
m
)
A. Ostiumprimumdefect
'i:tc
Septumprimum
lVC
Septum secundum Ostium secundum [A Septum primum
B. Ostiumsecundumdefect
Sinusvenosus Rightpulmonary defect veins Leftpulmonary verns Ostium primum
Pulmonary veins
Endocardial cushions lnterventricular septum C. Completeendocardialcushiondefect
Note Inapproximately 250/o of adult hearts, theatrialseptum actually remains open,butis keptfunctionally bythe closed pressure normal differential between therightandleftatria.
D. Sinusvenosusdefect
Figure l-5-1. Common configurations of atrial septal defects.
2. Atrial septal defect (ASD) is an abnormal communication betweenthe atria (Figure I-5-1). The clinical significancedependson the volume of the shunt. a. Ostium primum defects account for approximately 5o/oof all ASDs. The defect is in the lower atrial septum above the atrioventricular (AV) valves.It may be associated with maldevelopedAV valves. b. Ostium secundum defectsaccount for approximately 90o/oof all ASDs. The defect is in the center of the atrial septum at the foramen ovale, resulting from abnormalities of the septum primum, septum secundum,or both. It is not associatedwith maldeveloped AV valves. c. Complete endocardial cushion defect results in an ASD, a VSD, and a common AV canal.
Note pulmonary PDA causes hypertension dueto excess bloodto pulmonary artery (leads pressure). to t 88
d. Sinus yenosus accounts for approximately 5o/oof all ASDs. It causesa defect in the upper part of the atrial septum and may causeanomalous venous return from the pulmonary veins into the superior vena cavaor right atrium. e. Patent foramen ovale is a slit-like remnant of the foramen ovale and is usuallv not of clinical significance. 3. Patent ductus arteriosus (PDA) is a defect in which oxygenatedblood flows from the aorta to the pulmonary artery. This deprivesthe systemiccirculation of orygenatedblood
Pathology
and eventually leads to pulmonary hypertension. Indomethacin can be used to close a PDA, while the prostaglandinPGE can be utilized to keep it open if necessary. C. Cyanotic congenital heart disease (right-to-left shunts). In these diseases,blood is shunted from the right to the left side of the heart, causing poorly orygenated blood to be pumped out to the systemic circulation. This causesimmediate ryanosis and permits paradoxic embolism, in which venous emboli bypassthe pulmonary circulation and directly enter the systemiccirculation (Figure l-5-2).
Aorta
Aorta
Ductus arteriosus
Ligamentum arteriosum
Pulmonary valvular stenosis
ertton"ryf -/
artery
ding Right ventricular hypertrophy
aorta Ventricular septal defect
A. Tetralogyof Fallot
B. Transpositionof the great vessels
Figure l-5-2. Common forms of cyanotic congenital heart disease.
I . Tetralogy of Fallot has four specific anomalies and is the most common cyanotic con-
genital heart diseasein older children and adults. a. The four lesionsare: (1) VSD (2) An overriding aorta that receivesblood from both ventricles (3) Right ventricular hypertrophy ( ) Pulmonic stenosis (right ventricular outflow obstruction) b. The clinical significancedependson the degreeof right ventricular outflow obstruction. c. Deoxygenatedblood is shunted to the left side of the heart through the VSD, and blood flows from both ventricles into the enlargedaorta with little reaching the lungs. d. A PDA permits survival if the pulmonary artery is completely obstructed. 2 . Transposition of the greatvesselsresults from a failure of the truncoconal septum to spiral during development. The aorta arises from the right ventricle, and the pulmonary artery arisesfrom the left ventricle. This is often associatedwith other anomalies.Either PDA, a VSD, an ASD, or a patent foramen ovale mixes venous and systemicblood and, therefore, permits survival.
89
Grdiovascular System
3. Persistent truncus arteriosus is the failure of the aorta and pulmonary arteries to separate. There is also a VSD, usually at the membranous interventricular septum. The truncus arteriosusreceivesblood from both ventricles,so ryanosisresults. D. Obstructive congenital heart disease.This form of developmental defect typically does not causeryanosis. 1. Coarctation of the aorta a. In the preductal (infantile) tfpe, there is narrowing of the aorta proximal to the opening of the ductus arteriosus. b. In the postductal (adult) Qrpe,there is narrowing of the aorta distal to the opening of the ductus arteriosus. This is the most common tfpe, and generally allows survival into adulthood. 2. Pulmonaryvalve stenosisoratresia. This lesion maybe due to an unequaldivision of the truncus arteriosusso that the pulmonary trunk has no lumen or opening at the level of the pulmonary valve. It may causecyanosisif severe. 3. Aortic valve stenosis or atresia a. Complete atresiawill not support neonatallife. b. Bicuspid aortic valvesmaybe asymptomaticbut can lead to infectiveendocarditis,left ventricular overload, and sudden death. This lesion is the most common causeof aortic stenosis,replacingrheumatic fever.
E. Abnormalities associatedwith genetic syndromes 1. Marfan syndrome. One-third of patients have congenitalcardiovasculardiseasecharacterized by aortic dilatation and incompetence,aortic dissection,and ASD. 2. Down syndrome (trisomy 21). Twenty percent of patients may have congenital cardiovasculardisease,characterizedbyan ostium primum type of ASD and a VSD. 3. Turner syndrome patientsfrequently havecoarctationof the aorta and pulmonary stenosis. F. Abnormalities associatedwith perinatal insults 1. Maternal infection with rubella in the fifth to tenth weeks can lead to PDA, ASD, and VSD. 2. Fetal alcohol syndrome can lead to cardiovasculardefects,including VSD. 3. Maternal ingestion of drugs such as trimethadione (antiseizuremedication) and isotretionin (retin-A) can causefetal cardiacdefects.
(rHD) rscHEMrc HEART DTSEASE A. Overview 1. IHD occurs when the oxygen supply does not meet the orygen demand of the myocardial tissue. It is the leading causeof death (along with hypertensive and valvular diseases)in the United States. 2. Ischemiais caused(alone or in combination) by the following conditions: a. Narrowing of the coronary arteries, often precipitated by vasospasmor overlying thrombus is the most frequent causeof cardiacischemia.Most infarctions occur when multiple vesselsare narrowed.
90
Pathology
(l) Ninety percent of casesare due to atherosclerosis. (2) The underlying lesion is usually a complicatedplaque,with calcification,ulceration, or overlying thrombus. (3) Less common causesinclude dissecting aortic aneurysm, arteritis, coronary embolism, and cocaine-inducedvasospasm. (4) Perfusionis impaired when the cross-sectionalarea of the lumen is reducedby more thanTlo/o. b. Decreased oxygen-carrying capacity of the blood from anemia, carbon monoxide poisoning, pulmonary disease,or smoking may lead to cardiacischemia,particularly in combination with atherosclerosis. c. Increased myocardial demand from tachycardiaor hypertrophy may also increasethe risk of ischemia.
Note Thepathophysiology of isdiscussed atherosclerosis lateron inthischapter.
3. IHD is categorizedinto four syndromes. a. Angina pectoris is pain due to ischemia.Patientswith angina have an increasedincidenceof myocardialinfarction. b. Myocardial infarction is ischemic necrosisdue to insufficient blood supply. c. Chronic ischemic heart disease may or may not causeangina or myocardial infarction. Somepatientsmerely experienceheart failure. d. Sudden cardiac death is the presentingsymptom in 25o/oof patientswith IHD.
B. Angina pectoris. This syndrome is paroxysmal substernal or precordial chest pain, caused by transient myocardial ischemia without myocardial infarction. Prolonged and repeated angina pectoris may causefocal fibrosis and subendocardialmyocardialvacuolization,indicating gradual loss of myocytes. Angina and its resultant fibrosis are associated with impaired diastolicrelaxation,increaseddiastolicfilling pressure,and subsequentpulmonary congestionwith resultant dyspnea. l. Stable angina pectoris a. Paroxysmsare associatedwith a fixed amount of exertion. b. Typicat attackslast lessthan 10 minutes and are relieved with rest or sublingual nitroglycerin. c. EKG may show ST segmentdepressions(ischemialimited to subendocardium). d. Most angina pectoris is causedby severeatheroscleroticnarrowing of coronary arteries. 2. Prinzmetal angina pectoris (paroxysmal vasospasm) a. Vasospasmcausesdecreasedblood flow through atheroscleroticvessels. b. This form of attack frequently occurs at rest with ST-segmentelevationson EKG. 3. Unstable angina pectoris often leadsto myocardial infarction. a. It can presentwith prolonged chestpain, abnormally severepain, or pain at rest in a person with stableangina. b. It is often unresponsiveto nitroglycerin.
9t
Cardiovascular System
C. Myocardial infarction 1. Overview a. Myocardial infarction is ischemic necrosis of the myocardium, resulting from an abrupt decreasein coronary blood flow or a suddendemand for increasedmyocardial delivery, which cannot be met becauseof coronary artery narrowing. It is more commonly transmural, but can be subendocardial. b. Myocardial infarction is more common in men than women; the highest incidenceof fatal myocardial infarction is from 55 to 64 yearsold. c. Risk factors include hypertension, hypercholesterolemia,cigarette smoking, family history, diabetesmellitus, oral contraceptiveuse,and sedentarylife style. d. Type A personalities(aggressive, compulsive)may have an increasedrisk. e. Regular exerciseand moderate alcohol use (one glassof wine per day) may decrease the risk by raising the level of high-density lipoprotein (HDL). 2. Types of infarcts a. Tiansmural infarcts are infarctions of the fi.rll thickness of the ventricular wall. They are usuallydue to occlusionof vesselsfrom severecoronary atherosclerosis, formation of complicated atheromatous plaques with ulceration or fissure, and thrombosis. Occlusionsoccur most often in the proximal left anterior descending(50olo),right coronary (35o/o),and left circumflex (l5o/o)arteries. b. Subendocardial infarcts are infarctions limited to the inner half of the ventricular wall. The subendocardiumis more vulnerable to generalizedmyocardial hypoperfusion than are other areas,usually becauseof diftrse atherosclerosiswithout thrombosis and resultant borderline ischemia. Infarction occurs when flow is further compromised (e.g., CHF, shock, arrhythmia, vasospasm,severehypertension) or when oxygen demand is increased(e.g.,exertion,tachycardia). 3. Pathology a. Tiansmural infarcts ( I ) Grossly,transmural infarctspresentaccordingto the following scenario.A lesion extendsfrom the endocardium to the epicardium. No grosschangesare evident until 6-12 hours after the onset of myocardial infarction. In 6-24 hours, the myocardium becomesprogressivelypale,ryanotic, and swollen.In 24-48 hours, the infarct is well-demarcated,soft, and pale. In 3-10 days,the infarct becomes soft, yellow, and surrounded by a hyperemic rim. By 2 weeks,the infarcted area is surrounded by granulation tissuethat is gradually replacedby scartissue.By 2 months, the former myocardium is convertedto scartissue(Figure I-5-3).
92
Pathology
Note Wavyfibers+ highly eosinophilic bands of - very necrotic myocytes earlymicroscopic sign of myocardial infarction
Figure l-5-3. Myocardial infarcts (gross).
(2) Microscopically, transmural infarcts presentaccording to the following scenario. Within I hour, there is intracellular edema.Within 6 hours, there is wavinessof myocardial fibers, vacuolar degeneration,and contraction band necrosisat the periphery. Within 2+-72 hours, a neutrophilic infiltrate, increasedcytoplasmic eosinophilia, and coagulation necrosis become evident. Additionally, crossstriations begin to disappear.By the end of the first week, there is increased coagulativenecrosis,the appearanceof a mononuclear infiltrate, and granulation tissue at the margins where new vesselsstart to grow. In 8-10 days,there is an increasein granulation tissuewith ongoing phagocytosisand removal of necrotic myocardium by macrophages.By 4 weeks,collagenis becomingpredominant. By 2 months, there is a densefibrohyaline scarwith occasionallipofuscin-laden macrophages(FiguresI-5-4, I-5-5, and I-5-6). b. Subendocardial infarcts (1) Grossly, subendocardialinfarcts present as multiple small foci (0.5-1.5 cm) of necrosiswithin the inner half of the myocardial wall. (2) Microscopically, they develop like transmural infarcts, only over a longer period of time, causingthe inflammatory reaction to take somewhatlonger to develop.
95
System Cardiovascular
Figure l-5-4.Acute infarct,48 hours (microscopic).
Figure l-5-5. Healing infarct, 10 days (microscopic).
94
Pathology
"fi.t,
fi;r: Figure l-5-6. Healed infarct,3 months (microscopic).
Note 4. Clinical features a. There is acute,severe,crushing chestpain, often radiating to the jaw or left arm. b. The pain is associatedwith diaphoresis,a senseof impending doom, nausea,anxiety, and shortnessof breath. c. ECG abnormalitiesconsistof ST elevationand T-waveinversion (with Q-wave development) and ST depression(without Q-wave development).Q wavesmay develop with transmural infarcts.
presentations of Ml Atypical paincan withlittleor nochest in beseenmostfrequently diabetic women, theelderly, patients. patients, andsurgical
d. Elevatedcardiacenzymes(Figure l-5-7) include: (l) MB isoenzymeof creatinekinase (CK-MB), which is the most sensitivein common use (2) Lactate dehydrogenase(specificallythe LDH I isoenzyme),which is elevated rather specifically in myocardial infarction (3) Serum glutamic-oxaloacetic transaminase (SGOT) or aspartate transaminase (AST), also risesand falls predictably in myocardialinfarction, but may indicate liver damageinstead.
95
System Cardiovascular
Clinical Correlate CK-MB isthestandard enzyme usedto diagnose infarction inthe myocardial laboratory. Approximately 200/o is of CKinthemyocardium restisMM.ln MBtype;the muscle, skeletal only2olo of CKisMBtype.Therefore, to provemyocardial infarction, it isimportant notonlyto quantitate butto show CK-MB thatitsfraction oftotalCK LDHmaybe exceeds 5ol0. forshowing that valuable infarction myocardial occurred risen whenCKhasalready levels. andfallen to normal T isprobably a Troponin testforthisbutis better notwidely available.
(t,
= o
.= .n o tL
Time (hours) Figure l-5-7.Enzymology of myocardial infarction. (CK = creatinekinase;LDH = lactatedehydrogenase; AST = aspartatetransaminase;and SGOT = serum glutamic-oxaloacetic transaminase)
5 . Prognosis a. Suddencardiacdeath,secondaryto a fatal arrhythmia, occursin25o/oof patientswith an acutemyocardial infarction. b. Mortality after myocardial infarction is 35oloin the first year, 45o/oin the secondyear, and 55o/oin the third year. c. Eighty-five to ninety percentof survivors developcomplications. 6 . Complications are listed below in order of frequenry. a. Arrhythmias (ventricular fibrillation is the most serious).Ischemia and necrosisof the AV node and three fasciclesof the conduction systemcan lead to heart block with compromiseof cardiacfunction. b. CHF may be seenwith a loss of 20o/oor more of the ventricular muscle. c. Cardiogenic shock resultswhen there is a loss of 40o/oor more of the left ventricular muscle,resulting in the inability of the heart to maintain an adequateoutput to vital organs.Mortality is greaterthan 80%. d. Thrombus formation, resulting from lack of contractility of the infarcted area and abnormal endothelium, may follow myocardial infarction. This may be a source of systemicor cerebralemboli in large anterior wall infarctions. e. Aneurysm formation (outpouching of noncontractile scar) results in depressionof cardiac output; rupture is uncommon. It may be the site of ectopic ventricular electrical activiry leading to fibrillation. f. Myocardial (ventricular) rupture (l) Patients are most susceptiblel-7 days after infarct, when the myocardium is necrotic but granulation tissueformation has not really begun. (2) Rupture is most common with anteroapicalinfarction and is almost uniformly fatal; it resultsfrom suddenbleeding into the pericardial sacand tamponade. g. Postinfarction pericarditis (Dresslersyndrome) occurs 2-10 weekspostinfarction. h. Acute mitral insufficiency may be caused by papillary muscle infarction with or without rupture.
96
Pathology
7. Treatment and management a. Coronary artery bnrass with saphenousvein or internal mammary artery grafts restorescirculation and eliminatesangina. Grafts last approximately l0 yearsbefore restenosistypically occurs. b. Angioplasty (balloon dilatation) also restorescirculation; half restenosein 1 year.
Bridgeto Pharmacology Smalldailydoses of aspirin have beenshoum to reduce the incidence in men. of reinfarction
D. Chronic ischemic heart disease 1. Pathogenesis.Chronic ischemic heart diseaseresults from prolonged ischemia, most often due to atherosclerosis. 2. Pathology a. Grossly, chronic ischemia presents as a small or sometimes enlarged, brownishcolored heart. b. Microscopically, it presentswith myocyte atrophy and dififrrsefibrosis. 3. Clinical features.It is usuallyasymptomatic(exceptfor angina) until the late stages,when CHF supervenes. E. Sudden cardiac death 1. Overview. Suddendeath is defined as unexpecteddeath of cardiacorigin within t hour of the onset of acutesymptoms;it is usually due to a fatal arrhythmia. 2. Etiology. It is causedby IHD with coronary artery occlusion (most common) or by aortic valve stenosis,myocarditis, mitral valve prolapse, conduction disturbances,or cardiomyopathy. 3. Incidence. Out of 750,000 deaths every year in the United Statesas a result of heart disease,approximately50o/oare due to sudden cardiacdeath.
RHEUMATIC FEVER ANDRHEUMATIC HEART DISEASE A. Acute rheumatic fever (ARF) is a recurrent inflammatory diseasethat typically follows pharyngitis causedby group A B-hemolytic streptococci. l. Incidence. ARF is found mainly in children 5-15 yearsold. There has been a declining incidenceand mortality in the last 40 years,mostly due to penicillin, though the incidence beganto drop evenbefore penicillin was widely used. 2. Pathogenesis.Antistreptococcalantibodies made by the infected host cross-reactwith host connectivetissue(i.e.,cardiac,pulmonary, synovial,peritoneal) antigensand lead to end-organ damageby an immunologic mechanism. 3. Clinical features a. Onset is typically 1-3 weeksafter streptococcalpharyngitis,otitis media, or tonsillitis. b. Major Jonescriteria. In context of prior streptococcalinfection, the presenceof two of five clinical features (major Jones criteria) is sufficient to diagnose ARF. Alternatively,the presenceof one major fones criterion plus two minor |ones criteria (see"c" below) is also highly suggestiveof the disease. (1) Migratory polyarthritis involvesthe larger joints of the extremities,producing red, swollen,and painful manifestations.This featureis more common in adults than children.
Bridgeto Microbiology KeyFeatures of GroupA Streptococci . B hemolytic , HaveM protein thatconfers virulence . Catalase negative . Sensitive to bacitracin . Produce streptolysins SandO
97
System Grdiovascular
(2) Erfthema marginatum is a macular skin rash,often in a "bathing suit" distribution. (3) Sydenham's chorea is involuntary, choreiform movements of the extremities that are seenmore frequently in women. (a) Subcutaneousnodules containing Aschoff bodies. (5) Carditis may affectthe endocardium,myocardium, or pericardium. Myocarditis causesmost deathsduring the acutestage.Chronic scarringof the endocardium and heart valvesmay lead to chronic rheumatic heart disease(RHD). c. Minor Jones criteria include previous rheumatic fever, fever, arthralgias, prolonged P-R interval on ECG, elevatederythrocyte sedimentationrate, leukocytosis,and elevated C-reactiveprotein. 4. Complications. Initial episodesof ARF last weeksto months and often recur into young adulthood. Mortality is low, but the diseaseoften leads to chronic valvulitis of the mitral and aortic valves.
B. Rheumatic heart disease (RHD) causes dysfunctional, deformed heart valves through chronic inflammatory insult, deposition of fibrin and plateletthrombi, and then fibrosis. 1. Clinical features. The patient is usually asymptomatic from puberty until young adulthood. a. Valve leaflets become red and swollen and develop fibrinous, friable vegetations (verrucae)along lines of closure. b. The mitral valve is most commonly (75-80o/o)affected.Next in frequenry is the aortic and mitral valvecombination (20-25olo).The aortic valve alone is involved in 30o/o of patients.The tricuspid and pulmonic valvesare rarely affected. c. Valvedysfunction usuallypresentsasa combination of stenosisand insufficienry with one predominating. d. Fibrosis and deformity lead to "fish mouth" or "buttonhole" stenosisof the mitral valve,which may causethe patient to presentwith cardiacmurmurs,left atrial dilatation, mural thrombi, and right ventricular hypertrophy. e. Chronic valvulitis predisposesto infective endocarditis.CHF is the ultimate result, although it takesyears to develop. 2. Pathology a. Aschoffbodies
In a Nutshell = rheumatic bodies Aschoff heartdisease
(1) Aschoffbodies are pathognomoniclesions,usuallylocatedin interstitial myocardial connectivetissue,especiallynear vessels,but may be found elsewhere(e.g., subcutaneousnodules,pericardium). (2) Aschoff bodies consistof focal collectionsof perivascularfibrinoid necrosissurrounded by inflammatory cells.They contain large histiocytes (Anitschkow cells) with an irregular, ribbon-like nucleus and eosinophilic cytoplasm.These may becomemultinucleated (giant Aschoff cells). (3) Eventually,the Aschoffbody is replacedby a scar. 3. Treatment involves prophylaxis of infective endocarditis, balloon valvuloplasty, or valve replacement.
98
Pathology
HYPERIENSIVE HEART DISEASE Systemichypertension,leadingto left ventricularhypertrophy,produceshypertensiveheartdisease, A. Diagnosis requiresleft ventricular hypertrophy;a history of hypertension;and absenceof vahrllar, congenital,or aortic abnormalities. B. Pathology l. Grossly, this syndrome pres€ntswith cardiomegaly,left ventricular hypertrophy and eventualleft ventricular dilatation. Heartsmayweightwo to threetirnesnormal.
ltf!: Leftventricular trypertroptry canbedetected viax-rayor echocardiagram
2. Microscopically,h1)ertensiv€heart diseaseshowsdiffrrseand scatt€redmyocfte hypertrophy; and eventualfibrosis,atrophy,and degeneration(afteryears). 3. Chronic pressureoverloadresultsin compensatorymyocfte hypertrophy(myocytescannot replicate).Myoc''te hypertroPhyand fibrosis decreasemyocardialcompliance,limit diastolicfilling, increaseoxygendemand,and increasethe risk for myocardialischemia. C. Clinical features.HypertensiveheartdiseaseclinicallypresentsasCHF in onethird of cases, suddencardiacdeath,stroke,or renal failure (alsodue to atherosclerosis and ischemia).
(CHD GoNGESTTVE HEART FATTURE A. Overview 1. CHF is often the final outcomeof many cardiacdiseases, resulting from the inability of the heart to provide adequatecardiacoutput to meetthe body'smetabolicdemands. 2. It is most often due to decreasedmyocardialcontractility (e.g.,myocardialinfarction or fibrosis)or presswe/volume overload(e.g.,hypertension). 3. Compensatorychangesthat increasetle worHoad of the heart and ultimatd result in cHF:
t{ote
b. Tachycardiain responseto decreased strokevolume.
Although CHFispreviously discussed in the Grdiovascular Phpiology chapter, it is soclinically
c. saltandwaterretention, whichcauses anexpansion of bloodvotume.
ffi$::H
a. Hypertrophy and dilatation (Figure I-5-8) of the heart causedby compensationfor increasedworkload or volume.
Hff:ll,ur.
99
Grdiovascular System
Figure l-5-8. Biventricular dilatation (gross).
B. Left-sided heart failure (decreasedsystolic ejection of blood) 1. Etiology. Left-sided heart failure is most often causedby ischemic heart diseaseand valvular disease(particularly aortic stenosisor insufficienry), hypertension,or cardiomyopathy. 2. Clinical features a. Pulmonarycongestion and edema, resulting from pooling of blood in the pulmonary circulation, causeincreasedpulmonary venous pressure.Clinically, patients present with shortnessof breath,orthopnea,paroxysmalnocturnal dyspnea,and cough. b. Renal hypoperfusion stimulates the renin-angiotensin-aldosteroneaxis, causing retention of salt and water. Fluid retention exacerbatesthe pulmonary edema. Hypoperfusion may also causeprerenal azotemiaand acute tubular necrosis. c. Cerebral hypoxia, secondary to decreasedperfusion, nny lead to encephalopathy, stupor, or coma.
C. Right-sided heart failure 1. Etiology. Right-sided heart failure is most often causedby: a. Left-sidedheart failure, causingback pressurethrough the lungs b. Cor pulmonale, valvular disease(particularly pulmonary stenosisor insufficiency), and cardiomyopathy.Mitral stenosisand insufficiency lead to back pressureon the right ventricle. 2. Clinical features. Right-sided failure is characterized by systemic venous congestion, leading to: a. Chronic passivecongestion of the liver (nutmeg liver) with eventual centrilobular necrosis,followed by central hemorrhagic necrosis,and finally, (with fibrosis) cardiac sclerosis b. Renal hypoperfusion with salt and water retention (more severethan in left-sided heart failure) c. Splenomegaly
t00
Pathology
d. fucites, edema,pleural effrrsions,and cerebralhypoxia D. C,orpulmonale is right ventricular failure, resulting specificallyfrom pulmonary hypertension. 1. EtiologT a. Pulmonary parenchymal disease,causing increased pulmonary vascular resistance (e.g.,COPD, TB, pneumoconiosis,or carcinoid)
ClinicalCorrelate Hallmarkof Clinical Failure Right-Sided . Jugular distension venous (JVD)
b. Pulmonary vasculardisease(e.g.,vasculitis,shunts,or multiple emboli)
. Hepatomegaly
c. Restrictive chestwall abnormalities (a rare cause)
. Splenomegaly
2. Types
. Ceneralized edema
a. Acute cor pulmonale is a dilatation of the right ventricles caused by massive pulmonary embolization that may causetricuspid regurgitation. b. Chronic cor pulmonale is a gradual hypertrophy of the right ventricle, usually due to pressureoverload.
SHOCK A. pathogenesis.Shockoccurswhen decreasedblood volume or decreasedcirculation leadsto inadequate perfusion of body tissuesand cells. B. Etiology l. Decreased cardiac function leads to inadequate cardiac output. Myocardial infarction, arrhythmia, tamponade,or aortic stenosisall may lead to reducedoutput. 2. Reduction of blood volume, resulting from hemorrhage, adrenal insuffi.ciency(Addison disease),or fluid loss (vomiting and diarrhea),may lead to poor perfusion evenwith adequate cardiac function. 3. pooling of blood in peripheral vesselsmay occur as a result of the loss of vascular tone causedby bacterialtoxins and vasoactivesubstances(free radicals,anaphylatoxins).This results in loss of vascular volume into the extracellular space. C. Complications. Cellular hnroxia leads to increased anaerobic metabolism and resultant lactic acidosis,causing: 1. EncephalopathY 2. Myocardial necrosisand infarcts 3. pulmonary edemaand "shock lung" (adult respiratory distresssyndrome) 4. Acute tubular necrosisin the renal cortex 5. Various hypoxic injuries to other organs D. Stagesof compensation in shock l. Compensated stage. In this stage,early hypotension leads to reflex tachycardia and to peripieral vasoconstriction, stimulated by the CNS, causing cold, clammy, and pale extremities. 2. Decompensated stage a. Initial compensatory changes become insufficient to maintain adequate cardiac output.
to PhysiologY Flashback and tachycardia Reflex peripheral vasoconstriction viabaroreceptor occur BarorecePtors mechanisms. inthe in detail arediscussed Physiology Cardiovascular chapter.
b. Decreasedblood pressure,increasedtachycardia,metabolic acidosis,respiratory distress,and decreasedrenal output may all eventually occur.
t0l
Grdiovascular System
3. Irreversible stage. The above changes lead to irreversible cellular damage, coma, and death. E. Tr€atment. Corr€ction of the initial metabolic and physiologic derangements (prior to the irreversible stage) permit reversal of organ damage and prevent coma and death.
ENDOCARDITIS A. Infective endocarditis is the colonization of heart valves with bacteria. 1. Pathology a. Grossly, the colonies form large, friable, yegetative masses,overhanging the free margins of the valve leaflet, prosthetic valve, or other cardiac defect, b. Microscopically, a mass of clot, fibrin, and bacteria is seen.In the healing phase,there is fibrosis and calcification. c. Infective endocarditis usually involves the mitral valve. d. It can involve right-sided valves in intravenous drug users,but left-sided valves may be involved as a result of paradoxic embolization or when bacteria flow through the pulmonary capillaries. 2. Etiology
Note . Acutebaclerial endocarditis:
phyIococcu mostlikelySto s . Subacute: morelikely viridons StrEtococcus
a. There may be implantation of colonies ftom transient (i.e., dental procedures, minor skin infections) or persistent bacteremia (i.e., infected intrav€nous cathet€r). b. Strqrtococci cause6570 of infective endocarditis, usually producing a subacute bacterial endocarditis.
c. Staphylococcicause20-30 of infectiveendocarditis,usuallyproducingacutebacterial endocarditis.Intravenousdrug abuseoften causesstaphylococcalinfection ftorn the skin,but th€ spectrumof organisms is wide. d. candida is a causeof endocarditisin intravenousdrug users. e. Risk factors (1) Congenital cardiac anomalieswith high pressur€jet streams (e.9., VSD or stenoses)that produceendothelialinjury. (2) Valvular abnormalities(e.g.,mitral valve prolapse,prostheticvalves,bicuspid aortic valve,and RHD). (3) Immunosuppression,neutropenia,and intravenousdrug abusemay contribute to infectiveendocarditis. f. Bacterial by products are swept off infectedvalves,resulting in the absenceof an inflammatory reaction. This explains how a tfpically nonyirulent organism (e.g., Sfieptococcus vifidans) cancauseprogressivedisease, 3. Tlpes
Clinital Correlate Endocarditis involving therightsideof theheart suSgests intravenous druguse.
t02
a. Acut€bacterial endocsrditis (ABE) (1) Infeaion is usuallycausedby higl y vtulent organismssuchassaphyloacctts and streptococci(35%)' and it is tvpicallv seenin previouslvnorffi?f::l' (2) It oft€n involvesthe tricuspid valvein intravenousdrug users.
Pathology
(3) The acute onset clinically presentswith faneway lesions (erythematous,nontender lesions on palms and soles),representingembolized bacterial colonies, anemia,splinter hemorrhages in the nail beds (also representingemboli), high feverwith chills, hematuria causedby microemboli in the kidney,petechiae,and splenomegaly. (4) Vegetationsmay becomelarge,leading to myocardial abscessformation or systemic septic emboli. Vegetationsmay eat through valve leaflets,producing the suddenonset of valvular incompetenceand a new heart murmur (Figure I-5-9).
ts
'k
Figure l-5-9.Acute bacterial endocarditls, Staphylococcus aureus(gross).
b. Subacutebacterial endocarditis (SBE) ( 1) Etiology. Infection is causedby organismsof low virulence,suchasStreptococcus viridans, Staphylococcusepidermidis, enterococci, or Gram-negative bacilli. Candida infections are rare and are usually associatedwith indwelling vascular catheters. (2) Pathology. It is typically seenon previously abnormal valves.Regionsof turbulent blood flow produced by abnormal valves permit formation of sterile platelet-fibrin aggregateson valve leafletsthat become seededduring transient bacteremia.Vegetationsare lessbulky and lessinvasivethan in ABE. (3) Ctinical features. There is an insidious onset,clinically presentingwith positive blood cultures,Roth spots (retinal hemorrhageswith pale centers),Osler nodes (erythematous,tender lesionson fingersand toes),fatigue,low-gradefeverwithout chills, anemia,splenomegaly,and hematuria. 4. Complications of infective endocarditis a. Cardiacvalveperforation with acuteheart failure in acuteinfective endocarditis b. Myocardial abscessformation with perforation of the septum or involvement of the conductionsystem,leadingto heart block c. Mitral annulus and papillary muscle abscesses, leading to mitral valveprolapse
t05
cardiovroftt Systcm
d. Right-sided septic emboli, causing pneumonia or lung abscess in the brain, spleen,and kidney e. pft-sided septic emboli, causingstrokesand abscesses f. Nephritis may occur bY: (l) Immune complex deposition of IgM, complement component C3, and bacterial antigen in glomerular basementmembranes (2) Septicemboli,leading to renal abscessformation with rupture of the abscessinto renal tubules, causing hematuria B. Nonbacterid thrombotic (marantic) endocarditis l. Irsions are made of fibrin and platelets, producing sterile, small vegetations, loosely adhering along lines of closure of cardiac valves. The mitral valve is most commonly affected.These sterile vegetationsmay embolize, causing systemic infarctions. They may also provide a nidus for infective endocarditis.
t{ot! Marantic andvenucous arerare endocarditis and withacute compared endocarditis. subacute
2. Marantic endocarditis is associatedwith chronic illness (especiallycancer) and disseminated intravascular coagulation (DIC). There is also an increasedrisk with Swan-Ganz catheters,hypercoagulablestates,and starvation. C. Nonbacterial verrucous (Libman-Sacks) endocarditis l. This form of endocarditis typically produces mitral and tricuspid valvulitis in Patients with systemic lupus erythematosus (SLE). 2. Fibrinoid necrosisand subsequentsterile fibrosis of valvesmay occur. Patients may form small, warty vegetationson both sidesof their valve leaflets. 3. Nonbacterial endocarditis of this type rarely provides a nidus for infective endocarditis.
DISEASE HEART VALWLAR A. Mitral vdve prolapse 1. Etiology a. Prolapseof the mitral valve will lead to mitral insufficiency. The mitrd leaflets (usually the posterior leaflets) billow into the Ieft atrium during systole,leadingto insufficiency. b. Some casesmay be due to a defect in connective tissue metabolism. 2. Pathology a. Grossly, it presentsas large ballooning leaflets with elongated,drawn out, and possibly ruptured chordae tendineae. b. Microscopically, degeneration of the outer zona fibrosa and thickening of the inner zona spongiosaare seen. 3. Incidence. Mitral valve prolapse (MVP) is found in7o/o of the United Statespopulation, most commonly in young women; it is seenin most patients with Marfan's syndrome. 4. Clinical features a. Mitral prolapse presents with a characteristic midsystolic click and high-pitched murmgr. Patients are usually asymptomatic but may have dyspnea,tachycardia,chest pain, syncoPe,eventual CHR or, rarely, sudden death'
r04
Pathology
b. Prolapsemay coincidewith tricuspid or pulmonary valvedisease.It may alsobe associated with psychiatric conditions (e.9., anxiety, depression)through an unknown mechanism. 5. Complications include atrial thrombosis, calcification,infective endocarditis,embolization (to brain), rupture of chordae,arrhythmias,and suddendeath.MVP can alsolead to mitral regurgitation/insufficiencyand premature ventricular contractions ( PVCs). B. Mitral stenosis 1. Pathogenesis.Mitral stenosisis due to scarring, caicification, and fusion of the mitral valve, interfering with its opening (FiguresI-5-10 and I-5-11). It is most commonly causedby rheumatic heart disease.
Figure l-5-10.Normal mitral valve (gross).
Figure l-5-11.Mitral valve stenosis: "fish mouth" (gross).
t05
System Grdiovascular
2. Clinical features a. Mitral stenosispresentswith increasedleft atrial pressureand an enlargedleft atrium. Stenosismay be combined with mitral valve prolapse. b. An early diastolic opening snap is characteristic of mitral stenosis. Severemitral stenosiscan lead to backr,vardfailure (e.g.,CHF) if the valve fails to open sufficiently. 3. Complications. Prolonged stenosis,producing left atrial enlargement, may eventually produce chronic atrial fibrillation, which predisposesto atrial thrombosis.
Note = regu rgitation Insufficiency Backflow through theaortic valveleads to 1 LVvolume, t tittingpressure, therefore leading toLVfailure.
C. Aortic valve insufficiency 1. Acute a. It may lead to left ventricular failure due to increasedleft ventricular filling pressure, inadequatestroke volume, decreaseddiastolic filling time (due to reflex tachycardia), and myocardial ischemia. b. Acute insufficiencymay result from perforations or tearsfrom infective endocarditis. 2. Chronic a. The left ventricle will dilate and hypertrophy to accommodatethe gradual increasein regurgitatingdiastolicvolume and to maintain adequatenet cardiacoutput. b. A wide pulse pressure(clinically seenas bounding pulses)causesreflex tachycardia. c. It may be due to a congenitallybicuspid aortic valve,RHD, or syphilis. D. Aortic valve stenosis 1. Etiology a. Calcific (degenerative)heart diseasecauses90o/oof stenoticvalves. b. The aortic valve is affected somewhat lessthan the mitral valve in RHD. c. Congenital heart diseasecausesa higher percentageof stenosissince the advent of penicillin.
2 . Incidence increaseswith age. 3 . Pathology a. It is often associatedwith a congenitallyabnormal (e.g.,bicuspid) aortic valve. b. Grossly,it presentsaslargecalcifiedmasseswith thickening and fibrosis of valvecusps without fusion of valve commissures;rheumatic aortic valve stenosisinvolvesfusion of the valve leaflets. 4. Clinical features a. It presentswith angina, syncope,and CHF; it is often asymptomaticuntil late in the courseof the disease. b. Signsof increasingstenosisinclude decreasingperipheral pulse pressure,slowing of the carotid upstroke,and increasingleft ventricular hlpertrophy as a result of chronic pressureoverload. c. A systolicejection click is characteristicof aortic valve stenosis. 5. Complications. It may lead to sudden death,secondaryto an arrhythmia or CHF. 6. Treatment. Definitive treatment is surgicalreplacementof the aortic valve.
t06
Pathology
the ring of tissue surroundE. Mitral annulus calcification is a deposition of calcium within disorder' noninflammatory ing the baseof the mitral valve.It is a degenerative, mitral valvering to close 1. It may lead to mitral regurgitationbecauseof the inability of the during contraction of the Ieft ventricle' 2. It usually occurs in the elderly and is associatedwith IHD. F. Valve replacement may be indicated in: 1. Both mechanicaland bioprosthetic (usually porcine) valves a. Mitral and aortic valve stenosis b. Mixed mitral valve stenosisand insufficiency c. Mitral and aortic valve insufiiciency (regurgitation) 2. Complications that occur in 100/oof patients a year' include: a. Thromboembolism b. Infective endocarditis by calcification of c. paravalvularleak through the suture line (a problem exacerbated the mitral annulus) RBCs as a result of the d. Microangiopathic hemolysis (mechanicaltrauma to passing fragmented RBCs observing by diagnosed is presence-of u1 artificial valve). This (schistocytes)on the blood smear'
MYOCARDITIS that may lead to necrosis' A. Overview. Myocarditis is an inflammation of the myocardium seenin collagen vascular Noninfectious myocarditis may be due to a hypersensitivity reaction to pathology in viral contribute also may It allergies. diseases,rheumatic fever,SLE,and drug may alsoproduce myocarditis' myocarditis.Tiauma, which producesinflammation or necrosis, B. PathologY four chambers' A diffuse but 1. Grossly, it presentswith dilatation and hypertrophy of all foci of fibrosis can be patchy hemorrhage in the myocardium wiih eventual small,pale seen. lesionswith: 2. Microscopically, myocarditis is characterizedby focal inflammatory or granuloma in bacterial myocarditis a. A neutrophilic infiltrate, abscess, b. A mononuclear infiltrate and necrosisin viral myocarditis formation in Fiedler c. An eosinophilic infiltrate with giant cell and granuloma myocarditis C. Etiology (especially coxsackie B 1. Viral myocarditis is the most common form of myocarditis virus). as etiologic agents' a. Polio, rubella, and influenza viruseshavealsobeen described lead to cardiomyopathy and b. It is usually self-limited, but it may be recurrent and death. myocarditis on autopsy' c. Approximately one-third of AIDS patients show focal
Bridgeto MicrobiologY are B viruses Coxsackie RNA positive-sense to the belonging viruses famitY. Picornavirus
107
Grdiovascular System
2. Bacterial myocarditis may be due to diphtheria, meningococci, or other bacteria. These bacteria may damagethe heart directly or via secretedtoxins, such as diphtheria toxin.
Clinical Conetg-te Romana sign-unilateral swelling oftheeyelid-is a signof Chagas disease.
3. Protozoal etiology a. Trypanosomacruzi causesChagas disease, which is characterized by trypanosomecontaining myocardial pseudocysts,causing myocardial necrosis.Fifty percent of the population is infectedin endemic areasof South America and it is an important cause of congestiveheart failure in that areaof the world. b. Toxoplasmosisalso causesmyocardial pseudocysts. D. Clinical features 1. Myocardial involvement appearsdaysto weeksafter the primary infection. There is a variable severiry depending on the etiology. 2. Myocarditis may be asymptomatic with EKG abnormalities only, or it may present with the acute onset of dyspnea,tachycardia,weakness,or severeCHF. Edema is common to all forms of myocarditis. 3. It may have a protracted or a frrlminant course;most patients recover fully without longterm adverseeffects.
CARDIOMYOPATHY A. Primary cardiomyopathy is associatedwith ill-defined syndromes of unknown origin that may be divided into three subtypes:dilated, hlpertrophic, and restrictive. 1. Dilated (congestive) cardiomyopathy a. Pathology (1) Grossly, dilated cardiomyopathy presents with gradual dilatation of all four chambers,producing cardiomegaly. (2) Microscopic findings are nonspecific, with some patients showing scattered fibrosis and myocyte atrophy. b. Clinical features. There is decreasedcontractility, stasis, and formation of mural thrombi. c. Complications. Death is due to progressiveCHF, thromboembolism, or arrhythmia. d. Possible etiologies include: (1) Pregnancy-inducednutritional, hlpertensive, volume, or metabolic abnormalities (peripartal cardiomyopathy) (2) Alcohol toxicity or associatedthiamine deficiency (3) Geneticdilated cardiomyopathy (4) Poswiral infection
ClinicalCorrelate Young adultathletes whodie duringstrenuous activity are sometimes notedto have hadhypertrophic subaortic stenosis.
r08
2. Hypertrophic cardiomyopathy (idiopathic hlperthrophic subaortic stenosis; IHSS) a. Pathology (1) Grossly, hypertrophic cardiomyopathy presentswith cardiomegaly as a result of myocardial hypertrophy (left ventricle > right ventricle), marked asymmetrical hypertrophy of the ventricular septum, causingobstruction of the left ventricular outflow tract that is rarely clinically significant, endocardial thickening in the
Pathology
ventricular outflow tract (which may be a nidus for infective endocarditis), a thickened mitral valve, and dilated atria. (2) Microscopic findings include myofiber hlpertrophy, disorganization of septal myofibrils, and diffirse fibrosis. (3) A hypercontracting heart with diminished ventricular volume and decreased cardiac output may causedyspnea,angina, atrial fibrillation, syncope,sudden death,mural thrombus formation and embolization,infective endocarditis,and CHF. b. Clinical features. There is a variable clinical course, and patients may be asymptomatic. c. Possibleetiologies include: (1) Genetic (50oloof hypertrophic cardiomyopathyis transmitted in an autosomal dominant pattern) (2) Catecholaminehypersensitivity
Note Thegeneforhypertrophic cardiomyopathy ison chromosome 14q, whereit encodes a peptide inthe heavy chain of myosin.
(3) Myocardial ischemiacausedby abnormal intracardiacarteries (4) Primary collagendisorder,causingmyocardialfibrosis 3. Restrictive (infiltrative) cardiomyopathy and subtypescausemyocardial disease,leading to restriction of ventricular inflow and reducedcardiacoutput. a. Cardiac amyloidosis cardiomyopathy can occur in isolation or in association with systemicamyloidosis. It often occurs in the elderly and may also induce arrhythmias. b. Sarcoidosis/granulomatous cardiomyopathy is associatedwith systemicsarcoidosis. It often occursin the young (<25 years). B. Secondary cardiomyopathy. Myocardial diseasemay be associatedwith well-defined syndromes or settings,from metabolic disorders,such as diabetes,to nutritional deficiencies, such as scurvy.
PERICARDITIS A. Overview. Pericarditisis inflammation of the pericardium, usually as a result of local spread from adjacentmediastinalstructures(myocardial infarction, trauma, surgery,infections,or tumors). Primary pericarditis is usually due to systemicviral infection; uremia and autoimmune diseasesare also common causes. B. Fibrinous (serofibrinous) pericarditis is the exudation of fibrin and other plasma proteins with clumping of fibrin deposits.It is the most frequent form of pericarditisassociatedwith myocardial infarction. It may also be due to trauma, rheumatic fever,radiation, SLE, and infrequently, infections. Clinically, it may present as a loud pericardial friction rub with chestpain, fever,and, occasionally,symptoms of CHF.
Note lf yousee/hear the "friction words rub," thinkpericarditis.
C. Serous pericarditis is due to a small amount of exudative effusion with few inflammatory cells.It is usually causedby a nonbacterial,immunologic reaction (e.g., rheumatic fever, SLE),tumor, uremia, or a viral infection (e.g.,coxsackievirus),or it may be idiopathic. It is usually asymptomaticbut may clinically presentas a persistentdull chestache. D. Suppurative pericarditis is a purulent exudate with erythema of the serosa.Organization leadsto constrictivepericarditis and cardiac insufficiency.It is usually causedby bacterial, fungal, or parasitic infection and may clinically present with systemic signs of infection (fever,malaise)and a soft friction rub.
r09
System Cardiovascular
Note lf youseecaseous, thinkTB.
E. Hemorrhagic pericarditis is an exudate of blood, mixed with suppurative or fibrinous material. It is usually associatedwith tuberculosisor a malignant neoplasm;organization may lead to constrictive pericarditis. F. Caseous pericarditis usually develops into fibrocalcific constrictive pericarditis and is usually causedby tuberculosis. G. Chronic/resolved pericarditis and subtypes 1. Adhesive mediastinopericarditis causesobliteration of the pericardial sac by fibrous organization of suppurative or caseouspericarditis. The parietal layer of the heart becomesfusedto the inner layer of the pericardium, causingincreasedcardiacworkload, and leading to cardiachypertrophy and dilatation. 2. Constrictive pericarditis is a restrictive diseasecausedby thick fibrosis and scarring of the pericardialspace.The heart is unable to hypertrophy becauseof the surrounding scar tissue.Cardiac output diminishes as a result of decreasedfilling during diastole (right ventricle is unable to expand),and heart sounds are diminished.
PERICARDIAT EFFUSION Pericardialeffusion is leakageof fluid (transudateor exudate)into the pericardialspace.It may result in cardiactamponade,in which the collection of fluid compressesthe heart, limiting filling during diastole,and decreasingcardiacfilling. A. Serous effr,rsion results from hypoproteinemia or CHF. It usually develops slowly, rarely causingcardiaccompromise. B. Serosanguineouseffusion is usually due to trauma (e.g.,cardiopulmonary resuscitation), tumor, or TB. It rarely causescardiaccompromise. C. Chylous effusion is due to lymphatic blockage.It rarely causescardiaccompromise.
Clinical Conelate Hemopericardium canbea complication of vigorous CPR.
D. Cholesterol effusion is either idiopathic or due to myxedema;it is very uncommon. E. Hemopericardium occurs when blood flows into the pericardial sac as a result of trauma, ventricular rupture (after myocardial infarction), or aortic rupture. There is no inflammatory infiltrate. This condition can quickly causecardiactamponadeand death.
CARDIAC NEOPTASMS A. Primary cardiac tumors are rare. Eighty percent are benign. 1. Myxomas (atrial mlxoma). A myxoma is a benign tumor derived from multipotential mesenchymalcells.It is the most common primary cardiactumor in adults. a. Clinical features. Most tumors occur in the left atrium and are usually single.They may be any size,sessileor pedunculated. b. Complications include: (1) Ball-valve obstructions of the mitral valve,resulting in syncope,shock,or death (2) Impact trauma as a result of tumor movement during heart contraction (3) Embolization of the myxoma or its fragments 2. Rhabdomyomas are benign tumors derived from striated muscle. They are the most common primary cardiactumor in children (especiallythosewith tuberous sclerosis).
il0
Pathology
3. Angiosarcomas, rhabdomyosarcomas, mesotheliomas, lipomas, and papillary fibroelastomasare much lesscommon. B. Metastasesto the heart. Most metastasesto the heart come from bronchogeniccarcinoma and lymphoma from regionalnodes.They involve the pericardium more than the myocardium, and may interfere with the conduction systemor causepericardial effusions.
TRAUMATIC HEART INIURIES A. Penetrating injuries. In wounds causedby low-velocity penetration (e.g., knife wound, shrapnel,medical procedures),the damagefollows the path of the penetrating object. In high velocity (..9., bullet) wounds, damagefollows the path of injury, but tissueat a distance from the path of injury is also affectedas a result of releasedenergy. B. Nonpenetrating accidents,such as sudden deceleration,explosion, or compression,injure the heart by forcing contact with adjacentstructures. C. Automobile accidents are the most common causeof cardiac trauma. Compression,false aneurysm (occlusion of aorta due to blood accumulation in the adventitia),anterior right ventricular contusion, and anterior descending coronary artery damage may all occur. Compressioninjuries may exacerbateunderlying cardiacdisease,such as mitral valve prolapseor IHD. D. Bullet and knife wounds may causecardiac tamponade, hemopericardium, and myocardial rupture. During healing,thesemay developarteriovenousfistulas.
CONGENITAT ABNORMAIITIES OFVESSETS A. Berry aneurysms are focal weakeningsin cerebral vesselwalls, resulting in an outpouching. They are most common at branch points in the anterior circleof Willis and at the bifurcation of the middle cerebral artery. Symptoms are rare before age 20, after which time they may burst and causea subarachnoidhemorrhage. B. Arteriovenous (AV) fistula is a rare abnormal communication between a vein and an artery. 1. By diverting blood from the arterial to the venous circulation, it increasesvenousreturn, increasesthe workload to the right heart, and may, therefore,causeright heart failure. 2. AV fistulasmay also form as a result of trauma.
ARTERIAT HYPERTENSION A. Clinical features l. Arterial hypertension is defined as a consistentdiastolic pressureover 90 mm Hg (for adults over 18 yearsof age) or a systolicpressureover 140 mm Hg, or both on repeated determinations. 2. Hypertension causeshlpertensive heart diseasewith progressivethickening of the left ventricle,myocyte dropout, fibrosis,and eventualheart failure. B. Morbidity and mortality 1. Hypertensionis the secondleadingcauseof cardiacmortality after ischemicheart disease. 2. Hypertensionis stronglyassociated with both strokeand myocardialinfarction.It may also lead to CHR renal failure, coronary and peripheral artery disease,and aortic dissection.
ill
Cardiovascular System
3. Mortality hasbeendeclining asa result of early recognition,antihypertensivetherapy,and control of obesity. C. Essential (primary) hypertension is idiopathic and accounts for approximately 90o/oof cases.The pathophysiologyis unknown, but it may be due to geneticor environmental factors, most likely resulting in increasedsystemicvascularresistanceor increasedcardiacoutput. Type A personaliry obesiry stress,high-salt diet, and oral contraceptivesincreasethe risk; it is most common in African American malesaround 40 yearsof age. D. Secondary hnrertension is hypertension resulting from other diseases,most commonly renal disease.
ATHEROSCTEROSIS Atherosclerosisinvolves the progressiveformation of elevated fatty plaques (atheromata) in the intima of large-and medium-sizedmuscular and elasticarteries.The atheromatacausenarrowing of the vessellumen, weakeningof the media, and possiblyprogressionto ulceration,calcification, thrombosis,intralesionalhemorrhage,or aneurysmformation. This disorder affects primarily the coronary, cerebral,and iliac arteries and the aorta. It accountsfor 50oloof all deathsin the United States.Death occursmainly from myocardialor cerebralinfarcts. A. Pathology 1. Grossly, atherosclerosis presentswith: a. White or pale yellow plaques0.5-1.5 cm in diameter bulging into the lumen with a soft "gruel-like" center b. Lesions occur (in order of frequency) in the abdominal aorta, coronary arteries, popliteal arteries,descendingthoracic aorta, internal carotid arteries,and circle of Willis 2. Microscopically, atherosclerosis presents(from inside the lumen to the outer vesselwall) as:
Note = macrophages Foam cells afterlipidingestion
a. A fibrous cap composed of smooth muscle cells,collagen,connectivetissue matrix, and scatteredleukocftes b. A cellular zonecomposedof smooth muscle cells,macrophages,and lymphocytes c. A central core composedof necrotic cells,cholesterolclefts,lipid-filled foam cells,and plasmaproteins d. Proliferating capillarieswhen lesionsare well-advanced 3. Complicated plaques are seen in advanceddisease.They arise when calcification and thickening causeischemia of the intima. Fissure,ulceration, and rupture of atheromas into the lumen may cause: a. Thrombus formation with occlusionof the vessel,leading to infarction of the tissueit supplies b. Cholesterolemboli c. Hemorrhageinto the lesion d. Aneurysmal dilatation 4. Fatty streaks have the following characteristics. a. They are elevated,poorly demarcated,yellow intimal lesionslessthan 2 mm wide and 1 cm long.
il2
Pathology
b. They may be present in children asyoung as 1 year old and may or may not evolveinto atheromas. c. They are composedof lipid-containing cells(macrophagesand smooth musclecells), collagen,elastic fibers, proteoglycans,and extracellular lipid. d. They are most common in the thoracic aorta (<1 year) and coronary arteries. B. Etiology of atheromatous plaques 1. Responseto injury a. Endothelial injury may be due to hypertension, hyperlipidemia, chemicalsin tobacco smoke, diabetic angiopathy, and gross physical or chemical injury. b. Injury may lead to increased permeability of plasma proteins, platelet and inflammatory cell adherence,and thrombus formation at the site. c. Chemical mediators from the above cells may induce migration and proliferation of smooth muscle cells from the media into the intima. d. Production of abundant connective tissue matrix (collagen, elastic fibers, proteoglycans) by smooth muscle cells follows with ingrowth of intimal capillaries from the vasavasorum for nourishment. This may lead to subsequentleakageof more plasma proteins, finally resulting in the deposition and accumulation of lipid in the plaque. 2. The loss of growth control hypothesis suggeststhat smooth muscle proliferation in the media may be the initial event. C. Risk factors 1. Hlpertension. The risk of atherosclerosiscorrelatesmore closelywith diastolic than with systolic pressure. 2. Cigarette smoking. The death rate from ischemic heart diseaseis70-200o/ohigher in men who smoke at leastone pack per day than in nonsmoking men. 3. Hlperlipidemia a. Elevated serum cholesterol levels,especiallylow-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) b. Hyperlipidemia may be due to genetic (e.g.,familial hypercholesterolemias), dietary (e.g., high cholesterol and saturated fat intake), other clinical conditions (e.g., nephrotic syndrome, hypothyroidism), or a sedentarylifestyle. c. Elevatedhigh-densitylipoproteins (HDLs) may decreaserisk becauseHDL transports cholesterol out of tissuesback to the liver, while LDL transports cholesterol from the liver to the tissues. 4. Diabetes causesdamage to arterioles by depositing hyaline material in their walls and reducing blood flow. 5. Increasing age. Significant atherosclerosisis rarely seenin patients younger than 30 years of age;it becomessymptomatic in patients in their fifties and sixties. 6. Incidence is higher in men, in postmenopausalwomen, and in individuals with a positive family history. 7. Sedentary lifestyle, obesiry oral contraceptives, stress, and a compulsive, workaholic behavior pattern (tfpe A personality) increasethe risk. "U
il5
System Cardiovascular
D. Clinical features 1. Atherosclerosismay be asymptomaticfor decades. 2. Ischemia due to gradual vesselocclusion (e.g.,gangreneof the lower extremities,intermittent claudication) may eventuallydevelop. 3. Infarction due to sudden occlusion by thrombosis or embolization (e.g., myocardial infarction, renal artery occlusion) is the most dramatic sign. Twenfy-fivepercentof cases presentwith sudden death. of coronary atherosclerosis 4. Aneurysm formation with subsequentrupture (e.g., abdominal aortic aneurysm) may alsobe a presentingsign.
ARTERIOIOSCIEROSIS Note Thekidneyis particularly to vulnerable arteriolosclerosis.
Arteriolosclerosisis a diffrrsethickening of arteriolesand small arteries,resulting in narrowing of the lumen and ischemiaof involved tissue. A. Hyperplastic arteriolosclerosis is associatedwith malignant hypertension or necrotizing vasculitisand is characterizedby "onionskin hyperplasia,"i.e., concentric thickening of the intima, deposition of basophilicground substance,smooth muscleproliferation, and hypertrophy of the adventitia. B. Hyaline arteriolosclerosis is associatedwith diabetes,hpertension, and old age.It is characterized by hyaline thickening of arteriolesthat nanows the vessellumen. This form of arteriolosclerosisis further characterizedby eosinophfic material (thickenedbasementmembraneof endothelial and smooth muscle cells)in the intima and media and is a degenerativeprocess.It is best recognizedin the arteriolesof adiposetissue,where the vesselwalls appearasthick asthe diameter of the lumen.
Figure l-5-12.Coronary artery atherosclerotic occlusion, old (microscopic).
il4
Pathology
EMBOTISMS Embolisms may arise from solid, liquid, or gaseousmassestransported within the vesselsand originating from thrombi (98olo),fat (bone fractures), atheromas,gos€s(deep seadivers), or amniotic fluid (pregnanry). A. Emboli arising from the venous circulation involve the pulmonary circulation (pulmonary emboli). Thesemay paradoxicallyinvolve the systemiccirculation via a right-to-left cardiac shunt (e.9.,atrial septaldefect),which was not previously known to exist. B. Emboli arising from the arterial circulation involve nonpulmonary structures. 1. Seventy-fivepercent arise from cardiac mural thrombi due to myocardial infarction. Grossly, mural thrombi appear gray-red with alternating light and dark lines (lines of Zahn), which representclotted plasmaand red blood cells(RBCs),respectively. 2. Arterial emboli most commonly involve the legs,then the brain, other viscera,and the arms.
ANEURYSMS Aneurysmsare focal, abnormal, dilatations of arterial vesselsas a result of wall weakness.They may lead to rupture, which is a recognizedcauseof suddendeath,compressionof nearbystructures, and thrombus formation and embolism, which may causeinfarction of distal organsor structures. A. Atherosclerotic aneurysms are secondaryto atheroma formation. They usually occur in the abdominal aorta below the renal arteries,are associatedwith hypertension,and are found in men over 50 years of age.Fifty percent of atherosclerotic aneurysms over 6 cm in diameter will rupture within 10 years. B. Syphilitic aneurysms are due to chronic damageto the vasavasorum of the aortic media by syphilitic aortitis. This damage results in obliterative endarteritis, ischemia,and smooth muscle cell atrophy.It usually occursin the ascendingaorta and may impinge on the aortic valve, causing aortic insufficiency due to dilatation of the valve ring. C. Microaneurysms may appearin cerebralvesselsasa result of hlpertension and in retinal vesselsas a result of diabeticvasculitis. D. Dissecting aneurysms are due to degeneration of the tunica media, which allows blood from the lumen to enter an intimal tear and dissect through the layers of the media. They most frequently occur in the aorta. 1. They may progressivelyspreadinto aortic branches(e.g.,renal or coronary arteries),leading to compressionand obstruction of the lumen of the branch. 2. Etiology is unknown, but hypertensionand Marfan diseaseare predisposingfactors. E. Berry aneurysms are previously discussed.
VASCUTITIS
Bridgeto Biochemistry ln Marfan disease, thereisa defect inthegeneforfibrillin onchromosome l5q.Fibrillin isa rSO-kD a molecule, glycoprotein present in particularly connective tissue, thesuspensory ligament of thelens, thewallsof blood vessels, andtheskin.
Vasculitisis an inflammation of the vesselsthat may be localized (due to trauma, infections, toxins) or systemic.Multifocal vasculitismay lead to widespread,patchy necrosisand thrombi formation and is usually due to an immune reaction. A. Polyarteritis nodosa (PAN) is a systemicnecrotizing vasculitis of small- and medium-sized muscular arteries(often at bifurcations).
il5
System Cardiovascular
Bridgeto lmmunology (Ag-Ab) Antigen-a ntibody precipitate complexes onto vessel walls, where theyfix complement andattract neutrophils bymeans of gradients of C5afragments, phagocytose Neutrophils the complexes anddischarge granules lysosomal that destroy smooth muscle and fibers. elastic
1. Etiology a. Hepatitis B antigenemiacan be demonstratedin 30o/oof cases. b. Essentiallyall casesof PAN are thought to be due to antigen-antibody complexes. c. Autoantibodies may also play a role when they form complexeswith self-antigens. P-ANCA (perinuclear antineutrophil cytoplasmic autoantibodies) are frequently observedin PAN and may correlatewith diseaseactivity. 2. Pathology a. Grossly,PAN presentsas up to 1-cm segmentalaneurysmaldilatationsin vessels.It is seenpredominantly in the kidneys, heart, and gastrointestinaltract; the pulmonary circulation is spared. b. Microscopically, there are three different stages,the lesions of which may be all be presentsimultaneously. (1) Acute lesions havesharply demarcatedfibrinoid necrosisof the vesselwall and a neutrophilic infiltrate. (2) Healing lesions havea proliferation of fibrobiastsand a mononuclear infiltrate. (3) Healed lesions have fibrotic thickening, loss of elastictissue,and possibleaneurysmal dilatations.The loss of the internal elasticlamina is an excellentclue that old vasculitis is present. 3. Clinical features a. Symptoms depend on the systeminvolved. Patientsmost commonly have low-grade fever,weakness,and weight loss.They may alsohaveabdominal pain, hematuria,renal failure, hypertension,and leukocytosis. b. PAN is most common in young aduits. 4. Diagnosis is made by arterial biopsy. 5. Prognosis. Mortality is decreasedwith immunosuppressivetherapy. B. Churg-Strauss syndrome (allergic angiitis) is a variant of PAN that involves small and medium-sizedmuscular arteriesaswell asveins and venules.It involvesthe lung and spleen with intra- and extravasculargranulomasand is also associatedwith bronchial asthma and eosinophilia.
ln a Nutshell + tenderness Headache at = + elevated temples ESR temporal arteritis. Temporal arteritis hasbeena long-time USMLEfavorite.
C. Temporal (giant-cell) arteritis is a granulomatous inflammation of small- and mediumsizedarteries,particularlyextracranial arteries (especiallythe temporal artery). This is perhaps the most common form of vasculitis.Etiology is unknown. l. Pathology. Microscopically, this disorder presentsas a continuum of: a. Focal areasof multinucleatedgiant cells,forming granulomaswith fragmentedinternal elasticlamina b. Generalinflammation of vesselwalls with neutrophils,eosinophils,and lymphocytes c. Fibrosisof the intima with lumenal narrowing 2. Clinical features a. Giant cell arteritis occursin both malesand females,usually greaterthan 50 yearsold, and affectsmainly the cranial and most commonly the temporal arteries. b. It clinically presentswith:
il6
Pilrology
(1) Headache and facial pain (the most common symptoms) (2)Fever,malaise,weightloss,muscleaches,anemia,claudicationofthejaw,visual disturbancesin 40o/oof cases,and tender, firm temporal arteries (3) Elevated ESR, as in all inflammatory diseases (a) Bhndness,if not treated early (due to occlusion of ophthalmic artery)
,
3. Diagnosis. Temporal arteritis is diagnosed by arterial biopsy, usually of the superficial temporal artery. 4. Treatment. Patientsare treated with steroids, which usuallyproduce a dramatic response. D. Hypersensitivity (leukocytoclastic) angiitis affects small vessels(i.e., arterioles, venules, capillaries)predominantlyintheskin.Itmayalsoaffectvessels,lungs,kidneys,andother organs simultaneously and may causecrescenticglomerulonephritis. Hypersensitivity angiitis may be distinguished from PAN by the involvement of smaller vessels.Lesions are usu.lly.ll in the same stageat the sametime. 1. Etiology. Immune complexesare thought to be involved becauseit is often precipitated by a specific antigen, such as bacteria (e.g., Streptococcus),drugs (penicillin), tumor antigens,or serum sickness.The diseaseremits if the ofifending agent is removed. 2. Pathology. MicroscopicallR leukocytoclastic angiitis presentswith neutrophilic inflammation with or without fibrinoid necrosis. 3. Clinical features a. Hypersensitivity angiitis is often associatedwith well-defined clinical sfndromes that are thoughttoinvolvehypersensitivityreactionstoanapparentexogenousantigen. ( 1) Henoch-Schitnlein purpura is a diseaseof children that is characterizndby nonthrombocytopenic purpura, skin lesions, joint involvement, coliclcy abdominal pain, and renal lesions. (2) Vasculitides associatedwith infectious disease,neoplasms,and connectivetissue disorders all may have a common mechanism but obviously different antigens. b. Hypersensitivity angiitis clinically presentswith:
l
( I ) Purpura, petechiae,and necrotic ulceration predominantly on the skin of the feet and ankles (2) Fever,myalgia, anorexia,arthritis, and renal involvement E. Thromboangiitis obliterans (Buerger disease) is a recurrent acute and chronic inflamma-
In a ill6tfcll
tory disorderof smalland medium-sizedarteriesandveins,causingsegmentalthrombosis that occursin the extremitiesand may also affectadjacentnery€s.It occursalmost exdu-
lf youseegangrene in a
sivelyin cigarette smokers lessthan 35 years of age.
-r think youngsmoker
1. Etiology. Possiblecausesinclude a genetic predisposition, an immunologic reaction, and a direct toxic response(tobacco).
Buergerdisease'
2. Pathology. Microscopically, it presents with a neutrophilic inflammatory infiltrate, occlusiveormuralthrombosiswithmicroabscessesandgiantcells,andeventually,fibrous encasementof the artery vein, and nerye. 3. Clinical features include severe pain in the affected extremity, ulcers, gangrene, and thrombophlebitis. 4. Prognosis. Remission correlatesvery well with abstinencefrom smoking.
il7
System Cardiovascular
l{Ote ifyou OntheUSMLE, encounter a patientwith lung,sinus,andkidney disease, thinkWegener granulomatosis
F. Wegenergranulomatosisconsistsof a triad of necrotizingvasculitisof lungs and airways' xecrotizing granulomasof the upper respiratory tract, and necrotizing glomerulitis. It occurs in men more often than women. Patientsare usually older than 50 yearsof age. Etiology is unknown' 1. pathology,Microscopically, it presentsasregionsof necrotizingvasculitisand granuloma formationwith areasof fibrosis. 2. clinical features.Wegenerclinically presentswith cavitary pulmonary lesions,chronic ulcerations' sinusitis,renaldisease,nasophatyngeal 3. Prognosis.Thereis a poor prognosiswithout treatment,but mostPatientshavecomPlet€ drugs' remissionwith immunosuppressive G. Tak yasus arteritis (pulselessdisease)is a granulomatousinflammation of medium-tolargearteries,often branchesof the aortic arch. 1. Etiology. The causeis unknown. 2. Pathology a. Grossly,it presentswith: (1) Irregular fibrous thickeningof the wall of the aortic arch with narrowing of the orificesof the major branch arteries,leadingto weakpulsesin the carotids of cases (2) Involvementof the pulmonary arteriesin 50026 b. Microscopically,it pr€sentswith;
Gliniol Conelah thebloodpressure Check ln botharmsinyoung Asianwomento identt{y pressure dif{erences Takayasu suSSesting arteritis.
(1) Arl early mononuclearcell infiltrate ofthe vasavasorumand mediawith occasionalgranulomaformation (2) Massivefibrosis of the media 3' clinical features arteritis is most common in women (15-45 years)and in Asians. a. T?rkayasu as: o' ll crmcary Presenrs (1) Ocular disturbanc€s(visual abnormalities, retinal hemorrhages),neurologic abnormalities,and weakpulsesin the upper extremities (2) Weakness, fever,malaise,and arthralgias (3) Spontaneousremission for limited periods of time but relapsesif untreated (steroids) H. Kawasakidisease(mucocutaneouslymph node syndrome)wasfust describedin Japanand is still morecommonthere. 1. Epidemiology.The diseaseis usuallyseenin young children,but adult patientshavebeen described(rare). 2. Etiology. The causeis unknown.An RNA-dependentDNA polymerasehasbeenfound in somelesions,suggestinga viral etiology' 3. Pathology.Microscopically, it presentswith inflammation and necrosisof the entire vesselwall and possibleaneurysmformation. 4, Clinical f€atures,Kawasakidiseaseis an acutesyndromeconsistingof: a. Fever,conjunctivitis,erfthema and erosionsof the oral mucosa,a generalizedmaculopapularskin rash,and adenopathy
il8
Pathology
b. A mortality rate of l-2o/o as a result of coronary vasculitis or coronary aneurysm, thrombosis,or rupture c. Self-limited course
VENOUS DISEASE A. Thrombophlebitis is inflammation and thrombus formation of the veins.Ninety percentof casesoccur in the deep veins of the leg (i.e., deepvenousthrombosis). l. Pathology. Factors involved in thrombus formation (Virchow triad) are endothelial injury, alterationsin blood flow, and hlpercoaguabiliryof blood. Thrombi grosslyappear blue-red. 2. Clinical features a. Thrombophlebitis may be associatedwith or may be secondaryto: (1) Clotting disorders (deficiencyof antithrombin III, protein C, or protein S). In thesedeficiencies,normal clot dissolution (fibrinolysis) is abnormally slow. (2) Heart disease(CHR myocardialinfarction, valvular disease),leadingto sluggish flow
Bridgeto Heme/lymph Theroles of antithrombin lll, protein C,andprotein S in enhancing clotdissolution are discussed intheHematologic/ Lymphoreticular Physiology chapter.
(3) Immobilization (including bed rest), slowing venous flow (a) Neoplasia,sometimesproducing enzFmesthat promote clotting (5) Advanced agewith sclerotic veins and slow flow (6) Pregnanrywith obstruction of pelvic veins (7) Oral contraceptives,which activatesome clotting factors (8) Tissueinjury (postoperativecourse,trauma), which alsoactivatesclotting, sometimes systemically b. Thrombi may cause: (1) Embolization, particularly to the lungs (2) Bacterialsuperinfection,producing a septicnidus (3) Postphlebiticsyndrome (predisposition of recurrent thrombosis due to loss of venousvalves) (4) Recanalizationof the thrombus, restoring more normal flow c. Clinically, thrombophlebitis presentsinsidiously with few symptoms (localizedpain, erythema, and edema). It often presentsinitially as a pulmonary embolism or as multiple emboli; a large embolus may causesuddendeath. B. Venous occlusion may occur as a result of thrombophlebitis, deep venous thrombosis, or obstruction of outflow (pregnancy). C. Varicoseveins are dilated, tortuous veins,most likely resulting from increasedintraluminal pressureand inadequateexternal support. They occur most frequently in the superficial veins of the lower extremities.They are more common in women.
Note Some ofthevasculitides theveinsandvenulesaffect on seetheprevious section Vasculitis.
1. Pathogenesis.Varicoseveins are associatedwith the venous stasisof pregnanry,obesity, compressionby tumors, prolonged immobility of legs,and congenitaldefectsin venous walls (including valves).They may result in venousthrombosis and valvedamage.
I t9
Cardiovascular System
2. Clinical features.Varicositespresentwith edema,thrombosis,stasisdermatitis,and ulcerations. Unlike venous abnormalities of the deep veins of the lower extremities,varicose veins are rarelv a sourceof emboli.
VASCUTAR NEOPTASMS Vascularneoplasmsinclude all of the neoplasticgrowths of the vascularendothelialcells,forming well-defined endothelial-linedvascularchannelsin benign tumors, or ill-defined massesof anaplasticendothelialcellsin malignant tumors. A. Benign tumors 1. Hemangiomas a. Capillary hemangiomas form unencapsulatedwell-defined massesof capillarieswith a small amount of connectivetissuethat usually occur in the skin and mucous membranes. b. Cavernous hemangiomas form sharply defined, sponge-like tumors composed of large, dilated, cavernousvascular spaces.They usually occur on the skin, mucous membranes,and visceraand are rarely clinically significant exceptfor their cosmetic effects. c. von Hippel-Lindau disease is a syndrome of multiple cavernous hemangiomas involving the cerebellum,brain stem, liver, pancreas,and eyes.It is associatedwith renal rystsand renal cell carcinoma.This diseaseis transmitted via an autosomaldominant pattern with the genelocalizedto chromosome3p. 2. Vascular ectasias (telangiectasias)are actually a developmental abnormality but can closelymimic benign vascularneoplasms.They may be composedof abnormal aggregations of arterioles,capillaries,or venules. a. Nevus flammeus is a flat birthmark on the head or neck that usually spontaneously regresses. b. Port wine stain may grow proportionately with the child and may be associatedwith Sturge-Webersyndrome, a nevus formation in the skin supplied by the trigeminal nerve and associatedwith glaucoma,meningealangiomas,and mental retardation. c. Spider telangiectasias are a radial array of tiny arterioles, commonly occuring in pregnant women and patientswith hepatic cirrhosis. In men, they may be relatedto elevatedestrogenlevelsoccurring as a result of liver disease(e.g,alcoholism). B. Malignant tumors 1. Hemangiosarcomas are growths of atypical, anaplastic endothelial cells that usually metastasizeand are associatedwith a high mortality. a. Gross pathology. Hemangiosarcomasmost commonly occur in skin, breast,liver,and soft tissues.They are usually sharply defined red nodules,which become large,pale, soft masses. b. Microscopic pathology. Hemangiosarcomasshow varying degreesof anaplasiaand vesselsof different sizesand shapes.Vesselsare often merely slit-like spaces. 2. Hepatic angiosarcomasare tumors causedby toxic exposures. 3. Kaposi sarcoma was once a rare, slowly progressivediseaseseen in older men of Mediterranean or African descentor immunosuppressedtransplant patients. It is now
r20
Pathology
seen in one third of AIDS patients, most frequently in homosexual males. This form of the diseasemay be more aggressiveand frequently disseminates. a. Pathology (1) Grossly, it presentsas multiple violaceous nodules that may remain confined to the skin or may disseminate. (2) Microscopically, it presentsas a proliferation of endothelial cells, spindle cells, and inflammatory cellswith RBCs scatteredthroughout slit-like vascular spaces. (3) It has been shown to be causedby human herpesvirusrype S (HHVS). b. Prognosis. Kaposi sarcomararely causesdeath in otherwisenormal patients responsive to chemotherapyand interferon-cr (INF-cr), but it usually spreadsrelentlesslyin AIDS patients.
l2l
Cardiovascular Pharmacology Although manydrugsexertaneffectonthecardiovascular system, thefivegroupsof drugsdiscussed inthischapter actspecifically ontheheartorareuseful intreating cardiac disease: antihypertensives, glycosides, antiarrhythmis, cardiac antianginal agents, andantilipid agents. Thrombolytic agents are introduced, butarediscussed in moredetail intheHeme/Lymph Pharmacology chapter.
ANTIHYPERTENSIVES Antihypertensivesrepresenta categoryof agentsthat span severalclassesof drugs. They share the common feature of decreasingvascular tone, intravascular volume, or cardiac contractility. Vasculartone is modified by agentsthat alter CNS sympatheticoutflow, block sympathetic tone at the arterial smooth muscle receptor,or act directly to relax vascular smooth muscle. Their respectivepropertiesare summarizedlater in ThbleI-6-1. A. Central-acting sympatholytic agents 1. Clonidine a. Pharmacologic properties. Clonidine stimulates central and peripheral o2-adrenergic receptors and diminishessympatheticoutflow. An intravenousinjection or overdosecan causea transient initial increasein blood pressureasa result of stimulation of peripheral postsynapticvasoconstrictivecr2receptors.Fifty percentof the drug is metabolizedin the liver, and 50% is excretedunchangedby the kidney. b. Indications for use include moderate-to-severeessential(i.e., idiopathic) hypertension. Clonidine can also be used during narcotic withdrawal, as adjuvant therapy in ethanol withdrawal, and for the diagnosisof pheochromocytoma.It is frequently used in patients with renal hypertension. c. Side effects and toxicity. Clonidine causessedation and dry mouth (xerostomia) in more than half of patients and can also causeinsomnia, nightmares,and depression. Orthostatic hypotension and fluid retention can be alleviatedby adding a diuretic to the treatment regimen. Rebound hlpertensive crisis can occur after abrupt withdrawal. d. Drug interactions ( 1) Tricyclic antidepressantsand clonidine (methyldopa) canceleach other's effect. Antidepressantsincreasesympathetic activity by blocking reuptake of norepinephrine, whiie crr-agonistsare antihypertensiveby lowering it. (2) Ca2+channelblockers also decreaseheart rate and contractibility and will have additive effectto the cardiosuppressioninduced by ar-agonists.
Note Clonidine decreases sympathetic outflowcentral ly. It alsoactsperipherally by presynaptic q stimulating receptors, inhibiting thereby norepinephrine release and decreasing vascular toneand heartrate.
Note Methyldopa isconverted to cr-methyl NE,which stimulates cx,-adrenergic receptors andinhibits sympathetic outflow in a manner analogous to clonidine.
12,
System Grdiovascular
Note caninduce a Methyldopa positive direct Coombs butdoesnotseemto reaction, (seepenicillin) actasa hapten orbindto RBGasanimmune (seequinidine). complex
2. Methyldopa a. Pharmacologic properties. Methyldopa is structurally related to the catecholamine neurotransmittersand is convertedto cr-methylnorepinephrine.Its site of action is believed to be in the CNS, stimulating central cr2-adrenergicreceptors and inhibiting sympathetic outflow. Methyldopa is clearedpredominantly by renal excretion. b. Indications for use include moderate essential hypertension. Methyldopa usually requires concomitant diuretic therapy and is the drug of choice for hlpertension in pregnancy. Side effectsfrequently limit its use. c. Side effectsand toxicity include sedation,dry mouth, headaches,nightmares (especially in the elderly), depression,postural hypotension,salt and water retention (if a diuretic is not given), impotence,dr.tg feverwith or without Iiver involvement,positive direct Coombs reaction rn l0-20o/o(hemolysisis rare), lactation (in both sexes),and hepatitis (can lead to hepatic necrosisupon re-exposureto the drug).Rebound hypertension following sudden withdrawal may occur (lessoften than with clonidine).
ClinicalCorrelate Nonselective B blockers not be should usedin patients lungdisease withsevere because blockade can B, cause lifethreatening p,bronchoconstriction. selective antagonists should be usedinstead.
Mnemonic 'ABEAM" ofprblockers: Acebutolol Betaxolol Esmolol Atenolol Metoprolol ClinicalCorrelate lntravenous are B blockers oftenusedto treat hypertensive crises.
3. Guanabenzhas properties,indications,and side effectssimilar to clonidine. B. Agents acting at peripheral adrenergic receptors 1. Beta-adrenergic blockers (e.g., propranolol, nadolol, timolol, pindolol, labetalol, metoprolol, atenolol,acebutolol,esmolol,betaxolol) a. Pharmacologic properties. The mechanism of action is related to blockade of peripheral sympathetic p receptors. The role of the central receptors is unclear. Antihypertensiveaction is thought to be secondaryto decreasedcardiacoutput in the faceof a normal vascularresistance.Inhibition of renin secretionmay alsoplay a role. Despite differences,all gr blockers have the same antihypertensive efficacy.Atenolol, acebutolol, esmolol, betaxolol, and metoprolol have cardioselectiviryi.e., they are relativelyselectivein the blockadeof Fr receptors.Other agentsblock both B1and B2 receptors. Pindolol and acebutolol have intrinsic sympathomimetic activity (ISA) and thereforehavelessnegativeinotropic and chronotropic effects.Thesedrugs may be preferred in patients with decreasedcardiac functioning or a tendenry for bradycardia. Drugs with ISA do not increaseserum triglycerides or decreaseHDL lipids. Labetalol is unique in that it is a mixed antagonist; it blocks both p and ct,receptors. It decreasesperipheral vascularresistancewithout a concomitant reflex tachycardia. It also has some intrinsic sympathomimetic activity at p2 receptors,which may contribute to vasodilatation. c. Indications for use. Beta blockers are indicated for mild-to-severe essentialhypertension (alone or in combination with diuretics or vasodilators),supraventricularand ventricular tachyarrhythmias, treatment of angina, acute myocardial infarction (reducedrisk of reinfarction and death),hypertrophic cardiomyopathies(to decrease ventricular outflow obstruction), hyperthyroidism (propanolol), anxiety states(e.g., stagefright), migraine headache(prophylaxis),glaucoma(timolol and betaxolol ophthalmic solutions to reducesecretionof aqueoushumor), hypertensiveemergencies, and pheochromocytoma(labetalol). d. Side effects and toxicity (1) Side effects related to B blockade at nonvascularsites include bronchospasm (contraindicated in patients with reactive airway disease),masking of the sympathetic responsesto hypoglycemia (contraindicated in patients with diabetes mellitus), a negativeinotropic effect (exacerbates or precipitatescongestiveheart failure), an increaseor precipitation of heart block or bradycardia,and aggra'vation of vasospasm.
124
Pharmacology
(2) Hallucinations,nightmares,depression,and impotence (lesswith lipid-insoluble agents)can also occur.
ln a Nutshell
(3) Rebound hypertension,angina,or rarely evenMI, may occur after abrupt withdrawal.
areusedto: B blockers . Treathypertension
(4) Gastrointestinaleffectsinclude nausea,diarrhea,or constipation. (5) There is a decreasedmetabolism of B blockers with cimetidine and chlorpromazine.
. Decrease postMl mortality (withaspirin andnitrates) . Control tachyarrhythmias
(6) Increasedtriglyceride levelsand decreasedHDL cholesterollevelsare also seen (exceptwith drugs with intrinsic sympathomimetic activity).
. Treat glaucoma . Treathyperthyroidism
2. Alpha-adrenergic blockers a. Prazosin, terazosin, ifld doxazosin (a, selective)
. Treat pectoris chronic angina . Treat migraine headache
(1) Pharmacologic properties include blockade of vasoconstrictivecr-adrenergic type 1 recePtors (predominantly postsynaptic) on vascular smooth muscle. Thesedrugs relax both arteriolar and venoussmooth muscleand do not increase the heart rate during long-term therapy.
. Treat (e.9., anxiety stage fright) phobias andsocial (propanol)
(2) Indications for use include mild-to-moderate essentialhypertension (usually used with a diuretic or p blocker), CHF (preload and afterload reduction), pheochromocytoma (prazosin), and benign prostatic hypertrophy (reduces symptoms).
In a Nutshell
(3) Side effects and toxicity include severepostural hypotension and reflex tachycardia (usually after the first dose), dizziness(commonly seenwith prazosin), sedation,and headache. b. Phentolamine, tolazoline, and phenoxybenzamine (nonselective cr-blockers) (1) Pharmacologicproperties include blockadeof peripheralvascularo-adrenergic receptors(both cr1and o2). Phentolamineand tolazoline are administeredintravenously,and phenoxybenzamineis administered orally or intravenously. (2) Indications for use include diagnosisof pheochromocytoma (phentolamine), hypertensiveemergenciesdue to pheochromocytoma,peripheral vasculardisease (tolazoline), Raynaud'sphenomenon (phenorybenzamineand tolazoline), and autonomic hyryerreflexiaas a result of spinal cord lesions.Phentolamine is used to prevent dermal necrosisand sloughing from infiltrated drugs, such as norepinephrine. (3) Side effects and toxicity include sedation, miosis, postural hypotension, and reflex tachycardia. C. Adrenergic neuron blockers 1. Reserpine a. Pharmacologic properties include blocking the uptake of neurotransmitters into their storagevessicles,leading to depletion of catecholamineand serotonin storesin the brain, adrenalmedulla, and periphery.It alsodecreases cardiacoutput and peripheral vascularresistance. b. Indications for use include mild-to-moderate hypertension,though it is rarely used clinically becauseof its side effects.
areused with Bblockers caution in patients with reactive ainruay disease, diabetes mellitus, and congestive heartfailure. ln a Nutshell cr,-Blockers . Block a,-mediated vasoconstriction anddecrease afterload andpreload . Promote relaxation of urethra andtrigone anddecrease the urinary retention seenin patients prostatic withbenign hypertrophy
Note Phentolamine andtolazoline arecompetitive ct,antagonists. Phenoxybenzamine is noncompetitive because it bindsto cr receptors irreversibly.
125
System Cardiovascular
Note and reserpine Although mayshowupon guanethidine Stepl, youwon't USMLE themonthewards. encounter Note requires Cuanethidine 'l uptake to enternerve thatblock Drugs terminals. (e.g., tricyclic uptake willinterfere antidepressants) action. withguanethidine Note prevent blockers Canglionic reflexes. baroreceptor
c. Side effects and toxicity include sedation, bradycardia, vasodilatation (causing nasal congestion,flushing, conjunctival congestion),diarrhea,and depressionwith high suicide risk (contraindicatedin patientswith a history of depression). 2. Guanethidine a. pharmacologic properties. Guanethidine inhibits the releaseof stored norepinephrine from stimulated peripheral sympathetic nerve endings. It also can deplete peripheral norepinephrinestoresbut doesnot crossthe blood-brain barrier (no CNS effects). b. Indications for use include severe hlpertension, although it is rarely used today becauseof its side effects. c. Side effects and toxicity include severeorthostatic hlpotension, sexual dysfunction (delayedor retrogradeejaculation),and fluid retention. D. Ganglionic blockers include hexamethonium, trimethaphan, and mecamylamine. These ug.ni, block sympatheticand parasympatheticoutflow by blocking the nicotinic receptorsof the autonomic ganglia.They havebeen used as antihypertensivesin the past but are seldom used clinically for the treatment of hypertension today; the exception is the use of trimethaphan in the treatment of hypertension secondaryto acutedissectingaortic aneurysm. Thesedrugs are describedin greaterdetail in the Nervous SystemPharmacologychapter. E. Agents acting directly on vascular smooth muscle 1. Hydralazine
Correlate Clinical Hydralazine/nitrate isusedasan combination in to ACEinhibitors alternative CHF. treating Note lf youseea lupus-like witha positive syndrome patient an taking ANAin a think antihypertensive, is lf thepatient hydralazine. anantiarrhythmic, taking thinkprocainamide.
Bridgeto Pathology antibody antihistone Specific orantism thandsDNA rather SLE. arefoundin drug-induced
t26
a. Pharmacologic properties. Hydralazine causes the direct relaxation of vascular smooth muscle (possiblyvia nitric oxide) but has a greatereffecton arteriolesthan on venules. It is extensively conjugated by N-acetylation by the liver in the first pass. Bioavailability varies with individual rates of acetylation. Rapid acetylatorshavelower bioavailability than slow acetylators. b. Indications for use include moderate-to-severeessentialhypertension (used with p blockers to prevent reflex tachycardia and with a diuretic to prevent salt and water retention), and CHF (usedin combination with oral nitrates). c. Side effects and toxicity include reflex tachycardia,increasedmyocardial orygen consumption (which can be avoidedby adding a p blocker to the regimen),and headache and flushing relatedto vasodilatation,nausea,dizziness,and diaphoresis.A lupus-like syndrome with positive antinuclear antibody (ANA) is seenprimarily in slow acetylators (usually Caucasians).Salt and water retention occurs as a result of increased renin secretion,which can be avoidedby adding a diuretic to the treatment. 2. Minoxidil a. Pharmacologic properties. Minoxidil causesvasodilation by opening potassium channels,thereby hyperpolar izing and relaxing vascular smooth muscle. b. Indications for use include therapy for severehypertension refractory to conventional regimens.Minoxidil should be usedin combination with a p blocker and diuretic. c. Side effects and toxicity include salt and water retention, reflex tachycardia,hypertrichosis,and pericardial effi'rsion.
Pharmacology
3. Diazoxide a. Pharmacologic properties. While diazoxide is structurally similar to the thiazide diuretics,it causessodium and water retention, not diuresis.The mechanismof action is vasodilatation(via K- channelopening) of resistancevessels,primarily arterioles.It produceshyperglycemiaby inhibiting insulin release. b. Indications for use include hypertensiveemergencies,such asmalignant hypertension (contraindicatedif coronary artery disease,pulmonary edema,aortic aneurysm,or intracranial hemorrhageare present)and hyperinsulinemia(notably in insulinomas). hypotensionfollowing intravenousadminc. Sideeffectsand toxicity include excessive istration (true for all antihlryertensivesgiven intravenously);salt and water retention; hyperglycemia;reflex sympathetic activity, which can result in angina (should be administeredwith a B blocker in patientswith coronary artery disease);tissueirritation if extravasationoccurs;and hirsutism with prolonged administration.
Clinical Correlate Because minoxidil wasnoted to cause hypertrichosis, it was developed intoa topical formale-pattern treatment baldness. Bridgeto Endocrinology Diazoxide minoxidil opensATPdependent K*channels onB cellsofthepancreas, hyperpolarizing thecells and preventing release. insulin
4. Sodium nitroprusside a. Pharmacologic properties. Sodium nitroprusside directly relaxesvascular smooth muscle.It actson both arteriolar and venoussmooth muscle.Becauseof its very short half-life, it is administeredas a continuous intravenousinfusion. Sodium nitroprusside interactswith sulfhydryl groups in RBCsto produce a cyanideanion and nitric oxide (vasodilator).The ryanide is then metabolizedin the liver to thiocyanateand is slowly clearedby the kidney (half-life is 4 days). acuteCHF (preload and afterb. Indications for use include hlryertensiveemergencies, pulmonary mitral regurgitation with congestion.Sodium load reduction), and severe nitroprusside is used only in well-monitored, intensivecare settingsand for a short time becauseof ryanide toxicity. c. Side effects and toxicity include excessivevasodilatation that may produce hypotension, nausea,headache,palpitations,diaphoresis,and anxiety.The effectsof thiocyanate poisoning (i.e.,nausea,psychosis,musclespasm,tissuehypoxia) can alsooccur. F. Calcium-channel blockers (verapamil,diltiazem, nifedipine, nicardipine, and nimodipine) l. Pharmacologic properties. Thesedrugs block Ca2+entry into cells and mobilization of Ca2+from intracellular stores,thereby inhibiting excitation-contractioncoupling of the vascular smooth muscle (and smooth muscle in certain other sites). The result is a decreasein peripheral vascularresistance.Diltiazem and verapamil also slow conduction through the atrioventricular (AV) node. 2. Indications for use include mild-to-moderate hypertension(particularly if either angina or supraventriculartachyarrhythmia is also a problem), coronary vasospasm,supraventricular tachyarrhythmias (verapamil, diltiazem), migraine prophylaxis, esophageal spasm,and Raynaud'sphenomenon. 3. Side effects and toxicity include dizziness,headache,nausea,heart block (especially verapamil), exacerbationof CHR and hypotension (negative inotropy, especiallywith verapamil).
ClinicalCorrelate Thehyperglycemic sideeffect of diazoxide issometimes fortreating insulinomas. useful ln a Nutshell . Sodium nitroprusside directly relaxes vascular smooth muscle vianitric oxide. ' Nitricoxide stimulates guanylate cyclase+ tcCMP-+ vasodilatation. . lt isbestusedin hypertensive emergencies.
Clinical Correlate toxicity management Cyanide requires nitrites to begiven to reduce hemoglobin to methemoglobin whichbinds cyanide{orming This cyanomethemoglobin. prevents oxidase cytochrome inhibition intheelectron chain. Cyanomethtransport (Hb)isreconverted emoglobin to metHbbyadministering to allowexcretion of thiosulfate asthiocyanate cyanide (although alsohighly toxic!).
127
Cardiovascular System
Note blockers Calcium-channel differin theirclinical effects: . Nifedipine, nicardipine, and primarily nimodipine peripheral decrease resistance + decrease bloodpressure. . Verapamil anddiltiazem primarily reduce AVnode conduction.
Bridgeto General Principles Themechanisms ofaction of theangiotensins and bradykinin arediscussed inthe Autacoids chapter ofthe Pharmacology section of Principles Book2 Ceneral (Volume ll). Note "Captopril isthought cough" to becaused byirritation from increased bradykinin, an inflammatory mediator. Note ACEinhibitors are in patients contraindicated with renalartery where stenosis, physiologic angiotensin || isneeded to preserve renal function.
t28
G. Antagonists of the renin-angiotensin system 1. Captopril a. Pharmacologicproperties. Captopril inhibits angiotensin-convertingenzyme (ACE), which convertsangiotensinI to angiotensinII (a potent vasoconstrictor).ACE inhibitors also decreasebradykinin inactivation, thereby potentiating the vasodilatory effectsof bradykinin. It decreasesperipheral resistanceby lowering angiotensin II levels and increasingbradykinin levels.The decreasein angiotensin II also leadsto a reduction of aldosteronelevels.Becausevasodilatationof renal efferentarteriolesis greaterthan afferent arterioles,filtration pressureand the glomerular filtration rate (GFR) are reduced. Fifiy percent is metabolizedto inactive compounds. Both captopril and its metabolites are renally excreted. b. Indications for use include CHF (reducesboth preload and afterload) and mild-tomoderate essentialhlryertension;origin"lly, it was introduced for high-renin states, but it is now used with normal renin levels.It is often used in conjunction with a thiazidediuretic. Studieshave shown that the ACE inhibitors decreaseproteinuria and the rate of progressionof renal failure in diabetics. c. Side effectsand toxicity include distortion or loss of tastesensation(most common side ef[ect),dty cough, angioedema,dizziness,orthostatic hypotension,renal damage in patientswith preexistingrenal disease,proteinuria, rash,pruritus, eosinophilia,rare bone marrow toxicity (e.g.,agranulocytosis),and renal damagein the fetus. 2. Enalapril a. Pharmacologic properties. Enalapril is a prodrug ACE inhibitor with a spectrum of activity and mechanism of action identical to captopril. It is hydrolyzed to enalaprilat, the activecompound that persistsin plasmalonger and is more potent than captopril. b. Indications for use are the same as captopril, but enalapril is also availablein intravenousform for use in intensivecare settings. c. Side effectsand toxicity are similar to captopril, but enalapril showslesseosinophilia and a lower incidenceof tastedisturbance. H. Diuretics are used extensively in the treatment of hypertension (reduce intravascular volume). They are discussedin detail in the RenalPharmacologychapterin this book.
Pharmacology
Table I-5- l. Antihypertensive agents. Category
Agents
Mechanism of Antihypertensive Action
Central-acting sympatholytic agents
Clonidine, methyldopa, and guanabenzreceptors
Decreasesympathetic outflow by stimulating central crr-adrenergic
Peripheraladrenergic blockers
Alpha blockers: Phenoxybenzamine,phentolamine, tolazoline,prazosin,and terazosin
Block vasoconstrictivecr receptors
Betablockers: Propranolol, nadolol, timolol, pindolol, acebutolol,metoprolol, atenolol and esmolol Mixed antaeonists: Labetalol, carvedilol
Block peripheral p receptors
Block both a and p receptors
Adrenergicneuron blockers
Reserpineand guanethidine catecholamines
Reduceamount of circulating
Ganglionic blockers
Hexamethonium,trimethaphan, and mecamylamine
Block sympathetic and parasympathetic outflow
Direct vasodilators
Hy dr alazine,minoxidil, diazoxide, and sodium nitroprusside
Act directly to relax vascular smooth muscle and induce vasodilatation
Calcium-channel blockers
Nifedipine, verapamil,and diltiazem
Block Ca2*mobilization and entry into cells;dilate vesselsby inhibiting vascularsmooth muscle contraction
ACE inhibitors
Captopril and enalapril
Inhibitors of ACE; block synthesis of angiotensinII, a potent vasoconstrictor;increase circulating bradykinin
ANTIARRHYTHMICS Antiarrhythmic drugs affect the action potential and its conduction in many ways. Clinically, this is reflectedin alterationsof pulse rate and blood pressure,as well as changesin the ECG. The most widely used antiarrhythmic agents can be grouped into various classesby their electrophysiologic effects (Table l-6-2). Antiarrhythmic agents have proarrhythmic effects as well as antiarrhythmic effects.
129
Grdiovascular System
ln a Nutshell l-Na*channel blockers Class Class ll-B blockers Class lll-prolong action potential lV-calcium-channel Class blockers
Flashbackto Physiology Thephases ofthecardiac potential action aredescribed in detail in theCardiovascular Physiology section.
Thble l-6-2. Categories of drugs based on electrophysiologic effects. Category
Electrophysiologic Effect
ClassI
through Na+ Drugs that decreasemembrane responsiveness channelblockade Drugs that inhibit sympatheticactivity through B-adrenergicblockade Drugs that prolong the action potential (by blocking potassiumchannels) Drugs that block the slow inward calcium current
ClassII ClassIII ClassIV
A. ClassIA agents.ClassIA agentsdecreasethe rate of cardiacconduction by slowing the rate of phase 0 depolarization, slowing conduction, and prolonging repolarization.This is primarily due to the blockade of activatedNa* channels. 1. Quinidine a. Pharmacologicproperties. Quinidine is the dextrostereoisomerof quinine. It is given by the oral route, where it is rapidly absorbed,metabolizedby the liver, and excreted by the kidney. BesidesNa+ channel blockade, quinidine blocks muscarinic and ct, receptors. b. Electrophysiologic effects. Quinidine blocks Na+ channels and slows the phase 0 upstroke.At therapeuticlevels,quinidine prolongs the action potential conduction in the bundle of His and Purkinje fibers.It also decreases the automaticity of ventricular tissue.The resultant ECG showsprolongation of the QRS and QT intervals (torsade de pointes). It can increaseAV nodal conduction (vagolytic) in low dosesand thus increasethe ventricular rate during atrial flutter.
Note quinidine Before using totreat youmust anatrial arrhythmia, pretreat withanagent to slow ventricular response.
c. Indications for use include atrial arrhythmias, i.e., premature contractions, flutter, fibrillation, and ventricular arrhythmias, including ventricular ectopic beats.The patient must be pretreatedwith digitalis,a p blocker,or a Ca2+-channel blockerto avoidthe possible increasein ventricular responseto atrial dysrhythmias. This can be causedby a vagolytic effect of quinidine at the AV node. Quinidine can decreaseatrial fibrillation and flutter suchthat 1:1conductionthrough the AV node can occur. d. Sideeffectsand toxicity include severeprolongation of the QT and QRS intervals,SA nodal arrest,a high degreeof AV block, ventricular tachyarrhythmias,asystole,shortened AV nodal delay,and conversionof atrial fibrillation to ventricular fibrillation. Hypotensioncan alsooccur becauseof crblockade.Other effectsinclude nausea,vomiting, diarrhea(common), immunologic effects(e.g.,drug fever,anaphylaxis, autoimmune thrombocytopenia),cinchonism (e.g.,tinnitus, blurred vision), and delirium. e. Drug interactions. Barbiturates,phenytoin, primidone, and rifampin can increasethe metaboiism of quinidine. Cimetidine decreasesthe metabolism of quinidine. An increasedquinidine effect is seenwith amiodarone.Quinidine increasesthe effectsof warfarin and neuromuscular blockers, and the serum levels of digoxin and digitoxin. Quinidine is a weakbase;therefore,antacidsincreasesits absorption,increasingthe risk of toxicity. 2. Procainamide a. Pharmacologic properties. Procainamideis derived from procaine.It is given orally, intravenously, or by intramuscular injection. It is rapidly absorbed orally and is
tI0
Pharmacology
metabolized in the liver by acerylation to N-acetylprocainamide (NAPA). The rate of acetylation (genetically determined) is inversely related to the likelihood of developing a lupus-like syndrome. Both NAPA and procainamide are renally excreted. Its electrophysiologiceffects are similar to quinidine. b. Indications for use are similar to quinidine (either may work even if the other is ineffective), although procainimide seemsto be better for ventricular dysrhythmias and blocks muscarinic and c receptorsto a lesserdegree. c. Side effects and toxicity include a high degreeof block and bradyarrhythmias, conversion of atrial fibrillation to ventricular fibrillation, hypotension, a syndrome similar to lupus erythematosus,gastrointestinal disturbances (but not as common as with quinidine), and fever. 3. Disopyramide a. Pharmacologic properties. Disopyramide is well absorbed orally. The parent compound and metabolites are renally excreted.The hepatic first-pass effect metabolizes about half of the drug. b. Electrophysiologic effects are similar to quinidine and procainamide, though there is little effect on conduction velocity through the His-Purkinje system. c. Indications for use. Disopyramide's major role is in treatment and prevention of ventricular tachycardiaand ventricular ectopic contractions. d. Side effects and toxicity include a strong negative inotropic effect (can precipitate CHF), vasoconstriction,and anticholinergiceffects(e.g.,urinary retention, constipation, closed-angleglaucoma).
B. Class IB agents.The classIB agentsdecreasethe action potential duration by shortening the phase 3 repolarization. They have little effect on depolarization. Becausethey block inactivated sodium channels, they are usefrrl in disorders in which the myocardium becomes hlpoxic or dqnlarized (e.g.,post MI, digitalis toxicity). 1. Lidocaine a. Pharmacologic properties. Lidocaine is an amide local anestheticgiven by the intravenous or intramuscular routes. It is de-ethylated in the liver with a 90olofirst-pass effect; thus, the dosagemust be adjusted in patients with hepatic insufficiency. b. Electrophysiologic effects. Lidocaine decreasesautomaticity in Purkinje fibers and ventricular tissue.It has no effecton sinus node automaticity or AV node conduction. It can causeprolongation of PR interval, QRS interval, or worsening of dysrhythmias. c. Indications for use include primary therapy for ventricular arrhythmias (intravenous only). Lidocaine is also used as a local anesthetic. d. Side effects and toxicity are predominantly CNS related (e.g.,drowsiness,disorientation, seizures,psychosisin the elderly and those with CHF). Lidocaine can cause hlpotension. Cimetidine and propranolol increaselidocaine toxicity. Overall,it is one of the least cardiotoxic agentsof classI. 2. Tiocainide and mexiletine are newer class IB drugs with actions and effects similar to those of lidocaine. They are indicated for use in treating ventricular arrhythmias and causeCNS (e.g.,dizziness,tremor), gastrointestinal(e.g.,anorexia,nausea,vomiting), and hematologicside effects.
tIl
Cardiovascular System
C. Class IC agents (flecainide,encainide,propafenone,and moricizine). The classIC agents induce considerablephase 0 depressionby strongly binding to Na+ channels.They slow impulse conduction in all cardiac tissue, especiallyin the His-Purkinje system.They have little effect on repolarization. 1. Pharmacologic properties. Flecainide and encainide are well absorbed orally and are metabolizedby the liver. Encainideundergoessignificant first-passmetabolism. 2. Indications for use. Current use of all drugs in this classis limited to life-threatening ventricular arrhythmias that do not respond to drugs of the IA and IB classes. 3. Side effects and toxiciry These drugs can precipitate cardiac arrest and sudden death in patientswith preexistingcardiacabnormalities. D. Class II agents (B-adrenergic blockers). The antiarrhythmic efficacy of these agentsstems from their suppressionof phase4 depolarization and their inhibition of AV node conduction. They also decreasemyocardial contractility. Beta-adrenergic blockers used as antiarrythmics include propranolol, acebutolol,esmolol,and sotalol. l. Pharmacologic properties. These drugs are highly protein bound, metabolized in the liver, and excretedin urine. 2. Electrophysiologic effects. B blockers decreasethe automaticity of the SA node and Purkinje fibers, prolong conduction through the AV node, and increasethe R-R interval (i.e.,decrease the heart rate). 3. Indications for use include supraventricular tachyarrhythmias (slow ventricular rate by prolonging conduction through the AV node), atrial flutter, atrial fibrillation, paroxysmal supraventricular tachycardia,postmyocardial infarction (decreasesrisk of reinfarction and suddendeath), and acutemyocardialinfarction (in some situations). 4. Sideeffectsand toxicity relatedto B blockadeat nonvascularsitesinclude bronchospasm in asthmatics(risk reducedwith B1-selective agentssuch as metoprolol); exacerbationof peripheral vascular disease;masking the sympatheticresponseto hypoglycemiain diabetics;a negativeinotropic effectleadingto exacerbationor precipitation of CHF (maybe less severewith an agent such as pindolol, which has some intrinsic sympathomimetic activity); heart block; gastrointestinaleffects (e.g., nausea,diarrhea, constipation); and CNS efFects(e.g., hallucinations,nightmares,depression,impotence). E. Class III agents are all capableof prolonging the action potential duration and increasing the effectiverefractory period (ERP), i.e., the period during which an action potential will only be stimulated via a strong impulse. They block K+ channels and prolong repolarization. They haveno effect on phase0 depolarizationor the resting membrane potential. 1. Bretylium
ClinicalCorrelate Bretylium causes aninitial worsening ofventricular because anhythmias of the catecholamine release. Thisis whyit isonlyusedafterlA andlBdrugs fail.
lt2
a. Pharmacologic properties. The ammonium salt of bretylium is an adrenergic neuron blocker.It is administeredparenterallyand is excretedunchangedin the urine. b. Electrophysiologic effects include an increasein the action potential duration and the ERP.There is no effect on automaticiry responsiveness, or conduction. c. Indications for use include ventricular arrhythmias in intensivecare or arrest situations when drugs of the IA and IB classesare not successfrrl. d. Side effects and toxicity include hlpotension (from blockade of efferent limb of baroreceptorreflex),nausea,vomiting, vertigo, and dizziness.Hypertensionis seenin the presenceof sympathomimeticamines.
Pharmacology
2. Amiodarone a. Pharmacologicproperties. Amiodarone is structurally similar to thyroxine.After oral administration, 2-4 weeksare neededto achievesteadystate.It is metabolizedby the liver. The half-life rangesfrom 20-100 days. b. Electrophysiologic effects.Amiodarone prolongs the action potential and refractoriness in atrial and ventricular Purkinje fibers, slows spontaneoussinus node dischargerate (automaticity),and can causesinusbradycardia. c. Indications for use include refractory atrial or ventricular tachyarrhythmias(uselimited by toxicity). It is used for life threateningconditions that do not respondto conventional agents.
Note Because amiodarone's half-life issolong,loading doses haveto beusedfor upto threeweeks.
d. Side effects and toxicity include pulmonary alveolitis or fibrosis, gastrointestinal disturbances(e.g.,vomiting, nausea,anorexia),hyper- and hypothyroidism, hepatotoxicity, and corneal microdeposits. It may increaselevels of digitalis, quinidine, procainamide, and diltiazem. Photosensitivity and bluish skin deposits ("gray man syndrome" or "smurf skin") are also seen. 3. Sotalol a. Pharmacologic properties. Sotalol is a nonselectiveB-adrenergicblocking agent, which uniquely possesses both class II and class III antiarrhythmic characteristics. The bioavailabiliry of oral sotalol approaches100o/o,and the drug is not protein bound. It undergoesnegligible first-passhepatic metabolism with 75o/oof the dose excretedunchangedin the urine. b. Indications for use. Sotalol is approved only for use in the acute and prophylactic managementof life-threateningventricular tachyarrhythmias.It has also been used for the treatment of stableand unstableangina and hypertension. c. Side effectsand toxicity include new or worseningof ventricular arrhythmias,which occur in approximately4o/oof patients.The most prominent adverseeffectsare those related to B blockade (e.g.,fatigue,bradycardia,dyspnea,asthenia,dizziness).Sotalol is hydrophilic and has a low CNS penetration and central effects. F. Class IV agents. The Ca2+-channelblockers increase the conduction time through the AV node by blocking the slow calcium channels.They are used for treatment of supraventricular tachycardia(they protect ventriclesfrom fast atrial rates). 1. Pharmacologic properties. Verapamil is completelyabsorbedby the oral route but has substantialfirst-passmetabolismby the liver.Up to 70o/ois excretedby the kidneys. 2. Electrophysiologic effects include inhibition of the slow inward current of phase0 and phase2 of the action potential in slow fibers, and the prolongation of conduction time and ERP through the AV node. 3. Indications for use include paroxysmalsupraventriculartachycardiaand atrial fibrillation and flutter. 4. Side effectsand toxicity include hypotension,asystole,and AV block. Verapamil and diltrazemhave a negativeinotropic effect and should not be used in patientswith compromised cardiacfunction.
Note Verapamil, diltiazem, and bepridil aretheonly Ca2*-channel blockers used asantiarrhythmia. Bepridil's useislimited because it causes torsades depointes.
Clinical Correlate Verapamil should notbeused in patients withatrial fibrillation whoalsohave Wolff-Pa rkinson-Wh ite syndrome. Anincrease in conduction through the (bypas$ accessory tractcan leadto increased ventricular response andpossible ventricular fibrillation.
l15
System Cardiovascular
GTYCOSIDES CARDIAC A. Overview. Certain steroidsand their glycosideshave a characteristiceffect on the electrophysiologyof the heart.The digitalis leaf is the sourceof the cardiacglycosides,digoxin and digitoxin. 1. Pharmacologic properties
ln a Nutshell isvia inotropy Increased calcium 1 intracellular ("direct" effect)
Note glycosides Thecardiac produce theirantianhythmic of viaenhancement actions ("indirect" vagal activity effect).
a. Cardiac glycosidesinhibit the Na+-K+ ATPase in cell membranes. The inhibition of the Na+-K* po-p diminishes the Na+ gradient, which in turn decreases5t+-g^2+ exchange,thus leading to intracellular Ca2+ accumulation. This increasesthe Ca2+ available to the Ca2+-dependentcontractile proteins of the cardiac muscle cells. Contractile force increases,causinga positive inotropic effect. b. At the AV node, the glycosidesprolong the ERP and diminish the rate at which supraventricularimpulses are transmitted to the ventricles.The mechanism of this effect involvesenhancementof vagal activity and diminution of the sensitivityof the AV node to sympatheticinput. c. Bioavailabilityof oral preparationsis extremelyvariable,requiring monitoring of the serum levels of the drug. d. Absorption is retardedby food in the gastrointestinaltract, delayedgastricemptying, malabsorption,and antibiotics. 2. Indications for use include CHF (due to their positive inotropic effect), AV nodal depressionto control the ventricular responseto paroxysmalsupraventriculartachycardia, and atrial fibrillation or atrial flutter. Becauseof the tendenry of classI antiarrhythmics to increaseAV nodal conduction, glycosidesmay be usedbefore or in conjunction with classI antiarrhythmic agentsfor control of chronic atrial tachyarrhythmia. 3. Side effects and toxicity a. Life-threatening cardiac arrhythmias, such as ventricular ectopy,ventricular dysrhythmias,paroxysmaiatrial tachycardiawith block, and second-and third-degree(complete) heart block, all require that patientsbe closelymonitored.
Note produces asmany Digitalis The asit treats. arrhythmias indexisl-2. therapeutic Note should cardioversion Electrical withdigitalis beavoided because intoxication fibrillation canbe ventricular of induced asa result a threshold. reduced fibrillation due isdepolarized Thetissue to thepumpblock.
t54
b. Other side effectsinclude gastrointestinal(e.g.,anorexia,nausea,vomiting, abdominal pain), CNS (e.g.,fatigue, neuralgias,delirium, hallucinations), and visual disturbances (e.g.,abnormalcolor perception). c. Toxicity can be precipitated by hypokalernia, alkalosis,hypoxia, hypercalcemia,hyPomagnesemia,hypothyroidism, hyponatremia.Certain drugs increasetoxiciry including verapamil, quinidine, corticosteroids,thiazides, and other K+-wasting diuretics. d. Therapy for digitalis intoxication includes discontinuation of the drug, potassium supplementation (if hypokalemia is present), arrhythmia control (with phenytoin, lidocaine,or procainamidefor tachyarrhythmia).Bradyarrhythmiasmay be controlled with atropine and pacing;in casesof severetoxiciry antidigoxin immunoglobulin is administered. B. Specific agents 1. Digoxin, the most commonly used preparation, is 25o/oprotein bound, excretedmostly unchanged in urine (dosagemust be reduced in renal failure), and has a half-life of approximately 36 hours. An increaseddigoxin effect is seenwith verapamil, nifedipine, amiodarone, quinidine, tetrarycline, diazepaln, erythromycin, and hypothyroidism. A decreaseddigoxin effect is seen with antacids, prednisone, rifampin, and hyperthyroidism.
Pharmacology
2. Digitoxin is over 900/oprotein bound and is metabolizedby hepatic microsomal enzymes (one metabolic product is digoxin). Enzyme induction by drugs such as phenytoin, phenobarbital, rifampin, and phenylbutazoneincreasesdigitoxin metabolism. Tirere is significant enterohepaticcirculation, resulting in a half-life of 4-7 days.
ANTIANGINAT AGENTS Antianginal agentsinclude drugs that dilate coronary arteries,decreaseheart rate,decreasecardiac contractiliry decreasewall tension,or decreasevenousresistance. A. Organic nitrates (nitroglycerin) l. Pharmacologic properties a. Pharmacokinetics. Organic nitrates are well-absorbedorally but rapidly denitrate and inactivate through a first-pass effect in the liver. To remedy this, they are often given by the sublingual route. Oral preparations are also available,which are lessvulnerable to denitration (e.g.,isosorbidedinitrate). Nitrate toleranceoccurs secondary to sulfhydryl group depletion. This is best avoidedby a dosing regimen that allows a nitrate-freeinterval of at least l2 hours. b. Mechanism of action includes coronary vasodilatation and systemicvenouspooling to reducepreload.Vasodilatationis believedto be secondaryto the metabolismof nitrates to nitric oxide, which can activateguanylatecyclaseand increasecGMp; cGMR in turn, leadsto dephosphoryiationof the myosin light chain and inhibition of vascularsmooth musclecontraction. 2. Specific agents include nitroglycerin (sublingual, intravenous, transcutaneous,transbuccal), isosorbide dinitrate (oral preparation), and amyl nitrate (a volatile liquid administeredby inhalation). Toleranceto continuous useis a problem. 3. Indications for use include angina, coronary vasospasm,Prinzmetal's angina, CHF (afterloadreduction), and short-term managementof hypertension. 4. Side effectsand toxicity include postural hypotension,reflex tachycardia,and headache. B. Calcium-channel blockers l. Pharmacologicproperties. Ca2+-channelblockersinterferewith Ca2+influx required for excitation-contraction coupling in smooth and cardiac muscle, resulting in vasodilatation. The net effect is reduction in systemicvascular resistance,reduction in coronary vasospasm,and decreasedmyocardial oxygen demand. Effects on the cardiac HisPurkinje system result in a decreasedventricular responseto supraventricular tachyarrhythmias. 2. Indications for use include angina as a result of vasospasm(nifedipine, diltiazem), exertional angina, hypertension in patients also suffering angina, supraventricular tachyarrhythmias (especiallyverapamil), idiopathic hypertrophic subaortic stenosis(IHSS), and migraine headacheprophylaxis (verapamil). 3. Side effects and toxicity include hlpotension, AV nodal block, bradycardia,asystole, CHR dry mouth, and constipation.Digitalis toxicity is also increasedwith verapamil. C. Beta-adrenergicblockersrelieveanginaby modifring sympathetictone and, thereby,reducing heart rate and cardiaccontractility. The mechanismof action is relatedto the blockade of cardiacsympatheticB, receptors.Drugs have variablehalf-lives and cardioselectiviry(p1 versusB2).
Flashbackto Pathology Thepathophysiology of angina isdiscussed inthe Cardiovascu larPathology chapter.
ClinicalCorrelate AnginaSymptoms . Crushing pain;may chest radiate to leftarmor neck . Canalsoseeshortness of breath, nausea and vomiting, diaphoresis Response to sublingual nitroglycerin ishelpful indiagnosing and treating angina.
In a Nutshell Uses ofBBlockers in Cardiac Patients . Hypertension-decreases cardiac output andrenin secretion . Arrhythmias-especially SW (prolongs conduction through AVnode) . Angina-reduces heartrate andcontractility . PostMl-reduces riskof reinfarction anddeath
t55
Cardiovascular System
ANTILIPID AGENTS A. Nicotinic acid (niacin) 1. Pharmacologicproperties. Niacin is structurally relatedto the pyrimidines. It is available as an oral or parenteralpreparation. Nicotinic acid decreasesVLDI production by the liver by working multiple mechanisms,including inhibition of lipolysis,decreasedhepatic esterificationof triglycerides,and increasedlipoprotein lipase activity. It is used as a cofactorafter conversionto nicotinamide and nicotinamide adeninedinucleotide (NAD), which is unrelatedto its antihyperlipidemic action. 2. Indications for use include all hyperlipidemias excepttype I. It is especiallyuseful for type IIb, prevention of pellagra(lower doses),and peripheralvascularinsufficienry (causesperipheralvasodilatation). 3. Side effects and toxicity include cutaneous effects (e.g., pruritus, flushing, which is decreasedby taking aspirin), gastrointestinaleffects(e.g.,vomiting, diarrhea,dyspepsia), hyperpigmentation,increasedliver enzymelevels,hyperuricemia,and hyperglycemia. B. Clofibrate 1. Pharmacologic properties. Clofibrate is a fibric acid derivativethat increasesthe activity of lipoprotein lipase, which breaks down triglycerides(in VLDL) into fatty acids.It decreasesVLDL, has no effect on HDL, inhibits cholesterolsynthesisin the liver, and increasesits excretionin bile. 2. Indications for use include patientswith increasedVLDL and LDL levelswho havefailed to respondto diet therapy.It is especiallyuseful for type III hyperlipoproteinemia. 3. Side effects and toxicity include nausea,diarrhea, alopecia,rash, impotence, myalgias with elevated SGOT and CPK, cholelithiasis,cholecystitis,arrhythmias, angina, cardiomegaly,and thromboembolic disease.It is contraindicatedin pregnancyand in renal or hepatic insufficiency. Clofibrate displacesother drugs from plasma albumin and increasestheir effects,for example,phenytoin, tolbutamide, and warfarin. There is a need to monitor the prothrombin time in patients on both warfarin and clofibrate. C. Gemfibrozil 1. Pharmacologic properties. Gemfibrozil is a fibric acid derivativeand an analog of clofibrate. It lowersVLDL and raisesHDL levels. 2. Indications for use are similar to clofibrate. 3. Side effects and toxicity include mild gastrointestinalupset, abdominal pain, nausea, eosinophilia, and rash. Gemfibrozil may enhancegallstoneformation and may have a mild hyperglycemiceffect.It alsopotentiateswarfarin activity. D. Cholestyramine and colestipol l. Pharmacologicproperties. The mechanismof thesecompounds involvesbinding to bile acids in the gut and increasingtheir excretionin feces.The result is increasedconversion of cholesterolinto bile acidsand decreasedplasmacholesterol. 2. Indications for use include type IIa and IIb hyperlipidemias.They are often used with niacin.
t56
Pharmacology
3. Side effects and toxicity include nausea,abdominal cramps, constipation, steatorrhea, and impaired absorption of fat-solublevitamins. They also increaseVLDL synthesisand should be usedwith niacin and avoidedin patientswith hypertriglyceridemia.Drug interactions include binding to certain drugs (e.9.,tetrarycline, phenobarbital, digitoxin) if given simultaneously. E. Lovastatin and mevastatin 1. Pharmacologic properties. These drugs inhibit HMG CoA reductase, the enzyme that catalyzesthe rate-limiting step in cholesterolsynthesis.The decreaseof cholesterolsynthesis resultsin an increasedbreakdown of circulating LDL and an increasein HDL. These drugs are excretedthrough bile and feces. 2. Indications for use include typesIIa and IIb hyperlipoproteinemiaand secondaryhyperlipoproteinemia (e.g.,nephrotic syndrome,diabetes). 3. Side effects and toxicity include gastrointestinal symptoms, headache, and rash. Asymptomatic increasein liver enzymesmay occur.Liver function should be monitored, and the drug discontinuedif abnormalitiesarise.An increasein muscleCPK is also seen; rhabdomyolysis may occur.
THROMBOTYTIC AGENTS Thrombolytic agents include streptokinase, urokinase, and tissue plasminogen activator (t-PA). All three agentsact by promoting the conversionof plasminogento plasmin. Plasmin, in turn, actsto cleavefibrin and to dissolveclots. Besidestheir other indications,theseagents are used in the treatment of acutemyocardialinfarction. Thrombolytic agentsare describedin detail in the Hematologic/LymphoreticularPharmacologychapter of this book.
lt7
Respiratory Embryology Therespiratory in thefourthweekof development grove, system appears asthelaryngotracheal a median diverticulum inthecaudal groove endofthepharyngeal floor. Theendodermal liningofthis gives riseto theinternal epithelium ofthelarynx, trachea, bronchi, andlungs. Lateral margins ofthe groove fusein a caudal-to-cranial direction to formthelaryngotracheal tube,whichcommunicates withthepharynx viathelaryngeal orifice behind thecopula. Atthesame time,thedorsal lumenof thelengthening foregut narrows to formtheesophagus. Therespiratory diverticulum becomes separated fromthedorsal foregut bythetracheo-esophageal septum.
LARYNX A. Cartilage and musculature originate from the fourth and sixth pharyngeal arch mesenchyme. Laryngeal muscles are innervated by the vagus nerve. Derivatives of the fourth pharyngeal arch are innervated by the superior laryngeal nerve, and derivativesof the sixth arch are innervated by the recurrent laryngeal nerve. B. Laryngeal orifice becomes T-shaped as mesenchyme proliferates to form the thyroid, cricoid, and arytenoid cartilages. C. Falseand true vocal cords differentiate from tissue folds in the laryngeal epithelium.
TRACHEA, BRONCHI, ANDTUNGS A. Conductitg airways. The laryngotrachealtube grows caudally into the splanchnic mesoderm of the ventral foregut, where it divides into a midline trachea and right and left lung buds. 1. The right lung bud divides into three lobes and the left into two, correspondingto the number of main bronchi and lobes in the fi.rlly developedlung. 2. The bronchi divide repeatedlyin a dichotomous processthat continues after birth to form bronchioles. 3. Distal expansionsof terminal bronchiolesform alveoli. B. Respiratoryairways 1. Respirationis possibleby the seventhmonth, as the cells of the respiratory bronchioles becomeassociatedwith the endothelium of the capillariesto form primitive alveoli. 2. TWokinds of alveolar epithelial cells line the terminal sacs.
t4l
Respiratory System
a. Tlpe I pneumocytes are squamousepithelial cellsthat form the alveolar gasexchange surface. b. Type II pneumocytes are plump cuboidal-like cells that produce surfactant.
PIEURAICAVITIES As the lungs grow caudolaterallyinto the pericardioperitonealcanals,they penetratethe part of the intra-embryonic coelom that becomesthe pleural cavities.The lungs acquire a visceral pleura coveringderived from splanchnicmesoderm,and the body wall becomeslined by parietal pleura derived from somatic mesoderm.
CONG ENITAIABNORMALITI ES A. Esophagealatresia (closure)may be causedby posterior deviation of the tracheoesophageal septum.In the embryo, this preventsswallowingof amniotic fluid and resultsin fluid accumulation and an enlargeduterus.When an afflicted newborn attempts to feed,fluid overflows into the trachea,causingaspiration pneumonia. B. Tracheoesophagealfistula usually occurswith esophagealatresiaand consistsof an abnormal passagebetweenthe distal part of the esophagusand the tracheajust abovethe bifurcation. As a result, acidic gastric contents may passinto the lungs and causeseverechemical pneumonitis. Movement of air into the stomach also may causedilatation of the stomach, elevationof the diaphragm, and hamperedrespiration. C. Congenital cystsof the lungs are saccularenlargementsof terminal bronchiolesthat can be solitary or multiple. If not removed,they may result in chronic infection becauseof poor drainage. D. Prematurity l. Before 25-28 weeks,the fetal lungs cannot provide adequategasexchange,and the fetus is not viable.After that age,the alveolarsurfaceareaand the associatedcapillary network are developedenough to support life. 2. Between24 and 28 weeks,alveolarepithelial cells produce surfactant, a phospholipidcontaining substance that is necessaryfor effective ventilation. Surfactant overcomes surfacetensionwithin the alveoliand, thus, preventstheir collapsewhen the intra-alveolar liquid is replacedby air. 3. In premature infants, lack of surfactantcontributes to hyaline membrane diseaserespiratory distresssyndromeof the newborn. When an afflictednewborn takesthe first breath in responseto the anoxia produced during delivery and cutting of the umbilical cord, the alveoli do not remain patent, and the lungs are underinflated.
142
Histology Respiratory permits airandblood dioxide between Therespiratory system theexchange of oxygen andcarbon capillary membrane, thatseparates bloodfrom byproviding a thincellular deepinthelungs, portion (nasal pharynx, cavity, larynx, trachea, air.Thesystem isdivided intoa conducting alveolar thatcarries during inspiration andexpiration anda respiratory bronchi, bronchioles) thegases (alveoli) portion forgasexchange between airandblood. thatprovides
NASAL CAVITIES The nose contains the paired nasal cavitiesseparatedby the nasal septum. Anteriorly, each cavity opens to the outside at a nostril (naris), and posteriorly, each cavity opens into the nasopharynx. Each cavity contains a vestibule, a respiratory area, and an olf4ctory area, and eachcavity communicateswith the paranasalsinuses. A. Vestibule is locatedbehind the naresand is continuous with the skin. 1. Epithelium is composedof stratified squamous cellsthat are similar to the contiguous skin. 2. Hairs and glandsthat extendinto the underlying connectivetissueconstitutethe first barrier to foreign particlesentering the respiratorytract. 3. Posteriorly,the vestibular epithelium becomespseudostratified,ciliated, and columnar with goblet cells (respiratory epithelium). B. Respiratory area is the major portion of the nasal cavity. 1. Mucosa is composed of a pseudostratified, ciliated, columnar epithelium with numerous goblet cells and a subjacentfibrous lamina propria that contains mixed mucous and serous glands. 2. Mucus produced by the goblet cellsand the glandsis carried toward the pharynx by ciliary motion. 3. The lateral wall of each nasal cavity contains three bony projections, the conchae, which increasethe surfaceareaand promote warming of the inspired air. This region is richly vascularizedand innervated. C. Olfactory area is located superiorly and posteriorly in eachof the nasalcavities. 1. The pseudostratified epithelium is composedof bipolar neurons (olfactory cells),supporting cells,brush cells,and basalcells. The receptor portions of the bipolar neurons are modified dendriteswith long, nonmotile cilia. 2. Under the epithelium, Bowman's glands produce serousfluid, which dissolvesodorous substances.
Note Thereceptor cellsinthe pathway olfactory arethe olfactory cells epithelial themselves. cellsare Thebasal stemcells thatcontinuously turnoverto replace the Thisis olfactory receptor cells. animportant inthe example adulthuman neurons where arereplaced.
t4t
Respiratory System
ln a Nutshell Sinus Cavities . Frontal . Maxillary
D. Paranasal sinuses are cavities in the frontal, maxillary ethmoid, and sphenoid bones that communicate with the nasal cavities. 1. The respiratory epithelium is similar to that of the nasal cavities except that it is thinner. Few glands are 2. Numerous goblet cellsproduce mucus, which drains to the nasalpassages. found in the thin lamina propria.
. Ethmoid . Sphenoid
NASOPHARYNX ANDTARYNX A. Nasopharynx is the first part of the pharynx.
Note
l. It is lined by a pseudostratified, ciliated, columnar epithelium with goblet cells.
Theciliated cells'ciliabeatand protect theconducting and respiratory airways by propelling particles inhaled andsecretions toward the oropharynx.
2. Under the epithelium, a gland-containing connective tissue layer rests directly on the periosteum of the bone. 3. The cilia beat toward the oropharynx, which is composed of a stratified, squamous, nonkerati nized epithelium. 4. The pharyngeal tonsil, an aggregateof nodular and diffrrselymphatic tissue,is located on the posterior wall of the nasopharynx subjacent to the epithelium. Hypertrophy of this tissue as a result of chronic inflammation results in a condition known as adenoiditis. B. Larynx is a passagewaythat connectsthe pharynx to the trachea and contains the voicebox. Its walls are composed of cartilage held together by fibroelastic connective tissue. 1. The mucous layer of the larynx forms two pairs of elastictissue folds that extend into the lumen. The upper pair are called the vestibular folds (or falsevocal cords), and the lower pair constitute the true vocal cords. 2. The epithelium of the ventral side of the epiglottis and of the vocal cords is composedof stratified, squamous,nonkeratinized cells.The remainder of the larynx is lined with ciliated,pseudostratified,columnar epithelium. 3. All cilia, from the larynx to the lungs, beat upward toward the nasopharynx.
TRACHEA The trachea,a hollow cylinder supportedby 16-20 cartilaginousrings, is continuous with the larynx above and the branching primary bronchi below.
ln a Nutshell Trachea . Lined withciliated pseudostratified columnar epithelium . Supported by16-20 rings C-shaped cartilaginous
A. Mucosa of the tracheaconsistsof the typical respiratoryepithelium,an unusuallythickbasement membrane,and an underlying lamina propria that is rich in elastin.The lamina propria containslooseelastictissuewith blood vessels,lymphatics, and defensivecells.The outer edge of the lamina propria is defined by a densenetwork of elastic fibers. B. Submucosaconsistsof denseelasticconnectivetissuewith seromucousglandswhose ducts open onto the surfaceof the epithelium. C. Cartilage rings are C-shaped hyaline cartilage pieceswhose free extremities point dorsally (posteriorly). They are coveredby a perichondrium of fibrous connectivetissuethat surrounds each of the cartilages. Smooth muscle bundles (trachealis muscle) and ligaments span the dorsal part of eachcartilage. D. Adventitia consists of peripheral dense connective tissue that binds the trachea to surrounding tissues.
IM
Histology
BRONCHI PRIMARY
Note
The tracheabranchesat its distal end into the two primary bronchi. Short extrapulmonary segments of the primarybronchi existbeforethey enter the lungs at the hilus and then branch further. The histologic structure of the walls of the extrapulmonary segment of the primary bronchi is similar to that of the trachealwall.
isat Therightmainbronchus position than a morevertical particles, theleft.Inhaled tendto betrapped therefore, intherightlungmoreoften thanintheleft.
TUNGS A. Intrapulmonarybronchi. The primarybronchi give rise to three main branchesin the right lung and two branchesin the left lung, eachof which supply a pulmonary lobe. Theselobar bronchi divide repeatedlyto give rise to bronchioles. 1. Mucosa consistsof the typical respiratory epithelium and an underlying lamina propria similar to that of the trachea.However, alayer of looselywoven smooth muscle (muscularis mucosae),which separatesthe lamina propria from the submucosa,is present. 2. Submucosaconsistsof elastictissuewith fewer mixed glandsthan seenin the trachea. 3. Anastomosingcartilage plates replacethe C-shapedrings found in the tracheaand extrapulmonary portions of the primary bronchi. Theseplatesbecomeprogressivelysmalleras airway diameter decreases. B. Bronchioles do not possesscartilage,glands,or lymphatic nodules;however,they contain the highestproportion of smooth musclein the bronchial tree. Bronchiolesbranch up to 12 times to supply lobules in the lung, which are bound by connectivetissuesepta.The smallest conducting bronchiolesare calledterminal bronchioles. 1. Bronchiolesare lined by ciliated,simple, columnar epithelium with nonciliated bronchiolar (Clara) cells.Goblet cellsare presentin largebronchioles. 2. A smooth muscle layer interlacesthe elasticfibers of the lamina propria. The musculature of the bronchi and bronchioles contracts after stimulation by parasympathetic fibers (vagusnerve) and relaxesin responseto sympatheticfibers. 3. Terminal bronchiolesconsistof low-ciliated epithelium with bronchiolar cells. C. Respiratory bronchioles are areasof transition (hybrids) betweenthe conducting and respiratory portions of the airways.In addition to the rypical bronchiolar epithelium of the contain outpouchings of alveoli, which comprise terminal bronchioles,these passageways the respiratoryportion of this system.
ln a Nutshell Bronchioles . Contain noglands, or lymphatic cartilage, nodules . Scattered goblet cells . Abundant muscle smooth . Contract with parasympathetic stimulation Note contain bronchioles Terminal to secrete cellsknown Clara glycosami nsthat noglyca probably protect the lining. bronchiolar
1. Terminal bronchiolesgive rise to respiratorybronchioles. 2. Respiratorybronchiolesbranch to form two to three alveolarducts,which are long sinuous tubes. 3. Alveolar sacsare spacesformed by two or more conjoined alveoli.They are lined by the simple squamousalveolarepithelium. D. Alveoli are the terminal, thin-walled sacsof the respiratorytree that are responsiblefor gas exchange.There are approximately 300 million alveoli per lung, each one 200-300 pm in diameter. 1. Blood-air interface. Oxygen in the alveoli is separatedfrom hemoglobin in the red blood cells of alveolar capillaries by five layers of cellular plasma membrane and two layers of extracellularmembrane:the alveolarepithelial cell (apical and basalmembranes)and its basal lamina, the basal lamina of the capillary and its endothelial cell (basal and apical membranes),and the erythrocfte membrane. The total thicknessof all theselayerscan be asthin as 0.5 pm.
t45
Respiratory System
In a Nubhell TypeI Pneumocytes . Account for970/o of alveolar surface . Areextremely thin;asthin as25nm . Provide minimal barrier to facilitate diffusion of gas Typell Pneumocytes . Account for3olo of alveolar surface . Secrete pulmonary surfactant, whichreduces tension in alveoli surface
ClinicalConelate . Airin pleural space + pneumothorax . Bloodin pleural space + hemothorax
t46
2. Alveolar epithelium contains two cell types. a. Type I cells completely cover the alveolar luminal surface and provide a thin surface for gasexchange.This simple squamousepithelium is so thin (-25 nm) that its details are beyond the resolution of the light microscope. b. Type II cells are rounded, plump, cuboidal-like cellsthat sit on the basallamina of the epithelium and contain membrane-bound granules of phospholipid and protein (lamellarbodies).The contentsof theselamellar bodies are secretedonto the alveolar surfaceto provide a coating of surfactant that reducesalveolar surfacetension. 3. Alveolar macrophages (dust cells) are found on the surface of the alveoli. a. Derived from monocytes that extravasate from alveolar capillaries, alveolar macrophagesare part of the mononuclear phagocyte system. b. Dust cells,as their name implies, continuously remove particles and other irritants in the alveoli by phagocytosis.
E. Pleura 1. Visceral pleura is a thin serous membrane that covers the outer surface of the lungs. A delicate connective tissue layer of collagen and elastin, containing lymphatic channels, vessels,and nerves,supports the membrane. Its surfaceis coveredby simple squamous mesothelium with short microvilli. 2. Parietal pleura is that portion of the pleura that continuesonto the inner aspectof the thoracic wall. It is continuous with the visceralpleura and is lined by the samemesothelium. 3. Pleural @vity is a very narrow fluid-filled spacethat contains monocytes located between the two pleural membranes.It containsno gasesand becomesa true cavity only in disease (e.g.,in pleural infection, fluid and pus may accumulatein the pleural space).If the chest wall is punctured, air may enter the pleural space(pneumothorax),breaking the vacuum and allowing the lung to recoil.
Respiratory Anatomy Theanatomic $ructures thatplaya central roleintherespiratory system arelocated intheheadand neckaswellasthethorax. Thischapter reviews these structures inturn,starting withthenasal cavities andending withthelungs.
NASAL CAVITIES A. Nasal cavities are separatedby the nasal sqrtum, which consistsof the vomer, the perpendicular plate of the ethmoid bone, and the septal cartilagewith small contributions from the maxilla and palatine bone. The lateral wall of each nasal cavity featuresthree scroll-shaped bony structures called the nasal conchae. The nasal cavities communicate posteriorly with the nasopharynx through the choanae. Each spaceinferior to each concha is called a meatus. The paranasalsinusesand the nasolacrimal duct open to the meatus. The inferior concha is a separatebone, and the superior and middle conchaeare parts of the ethmoid bone. 1. Inferior meatus. The only structure that opens to the inferior meatus is the nasolacrimal duct. This duct drains lacrimal fluid (i.e., tears) from the lacrimal sacat the medial aspect of the orbit to the nasal cavity.
ClinicalCorrelale Themaxillary mu$drain sinus gravity upward again$ because themaxillary o$iumislocated highonthemedial wallofthe sinus. This isoneofthe reasons maxillary sinus infections areoften difficult totreat.
2. Middle meatus a. The hiatus semilunaris contains openings of frontal and maxillary sinusesand anterior ethmoidal air cells. b. The bulla ethmoidalis contains the opening for the middle ethmoidal air cells. 3. Superior meatus contains an opening for the posterior ethmoidal air cells. 4. Sphenoethmoidal recessis located above the superior concha and contains an opening for the sphenoid sinus.
ClinicalCorlelate
B. Innervation 1. Somatic innervation. General sensory information from the lateral wall and septum of the nasal cavity is conveyedto the CNS by branches of V, and Vr. 2. Autonomic innervation. Preganglionic parasympathetic fibers destined to supply the glands of the nasal mucosa and the lacrimal gland travel in the nervus intermedius and the greater superficial petrosal branchesof the facial nerye (CN VII). Thesefibers synapse in the pterygopalatine ganglion, which is located in the pterygopalatine fossa. Postganglionic fibers traveling to the mucous glands of the nasal caviry paranasal air sinuses,hard and soft palate, and the lacrimal gland follow branches of V, and in some casesV, to reach their destinations. 3. Special sensory innervation. The olfactory mucosa of the upper nasal cavity is supplied by afferent fibers of CN I.
Insomeindividuals, theroots ofthemaxillary molar teeth protrude wellintothe maxillary sinus. Because these teeth andthesinus share a common innervation sensory viaV,,it isoften difficult to distinguish between a dental abscess anda maxillary sinus infection.
147
SYstem Respiratory
Bridgeto HistologY wallconsists Thepharyngeal laYer, a fibrous of a mucosa, which anda muscularis, is ofaninner composed layer(i.e., longitudinal stylopharyngeus, palatopharyngeus, andan salpingopharyngeus) layer(i.e., outerctrcular inferior middle, superior, muscles). constrictor
Correlate Clinical the Wheninflamed, areknown pharyngeal tonsils enlarged These asadenoids. tissue of lymphoid clumps thechoanae, mayblock to become thepatient causing a "mouthbreather."
Correlate Clinical of theremoval Tonsillectomy, is tonsils, thepalatine bythefactthat complicated havea veryrich thetonsils Theyreceive bloodsupply. bloodfrombranches arterial ascending ofthefacial, maxillary, pharyngeal, lingual, arteries. andpalatine
AREAS ANDRELATED PHARYNX sharedby the digestiveand respiratory systems.It haslateral,posA. The pharynx is a passageway (nasopharynx, terioi and medij *a[s throughout but is open anteriorly in its upper regions wall of The anterior cavity. oral the oropharynx), communicating with the nasal cavity and the laryngopharynx is formed by the larfnx' cavity. It B. Nasopharynx is the region of the pharynx located directly posterior to the nasal communicateswith the nasalcavity through the choanae(i.e.,posterior nasalapertures). 1. The torus tubarius is the cartilaginousrim of the auditory tube' tubarius; 2. The pharyngeal recessis the spacelocated directly above and behind the torus tonsil. nasopharyngeal it contains the salpin3. The salpingopharyngeal fold is a ridge consisting of mucosa and the underlying tubarius' the torus from pharynx the gopharyng.u, -,m.le, which runs down the wall of It comC. Oropharynx is the region of the pharynx located directly posterior to the oral cavity. by are bounded fauces The fauces. the called a space through carrity oial municates with the pillars. posterior and anterior the as known muscle, and mucosa of two folds, consisting the 1. The anterior pillar of the fauces, also known as the palatoglossal fold, contains palatoglossusmuscle. the 2. The posterior pillar of the fauces, also known as the palatopharyngealfold, contains palatopharyngeusmuscle. 3. The tonsillar bed is the spacebetween the pillars that housesthe palatine tonsil. from the D. Laryngopharynx is the region of the pharynx that surrounds the larynx.It extends piriform the as known are extensions Its lateral .oriil"g.. cricoid tip of ihe epiglottis to the recess. to the E. Oral cavity. The portion of the oral cavity that is posterior to the lips and anterior and mylohyoid the by formed teeth is called the vestibule. The oral cavity proper has a floor buccithe of consisting walls, geniohyoid muscles,which support the tongue. It has lateral the nator musclesand buccal mucosa,and a roof formed by the hard palate anteriorly and the to an opening by soft palate posteriorly. Its posterior wall is absent and is replaced oropharynx, which is flanked by the pillars of the fauces. 1. The palateseparatesthe nasaland oral cavities' plate a. Hard palate is formed by the palatine processof the maxilla and the horizontal V2. CN from fibers sensory of the palatinebone. Its mucosais supplied with b. Soft palate consistsof a fibrous membrane, the palatine aPoneurosis,coveredwith mucosa.The portion that hangsdown in the midline is the uvula, which containsthe musculusuvulae.Two additional muscles(i.e.,levator palati, tensor palati) insert into the palatine aPoneurosis. ante2. The tongue is a mobile, muscular organ necessaryfor speech.It is divisible into an terminalis. sulcus the by third one posterior a rior two thirds and (i.e., a. Muscles of the tongue. These include the intrinsic and extrinsic muscles palatoglossus,styloglossus,hyoglossus,genioglossus).All of the musclesare innervated by CN XII except the palatoglossus,which is supplied by CN X'
t48
Anatomy
b. Arterial supply. The tongue is supplied by the lingual branch of the external carotid artery. c. Venousdrainage.The lingual veins,which lie on the undersurfaceof the tongue,drain to the internal jugular veins. d. tymphatic drainage. The tip of the tongue drains to the submental nodes,and the remainder of the lateral margins of the anterior two thirds drains first to submandibular, then to deep cervical nodes. The posterior one third drains directly to deepcervicalnodes(FigureII-3-I). e. Innervation (1) Generalsomatic innervation of the anterior two thirds is by the lingual branch of the mandibular nerve (Vr).
ClinicalCorrelate Thelingual veins are conspicuous under thevery thinmucosa ofthe undersurface ofthetongue. Nitroglycerin, a treatment for pectoris, angina isplaced under thetongue intablet formfor rapidabsorption into thebloodstream through these veins.
(2) Thsteinnervation of the anterior two thirds is by the chorda tympani of the facial nerve (\III). (3) Thsteas well as general sensationof the posterior one third is via the lingual branch of the glossopharyngealnerve (IX). (4) Motor innervation of the whole tongue is provided by the hypoglossalnerve (XII).
To deep cervicalnodes
To deep cervicalnodes
ClinicalCorrelate Thelymphatia fromthe portion middle ofthetongue drainbilaterally to deep cervical nodes. Thisfactis important when to remember tracing thespread of cancer fromthecentral regions ofthe tongue.
To submandibular nodes
To submental nodes Figurell-3-1.Lymphaticdrainageof the tongue.
t49
Respiratory System
F. The larynx is the voicebox. It also maintains a patent airway and acts as a sphincter during lifting and pushing (Figure II-3-2). 1. Skeleton of the larynx a. Three laryngealcartilagesare unpaired (i.e.,thyroid, cricoid, epiglottis),and three are paired (i.e.,arytenoid, cuneiform, corniculate). b. The fibroelastic membranes include the thyrohyoid membrane and the cricothyroid membrane (conuselasticus).The free,upper border of the latter is specializedto form the vocal ligament on either side.
Thyroidcartilage Vocalismuscle Vocalligament Thyroarytenoid
muscle(J tension)
Lateral arytenoid muscle
Posterior cricoarytenoid muscle
Action of posterior cricoarytenoidmuscle (abductionof vocal ligament)
Action of lateral cricoarytenoidmuscle (adductionof vocal ligament)
Hyoidbone Corniculate cartilage Thyroid cartilage
Arytenoid cartilage
Transverse arytenoid muscle
Cricoidcartilage
Cricothyroid muscle(l tension)
Posterior cricoarytenoid muscle
Trachea
Lateral
Posterior
Figure ll-3-2.The larynx.
r50
Anatomy
2. Muscles of the larynx (TableII-3-l)
ClinicalCorrelate
Thble II-3-f .Intrinsic musclesof the larynx.* Muscle
Primary Function
Posteriorcricoarytenoid
Abducts vocal fold
Lateral cricoarftenoid
Adducts vocal fold
Cricothyroid
Tensesvocal fold
Thyroarytenoid (including vocalis)
Relaxesvocal fold
Thyroepiglotticus
Opens laryngealinlet
Aryepiglotticus
Closeslaryngealinlet
Oblique and transversearytenoids
Closeslaryngeal inlet
Croup, or laryngotracheal bronchitis, isa common ailment of infants and children. lt iscaused bythe inflammation andswelling of "false" thesubmucosa ofthe vocal folds, thevestibular folds thatarelocated superior to the "true"vocal foldscontaining thevocalis muscle. Thevirus responsible forcroupisthe parainfluenza virus.
*Note that the cricothyroid is innervated by the external laryngeal nerve, a branch of the superior laryngeal branch of the vagus nerve. All other intrinsic laryngeal muscles are supplied by the recurrent laryngeal branch of the vagus nerve.
3. Arterial supply. The superior and inferior laryngealarteriesarise from the superior and inferior thyroid arteries, respectively. 4. Venous drainage. The superior and inferior laryngeal veins drain to the superior and inferior thyroid veins, respectively. 5. Lymphatic drainage. Lymph from the larynx drains to the deep cervical nodes. 6. Innervation. The superior laryngeal nerve, a branch of the vagus nerve, divides to form the internal laryngeal nerve, which conveys sensory information from the laryngeal mucosa above the vocal folds, and the external laryngeal nerve, which supplies motor fibers to the cricothyroid muscle.The remaining laryngealmucosa and intrinsic muscles are supplied by the recurrent laryngeal nerve.
Note Theinternal laryngeal nerve plays animportant roleinthe cough whichkeeps reflex, the interior freeof ofthelarynx foreign material.
t5l
Respiratory System
CAVITIES ANDPIEURAI PLEURA Parietalpleura lines the inner surfaceof the thoracic cavity;visceralpleura follows the contours of the lung itself (FigureII-3-3).
Rightlung
Left lung
Superiorlobe
Superiorlobe
Middlelobe lnferiorlobe
Inferiorlobe
Costodiaphragmatic recesses
Diaphragm
Mediastinum
Figure ll-3-3.Pleural cavities and mediastinum.
Note oftheparietal Theboundaries pleura approximately extend tworibslowerthanthe ofthe corresponding areas lungs themselves.
A. Pleural cavity 1. The pleural cavity is the spacebetweenthe parietal and viscerallayersof the pleura. It is a sealed,blind space.The introduction of air into the pleural cavity may causethe lung to collapse(pneumothorax). 2. It normally containsa small amount of serousfluid elaboratedby mesothelialcellsof the pleural membrane. B. Pleural reflections are areaswhere the pleura changesdirection from one wall to the other. 1. The sternal line of reflection is where the costalpleura is continuous with the mediastinal pleura behind the sternum (from costal cartilages 24). The pleural margin then passes inferiorly to the level of the sixth costal cartilage.
t52
Anatomy
2. The costal line of reflection is where the costalpleura becomescontinuous with the diaphragmaticpleurafrom rib 8 in the midclavicularline, to rib 10in the midaxillaryline, and to rib 12lateralto the vertebralcolumn. C. Pleural recessesar€ potential spacesnot occupiedby lung tisue exceptduring deepinspiration. 1. Costodiaphragmaticrecesscsare spacesbelow the inferior borders of the lungs where costaland diaphragmaticpleuraare in contact. 2. Costom€diastin l recessis a spacewherethe left costaland mediastinalparietal pleura meet,leayinga spacedue to the cardiacnotch of the left lung. This spaceis occupiedby the lingula of the left lung during inspiration.
9f!if!...Co-ryqfala Painresulting from inflammation of thecentral ponronof thediaphragmatic pleuramaybereferred to the shoulderregion(C3-G dermatomes).
D. lnnervatiol ofthe parietal pleura 1. The costaland peripheral portions of the diaphragmaticpleura are suppliedby intercostalnerves. 2. The centralportion of the diaphragmaticpleura and the mediastinalpleuraare supplied by the phrenic nerve.
TUNGS A. Regions(FigureII-3-4) l. The costalsurhce is a largeconvenarearelatedto the inner surfaceof the ribs. 2. The rnediastinalsurfaceis a concavemedial surface. a. The left lung hasa deepcardiacimpression. b. The mediastinalsurfacecontainsthe root, or hilus, of the lung. c. The pulmonary ligamentis a doublefold of pleurahanginginferior to the root of rhe lung. The layersenclosethe costodiaphragmatic recess.
Oinital Conelate Because of theprotrusion of thecupolaof thelungthrough thesuperior thoracic aperture, it is oossible for a stabwound at therootof theneckto resultin a collapsed lung'
3. The diaphragmeticsurface (base)is r€latedto the convexsurfaceof the diaphragm.It is more concaveon the right due to the presenceof the liver. 4. The apex (cupola) protrudes into the root of the neck. It is crossedby the subclavian artery anteriorly. 5. The hilus is the point of attachmentfor the root of the lung. It containsthe bronchi, pulmonary and bronchialvessels, lymphatics,and nerves.
r55
System Respiratory
t\,
Anteriorview
;
.'.
i
\l t
I I
1
'l ii
t\
Costodiaphragmatic reoess Fosterior view
ClinicalConelate Bronchopulmonary segments aresignificant because each and hasis ownbronchial arterial supply andcanbe removed withminimal involvement ofadjacent segments. Flashback to Embryology between theleft Running pulmonary artery andthe aorta isafibrous cordcalled lt theligamentum arteriosum. isa remnant ofthefetal ductus arteriosus, which provided forblood ashunt ofthe fromtherightventricle thelungs. fetalheartto bypass
t54
Figure ll-3-4. Lungs and pleura. B. Lobes and fissures 1. The right lung is divided by the oblique and horizontal fissuresinto three lobes: superior, middle, and inferior. 2. The left lung has only one fissure, the oblique, which divides the lung into upper and lower lobes. The lingula of the upper lobe corresponds to the middle lobe of the right lung. C. Bronchopulmonary segments of the lung are supplied by the segmental (tertiary) bronchus, artery and vein. There are 10 on the right and eight on the left. D. Arterial supply 1. Right and left pulmonary arteries arise from the pulmonary trunk. The pulmonary arteries deliver deorygenatedblood to the lungs from the right side of the heart. 2. Bronchial arteries supply the bronchi and nonrespiratory portions of the lung. They are usually branches of the thoracic aorta. E. Venous drainage 1. There are four pulmonary veins: superior right and left and inferior right and left. Pulmonary veins carry oxygenatedblood to the left atrium of the heart.
Anatomy
2. The bronchialveins drain to the arygos system.They share drainage from the bronchi with the pulmonary veins. F. Lymphatic drainage 1. Superficial drainage is to the bronchopulmonary nodes; from there, drainage is to the tracheobronchialnodes. 2. Deep drainage is to the pulmonary nodes; from there, drainage is to the bronchopulmonary nodes. 3. Bronchomediastinal lymph trunks drain to the right lymphatic duct and the thoracic duct. G. Innervation of lungs. Anterior and posterior pulmonary plexuses are formed by vagal (parasympathetic)and sympatheticfibers. 1. Parasympatheticstimulation has a bronchoconstrictiveeffect. 2. Sympatheticstimulation has a bronchodilator effect.
t55
Respiratory Physiology Therespiratory system isstructurally andfunctionally adapted fortheefficient transfer of gases between theambient airandthebloodstream aswellasbetween thebloodstream andthetissues. Themajorfunctional components oftherespiratory system aretheainruays, alveoli, andblood vessels ofthelungs; thetissues of theche$wallanddiaphragm; thesystemic bloodvessels; red plasma; bloodcells and andrespiratory control neurons inthebrainstem andtheirsensory and motorconnections. Thischapter revievvs ventilation andthemechania bloodflowinthepulmonary of breathing, circulation, andtheexchange of gases between airandbloodandbetween bloodandtissues. principles problems Application ofthephysiologic to specific clinical includes discussion of pulmonary pulmonary obstructive andrestrictive disorders, sleep apnea, edema, andadaptation to highaltitude andexercise.
INTRODUCTION TOLUNG FUNCTION A. Provision of O, for tissue metabolism occurs via four mechanisms. 1. Ventilation-the alveoli
transport of air from the environment to the gasexchangesurfacein the
2. Ordiffusion from the alveolar air spaceacrossthe alveolar-capillary membranes to the blood 3. Tfansport of Orby the blood to the tissues 4. Ordiffusion from the blood to the tissues B. Removal of CO, produced by tissuemetabolism occursvia four mechanisms. 1. CO2diffrrsion from the tissuesto the blood 2. Transport by the blood to the pulmonary capillary-alveolar membrane 3. COrdifftrsionacross the capillary-alveolar membrane to the air spacesof the alveoli 4. Ventilation-the
transport of alveolar gasto the air
C. Functional components 1. Conducting airways (conducting zone; anatomic dead space) a. These airways are concerned only with the transport of gas, not with gas exchange with the blood.
r57
Respiratory System
b. They are thick-walled, branching, cylindrical structures with ciliated epithelial cells, goblet cells,smooth muscle cells,C1aracells,mucous glands,and (sometimes)cartilage. 2. Alveoli and alveolar septa (respiratory zoneilung parenchyma) a. Theseare the sitesof gasexchange. b. Cell types include: Type I and II epithelial cells,alveolar macrophages c. The blood-gas barrier (pulmonary capillary-alveolar membrane) is ideal for gas exchangebecauseit is very thin (<0.5 pm) and has a very large surfacearea (5G-100 m2). It consistsof alveolarepithelium, basementmembrane, interstitium, and capillary endothelium.
LUNG VOTUMES ANDCAPACITIES A. Lung volumes (Figure II-4-1)-There are four lung volumes, which when added together, equal the maximal volume of the lungs. 1. Tidal volume (%) is the volume of one inspired or expired normal breath (average human = 0.5 liters per breath). 2. Inspiratory reserve volume (IRV) is the volume of air that can be inspired in excessof the tidal volume. 3. Expiratory reserve volume (ERV) is the extra amount of air that can be expired after a normal tidal expiration. 4. Residual volume (RV) is the volume of gasthat remains in the lungs after maximal expiration (averagehuman = l.2liters). B. Lung capacities(Figure II-4- 1) are composedof two or more of the lung volumes. 1. Total lung capacity (TLC) is the volume of gas that can be contained within the maximally inflated lungs (averagehuman = 6 liters). 2. Vital capacity (VC) is the maximal volume that can be expelled after maximal inspiration (averagehuman = 4.8 liters). 3. Functional residual capacity (FRC) is the volume remaining in the lungs at the end of a normal tidal expiration (averagehuman = 2.2liters). 4. Inspiratory capacity (IC) is the volume that can be taken into the lungs after maximal inspiration following expiration of a normal breath. C. Residual volume cannot be directly measured by spirometry. Because FRC and TLC include the residual capaciry they cannot be directly measuredby spirometry either. Helium dilution techniques or the application of whole body plesthygmography are used to determine thesecapacities.
t58
Physiology
1 I
1I I
I
I
Inspiratory reserve Inspiratory volume capacity
Total lung capacity Vital capacity
I =o J
Tidal volume
Expiratory. reserve volume Residual volume
/l\
Functional residualcapacity
Figure ll-+1. Lung volumes and capacities as measured by spirometry.
D. A forced vital capacity (FVC) is obtained when a subject inspires maximally and then exhalesas forcefully and as completely as possible.The forced expiratory volume (FEV,) is the volume of air exhaledin the first second.Typically, the FEV, is approximately 80o/oof the FVC (FigureIl-4-2). 1. In obstructive lung diseases,such as bronchial asthma,the FEV, is reducedmuch more than the FVC, producing a low FEVr/FVC.
Clinical €orrelate . Obstructive airway ratio diseasesJ FEV,:VC . Restrictive airuaydiseasesnoreduction of FEV,:VC ratio
2. In restrictive lung diseases,such as pulmonary fibrosis, both the FEV, and the FVC are reduced.This characteristicallyproducesa normal or increasedFEV,/FVC.
4 Lung 3 volume change 2 (liters)
1234 Seconds Figure ll-4-2.Recordings made during a forced vital capacity maneuver.
t59
Respiratory System
NOMENCTATURE PHYSIOTOGY OFPUTMONARY A. Measurementsandtheir symbols: p = pressure;C = concentration;V = volume of gas;F = fractional concentration;Q = volume of blood; S = saturation. B. A dot over a symbol indicatesa time derivative:V= gasflow or ventilation (L/min); Q = blood flow (ml/min). C.Sitesandgassamples:I=inspired;e=alveolar;p=deadspace;n=expired;t=tidal. D. Sitesandbloodsamples: a = arterial;v = venous;v= mixedvenous;g = pulmonarycapillary. Thble II-4-f . Examples of symbol use. Symbol
Meaning
Units
Pto, VA Poo, P"o,
Partial pressureof O, in inspired gas Alveolar ventilation Partial pressureof O, in alveolar gas Partial pressureof O, in arterial blood
mm Hg L/min mm Hg mm Hg
GASLAWS ASAPPTIED TORESPIRATORY PHYSIOTOGY A. Dalton's law: In a gasmixture, the pressure(P) exertedby eachgasis independentof tle pressureexertedby the other gases.The total measuredpressureis the sum of that er<erted ry all of the gases: P,r,= PH,o+ Po, + Pcoz+ PN" A consequence of this is asfollows: partial pressure= total pressurex fractional conc€ntratiotr l. This equationcanbe usedto determinethe partial pressureof oxygenin the atmosphere. Assumingthat the total pressure(or barometricpressure[P"]) is atmosphericpressureat sealevel(760mm Hg) andtheftactionalconc€ntration of 02 is 2lyo,or 0.21: lofg PaltialPressures of Ol at Sea lorcl (NormalValues) Atmospheric Po,= 160mmHg lnspired orygen(Ft^) = 150mmHg AlveolaPo,(P6,) = 100mmHg Arterialpo,(paor)= l0ommHg MixedvenousPo,(Pp,)= 40 mmHg
po, = 760mm Hg x o.2t = 160mm Hg 2. As air movesinto the airways,the partial pressuresof the variousgasesin atmosphericair are reducedbecauseof the addition of water vapor (47 mm Hg)IThe partial piessureof inspired orygen canbe calculatedasfollows: Io,= (P,*d- PH,o)xEroz= Q60- 47\x 0.21= 150mm Hg B. Henr/s law statesthat the concentrationof a gasdissolvedin liquid is proportional to its partial pressureand its solubifity coefficient((). Thus,for gasX, txl =\xpx lhe useof this law is d€monstratedlater in this chaPter. C. Fick'slaw statesthat the volumeof gasthat diftrsesacrossa barrier per unit tirne is givenby:
%"r=f"ox(P,-Pr)
r50
Physiology
where A and T are the areaand thicknessof the barrier, P, and Prare the partial pressruesof the gason either sideof thebarrier, and D is the diffirsion constantof the gas.D is directlyproportional to the solubility of the gasand inverselyproportional to the squareroot of its molecular weight.
VENTITATION A. Tiotalventilation (Vr, minute ventilation) is the total gasflow into the lungs per minute. It is equal to the tidal volume (Vr) x the respiratory rate (n). Total ventilation is the sum of dead spaceventilation and alveolar ventilation. B. Anatomic dead spaceis equivalentto the volume of the conducting airways(150 mL in normal individuals), i.e.,the tracheaand bronchi up to and including the terminal bronchioles. Gas exchangedoes not occur here. Physiologic dead spaceis the volume of the respiratory tract that doesnot participate in gasexchange.It includesthe anatomic dead spaceand partially functional or nonfunctional alveoli (e.g.,becauseof a pulmonary embolus preventing blood supply to a region of alveoli). In normal individuals, anatomic and physiologic dead space are approximately equal. Physiologic dead space can greatly exceedanatomic dead spacein individuals with lung disease. C. Dead spaceventilation (Vo orVp x n) is the gasflow into dead spaceper minute. Alveolar ventilation (Ve orVe x n) is the gasflow entering functional alveoli per minute. D. Therefor., Vr = VR + Vp. E. AlYeolar ventilation
Note
l. It is the singlemost important parameterof lung function.
Thealveolar ventilation equation isuseful topredict
2. It cannot be measureddirectly. 3. It must be adequatefor removal of the CO, produced by tissuemetabolism.If it is not, alveolar and, therefore, arterial, Pco,increases,asshown by the alveolar ventilation equation: \bo, Po.o, =
Jt
(Vco, = rate of CO, production by tissues)
(andPa6sr) Pn66, when alveolar ventilation changes. (normally Forexample, P066, 40mmHg)willdouble to g0 mmHgbyhalving ventilation (hypoventilation).
4. Po.o,is an indication of the adequaryof alveolarventilation. a. Po.o,is impossible to measureclinically.
Note
b. Pa.o,is a closeestimateof Pl.o,.
. Poo, = 150mmHg= 40mmHg/0.8 100mmHg
5. Pe.o.and Pa.o.are better indications of Vo than is alveolar Por. 6. Whereasthe partial pressureof inspired O, is 150 mm Hg, the partial pressureof O, in the alveoli is typically 100mm Hg becauseof the displacementof O, with COr. Poo.cannot be measureddirectly but can be estimated with the alveolar gas equation: PA.o. Poo,
Pto, -
a. R is the respiratory exchange ratio (Vcor/Vo)
. Thishypoventilating person wouldhavea Pn of 50 mmHg: 1 5 0m mH g= 50mmH8 B0mmHg/0.8
-
and is equal to CO, production/O,
con-
sumption. R is typically 0.8 in the resting individual; it can approach 1.0 with exercise.
t6l
SYstem RespiratorY of P'l'or' b. Note that Pe.or,and therefore Pu.or,is used for the estimation Pa.o,is used to estimats PAcoz' c. Pao,cannot be used to estimate PRo,in the way that
AIRFIOW rower pressure just as fluids do' A A. Air moves from areas of higher pressure to areas of pressuregradient needsto be establishedto move air. when the musclesof inspiration B. Alveorar pressurebecomesressthan atmosphericpressure pressure. Intrapleural pressure enlarge the chest caviry thus lowering the intrathoracic of intra-alveolar pressure' The decreases,causing etp"nsion of the alveoli and reduction air into the airways' The drives alveoli pressure gradient-between the atmosphere and the opposite occurswith exPiration' (ml/min). c. Air travelsin the conducting airwaysvia bulkflow its velocity. velocity representsthe D. Bulk flow may be turbulent or laminar, depending on flow: speedof movement of a single particle in the bulk Velocity (cm/sec)=
Flow (cm3/sec) Cross-sectional area (cm2)
transitional flow is likely to At high velocities, the flow may be turbulent. At lower velocities, (streamlined).Reynold's number predicts occur.At still lower velocities,flow may be laminar will be turbulent' the air flow. The higher the number, the more likely the air
TRANSITIONAL
TURBULENT
ooocoo-o
ol-) c_c^taq^f \, \J'.)'t o a LAMINAR
ln a Nutshell theLung AirFlowthrough . Conducting zone:bulkflow . Respiratory diffusion zone:
Figure ll-4-3. Patterns of air flow'
into the lungs becauseof the E. The veloclty of particle movement slows as air moves deeper
areadue to branching. Diffusion 1sthe primary mechenormous increasein cross-sectionar alveoli (the respiratory zone)' anism by which gasmoves between terminal bronchioles and produce gasflow (V) is directly F. Ainvay resistance.The pressuredifference (Ap) necessaryto walls' airway related to the resistancelR; ."ut.d by friction at the l.
AP=VR
be describedby Poiseuille's law' 2 . The pressure-flow characteristicsfor laminar flow can
t62
Physiology
p - -
8nlV . TCr4
where Tl = viscosity of the gas,I = length of the airway, and r = radius of the airway. 3. The resistancecan be easily calculated using this relationship in conjunction with AP = \lR to give: R=
Srll nr4
Note the importance of the airway radius: if the radius is halved, resistanceincreasesby 16fold and air flow decreases by 16-fold. 4. Medium-sized ainvays (>2 mm diameter) are the major site of airway resistance.Small airways have a high individual resistance.However, their total resistanceis much less becauseresistancesin parallel add as reciprocals. 5. Factors affecting airway resistance a. Bronchoconstriction (increasedresistance)can be causedby parasympatheticstimulation, histamine (immediate hypersensitivityreaction), slow-reactingsubstanceof anaphylaxis(SRS-A= leukotrienesCn,Dn,En;mediator of asthma),and irritants.
Flashback to Cardiovascular Notethattheparameters defining airflowarethesame onesdiscussed in relation to bloodflowinthe Cardiovascular Physiology chapter.
b. Bronchodilation (decreasedresistance)can be causedby sympathetic stimulation (via beta-2 receptors). c. Lung volume also affects airway resistance.High lung volumes lower airway resistancebecausethe surrounding lung parenchymapulls airwaysopen by radial traction. Low lung volumes lead to increasedairway resistancebecausethere is lesstraction on the airways.At very low lung volumes, bronchioles may collapse. d. The viscosity or density of inspired gasescan affect airway resistance.The density of gasincreaseswith deepseadiving,leading to increasedresistanceand work of breathing. Low-density gaseslike helium can lower airway resistance. e. During a forced expiration, the airways are compressedby increased intrathoracic pressure.Regardlessof how forceful the expiratory effort is, the flow rate plateausand cannot be exceeded.Therefore, the air flow is effort-independent; the collapseof the airways is called dynamic compression. Whereasthis phenomenon is seenonly upon forced expiration in normal subjects, this limited flow can be seen during normal expiration in patientswith lung diseasewhere there is increasedresistance(e.g.,asthma) or increasedcompliance(e.g.,emphysema).
Clinical Conelate
MECHANICS OFBREATHING A. Muscles of respiration l. Inspiration is alwaysan active process.The following musclesare involved: a. The diaphragm is the most important muscle of inspiration. It is convex at rest and flattens during contraction, thus elongating the thoracic cavity.
Patients withemphysema exhale with"pursed" or partially closed lipsto increase backpressure through the ainruays, whichhelps maintain theirpatency
b. Contraction of the external intercostals lifts the rib cage upward and outward, expanding the thoracic cavity.Thesemusclesare more important for deep inhalations. c. Accessory muscles of inspiration, including the scalene (elevate the first two ribs) and sternocleidomastoid (elevate the sternum) muscles, are not active during quiet breathing but become more important in exercise.
t65
Respiratory System
2. Expiration is normally a passiveprocess.The lung and chestwall are elastic and naturally return to their resting positions after being actively expanded during inspiration. Expiratory musclesare used during exercise,forced expiration, and certain diseasestates. a. Abdominal muscles (rectus abdominis, internal and external obliques, and transversus abdominis) increaseintra-abdominal pressure,which pushesthe diaphragm up, forcing air out of the lungs. b. The internal intercostal muscles pull the ribs downward and inward, decreasingthe thoracic volume. B. Elastic properties of the lungs 1. The lungs collapseif force is not applied to expand them. Elastin in the alveolar walls aids the passivedeflation of the lungs. Collagen within the pulmonary interstitium resistsfurther expansion at high lung volumes. 2. Compliance is defined as the changein volume per unit changein pressure(AV/AP). 3. In vivo, compliance is measured by esophagealballoon pressureversus lung volume at many points during inspiration and expiration. Each measurementis made after the pressure and volume have equilibrated, so this is called static compliance. The compliance is the slope of the pressure-volume curve (Figure II-4-4).
1.0 o .= 0.75 o E
= 0.50
o
0.25
10
20
30
Pressure(cm HrO) Figure L-4-4. Pressure-volume relationships in a lung inflated and deflated with air or with saline. 4. Severalobservations can be made from the pressure-volume curve. a. Note that the pressure-volume relationship is different with deflation than with inflation of air (hysteresis). b. The complianceof the lungs is greater(the lungs are more distensible)in the middle volume and pressureranges. c. At high volumes and expanding pressures,the compliance is lower (the lungs are stiffer). d.'Evenwhen the lung has no expandingpressure,some air remainsin the lungs. e. When saline is used to fill the lung, compliance is much greater (small pressure changesbring about large changesin volume). With saline inflation, there is little differencein the pressure-volume relationship with inflation or deflation. This indicates that the differencesseenbetween inflation and deflation of air must be due to surface forces in the air-liquid interface of the alveoli.
t64
Physiology
5. Causesof decreasedcompliance a. Pulmonary fibrosis b. Pulmonary venouscongestionand edema c. Deficiencyof surfactant 6. Causesof increased compliance a. Emphysema b. Age
Emphysematous lung
(D
(D
E
E
I
I
o
E f
5
f
Pressure
I
Pressure
II
I
Pressure
Figure ll-4-5.Pressure-volume relationships (compliance) in a normal lung, a lung with increased connective tissue ("stiff"), and in an emphysematous lung.
C. Surface tension forces 1. In a liquid, the proximity of adjacentmoleculesresultsin large,intermolecular,attractive (Van der Waals)forcesthat serveto stabilizethe liquid. The liquid-air surfaceproduces an inequality of forcesthat are strong on the liquid sidebut weak on the gassidebecause of the greater distancebetween moleculesin the gas phase.Surface tension causesthe surface to maintain as small an area as possible.In alveoli, the result is a spherically curved, liquid lining layer that tends to be pulled inward toward the center of curvature of the alveolus.The spherical surfaceof the alveolarliquid lining behavesin a manner similar to a soapbubble. The inner and outer surfacesof a bubble exert an inward force that createsa greater pressureinside than outside the bubble. The pressuredifference causedby the curved alveolar surfacecan be determined from LaPlace'slaw for a sphere, where AP is the pressuredifferenceacrossthe surface(dynes/cm'),T is the surfacetension (dynes/cm),and r is the radius of curvature of the surface(cm): LP = 2Tlr 2. Interconnectedalveoli of different sizescould lead to collapseof smaller alveoli (atelectasis) into larger alveoli (Figure II-4-6). Becauseof surfacetension, the pressureinside the smaller alveolus(smaller radius of curvature) is greaterthan that of the larger alveolus. Without surfactant, gas would therefore move from smaller to larger alveoli, eventually producing one giant alveolus.
r65
System Respiratory
P t= " 1r, Pr=2'lr,
Figure ll-4-6. Effects due to LaPlace's law on adiacent alveoli of different radii in the absence of surfactant. Pressurein the smalleralveolus(r = 1) would be twice the pressurein the largeralveolus(r = 2).
3. Pulmonary surfactant a. Pulmonary surfactant is a phospholipid (comprised primarily of dipalmitoyl phosphatidylcholine) synthesizedby type II alveolar epithelial cells. b. Surfactantreducessurfacetension,thereby preventingthe collapseof small alveoli. c. Surfactantincreasesthe complianceof the lung and reducesthe work of breathing.
ClinicalCorrelate infants before Premature the may 35thweekof gestation neonatal experience distress respiratory syndrome (NRDS), which is bya lackof characterized pulmonary surfactant production intheimmature lungs. NRDS canbescreened forbysampling theamniotic fluidforthelecithin to ratio, sphingomyelin whichis less than1.5in NRDS. usually
t66
d. Surfactant keepsthe alveoli dry becausealveolar collapsetends to draw fluid into the alveolarspace. e. Surfactantcan be produced in the fetus as early as gestationalweek 24but is synthesized most abundantly by the 35th week of gestation. Neonatal respiratory distress syndrome can occur with premature infants and results in areasof atelectasis,filling of alveoli with transudate, reduced lung compliance, and V/Q mismatch, leading to hypoxia and CO, retention.
THORACIC WALIMECHANICS The chestwall tendsto passivelyspring outward. The lungs recoil inward. Theseopposingrecoil forcescreatea negativepressure(-3 to -5 mm Hg) within the intrapleural spaceat rest.At equilibrium, when the elastic recoil of the lungs is balancedby the tendenry of the chest wall to spring out, the lungs are at FRC.With the expansionof the chestwall during inspiration, a more negativeintrapleural pressureis generated.This negativepressureactsto expandthe lungs. Less negativeintrapleural pressure(aswith relaxation of the musclesof inspiration) allowsthe passive recoil of the lungs and expiration. The introduction of air into the intrapleural space (pneumothorax) causesthe intrapleural pressureto become equal to atmospheric pressure. This causesthe lungs to naturally recoil (collapse)and the chestto naturally spring out.
Physiology
P=0 P=-5
Normal
P nneeuum moot thhoor ar ax x
Figure ll-4-7.Intrathoracicand lung pressures in the normal"resting" state and with pneumothorax (air in the intrathoracic space). Note that with a pneumothorax,the lung collapsesand the chestwall "springs"outward.
DIFFUSION OFGASACROSS A BARRIER A. Principles of gas diffusion (FiclCslaw of diffirsion) 1. V gas = A D( P r-P2 )/T whereVg",= volume of gasmoving through the barrier per unit time, A = areaof the barrier, P, -Pr= partial pressuregradient acrossthe barrier, T = thicknessof the barrier, D = diftrsion constanto solubilitv/VMw. 2. The amount of gas (Vgur)that moves acrossa barrier, such as the blood-gas barrier, is dependentupon the following: a. The surfaceareafor diffusion (-70 m' in the adult lungs) b. The reciprocalof membrane thickness c. A diffi,lsion constant,which is directly proportional to solubiliry and inverselyproportional to the squareroot of the molecular weight of the gas (1) COris more highly solublein tissuefluid than is O, andthus diffirsesmore rapidly acrossthe blood-gas barrier. d. The partial pressuregradient acrossthe blood-gas barrier is the driving force for gas movement. This gradient between alveolar gas and mixed venous blood is much greaterfor O, (60 mm Hg) than for CO, (6 mm Hg). This greaterpartial pressuregradient for O, offsets the solubility advantagefor CO, at sealevel, but the advantageis lost at higher altitudes,at which Poo,ir diminished.
r67
System Respiratory
CAPIIIARY ATTHEPULMONARY GASEQUIUBRATION A. The transit time through the pulmonary capillary is = 0.75 seconds. B. Normally, the equilibration of O, and CO, is completeby 0.3 seconds. C. Exercisereducesthe time availablefor equilibration, but there is still ample reservefor a healthy individual. For O, this reserveis reducedat high altitude becauseof a smaller partial pressuregradient. D. Thickening of the alveolar-capillarymembrane slowsdiffusion so that equilibration may not be complete.Exerciseaccentuatesthis effect. E. Perfusion-limited and diffrrsion-limited exchangeof gases l. Gasesthat equilibrate betweenthe alveolargasand the pulmonary capillariesare called perfusion-limited gases.This is becausethe amount of gastaken up by the blood is not dependenton the propertiesof the blood-gas barrier. However,the uptake of the gascan be increasedif blood flow increases.Examplesof gasesthat are perfusion limited are O, (under normal conditions), nitrous oxide (NrO)' and COr. 2. Gasesthat do not equilibrate betweenthe alveolargasand the pulmonary capillariesare said to be diffusion-limited gases.In other words, the uptake of gasinto the pulmonary capillaries is limited becauseof diffusion properties of the blood-gas barrier, not the amount of blood perfusing that region. a. O, canbe diffusion-limited under certainconditions.If the blood-gasbarrier is thickened (e.g.,fibrosis) or if there is a decreasein the surfaceareaover which gasexchange can occur (e.g.,emphysema),O, may not fully equilibrate.The diffusion limitation therebydecreasing will be evenmore apparentwith exercise(cardiacoutput increases, the equilibration time) or with the breathing of a low-O, mixture (decreasingthe O,
ClinicalCorrelate (DL)can capacity Diffusing with: decrease . Thickening oftheblood-gas (e.g., fibrosis dueto barrier berylliosis, sarcoidosis, or idiopathic asbestosis, fibrosis) . A decrease inthesurface banier area oftheblood-gas (e.9., emphysema, pneumonecomy, space lesion ofthelung) occupying . A decrease intheabilrty ofO, of to bindwithHbbecause pulmonary blood decreased (e.g., of occlusion volume Hb blood flow)orabnormal (e.g., anemia) states
driving force). b. Carbon monoxide (CO) is considered diffusion limited. CO binds so avidly to hemoglobin that there is very little increasein the partial pressureof CO in the blood after inhalation of CO. As a result,CO is usedto measurethe diffrrsing capacity of the lung.
IN BTOOD GASTRANSPORT A.O, 1. In solution a. The solubility coefficientfor O, isvery low (0.003mL/100 mL blood ' mm Hg). b. Thus, in arterialblood (Pao: 100mm Hg), the amount of O, carriedin solution is: (0.003mL o,/100 mL blood ' mm Hg) x (100mm Hg) = 0'3 mL o2l100mL blood 2. lncombination with hemoglobin (Hb) a. 1.34mL O, combineswith 1 g Hb b. Normal Hb is -15 g Hb/100 mL blood c. Thus, the amount of O, that can be carried by Hb (O, capacity) is: 1.34mL Orlg Hb x 15 g Hb/100 mL blood = 20 mL O2l100mL blood
t68
Physiology
3. Tiotaloxygen content of the blood equals the dissolvedO, plus the O, bound to Hb: 1.34mL O g Hb ' 100 mL blood
0.003mL O
X PO, 100 mL blood ' mm Hg PO,
roo I
mL O'
=-roo ,r* utooa TOTAL
BOUND
DISSOLVED
-x gHb x
-l Tosat
4. The hemoglobh-O, dissociation curve (Figure II-4-8) a. The amount of O, carried by Hb increasesnonlinearly with increasingPo, due to changesin affinity as more O, is bound (cooperativrty).
Note exhibits TheHbmolecule positive the cooperativity; of O, binding ofa molecule atonehemegroupincreases affinity of the theoxygen groups. otherthreeheme
O, combined with Hb b. O" saturation =
Orcapacity
x 100
c. In arterial blood, the Po, is typically 100mm Hg. At this partial pressure,Hb is 97.5o/o saturated.In venous blood, the Po, is typically 40 mm Hg, and Hb is 75olosaturated. d. The Pro,or the Po, at which Hb is 50olosaturated,is typically 27 mmHg. e. At a high Por,asoccursat the pulmonary capillaries,large changesin Po,produce only small changesin Hb saturation,so that the O, content of arterial blood can remain relatively constantdespitewide fluctuations in inspired Po,. f. At a low Po, Q040 mm Hg), as occurs in the tissues,large amounts of O, can be deliveredto the tissuesbecausesmall changesin Po,produce large changesin Hb-O, binding. A small decreasein Po,can releaselarge amounts of O, to the tissues. g. The curve shifts to the right (Prois increased)when the Hb-Oraffinity is decreased. This facilitates O, unloading and occurs with the following conditions: (1) IncreasedPco, (which leadsto decreasedpH) causesmore O, deliveryto the tissues(Bohr effect) (2) Increased temperature (3) Increased2,3-diphosphoglycerate(DPG) is produced by RBCsduring anaerobic glycolysis An easywayto rememberthis is that exercisingmuscles(which require more Or) produce more CO, tend to be acidic (becauseof the CO, and lactic acid), are hot, and rely more on anaerobicrespiration,thus generating2,3-DPG.
ln a Nutshell to therightintheHbShifts curve: 0, dissociation . Reflects thatthereislower between HbandO, affinity . Proisincreased, andO,is fromarterial unloaded bloodto thetissues. . lncreases in Pco,, temperature, and2,5-DPC ina concentration result shiftto theright. . A decrease in in pHresults right. a shiftto the
r69
Respiratory System
100 90 *
80
c rl -9 o) o
70
60 E 50 t p H o s I P"o, o 40 I opo c o
E 5 (d
a
lpx t P.o, I onc
30 I temp 20 10
I temp
0 0 10 20 30 40 50 60 70 80 90 100 Figure ll-&8.The oxygen-hemoglobin dissociation curve. Effectsof pH, temperature,PCO2,and 2,3-DPGare shownby the arrows.
In a ltubhell to theleftin theHb-O, Shifts dissociation curve:
h. The curve shifts to the left (Prois decreased)when the Hb-O, affinity is increased. This facilitates Or loading in the lungs and makesO, unloading in the tissuesmore difficult. This occurs under the following conditions: ( 1) Low Pcor,high pH, low temperature, and low 2,3-DPG
. LowP.or, lowtemperature, low2,3-DPG, highpH
(2) Fetal hemoglobin (hemoglobin F) has a lower affinity for 2,3-DPG than does adult hemoglobin, thus causing a left-shift of the curve.
. ln thefetus,HbF(whichhas affinity for0, than a higher Hb)allows doesregular 0, to beextracted from maternal Hb.
(3) Carbon monoxide, which has a 240x greater affinity for Hb than does O, competeswith O, for binding sites on Hb. The remaining sites on Hb have a higher affinity for O, than normal. Carbon monoxide poisoning is very dangerous becauseit lowers the O, content of the blood and produces a left-shift of the hemoglobin-O, dissociation curve, thus impairing the ability of bound O, to dissociate.
. ln COpoisoning O,isnot fromHbto the released resulting intissue tissues, hypoxia.
ilote (Q for Thesolubility constant C0,isabout20x thatof 0,.
B. CO2 l. Dissolved a. Solubility coefficient= 0.06 ml/mm Hg Pco, ' 100 mL blood b. In arterial blood, Pco, = 40 mm Hg: 0.06 mL CO,
2.4 mL CO,
X 40 mm Hg COrmm Hg CO, ' 100mL blood 100mL blood 2. Bicarbonate (major form: 9oo/oof total COr)
COr+Hro 5
H2co3€H*+
HCoy
a. CO, diftrsesfrom the tissuesinto the RBCsand plasma.
t70
Physiology
b. Carbonic anhydrase (CA), which is present in RBCs, catalyzes the formation of H2CO3from CO, andHrO.H2CO3thendissociates to form HCO,- (bicarbonateanion) and H*. c. HCOr- diffirsesinto plasma,and Cl- diffirsesinto RBCsto maintain electroneutraliw. This movement of Cl- is called the chloride shift. d. RBCsare permeableto anionsbut not to cations.The H* left behind in the RBC is better bufferedby deoxyhemoglobinthan by oxyhemoglobin.Therefore,the unloading of O, is advantageousfor CO, loading (Haldane effect).
COzascarbamino Hb
C O z+H zO* H zC Og+H * + H C Os-
Figure ll-4-9.CO2transport in blood.
3. CO2combineswith terminal amine groups on Hb to form carbamino Hb. This reaction is chemically different from O, binding by Hb. CO, binds to the deoxygenatedform of Hb. So again,the unloading of O, helps with the loading of COr. 4. In the lungs, all of the abovereactionsoccur in reverse.Cl- movesout of the RBC. HCO3re-entersthe RBC and combineswith H* to make H2CO3.H2CO3dissociatesto CO, and HrO, and the CO, is exhaled.
ln a Nubhell . ln thetissues, Cl-shiftsinto RBCs. . Inthelungs, Cl-shifts out OfRBG.
HYPOXEMIA ANDHYPERCAPNIA A. Hlpoxemia. Pao,(85 mm Hg when breathing atmosphericair. 1. Possiblecauses a. Decreasedinspired Por,aswith high altitude or anestheticmismanagement b. Alveolar hnroventilation, where reduced Pao,is accompaniedby increasedPa.or.This may be due to pulmonary or neuromusculardisease,CNS depression(e.g.,becauseof sedativeihypnoticsor opiates),or inadequateventilation during anesthesia. c. Right-to-left shunts occur in which venous blood blpassesthe alveoli and "dilutes" the oxygenatedblood returning to the left heart. Congenital heart diseaseor atelectasis (alveolar collapse) with continued blood flow cause shunting. Hnroxemia due to shunting is not completely correctable by breathing l00o/oOr. This is becausethe shunted blood is never exposedto the high Po, and continues to depressthe arterial Or.
l7l
Respiratory System
!_ote Administration of 100o,o, inthe canreverse hypoxemia C8se of V/Qmismatch butnot ;nthecaseol ananatomic shunt
d. Under certaincircumstanc€s, Pao,do€snot fully equilibratewith P,ro,.In other words, (e.9., o, is diftrsion-limited becauseofa thickenedblood-gasbarrier seenwith fibrosrs,' e. Ventilation/perfusion mismatch is the mostcommoncauseof hpoxemia and occurs in manytypesof pulmonarydisease. B. Hlaercapnia.IncreasedPaco,to levels>42 mm Hg. l. Possible causes a. Hnroventilrtion-rernember tlnt Pa.o,is the bestindicator of alveolarventilation,so it mak€ssensethat inadequatealveolarventilation would be the most probablecause of hnrercapnia.
Gliniol GOffelan. Theventilatory driveof patients withchroniclung disease is primarily dueto urErr rryPuxcrrrrd' rdurer urdrr pH. levels CO, or Administration of a highO, mixtureto relievethe hvDoxemia iscontraindicted
b. VerF*severe ventilationy'perfusionmismatch is capableof causinghypercapnia(see 2. IncreasedPa"o,is the major stirnulusfor increasingventilation. If hypercapniaexists,it is highly likely that the respirator)'muscl€sand lungswill not be ableto respondadequately to restorePa.o,' 3. With adaptationto chronichypercapnia, decreased Pa^ canbecomethe majorstimulus for increasingventilation. If sucha iatient is givenOr,"iespiration,nay fail if ventilatory assistance is not givenat the sametime.
SPECTATFEAIURESOFTHEPUTMONARYCIRCULATION becausethisremovesthe hypoxic drive,leadingto severe hypoventilation.
A. pressure,flo-' end r€sistanc€ t. The right ventricle is normally a low-pressure,high-volumepump. It pumps the sarne volume of blood asthe left ventricle,the cardiacoutput (CO), but at a much lower pressure(20-25% of the pressureof the left ventricle). a. The systolicpressureis 25 mm Hg; the diastolicpressureis 8 mm Hg. b. The shapeof the right ventricleis adaptedfor low-pressure,high-volurnepumpinga'wide-bore, short-stroke"purnp. 2. Pulmonary arteries are large-diametervesselswith thin walls,making them distensible and collapsible(compliant). a. They havelesssmooth musclethan systemicaderies. b. Theyreceivethe entir€ cardiacouq)ut,yet the meanpulmonary arterialpressureaverages17mm Hg and dropsoff rapidly in distal pulmonary arteries. l. The differencein meanpressure(AP) from the pulmonary artery to the left atrium (171 mm Hg) is much lessthan that in the systemiccirculation (100-4 mm Hg). L The reasonfor the low pressurein the pulmonary circulation ascomparedwitl the systemic circulation is its much lower resistance(R):
= = R(pulmonary) :## #
R (systemic)=
172
Ap CO
=
98 mm Hg 5 Lhrrir,
= 3 mmHg/(L/min)
= 19 mm Hg/(L/min)
Physiology 5' Furthermore' as flow in the pulmonary circulation increases(increased cardiac output, co)' the resistancecan decreaseto even lower levelsbecause of two mechanisms: a' Distension of individual vesselsproduces larger vessel radii and thus reduces resistance. b' Recruitment of previously collapsed vessels (especially at the top of the lungs) increasesthe total cross-sectional area through which blood is flowing and th-us reducesresistance. 6. Effects of lung inflation on pulmonary vesselradius and resistance a' Small vesselsadjacent to alveoli ("alveolar vessels")are compressedat high lung volumes by the air pressureinside the alveoli. b' Large extra-alveolar vesselsare expanded during inspiration by the reduction of intrathoracic pressureand by radial traction on tl"r.lressels by ih" expanding lung parenchyma. c' Pulmonary resistanceis high at low lung volumes because of narrowing of the extraalveolar vessels.Resistanceis lowest at;iddle lung volumes, but at high lung volumes' resistanceis increasedagain becauseof narrowing of alveolar u.Jsels (rigures I I - 4- 10a n d II-4 -1l ).
extra-alveolar vessels
extra-alveolar vessels
4 alveolar vessel
alveolar vessel
alveolar vessel
LOW LUNG VOLUME
MEDIUMLUNG VOLUME
HIGHLUNG VOLUME
Figurell-+10. Effectsof expandinglung volumeon diameters of atveolar and extra-alveolarblood vessels.
o o c (d .(t, o
E
(d J
o
U'
Lungvolume
Figurell-4-11.Biphasicchangesin pulmonaryvascularresistance with expandinglung volume.
t7,
Respiratory System
7. Effects of gravity-induced hydrostatic pressure on blood flow at different lung levels in the upright human (Figure II-4-12) a. Blood flow is greatestin the lowestportions of the lung (zone 3) becausepulmonary arterial, venous, and capillary (alveolar vessel)pressuresare largest in this lowest region, distendingthe blood vesselsand lowering vascularresistance(P. > Pv > PA). b. Blood flow is intermediatein the middle portions of the lung (zone 2).ln this zone, alveolargaspressureis greaterthan that in pulmonary capillaries,causingnarrowing of thesevessels, thus increasingvascularresistance(P") Po> Pu).In zone 2, blood flow is intermittent. During systole,P" exceedsPo, producing a blood flow that is determined by P"- Po(not the typical P"- Pv).During diastole,P" falls below Po,causing blood flow to cease. c. Blood flow is lowest in the upper portions of the lung (zone f ). A situation can occur in which there is no blood flow becausethe alveolarpressureis greaterthan the arterial and venouspressures,leading to collapseof the capillaries(Po > P" > Pv). Zone I doesnot existunder normal conditions becausethe pulmonary arterial pressureis just sufficient to perfusethe top of the lung. This zone may be presentif the arterial pressure is abnormally low (e.g.,becauseof hypotension due to hemorrhage) or if the alveolarpressureis abnormally high (e.g.,with positive-pressureventilation). d. Theseeffectsdescribean upright individual at rest.An individual in a supine position would have fairly uniform blood flow from the apex to the base(although posterior blood flow would exceedblood flow in anterior regions). Exerciseincreasescardiac output, resulting in a more uniform distribution of blood flow in the lung.
PotP">Pv
No flow is possible. Pnis sufficientto collapsecapillaries.
P">PA>Pv Intermittentflow. Flow is driven by Pu- Podifference. P">Pv>PA Flow always possible.Flow is driven by P"- Pu difference. Figure ll-4-12.Blood flow at three zones in the upright lung.
174
Physiology
B. Regulation of pulmonaryblood flow 1. Hypoxic vasoconstriction results from a low alveolar Por. a. In contrastto systemicarteriolar smooth muscle,which relaxesin responseto low Po, alveolar hypoxia causesconstriction of small pulmonary arteries. This responseis adaptive in that it shunts blood flow away from poorly ventilated alveoli (e.g., after bronchial obstruction). b. Fetal lungs exhibit hypoxic vasoconstrictionproducing a low pulmonary blood flow. There is a sudden rise in Pao, with the first breath, leading to a marked decreasein pulmonary vascularresistance.This allows the entire cardiacoutput to flow through the pulmonary vasculaturewithin severalbreaths. c. A generalizedhypoxic vasoconstrictionoccursat high dtitude. This is not an advantageous responsebecausethe increased pulmonary arterial pressure can lead to increasedwork and hypertrophy of the right heart.
ln a Nubhell Alveolar hypoxia causes local vasoconstriction in Pulmonary bloodflowThisresponse is opposite to thesystemic vascular response to hypoxia, whichisvasodilatation. The pulmonary vascular vasoconstriction isimportant because it diverts bloodaway frompoorlyventilated areas of thelungandtoward well ventilated areas.
d. Hypoxic vasoconstriction occurs in experimentally denervatedlungs and in transplanted lungs and is therefore not dependent on an intact nerve supply. Local chemical mediators or a direct effect of low alveolar Po, are implicated. C. Pressure measurements in the pulmonary circulation 1. All vascular pressuresin the pulmonary circulation can be measuredclinically with a b alloon -tipped catheter,the Swan-Ganz catheter. a. The Swan-Ganzcatheter has two lumens-an air-fi.lled lumen and a saline-filled lumen. (1) The heparinized,saline-filledlumen can be attachedto a pressuretransducerfor pressuremeasurementor can be usedfor blood samplingby withdrawal of blood into a syringe. (2) The air-filled lumen can be attachedto an air-filled syringethat is usedto inflate a balloon surrounding the tip of the catheter. 2. The Swan-Ganzcatheteris flow directed. a. Inserted into a systemicvein with the balloon collapsed,it can be passedto the right atrium. b. With the balloon inflated, it is then swept along through the right atrium, acrossthe tricuspid valve into the right ventricle, then acrossthe pulmonic valve into the pulmonary trunk, and onward into a small pulmonary artery where the balloon becomes lodged or "wedged."The saline-filledlumen no longer measuresthe pulmonary arterial pressurebecausethe blood previouslyflowing in this small artery hasbeen diverted to other small pulmonary arteriesin parallelwith it. The saline-filledlumen is now in a position to measurepressure(the pulmonary wedge pressure) in the vessels downstream from the catheter tip, which ultimately reflects the left atrial pressure.
THEMATCHING OFVENTITATION ANDPERFUSION A. The total minute ventilation and the cardiac output in adults are both approximately 5-6 L/min. Therefore,the overall ventilation/perfusion (VCD is approximately r. n VQ raiio of I is ideal for maximal exchangeof O, and COr. B. However,in eachlung compartment, the VQ can vary from 0 to oo.
175
Respiratory System
C. If an alveolus or group of alveoli are servedby an obstructed airway, the local ventilation may be 0. VA/Q: 0. The Po, and P"o, of the alveolar gas and pulmonary capillary blood approach that of mixed venous blood (Figure II-4-13). This is called a physiologicshunt. D. If an alveolusis being ventilated but hasno blood supply, ascould happen with a pulmonary embolus, V^/Q = -. The Po, and P.o, of the alveolar gas approach that of inspired air. The ventilation of these alveoli is wasted producing physiologic dead space.
Oz = 150 mm H g
n ) I\ co2-o
ln a.Nubhell . Normal V/Qratio-t . Airwayobstruction -+ = o. lf thereis ventilation bloodflow,V/Q=g. normal Pno,andPno,approaches venous thevalueof mixed blood. . Bloodflowobstruction -> V/Q- infinity. Nogas Pno, exchange occurs. and Pn.o,approach thevalueof inspired air.
@
Il
v v v , (o,=o\
\
obstruction of ventilation
or=fo(
c o 'o = + o L
oz=1oo \ \
normal ventilation
/*\
t ( o r = 1 s o\ \
obstruction of arterialvessel
Figure ll-4-13. The effects of altering ventilation or perfusion in the lung.
E. Neither ventilation nor perfusion are uniform throughout the lung. 1. Ventilation. Upright individuals have the greatest ventilation in the lower regions of the lungs. This is becauseintrapleural pressureis more negativesurrounding the apical portions of the lung, so that apical alveoli are more distended.Thesealveoli are stiff and difficult to distend further to ventilate them. Basal alveoli are lessdistended, more compliant, and easier to ventilate. With each inspiration-expiration rycle they exchangemore gas. 2. Perfusion. Perfusion is also greatest in basal areasof the lung becauseof the higher vascular pressuresdue to gravity (seeFigureII-4-12). 3. Ventilation increasesslowly from the apex to the base of the lung. Perfusion increases more rapidly from the apex to the baseof the lung. As a result, the ventilation/perfusion ratio is highest at the top of the lung and lowest at the bottom (Table lI-4-2).
r76
Physiology
Thble ll-4-2.Ventilation Rib Number
and perfusion (L/min) at various levels of the l ntg.
Blood Flow (L/min)
I (top) 2 3 4 5 6 (bottom)
Ventilatio n (o/olung vol)
Ve/Q
0.045
3.20
0.014 0.02 0.05 0.07 0.08 0.1
0.035 0.05 0.0s 0.055 0.06
r.75 1.00x
0.7r 0.69 0.60
Note that blood flow increasesmore sharply from top to bottom of the lung than does ventilation. Thus, below rib 3, perfusion is lessthan ventilation ana V^lQ is lessthan l; at the level of about rib 3, ventilation and perfrrsion are equal and Volq = 1*; at higher levels,ventilation is greater than perfusion andVo/Q is greaterthan l.
F. The baseof the lung has a lower Po, becauseof its lower V/Qratio. Becausea disproportionate amount of blood comes from the base,there is a slight depressionof arterial Por. This contributes to the alveolar-arterialO, differenceof about 4 mm Hg io the normal individual.
VA/eINEeuAury tNpATHorocrc srATEs A. The degree of V^/Q inequality (with increasesin both high and low VQ alveolar units) increasesdramatically in various pulmonary diseases,reducing the efficiency of gas exchange.
ClinicalCorrelate Theapexofthelunghasa higherPo,because of its higherV/Qratio.Reactivation tuberculosis tends to involve thelungapices because Mycobacteriun tubercuI osis requires O,to grow.
B. Causesof lowVo/Q 1. Airway obstruction impairs alveolar ventilation. a. Physicalobstruction (e.g.,mucus or object) b. Bronchoconstriction 2. Decreasedlung compliance impairs alveolar ventilation. a. Pulmonary edema"stiffens" the lung, decreasingalveolarventilation aswell asimpairing gastransport from alveoli into the blood. b. Pulmonary fibrosis decreaseslung compliance, impairing ventilation; also,thickening of the blood-gas barrier impairs gastransport from the alveoli to the blood. C. Causesof highVn/a l. Pulmonary embolism (impairs circulation) 2. Hemorrhage (impairs circulation) 3. Positive-pressureventilation (can impair circulation by collapsing pulmonary blood vessels) 4. Anesthesia(can impair circulation) D. Pulmonary responsesthat normally minimize U/a mismatch 1. Hypoxic vasoconstriction. Constriction of small pulmonary arteries in responseto alveolar hypoxia reducesflow to hypoxic alveoli. 2. Hypocapnic bronchoconstriction. IncreasedVQ leads to reduced Pr.o^, causing local bronchial smooth muscle contraction.
177
Respiratory System
CONTROT OFBREATHING A. Central control of breathing 1. Medullary respiratory center a. The dorsal respiratory group is responsible for inspiration and for generating the basic rhythm of breathing. This cell group receivesinformation from peripheral chemoreceptors,baroreceptors,and various lung receptorsvia the glossopharyngeal and vagus nerves.It outputs via the phrenic nerve to the diaphragm. b. The ventral respiratory group is inactive during quiet breathing but is involved in regulatingbreathing when ventilation is greaterthan normal (e.g.,during exercise).It is particularly important in sendingexpiratory signalsto the abdominal musclesduring active expiration. 2. The apneustic center, located in the lower pons, causesdeep and prolonged inspiratory gasps (apneuses).It is unclear whether this functions in normal breathing,but apneuses interrupted by brief expirations are seenin some types of brain injury. 3. The pneumotaxic center,located in the upper pons, actsprimarily to inhibit inspiration. This can increasethe respiratory rate. 4. The cerebral cortex plays a role in voluntary breathing. Hyperventilation is easier to accomplish voluntarily than is hypoventilation. B. Efferent pathways 1. Phrenic nerve to diaphragm 2. Motor neurons to intercostalmusclesand abdominal muscles
ln a Nubhell
C. Afferent systems 1. Chemoreceptors for CO,
CentralChemoreceptors . Aresensitive to CSFpH. . Increases in P.o. and[H.] stimulate breathing rate. Decreases in P.o,and[H.] inhibit thebreathing rate.
a. Medullary CO, receptors actuallyrespondto H'. CO, passesthrough the blood-brain barrier into cerebrospinalfluid (CSF) and reactswith HrO to form H2CO3HCOr- and H* are subsequentlyproduced, and the H* stimulatesthe chemoreceptors.Increases h P.o, and [H.] in the CSF stimulate breathing, ord decreasesin Pco, and [H*] inhibit breathing. Theseare the most important receptorsthat respond to changesin CO, levels.
. Hypoxia doesnot$imulate central chemoreceptors atall.
b. Peripheral CO, receptors are located in the carotid and aortic bodies. Increasesin P.o, lead to increasesin ventilation. (1) Quantitatively,peripheral CO, receptorsare not as important as their central counterparts. (2) This responseis potentiatedby decreases is Pao,(FigureII-4-14).
t78
Physiology
ln a NuGhefl
P?or= 100 mm Hg Alveolar ventilation (Umin)
. Increases in P.o,in arterial peripheral bloodstimulate thus chemoreceptors, therateof increasing breathing. . Theperipheral arenotas chemoreceptors asthecentral important in chemoreceptors in to changes responding P.o,. arterial
Pa6er(mmHg) Figure ll-rt-l4. Influence of Pagron chemorcceptor responsiveness to Pa6qr.
2. Chemoreceptors for O, a. Peripherd O, receptors are located in the carotid and aortic bodies. Decreasesin Po, lead to increased ventilation. (1) However, Poz must fall to fairly low levels (below 6G70 mm Hg) to have an effect. (2) This responseis potentiatedby increasesis Pa.o" (Figure II-4-15). 3. Chemoreceptors for pH a. Peripheral pH recePtorsare located in the carotid bodies. b. Decreasesin pH lead to increasedventilation.
In a Nubhell Po,, Decreases in arterial below70mmHg, especially theperipheral stimulate andincrease chemoreceptors rate.These thebreathing receptors aretheonly to onesthatrespond (J hypoxia Po).
In a NuBhell . Anincrease in [H*] (decrease in pH)stimulates body carotid to increase chemoreceptors rate thebreathing in ofchanges independent level. P.o,
r79
Respiratory System
80 70 60 Alveolar 50 ventilation (Umin)
40
P".or= 50 mm Hg
30 20
P^"or= 45 mm Hg
10
P^"or= 38 mm Hg
60
80
100
120
P""o, (mmHg) Figure ll-4-15.Response to hypoxia. Note the nonlinearresponseto hypoxia as comparedwith the linearresponseto hypercapniain Figurell-4-14.Note also the relativeinsensitivityof this systemas comparedwith the CO2system.
4. Other sensory receptors a. Stretch receptors in smooth muscle of airwaysrespond to increasedbronchial wall distention. Steadylung inflation leadsto an increasein the duration of expiration (HeringBreuer inflation reflex). Conversely,marked deflation of the lung leadsto a decreasein the duration of expiration (Hering-Breuer deflation reflex). Thesereflexesare largely inactive until tidal volumes exceed1 liter, aswould occur in exercise. b. Irritant receptors, located between epithelial cells in the airways, respond to noxious gases,smoke, particulates, and cold air. Afferent signalstravel up the vagus nerve and result in bronchoconstriction,coughing,and mucus secretion. c. J (juxtacapillary) receptors are located in the lung parenchyma near capillaries.They are stimulated when pulmonary capillaries become engorgedwith blood or as a result of interstitial edema.They are thought to causerapid, shallow breathing and dyspnea as seenin patients with left heart failure and interstitial lung disease. D. Role of the respiratory system in acid-base regulation 1. COr-generated by cellular metabolism + increasedH*. CA CO, + HrO <--> H2CO3€€
H* + HCOr-
2. Elimination of CO, at the alveoli reducesblood [H.] by shifting the equilibrium of this reaction to the left. 3. Retention of CO, increasesblood [H-] by shifting the equilibrium of this reaction to the right. 4. Respiratory acidosis: Hypoventilation leads to increasesin Pa.or.As a result, [Hn] increases,and blood pH decreases.
r80
Physiology 5' Respiratory alkalosis: hnrerventilation decreasesPa.or. As a result, [H*] decreases, and blood pH increases.
ClinicalCorrelate
6' Adjustments to the respiratory-inducedpH changesare made by the kidney (renal compensarion).This generallytakes2_3 days.
Respiratory Acidosis: - t pco,
7' Respiratorycompensationfor nonrespiratoryacid-baseimbalances requiresonly minutes to hours.
Causes:
SLEEP APNEA A' sleep apneais a problem of respiratorycontrol in which loss of pharyngealmuscletone during sleepclosesoffthe upper airway.Thisairway obstruction can be severeenough to impair ventilation to the point that the patient becomeshypoxemic, and in some cases,hypercapr nic' stimulation of the respiratorycontrol systemsby the abnormal blood gasesawakensthe patient often during the night. The result is that the patient rarely experiencesdeep sleepor rapid eyemovement (REM) sleep. B' Sleepdeprivation causesfatigue during the day,and the patient has a tendencyto fall asleep at inappropriate times, making them prone to accidents.
. Sedatives, anesthesia . ALS, multiple sclerosis, polio, Cuillian-Barre . Ainruay obstruction . Adultrespiratory distress syndrome . Chronic obstructive pulmonary (C0pD) disease
c. Left untreated,sleepapneacan lead to many physicalproblems: 1' Pulmonary hypertensionas a result of hypoxia (hypoxic vasoconstriction) 2. Hyperemia 3. Increasedcardiacload 4. Cardiac arrhythmias 5. Prematuredeath D. Factors that contribute to sleepapnea 1. Obesity 2. Largetongue and tonsils 3. Small jaw 4. Deficient skeletalmuscle tone E. Tieatment of sleep apnea centers around ways to prevent or relieve the upper airway obstruction. 1. Dental appliancesthat force the mandible forward 2. Weight loss 3' continuous positive-pressurerespirators(GPAP)applied over the nosewhile sleepingor BiPAP,which is similar but appliespositive airway pressure only during the innj. .!.t. of respiration 4' Surgicalproceduresto remove the uvula or excesstissuesfrom the soft pallet and pharynx
t8l
Respiratory System
EXERCISE A. Oxygen consumption lVor) rises as does CO, production (Vcor). However,Vco, typically rises more than Vo, because more carbohydrate than fat is used for energy. The respiratory exchangeratio (R) rises from 0.8 to about 1.0 with exercise. B. Vo, increaseslinearly with the exercisework rate until Vo, becomes constant (Vor,"u*).An increasein work rate above this level can occur only becauseof anaerobic glycolysis. C. Ventilation increaseswith exercise.At first, it increasesproportionately with Vor. The mechanism responsiblefor this is unknown. As the exercisebecomesmore vigorous, ventilation can increasestill further, possibly becauseincreasesin lactic acid liberate more CO, which further increasesventilation. D. Pulmonary blood flow increases with exercise(becausecardiac output increases),leading to a more uniform distribution of blood flow in the lung. This decreasesventilation-perfusion inequality. However,in a person with normal lung physiology,this inequality is so small that it would have little effect. E. During moderate exercise,there is little changein arterial Por, Pcor, and pH. During strenuous exercise,the increasein ventilation exceedsCO, production,leading to a decreasein Pco, and an increasein Por. pH decreasesduring strenuousexercisebecauseof lactic acidosis.
HIGHATTITUDE A. Becausethe barometric pressureis diminished at high altitudes,the inspired Po, and alveolar Po, are decreased.This leads to a decreasein arterial Po, (hnroxemia). B. The hypoxemia is detectedat peripheral chemoreceptors,leading to reflex hyperventilation, causing a respiratory alkalosis. This alkalosis (along with the hypoxemia) contributes to acute mountain sickness,the symptoms of which include fatigue, headache,vertigo, nausea and vomiting, and insomnia. Acetazolamide, a carbonic anhydrase inhibitor, can reduce thesesymptomsby correctingthe alkalosis. C. The hypoxemia also stimulates the production of erythropoietin from the kidney, which increasesthe production of red blood cells.This increasein red blood cell concentration (polycythemia) increasesthe oxygen-carrying capacity of the blood. D. A right-shift of the oxygen dissociation curve occurs as a result of an increasedconcentration of 2,3-diphosphoglycerate. This resultsin better O, unloading in the tissues. E. The decreasedalveolar Po, results in pulmonary vasoconstriction. Pulmonary vasoconstriction is an advantageousresponseto diminished ventilation of a portion of the lung in order to shunt blood to areasthat are better ventilated. The generalizedpulmonary vasoconstriction that occurs with high altitude can, however,lead to increasedwork of the right heart, right heart hypertrophy, and pulmonary edema.
r82
Physiology
PATTERNS OFBREATHING-TERMI NOTOGY A. Eupnea-normal
quiet breathing
B. Thchypns4-insleased respiratory rate C. Hyperpnea-increased rate and depth of respiration D. Dyspnea-sensation of breathlessness, labored breathing 1. Orthopnea-dyspnea while recumbent but not upright E. Apnea-cessation of respiration F. Cheyne-Stokes respiration-an abnormal pattern with increasing and decreasing tidal volume and periodic apnea.It is causedby CNS disordersand poor circulation to the brain. G. Kussmaul breathing-regular, rapid breathing with a large tidal volume. It is usually caused bv metabolic acidosis.
t83
Respiratory Pathology pollutants, Thelungisa majordestination foranything thatcanfloatintheair,including spores, bacteria, viruses, andsmoke. Asa result, it isa primary siteforinflammation, infection, and neoplasia. Lungcancer isnowtheleading cause of cancer deathin bothmenandwomen; approximately 900/o of cases arecaused bycigarette smoking. Inadditon, common allergic anddestructive inflammatory conditions, suchasa$hma, bronchitis, andemphysema, areseriously exacerbated bysmoking. This pulmonary pathologies chapter discusses thedifferent withinfectious associated andneoplastic diseases aswellasthecommon environmental agents knownto cause and/orexacerbate pulmonary disorders.
CONGENITAL ANOMATIES A. Pulmonary cysts. There are two types of pulmonary rysts causedby premature separation of the embryonic foregut. 1. Bronchogenic cysts are centrally located, adjacent to bronchi or bronchioles, and occur with or without connections to airways. They are lined by ciliated, mucus-secreting bronchial columnar epithelium and may be single or multiple. Their size varies from microscopic to greaterthan 5 cm in diameter, and they may be associatedwith other rysts of the liver, kidney, or pancreas. 2. Pulmonary cysts are multiple and peripherally located, lacking communication with main bronchi. Infection is frequent (e.g.,abscess);rupture can causepneumothorax and compression of adjacent lung tissue. Dilatation may rupture vessels,leading to hemopWsis. B. PulmonarFatresia. Bilateral pulmonary atresiais not compatible with life; unilateral atresia is usually accompaniedby other serious malformations. C. Pulmonar''hlpoplasia of the lung.
refers to incomplete development of the entire lung or a single lobe
D. Congenital lobar inflation results from bronchial obstruction due to absenceor hypoplasia of the bronchial cartilage with compensatory overinflation of the remaining lung. E. Pulmonar'' sequestrations. Extrapulmonary lung tissue is usually supplied by systemic blood vesselsrather than by pulmonary arteries. It is usually located behind the lung or below the diaphragm.
Bddgeto Gasfiin{estinal Neonates witheither esophageal atresia or tracheoesophageal fistula arevulnerable to pneumonia. aspiration
t85
Respiratory System
Note
INFECTIONS
Thespectrum of infectious pneumonia agents causing continues to change as andthe antibiotia evolve number of immunocompromised patients rises.
Infections in the lung are more common than infections in any other organ, excluding the skin; viral infections are more frequent than other forms of pulmonary infection. A. Bacterial pneumonia occurs when pulmonary defensemechanisms are weakened (e.g., decreasedcough, gag, or nasal clearance;mucociliary damage; macrophage phagocytic defects;pulmonary edema; pooling of secretions;bronchial injuqr) or when the host is otherwise immunocompromised (e.g.,chronic disease,immunologic deficienry,immunosuppressivetherapy,leukopenia).It can be classifiedin severalways: 1. By etiologic agent (e.g.,staphylococcal,streptococcal) 2. By host response(e.g.,suppurative,fibrinous) 3. By anatomic distribution pneumonia)
(e.g., bronchopneumonia, lobar pneumonia, interstitial
B. Bronchopneumonia causesa patchy consolidation of the lung and usually arises as an extensionof pre-existingbronchitis or bronchiolitis. 1. Incidence. It occurs most commonly in infanry and old age.The most common agents pneumoniae,Staphylococcus, Haemophilusinfluenzae,Pseudomonas, include Streptococcus and coliforms. Fungi may be pathogenicin immunosuppressedhosts.
ln a Nutshell Bronchopneumonia . Patchy consolidation involving oneormore lobes . Acute inflammation (neutrophils) into extending alveoli frombronchioles
2. Clinical features include fever, a cough productive of purulent sputum, rales over involved areas,and pleuritic chest pain if peripheral regions are involved. Chest x-ray showsfocal opacities. 3. Pathology a. Grossly, up to 3-4 cm foci of lung consolidation with purulent inflammation are seen.Consolidation is frequently multilobar, bilateral, and basal becauseof gravitational pooling of the infection. b. Microscopic findings are usually a purulent exudate,dominated by neutrophils filling airwaysand alveoli (Figure II-5-1), unlessthe patient is immunosuppressed. 4. Complications include lung abscess, spreadto the pleural space(empyema),spreadto the pericardial cavity (suppurative pericarditis), bacteremiawith metastatic infection, and respiratory failure.
r86
Pathology
Figure ll-5-1.Acute bronchopneumonia(microscopic). C. Lobar pneumonia is usually causedby a bacterial infection, most commonly causedby S. pneumoniae,Ieading to widespreadconsolidationin largeportions of a lobe. l. Incidence. Lobar pneumonia occurs most often in midlife. Men are involved 3-4 times more frequently than women. Kebsiella and type II pneumococcus occur in elderly, alcoholic,and diabetic patients. 2. Clinical features. There is an acute onset of fever,chills, malaise,and cough with watery sputum initially, followed by frankly purulent, rusty sputum. Shortness of breath, orthopnea,and cyanosiscan occur if pneumonia is sufficientlysevere.Pleuritic chestpain and pleural friction rub occur with peripheral involvement.Limited breath sounds and ralesoccur early,proceedingto dullnessand percussionwith egophony.Increasedtactile and vocal fremitus occur with more severe consolidation. Chest x-ray shows lobar involvement.
Bridgeto Microbiology Pneumonia in diabetis or alcoholis, IhinkKlebsi elIo. Another classic cluefor pneumonia Klebsiello is "currantjelly"sputum.
3. Pathology. There are generally four stagesof the inflammatory response;antibiotics shorten or stop the natural progression. a. The initial stage (24 hours) features acute congestion and hyperemia, vascular engorgement,and intra-alveolarfluid (edema)with few neutrophils and many bacteria. The lung is grosslyboggy,firm, and engorged. b. Earlyconsolidation (24 days)is called"red hepatization" and featuresconsolidation with a neutrophilic infiltrate and fibrin within alveolarspaces.Overlying pleuritis is common. Grossly,the lung is red (due to extravasationof red cells),firm, and airless with a liver-like consistency. c. Late consolidation (4-8 days) is called"gt"y hepatization." There are large amounts of fibrin with decreasingnumbers of red blood cells and white blood cells (many degenerating).Pleuritis is common, and empyema may occur. There is little or no fluid within the exudate.Grossly,the lung has a grayish-brown dry surface. d. Resolution begins after 8 days.There is enzymaticdigestion of the consolidatedexudate, which consistsof fibrin, RBCs,and WBCs. This produces granular, semiliquid debris that is either resorbed,consumedby macrophages,or expectorated("coughed up"). Complete resolution and return to normal ventilatory function occursover 1-3 weeks.
ln a Nutshell LobarPneumonia . Called "lobar" because it involves theentirelobe . Mo$oftendueto pneumonioe Streptococcus . Characterized mainly byan intra-alveolar that exudate in consolidated results lobes(s) ofthelung . Redhepatization followed gray by hepatization
t87
Respiratory System
4. Complications include lung abscess,empyema, and exudate organization rather than resorption. This causesrespiratory difficulty and bacteremia,with metastasesto heart valves (endocarditis),spleen,brain (meningitis), kidney, joints, and pericardium (pericarditis). D. Viral and mycoplasmal pneumonia (atypical pneumonia). Thesereactions are called a!rp. ical becauseof lack of alveolarexudate.Instead,inflammation is found in the lung interstitium and alveolar septae (interstitial pneumonia). Pneumonia is frequently caused by Mycoplasmapneumoniaein crowdedconditions and by viruses,including influenzaA and B, respiratory syncytialvirus (RSV), and adenovirus.
ln a Nutshell Interstitial Pneumonia . Mostcommonly by caused viruses andMycoplosmo pneumonioe . Inflammation isfoundin thelunginterstitium and alveolar septae; thereisno alveolar exudate. . Involves oneor morelobes
Bridgeto Microbiology Theotherfungal diseases affecting tract therespiratory (e.g., histoplasmosis, coccidioidomycosis, bla$omycosis, aspergillosis) arediscussed in detailinthe Mycology chapter ofthe Microbiology in section Ceneral Principles Bookt 0olumel).
1. Clinical features include fever, malaise, and a dry, hacking cough; these symptoms resemblethoseof a severeupper respiratoryinfection. Constitutional symptomsare common: headache,muscle aches,and leg pains.Elevatedcold agglutinins are found in 50% of patientswith mycoplasmalpneumonia and in 20o/oof patientswith adenovirus.There is lessthan 1olomortality. Symptomsare out of proportion to physicalfindings. 2. Pathology a. Grossly, there is patchy-to-diffuse involvement, bilaterally or unilaterally. Affected areasare red-blue with a congestedinterstitium but without consolidation or pleural involvement.There is no pus. b. Microscopically, there is an inflammatory interstitial pattern with widened and edematous alveolarseptae.A mononuclear infiltration of lymphocytes,histiocytes,and plasma cells is usually found. Acutely,neutrophils can be seen.Alveolar damagecan causeexudation of proteinaceousmaterial, cellular exudate,and hyaline membrane lining the alveolarwalls. 3. Diagnosis. Mycoplasmapneumonia is often diagnosedby sputum cultures,complement fixation tests,and nonspecificcold agglutinins reactingwith red blood cells.Cold agglutinins are immunoglobulin M (IgM) antibodieswith specificiryfor the I antigen on adult RBCs.Fetal RBCscarry the i antigen but not I, so specificityis easilytested.Monoclonal cold agglutininsin elderly patientsare indicative of a lymphoproliferative disorder. E. Pneumorystiscarinii pneumonia (PCP). P. carinii is now believedto be a fungal organism; it infects immunocompromised patients. It is commonly seen in acquired immunodeficiency syndrome (AIDS), in oncology patients,and in undernourished children. 1. Clinical features.Patientspresentwith fever,dyspnea(shortnessof breath),hypoxia (low oxygen saturation), and bilateral interstitial infiltrate on x-ray. Lessoften, patients complain of cough. 2. Pathology. Findings include an intra-alveolarexudatewith pneumocysts,cell debris,and proteinaceousfluid. Usually,there is an interstitial inflammatory reaction of mononuclear cells,fibrin, and RBCs.Occasionally,fibrosis, calcification,and granuloma formation occur. Grossly, the lung is red, airless,and beefr. 3. Diagnosis is basedon demonstration of organismsvia silver stain or fluorescent antibody. Sputum induction has a sensitivityalmost equal to that of bronchial washingsand lung biopsy via a bronchoscope. F. Aspiration pneumonia results from aspiration of oral secretionsor gastric contents.It is seenin alcoholics and other debilitated patients with neurologic or anatomic impairment affectingthe swallowing mechanism.A chemical pneumonitis results,often with secondary bacterialinfection from mouth anaerobes,causingnecrosisand abscessformation. G. Pulmonary abscessrefersto an area of inflammation with a central region of liquefaction necrosis.It occursat any agebut is more common in young adults (men > women). It is rare in infants.
r88
Pathology
1. Pathogens include aerobic and anaerobicStreptococcus, S. aureus,gram-negativerods, and mouth anaerobes,including Bacteroides, Fusobacterium,and Peptostreptococcus. 2. Routes of infection a. Aspiration of gastric contentsand mouth flora b. Bacterialpneumonia (inhalation) c. Septicemboli from the venous circulation or the right side of the heart d. Neoplasiawith postobstructivepneumonia e. Miscellaneoustrauma, extension of infection from other organs, hematogenous spread,or cryptogenic (no identifiable cause) 3. Clinical features include fever, paroxysmal cough with foul-smelling, purulent or sanguineous sputum, and weight loss. Clubbing can occur within weeksof abscessformation. Ten to fifteen percent of patients have underlying carcinoma. With appropriate resolvewithout sequelae.An air-fluid level is antibiotics,75o/oof pulmonary abscesses often seenon chestx-ray. 4. Pathology a. Grossly,lung gangrene(fetid, green-blackmultilocular cavities)is seen. b. Microscopically, there is suppurativedestruction of lung parenchymawithin the central area of cavitation. 5. Complications include respiratory failure, extensionof infection into the pleural space, and embolization to the brain and meninges. H. Pulmonary tuberculosis (TB) primarily affects the lungs and is caused by acid-fast Atypical mycobacmycobacteria.Almost all casesare causedby Mycobacteriumtuberculosls. teria can causeinfection, especiallyin the immunocompromised host. BecauseM. tubercu/oslsis a strict aerobe,reactivationtends to occur in the apex of the lung and renal cortex. There is an increasedincidencein areaswith poor sanitary conditions, poverty,overcrowding, malnutrition, and limited accessto medical care. The emergenceof AIDS and other immunosuppressedstateshas led to a resurgencein the incidenceof TB. Of concern now is the occurrence of multiple drug-resistant TB.
BridgeToMicrobiology in M.tuberculosis isdiscussed intheMicrobiology detail section t ofCeneral Principles Book (Volume l).
l. Primary pulmonary TB a. Pathology.The lung is the usual location of initial infection, typically the lower part of the upper lobe or the upper part of the lower lobe. Parenchymalor subpleural lesions occur associatedwith enlarged,ipsilateral caseouslymph nodes, which are "draining" the parenchyma.The "Ghon complex" refersto radiographicevidenceof a calcifiedperipheral lesion in conjunction with a calcifiedhilar lymph node. b. Clinical features. Most patients are asymptomatic,and the lesionsbecome fibrotic and calcified over time. It is the macrophagethat leads to phagocytosisof tubercle bacilli, epitheloid giant cell fusion, and granuloma formation with central caseous necrosis.The tuberclebacilli survive in granulomasfor years,only to reactivatewhen the patient's immune systemis depressed(e.g.,elderly or malnourished patients or patientswith HIV). 2. Secondarypulmonary TB. Most casesrepresentreactivation (rather than reinfection) of old TB that had disseminatedat the time of primary TB. Reactivationoccurs often in areasof high oxygentension,such asthe lung apices.Only 5-I0o/oof patientsexposedto TB developreactivation.ReactivationTB usually occursin debilitated elderly patients.
r89
RespiratorySystem
a. Pathology (1) Grossly, there is a small focus of consolidation,usually lessthan 3 cm, in the lung apex.Hilar ly-ph nodes are also involved, developingfoci of tuberculous activity. Parenchymallesionscan developsmall areasof caseousnecrosisthat may not cavitate. The usual course is fibrous encapsulation,leading to fibrocalcific scarsand pleural adhesions.A thick, collagenouswall may totally enclose caseousdebris. This may never resolveand can remain asa granular lesion. (2) Microscopically, characteristicgranulomas composedof epithelioid cells,with occasionalLanghans'giant cells,are seen.Granulomas are surrounded by fibroblastsand lymphocytesand exhibit a region of central caseation(Figure II-5-2). Tlrberclescoalesce,and large areasof the lung becomescarred. b. Complications include hemoptysis resulting from ulceration of the bronchial mucosa, pleuritis, tuberculouspneumonia,and bronchopleuralfistula with empyema. 3. Late progressive pulmonary TB shows progression of an early tuberculous apical lesion to a fibrocaseousareawith cavitation. Spreadis through erosion into an airway to other regionsof the lung, resulting in multiple lesionsthat may cavitate.Spreadmay also occur via the lymphatic systemor blood, leading to distant dissemination.The pleura is often involved and may lead to exudativepleural effusion,frank tuberculousempyema,or massive obliterative fibrous pleuritis. Bronchi are also involved as a result of seedingand can causemucosalulcers.Pathologyrevealscaseatinggranulomas (Figure II-5-3).
Figurell-5-2.Pulmonarygranuloma(microscopic).
t90
Pathology
4.li:4t :'' ', ;/,/it'!?ai, i
:
: ta'::l at i ':;::: i: ; ' : : '4,', a a !.!'.4?/'?i: . I i '!1"'. :
ii !r :
ln n.:;1
Figure ll-5-3. Multiple causeating granulomas in pulmonary tuberculosis (microscoPic).
4. Miliary TB is due to spreadvia blood or lymphatics. Diseasemay remain confined to the lung but usually disseminateswidely. For example,erosion into a pulmonary artery leadsto lung lesions;erosion into a pulmonary vein leadsto systemiclesions.Extrapulmonary sites of involvement include the renal cortex,lymph nodes,genital tract, peritoneum, bone marrow, adrenalgland, pericardium, and meninges. a. Pathology (1) Grossly, there are small, distinct, firm, yellow and white areasof consolidation. (2) Microscopically, there are individual or multiple confluent regions, showing granulomaswith areasof central caseation. b. Diagnosis is made by skin test, chest x-ray, sputum smear,and culture. If indicated, lung biopsy,urine, gastric aspirate,and CSF need to be evaluated. 5. Isolated organ TB occurs when organismsare destroyedduring hematogenousor lymphatic spreadexcept in a particular organ, €.8.,lymph nodes (scrofula),vertebrae (Pott disease),meninges(tuberculousmeningitis), adrenals,kidneys,and genitals. I. Legionella infections. Legionellapneumophila (a gram-negativebacillus) is the etiologic agent of theseinfections.It is usually found in soil or water.Tiansmissionis via inhalation into the lungs. Major environmental sourcesinclude water reservoirs and cooling units of air conditioning systemsthat may contain blue-green algae and amoebae,among which Legionellacan survive for prolonged periods.
Correlate Clinical pneumophilo Legionello of infection isa result from inhalation oftheaerosol water, most contaminated foundinair commonly systems. conditioning
1. Clinical features. Community outbreakstraced to an infected water source reveal two patternsof illness. a. Pontiac fever is a mild, nonfatal, systemicfebrile illness. b. Legionnaires diseaseis a severepneumonia with l5-20o/omortality. After approximately 5 days of incubation, patients develop fever, dry cough, malaise,chest and abdominal discomfort, confusion, and, occasionally,diarrhea.Frequently,pulse-temperature dissociation exists (a high temperature with no increasein pulse). Severe
t9l
Respiratory System
caseshaveblood-tinged sputum, dyspnea,high fevers,and impressivesystemicsymptoms. Death may occur due to progressiveventilatory failure or from a shock-likesyndrome with disseminatedintravascularcoagulation(DIC) and renal failure. 2. Pathology. Bronchopneumoniawith fibropurulent exudatecan coalesceand occasionaily mimic lobar pneumonia. Microscopically, there is a mononuclear infiltration with macrophagessurrounding necrotic tissue. Surrounding the mononuclear infiltrate are proliferating pneumocytes,hyaline membranes,and edema. 3. Complications a. Inflammation of small pulmonary arteriesand veins can lead to thrombosis. b. Abscessformation is frequent,but the abscesses are small. c. Organization and scarring secondaryto destructive lesions can lead to ventilatory impairment. d. Fibrinous pleuritis is usually mild with serouseffi,rsion. e. Bacteremiais alwaysa risk. L Diphtheria (due to C. diphtheriae)and whooping cough (due to B. pertussis)both cause toxin-mediated upper respiratory tract infections that can be accompaniedby lower respiratory tract infection. The diphtheria toxin inducesnecrosisof the epithelium of the upper respiratory tract, resulting in the formation of a "diphtheric pseudomembrane."
Note
(COPD) GHRONTC OBSTRUCTTVE PUTMONARY DTSEASE
COPD isa groupof disorders thatincludes:
COPD is a group of disorders characterizedby increased resistanceto airflow during both inspiration and expiration due to airway obstruction. The obstruction can occur at any level from the trachea to terminal bronchioles.This group representsthe most common form of pulmonary diseaseand includesemphysema,chronic bronchitis, asthma,and bronchiectasis.
. Emphysema . Chronic bronchitis . Asthma . Bronchiectasis Note . cr,-Antitrypsin inhibits the destruction of elastin by elastase, a proteolytic enzyme carried by inflammatory cells. Elastase actsonalveolar walls. . a,-Antitrypsin deficiency isa hereditary disorder that results in defective secretion of a,-antitrypsin bytheliver. Inhomozygotes, this eventually results in panacinar emphysema and hepatic cirrhosis.
r92
A. Emphysemarefersto distention of air spacesdistal to the terminal bronchiole with destruction of alveolarseptae,probably secondaryto ischemia. 1. Incidence. Emphysemais associatedwith cigarette smoking, urban living, and pollution. Cigarettesmoke causesan increasein elastaseavailability (releasedby neutrophils and macrophages)and a decreasein antielastaseactivity (due to oxidant effects).Men are affectedmore frequently than women. 2. Types a. Centrilobular emphysema affects the central and proximal part of a lobule; distal alveoli are not involved. It is more common and usually more severein the upper lobes.Inflammation surroundingbronchi,bronchioles,and alveoliis common. b. Panacinar emphysema causesa uniform enlargementof lobules, including terminal and respiratory bronchioles as well as distal alveoli. It is more common and more severein the lower lobes. Alpha,-antitrnrsin deficiency is thought to lead to an imbalancebetween proteaseand antiproteaseactivity. This imbalance then leads to panacinaremphysemaby young adulthood, especiallyin the lower lungs. c. Paraseptalemphysema involvesthe distal region of the acinus, sparing terminal bronchiolesand respiratorybronchioles.It is most severealong the pleura, septae,and the lobule edge.It commonly occursadjacentto areasof fibrosis,scarring,or atelectasis and is more severein the upper lung. Paraseptalemphysemaforms multiple confluent distendedair spaces. It may be the causeof spontaneouspneumothorax(collapsedlung) in young adults.
Pathology
d. Irregular emphysema describesirregular acinus involvement. It is associatedwith scarring. e. Bullous emphysema refers to large, balloon-like distended air spacesin the lung periphery,which can lead to pneumothorax. f. In interstitial emphysema,an alveolartear allows air into the connectivetissuestroma of the lung, mediastinum,or subcutaneoustissue. 3. Pathology a. Centrilobular emphysema(Figure II-5-4) (1) Grossly, the lungs may not be particularly enlargedor pale unlessdiseaseis well advanced.The upper two thirds are more severelyinvolved. (2) Microscopically, central airspaces(respiratory bronchioles and alveolar ducts) are destroyedwith sparing of peripheral alveoli; inflammation around bronchi and bronchiolesis common. b. Panacinar emphysema (1) Grossly, panacinar emphysema causes hyperinflated lungs with increased crepitance.Involved areasare pale as a result of blood vesseldestruction and compression. (2) Microscopically, there is little inflammatory involvement of septae or alveoli associatedwith their destruction.
Figure ll-5-4.Gentrilobular emphysema (gross).
4 . Clinical features include dyspneawith or without cough,weight loss,barrel-chest due to hyperinflation, pursed-lip breathing, prolonged expiratory time, and cor pulmonale (right-sided heart failure).*Pinkpuffers" are patientswho overventilateto maintain oxygenation despitethe elevatedwork of breathing.x-Raysrevealhyperinflation with flattened diaphragms.
t95
Respiratory System
5. Pathogenesis.There are two theories. a. Protease-antiproteasetheory, as describedpreviously. b. Loss of bronchial cilia as a result of smoking leads to mucus plugging and alveolar overdistension.Alveolar overdistention,resulting from obstruction, can compromise the septalblood flow,leading to ischemiaand alveolardestruction.Inflammation and mucus plugging may exacerbatethe obstruction. 6. Complications include cor pulmonale as a result of increasedpulmonary vascularresistance,ventilatory failure, polycythemia,and pneumothorax. B. Chronic bronchitis is a common disorder that can lead to obstructive airway disease. Chronic bronchitis is a clinical diagnosis,that is, persistentcough with sputum production for at least3 months for 2 consecutiveyears.Sputum variesfrom uninfected mucus (simple chronic bronchitis)to purulent (mucopurulentchronic bronchitis). 1. Pathogenesis.There are two major factors. a. Chronic irritation from inhaled substances(e.9., nitrogen dioxide, sulfur dioxide) may causeinflammation.
In a Nutshell Chronic Bronchitis . lsa clinical diagnosis of persistent cough with production sputum forat for least 3 months 2 years consecutive . lsassociated with infections, cigarette airpollution, and smoking, genetic factors various . Canpresent withmucus plugging, inflammation, fibrosis, and edema, muscle atrophy smooth . lncreases = Reidindex thickness layer ofgland thickness ofbronchial wall Note ln contrast to delayed hypersensitivity skintestsin TB,where thereaction takes 2-3 daysto form,thelgEisreferred mediated reaction to asimmediate hypersensitivity andproduces a wheal andflarein a few minutes.
t94
b. Recurrent infections do not initiate bronchitis, but they do perpetuateit and result in acute exacerbations. Common organisms include Haemophilus influenzae, Streptococcus viridans, and S. pneumoniae.Smoking can lead to both irritation and infection. Smoke destroysthe lung's ciliary tree, damagesthe mucosa,and interferes with WBC function. It is believedthat changesin the small airwaysare important in the pathogenesisof bronchitis. Small airway obstruction representsthe earliestmanifestation of COPD. Inflammation and mucus plugging increaseresistanceto air flow in theseusually low-resistanceairways.Continued exposureto irritants and repeated infection eventuallylead to chronic bronchitis. 2. Pathology a. Grossly,lungs are boggy,hyperemic,and hyperinflatedwith copious mucus plugging the airways. b. Microscopically, there is hypertrophy of the submucosaiglands first in the large airways and then in smaller airways.Bronchial epithelium may exhibit squamousmetaplasia or dysplasia.Mucus plugging, inflammation, edema,smooth muscle hypertrophy, and fibrosis are all common. 3. Ctinical features. There is a productive cough with copious sputum production, dyspnea, barrel chest, ryanosis,hypercapnia,hypoxia, and frequent infection. Patients are classicallyknown as"blue bloaters" becausethey are constantlycyanotic. 4. Complications. Respiratory failure usuallyoccursduring a bout with an acuteinfection. Cor pulmonale may occur asa result of pulmonary hypertension(increasedresistanceof pulmonary vasculatureas a result of alveolardestruction and hypoxic vasoconstriction). Dysplasiaof bronchial epithelium may lead to cancer. C. Asthma is characterizedby enhancedairway reactiviry leading to intermittent episodesof reversible paroxysmal airway narrowing. 1. Types a. Extrinsic asthma (allergic, atopic). Attacks are triggered by environmental antigens (e.g.,dust, pollen, food). There is frequently a family history of atopy (e.g.,rhinitis, asthma,and eczema).Bronchospasmis mediatedby a tfpe I immunoglobulin E (IgE) hlpersensitivity responseto a particular antigen.Histamine,leukotrienes([Cn, LID4, and LTE'), prostaglandin D, (PGD2),chemotacticfactors, and platelet activation all
Pathology
lead to airway-constricting inflammation and increasedvascular permeability. Serum IgE levels are elevated,and a positive skin test may be demonstrated to the offending antigen. b. Intrinsic asthma (idiosyncratic). Exacerbations frequently follow a viral infection that causesinflammation and a lowering of the vagal threshhold for irritants. Other causesof increasedairway reactivity include stress,pollution, occupationalexposure, exercise,and cold weather. There is no family history, skin tests are negative,and IgE levelsare normal. c. Aspirin-induced asthma may be seen in adults. There is a classic triad of nasal polnrs, rhinitis, and bronchoconstriction. It may be causedby excessiveleukotriene production from inhibition of the cycloorygenasepathway,and it is not immunologically mediated.This syndromemaybe seenwith almost all NSAIDs and acetylsalirylic acid (aspirin) compounds. 2. Pathology Bronchi and a. Grossly,asthmacauseshyperinflatedlungs with small areasof atelectasis. bronchiolesare occludedby thick, tenaciousmucus plugs. b. Microscopically, mucus plugs contain shed epithelium in a spiral configuration ("Curschmann spirals"). Eosinophils and membrane protein form crystalloid collections (Charcot-Leyden crystals). Basementmembrane thickening, an inflammatory infiltrate with large numbers of eosinophils,edema,and submucosalgland hyryertrophy occur. Hypertrophy of bronchial wall muscle is probably caused by repeatedbronchospasm. 3. Clinical features include cough, dyspnea,and wheezing. x-Ray revealshlperinflation. If airway obstruction is severe,the patient may not be able to ventilate,leading to respiratory failure (increasedPco, and decreasedPor). Between attacks,patients are asymptomatic. Emphysemacan alsooccur becausehyperinflation leadsto local ischemiaasa result of capillury compression.
ln a Nutshell SomeMicroscopic Pathologic Findings in Asthma . Mucus plugs containing Curschmann spirals and Charcot-Leyden crystals . Eosinophilic infiltrate . Edema . Submucosal gland hypertrophy . Bronchial wallmuscle hypertrophy
D. Bronchiectasis is an abnormal, permanent dilatation of airways causedby chronic necrotizing infection and obstruction. 1. Pathogenesis a. Bronchial obstruction (e.g.,tumor, foreign body, COPD, mucus plug) leadsto atelectasisand airway smooth musclerelaxation. b. Infection further weakens the airway wall. Organisms include Staphylococcus, Streptococars,enteric anaerobes,and H. influenzae.Patients are susceptibleto recurrent infection due to impaired defenseagainstpathogenscausedby cough, injury to the mucociliary apparatus,and impaired phagocytosis. c. Examplesof disordersin which chronic infection leadsto bronchiectasisinclude: (1) Cystic fibrosis, which is characterizedby exocrinegland dysfunction,leading to viscoussputum (2) Kartagener syndrome, one of severalimmotile cilia syndromes,is characterized by a triad of sinusitis, bronchiectasis, and situs inversus. Absenceof pulmonary cilia interfereswith bacterialclearance. (3) Anomalous intralobar sequestration,which frequently becomesinfected,leading to airway dilatation
t95
System Respiratory
2. Patholog;y a. Grossly, bronchiectasispredominantly affectsthe lower lobes. Dilated airways may be cylindroid, fusiform, or saccular.The lumen is filled with a purulent exudate,and the mucosa is edematousand ulcerated. b. Microscopic findings vary with the chronicity and activity of disease.There may be an acute or chronic inflammatory exudate within bronchi and bronchioles associated with desquamation of the lining epithelium with extensiveareasof necrotizing ulceration. There may also be areasof "pseudostratification"or squamousmetaplasia.In some cases,necrosisleads to abscessformation. 3. Clinical features include cough, fever,and foul-smelling purulent sputum, which is most copious in the morning due to pooling. Clubbing and frequent pneumonia may also be seen. 4. Complications include lung abscess,pneumonia, empyema, and septic emboli.
RESTRICTIVE LUNG DISEASE This is a group of diseasescharacterizedby decreasedlung compliance, i.e., stiff lungs. The decreasedcompliance results in small lung volumes with augmented air flow rates. Varying pathologic processescan result in restriction, including extrinsic disease(neuromuscular,chest wall, myasthenia) and intrinsic lung disease.Intrinsic lung processesinclude interstitial and infiltrative disease,adult respiratorydistresssyndrome (ARDS),pneumoconiosis,and granulomatous disease. A. ARDS is the final common pathway of acute diffrrse alveolar damage (both physiologic and pancreatitis, histopathologic).It can be causedby a variety of insults,including sepsis/shock, burns, trauma, drug overdose,pneumonia,and toxins. 1. Clinical features include the rapid onset of severe respiratory insufficiency, resulting from alveolarflooding with impaired ventilation (decreasedPor; increasedPcor). ARDS frequently requires intubation for ventilatory support. There is a compensatory hyperdynamic state with hyperventilation and increasedcardiac output (increasedheart rate or stroke volume) to ensure oxygen delivery and avoid anaerobic metabolism. X-ray reveals a diffirse alveolar infiltrate. 2. Pathogenesis a. Alveolar membrane damage allows fluid, protein, and cellular debris to enter the interstitium and alveolar space.There is both endothelial and epithelial injury. This damageis due, in part, to neutrophils and macrophagesgenerating oxygen free radicals and degradativeenzfmes as part of an inflammatory reaction. b. Coagulation. Fibrin is found in many alveolar spacesasa component of hyaline membranes.Fibrin is also located within the pulmonary arteries and capillariesand can causethrombotic occlusion. c. The complement cascadeappearsto attract and sequesterneutrophils (C5a). In addition, the "attack complex" (C6C7C8C9) of complement can directly injure cells. d. Cpokines. Macrophages release interleukin-l (IL-l) and tumor necrosis factor (TNF), which attract neutrophils and stimulate them to releasetoxic metabolites. e. Arachidonic acid metabolites produce chemoattractants such as leukotrienes and products of the cycloorygenasepathway.
r96
Pathology
3. Pathology a. In early gross pathology, the lung shows heavy, firm, boggy congestion and is atelectatic.Interstitial edemaand alveolaredemacauseseptalwidening. In late gross pathology, chronic inflammation can lead to fibrosis. There can be focal areas of intraalveolarhemorrhageand patchy atelectasis. b. Microscopically, edematous alveolar septaewith proteinaceous fluid within alveolar spacesare found. Frequently, hyaline membranes of fibrin and cellular debris line injured alveoli. Inflammatory cells are present and can eventually lead to fibroblast proliferation and collagenformation. In more chronic cases,alveolarspacesbecome relined with cuboidal, type II pneumocftes.The interstitium is widened. B. Pneumoconiosis refers to the presenceof environmental "dust" in the lung and the lung's responseto this foreign entity. It appliesto any aerosol,whether in the form of fumes or particulate matter. Developmentof diseasedependsupon the amount of exposure,the sizeand shape of the particles, and the solubility and cytotoxicity of the offending material. AII can result in progressivemassivefibrosis with diffi.rsescarring and restrictive lung disease. 1. Coal workers'pneumoconiosis occurs after prolonged periods (>10 years)of exposure to coal dust containing both carbon and silica.
ln a Nubhell ARDS . Manycauses, including shock, trauma, sepsis, and aspiration . Diffuse alveolar damage, protein-rich fluid with leaking intoalveoli. . Hyaline membranes, made offibrinandcellular fragments, formin alveoli. . lmpairs gasexchange and in hypoxia results . Fatal in over500/o of cases
a. Clinical features. Most patients are asymptomatic or have a slight cough productive of blackened sputum. X-ray revealsdiffirse nodularities ("tattooirg").A small number of casesgo on to develop progressivediseasewith dyspnea,chronic cough with blackenedsputum, poorly localized chest pain, and frequent infections. If exposure continues, progressive massive fibrosis with large blackened scars (usually in the upper regions of various lobes) with cor pulmonale can develop,and the pleura can becomeretractedand thickenedif near fibrotic lesions. b. Pathology. Microscopically, "coal dust macules" are formed initially by the aggregation of macrophages,creating intensely pigmented areas.With continued exposure and inflammation, these macules become fibrotic nodules with new collagen and reticulin (i.e.,progressivemassivefibrosis). 2. Anthracosis is causedby the inevitableinhalation of some carbonaceousparticlesby city dwellers, cigarettesmokers,and miners. a. Clinical features. Deposition of carbon dust can be seen as black pigment in lung parenchyma,pleura, and lymph nodes.When isolated,it is not associatedwith symptomatic disease. b. Pathology. Macrophages aggregateinto small, peribronchiole regions in an attempt to phagocytosethe dust. 3. Silicosis. Chronic silicosisoccurs with prolonged exposureto silica dust (mining, glass production, sandblasting, farming, road construction), causingan insidious diseasethat can progressto respiratory failure and death. a. Clinical features. Patients with silicosis are at increasedrisk of developing TB. There is no associatedincreasedcancerrisk. b. Pathology. Collagenousfibrotic nodules form whereverthe silica is deposited,probably due to macrophage releaseof lysosomal enzymes and production of fibroblast growth factor (FGF). Initial involvement tends to be in the upper lobes and perihilar region. Pleural involvement creates dense fibrous plaques and adhesions that may obliteratethe pleural cavities.Similar nodulesappearin the lymph nodesand may calciff, resulting in an "eggshell"pattern on chestx-ray. Nodules can increasein size to such an extent that bronchioles,alveoli,pulmonary arteries,and subpleuraltissuecan all be compressed(i.e.,progressivemassivefibrosis).Uninvolved parenchymatends to be hyperinflated and emphysematous.
Note Silica dustinthelungs is ingested byalveolar macrophages, whichbecome damaged. There isthena release ofthemacrophages' lysosomal enzymes and production in of FCF,resulting fibrotic silicotic nodules.
197
Respiratory System
4. Asbestosisis a diseasecausedby a family of fibrous silicatescommonly found in shipyards,insulation, and roofing industries. a. Clinical features. Many years after exposure,patients complain of dyspnea,chronic dry cough, recurrent respiratory infections (especially viral), and weight loss. Respiratory failure can occur many years after exposure has ceased.Patients with asbestosexposure are at increased risk of developing bronchogenic cancer and mesothelioma (pleural and peritoneal). Smoking causesa multiplicative increasein the risk of developinglung cancer.Patientswith asbestosis are also at risk of developing renal and gastrointestinalcarcinoma. b. Pathology. Smaller asbestosfibers that reach smaller airways and alveoli are phagocytosed by macrophagesafter being covered with hemosiderin and glycoprotein (ferruginous body). This may incite an inflammatory responsedue to lysosomalrupture or oxygenfree radicals.Fibroblastsare abundant and createstriking interstitial fibrosis with septal wall widening, which is usually worse in the lower lobe and near the periphery. This processmay also involve the visceral pleura. In addition, patients developdensehyalinizedand possiblycalcifiedparietal pleural plaquesof varying size. Uninvolved parenchyma becomes hyperinflated, leading to "honeycombing." Secondarybronchiectasismay complicatethe picture. Extensivescarringmay narrow or obliterate alveoli,lymphatics, or pulmonary vessels,leading to pulmonary hypertension and cor pulmonale. 5. Berylliosis is causedby heavy exposureto airborne beryllium or its salts.Becauseof its high tensilestrength and resistanceto heat and fatigue,beryllium is still used in the electronic, ceramic, aerospace,and nuclear energy industries. Diseasecausedby beryllium probably representsa type IV hypersensitivityreaction, with noncaseatinggranuloma formation and eventualfibrosis.There is an increasedincidenceof bronchogeniccancer in patientswith berylliosis. C. Hypersensitivity pneumonitis (external allergic alveolitis) is an immunologically mediated interstitial lung diseasecausedby exposureto organic dustsand other occupationalantigens. 1. Clinical features. Patients tend to have a heightened responseto the offending agent, involving alveoli rather than the airways.Acute attacks are characterizedby fever, cough, dyspnea,and leukocytosis. Nodular and diffuse infiltrates appear on x-ray. Pulmonary function testsmay revealrestriction. Acute attacksare probably mediated via a type III immune complex reaction. If exposure is chronic, progressiverespiratory failure can occur with interstitial fibrosis and obliterativebronchiolitis. 2. Pathology. Microscopically, macrophages,plasma cells, and lymphocytes within the interstitium can be found. Peribronchiolargranuloma can be seen(chronic diseaseprobably representsa type IV delayedhypersensitivityreaction). 3. Types a. Farmer's lung is causedby thermophilic actinomycetesthat grow on hay. b. Byssinosis is causedby cotton, linen, or hemp exposure,leading to bronchospasm (possiblyhistamine related). D. Goodpasture syndrome is a necrotizing hemorrhagic interstitial pneumonia that can lead to hemoptysis (coughing up blood) and rapidly progressive glomerulonephritis (with crescentformation). The diseaseappearsto involve antibody recognition of a common pulmonary and renal basementmembrane antigen.
t98
Pathology
1. Clinicat features. Goodpasture syndrome usually occurs in individuals in their twenties and thirties and is more common in men. Death usually occurs as a result of complications of renal failure, but massivehemoptysiscan be responsible. 2. Pathology
In a Nutshell
a. GrosslR heavylungs with areasof red-brown consolidationare seen. b. Microscopically, there is focal necrosisof the alveolarwall, associatedwith intra-alveolar hemorrhage,fibrous thickening of the septa,hypertrophy of lining septal cells, and hemosiderin-containingmacrophages.Immunofluorescencestudiesreveallinear deposits of immunoglobulin along renal and pulmonary basementmembranes. 3. Prognosis hasbeen improved by using immunosuppression to inhibit antibody production and by plasma exchangethat can remove antibody and other immune response mediators. E. Idiopathic pulmonary hemosiderosisis an uncommon condition. 1. Clinical features.It is characterizedby the insidious onset of cough, hemoptysis,weight loss,and diffuse pulmonary infiltrates.It occursin young adults and children.Diseasecan vary from mild (occasionalhemoptysis) to severe(pulmonary fibrosis). Most patients have a chronic remittent course over years that eventually improves. The etiology is unknown.
Goodpasture Syndrome glomerular Antibodies against basement andpulmonary result in a membranes pneumonitis and hemorrhagic glomerulonephritis. reveals lmmunofluorescence linear deposits of lgCalong basement theglomerular you membrane. lf seea patient withbothhemoptysis think andhematuria, syndrome. Coodpasture
2. Pathology. There are focal areasof red to red-brown consolidation with degeneration, shedding, and hyperplasia of alveolar epithelial cells and alveolar capillary dilatation. Varying degreesof fibrosis may be seen.Hemorrhage occurs into alveolarspaces.Septae and free macrophageswithin alveolarspacescontain hemosiderin. F. Pulmonary alveolar proteinosis 1. Ctinical features. The diseaseis insidious in onset with cough productive of gelatinous material. The courseis variable,but patients can progressto pulmonary fibrosis (rarely) with dyspnea,cyanosis,and respiratory insufficiency. 2. Pathology. Pulmonary alveolarproteinosisis characterizedbythe accumulationof dense, homogeneous,granular, strongly PAS-positivematerial within the intra-alveolar space. This material contains abundant phospholipid and protein with lamellar bodies and refractile crystals. 3. Etiology. The causesremain obscureand are probably variable,including overproduction of surfactant-like material and a possiblemacrophagedeficiency that preventsalveolar scavenging. G. Diffuse idiopathic pulmonary fibrosis, or usual interstitial pneumonitis (UIP) is a syndrome of unknown etiology that resultsin chronic interstitial pneumonitis, which can lead to interstitial fibrosis and respiratory failure. 1. Clinical features. Men are affected more than women. The usual age for diagnosisis 30-50 years.Progressionis unpredictable;some individuals develop cor pulmonale and cardiac failure within severalyearsdue to lung disease,whereasothers experiencespontaneousremission.The rare, rapidly progressiveform of this diseaseis sometimesknown as the Hamman Rich syndrome. 2. Pathology. There is alveolar wall damage (possibly as a result of immune complex formation), especiallyto type I pneumocytes,that leadsto interstitial edemaand alveolitis. Hyperplasiaof type II pneumocftes occurs in an attempt to restorethe alveolar lining. Recruitment of fibroblastscan lead to fibrosis of both the interstitium and intra-alveolar exudate.The end stageof this processis the "honeycomb lung."
t99
Respiratory System
H. Desquamative interstitial pneumonitis (DIP) is a rare illness of unknown etiology that may be a precursor of interstitial fibrosis of the usual type. 1. Clinical features. Patients present with cough and dyspnea that can progressto ventilatory failure with ryanosis and clubbing. Radiographically, bilateral lower lobe groundglassinfiltrates are noted. Patients with DIP tend to respond more favorably to steroids than do patients with UIP. 2. Pathology. Mononuclear cells are found within alveoli, presumably desquamatedfrom alveolarwalls. Ninety percent of thesemononuclear cellsare macrophages,many of which contain lipid and PAS-positivevacuolesin addition to phagocytosedlamellar bodies. I. Pulmonary eosinophilia is a diverse group of illnessescharacterizedby eosinophilic pulmonary infiltrates. l. Simple pulmonary eosinophilia (Liiffler syndrome) a. Clinical features. Patients develop dyspnea with evidence of both restriction and obstruction on pulmonary function tests. b. Patholog;y.Tiansient pulmonary infiltrates of varying size and shapewith peripheral eosinophilia are seen.There is alveolar septal thickening as a result of eosinophils and occasionalgiant cellswith focal hyperplasiaof alveolarepithelial cells.This most likely representsa type I immune response. 2. Chronic eosinophilic pneumonia a. Clinical features. Patients develop high fevea night sweats,and dyspnea,all of which respondto steroids.This may representa primary immunologic processor a response to a number of parasitic, fungal, or bacterial infections, hypersensitivity pneumonitis, drug allergy,asthma, or allergic bronchopulmonary aspergillosis. b. PathologT. Peripheral and focal areasof cellular consolidation that represent alveolar and interstitial infiltration by lymphocftes and eosinophils iue seen. l. Sarcoidosis is a multisystem disorder of unknown etiology, characterizedby noncaseating granulomata. The diseaseusually involvesthe lung, followed by skin and eyemanifestations.
In a Nubhell Interstitial LungDiseases . Hypersensitivity pneumonitis . Coodpasture syndrome . ldiopathic pulmonary hemosiderosis . Pulmonary alveolar proteinosis . Diffuse idiopathic pulmonary fibrosis . Desquamative interstitial pneumonitis . Pulmonaryeosinophilia . Sarcoidosis 200
l. Epidemiology. SarcoidosisaffectsBlacks more than Caucasians,women more than men. Sarcoidosisis gener"lly. diseaseof young adults aged20-35 years. 2. Pathology. The granulomatous nature of the lesions suggests an immunologically mediated diseaseof the delayedhypersensitivity type. In fact, although patients have low peripheral T-cell counts (and are usually anergic), the number of T-helper cellswithin the lung is greatly increased,whereasT-suppressorcells are lacking. 3. Clinical features. Becausesarcoidosis is a multisystemic illness, presenting complaints vary markedly. a. Most patients seekmedical attention with the onset of respiratory symptoms, such as dyspnea,cough, chest pain, or hemoprysis. Others have systemic symptoms, such as fever,fatigue, weight loss, anorexia, and night sweats. b. Eighty percent presentwith hilar and mediastinal lymph adenopathywithout parenchymal involvement ("potato nodes") seenreadily on chestx-ray.Within the nodesare noncaseatinggranulomata that often contain Schaumann bodies (collection of calcium and protein) and asteroid bodies (star-shapedinclusions within giant cells). Occasionally, small nodules can be found in the lung parenchyma. c. Fifty percent present with a hypersensitivity reaction with fever, polyarthritis, erythema nodosum, and hilar adenopathy.
Pathology
d. Other involved organsinclude skin (nodules,plaques,macules),eyes(iritis, iridocyclitis), liver, spleen,and bone marrow. All involved organs display similar histopathology. 4. Diagnosis. Becauseof the variable presenting complaints, the diagnosis of sarcoidosisis frequently made clinically. Tissue demonstrating noncaseatinggranulomas confirms the clinical impression (Figure II-5-5). This distinguishessarcoid from TB, which shows caseatinggranulomas (central areasof caseousnecrosis).
* ':: ,'# g$
a'
Figure ll-5-5.Sarcoidosis: noncauseating granulomas (microscopic).
5. Prognosis. Sarcoidosis follows an unpredictable course characterized by alternating periods of remission and activity. Most patients recover with minimal or no residual effects.Twenty percent have permanant loss of pulmonary function or visual acuity. Ten percent develop chronic diseasewith pulmonary fibrosis and cor pulmonale. K. Pulmonary disease with collagen vascular disorders. Many collagen vascular disorders affect the lung and can lead to diffirse interstitial fibrosis. 1. Scleroderma classicallycausesinterstitial fibrosis. 2. Lupus erfthematosus causestransient pulmonary infiltrates and, occasionally, severe pneumonitis. 3. Rheumatoid arthritis may cause chronic pleuritis with or without an effirsion, diffi,rse interstitial pneumonitis with fibrosis, intrapulmonary nodules, rheumatoid nodules with pneumoconiosis( Caplan syndrome),or pulmonary hypertension. 4. Wegener granulomatosis is an acute necrotizing vasculitis with granuloma formation involving the lung in addition to the kidney and upper respiratory tract. It may consolidate and causescarring. 5. Lymphomatoid granulomatosis is a pleomorphic cell infiltration and destruction of lung tissue,which in some casesis a true monoclonal B-cell lymphoma.
20r
Respiratory System
In a Nutshell
VASCUTAR DISORDERS
Cardiogenic Pulmonary
A. Pulmonary congestion and edema result from an accumulation of fluid and protein within the pulmonary interstitium and alveolar spaceas a result of hemodynamic (Starling) derangementsor from increasedcapillary/alveolarpermeability.
Edema . Leftventricular failure . Mitral stenosis Noncardiogenic Pulmonary Edema . Septic shock . Pancreatitis . Burns . Toxin inhalation . 0,toxicity . Narcotic overdose . Pneumonia . Organic solvents
1. Most commonly, pulmonary edema developswhen there is an increasein pulmonary capillary pressure,as with left heart failure. Volume overload of the nephrotic syndrome and decreasedlymphatic drainagealso lead to transudation of fluid acrossthe alveolar membrane.As fluid accumulatesin the interstitium, interendothelialjunctions stretch, leading to increasedpermeability to both fluid and macromolecules.The lymphatic flow must be increasedlO-fold beforethe lung's drainagemechanismis overwhelmed,leading to edema.It is only after even higher capillary pressuresare achievedthat fluid moves from the interstitium into the alveolarspace. 2. Alveolocapillary permeability. Edema results after injury to both capillary endothelial and alveolarepithelial cells.Fluid and protein accumulateinitially in the interstitium and subsequentlyin the alveolar space.Noncardiogenic pulmonary edema can result from septic shock, pancreatitis,burns, toxin inhalation, oxygen toxicity, narcotic overdose, pneumonia, organic solvent hypersensitivity,and other causes.Pathologically,the lungs are heavy, wet, and subcrepitant, mostly involving the bases.Alveolar capillaries are engorged,and the alveolar spacecontains a granular pink precipitate.Alveolar microhemorrhageand hemosiderin-containing macrophages are present(FigureII-5-6). If the processbecomeschronic, macrophageswith hemosiderin are abundant,and alveolarwall fibrosis resultsin firm, brown lungs ("brown induration"). Thesepatientsare particularly susceptibleto bronchopneumonia(FigureII-5-7).
Figure ll-5-6.Ghronic passive congestion with hemosiderin-filled macrophages (microscopic).
202
Pathology
Figure ll-5-7.Chronic passive congestion with interstitial fibrosis (microscopic).
B. Pulmonaryhypertension. The pulmonary circulation is characterizedby low pressureand work. Pulmonary hypertenlow resistance,which protect the right ventricle from excessive sion usually occursas a result of elevatedpulmonary vascularresistance. 1. Primarypulmonaryhlpertension has an unclear etiology,although there are numerous theories.It generallyaffectsyoung women 2A40 yearsof age.Sometheoriesinclude: a. Multiple small pulmonary emboli, which becomeorganizedand incorporated within arterial walls b. Neurohormonal-induced vascular hyperreactivity, causing chronic vasoconstriction and pulmonary hypertension c. Immune complex-mediated disease d. Diet or medicinal products, such as appetite suppressants,which may causedirect endothelialdamage causingelevatedpul2. Secondarypulmonary hn>ertension resultsfrom known diseases, monary vascularresistanceand pulmonary pressures. a. Increasedpulmonary blood flow may be due to atrial septaldefect,ventricular septal defect,patent ductus arteriosis,or Eisenmengercomplex. b. Hypoxic vasoconstriction may be seenin COPD and interstitial lung disease. c. Elevatedleft heart pressures,transmitted back to the right sideof heart,may occur in congestiveheart failure, mitral stenosis,and left atrial myxoma. necrotizingvasculid. Destruction of pulmonaryvessels may occur in schistosomiasis, tis, multiple pulmonary emboli, sickle cell anemia,scleroderma,and COPD. 3. Pathology. A variety of vascularlesions with much overlap between primary and secondary hlpertension is seen.
20t
Respiratory System
In a Nubhell Pulmonary Embolism . Verycommon occurence . Occurs during timesof venous stasis, especially prolonged during bedrest orsittingCHF, andin primary venous disease . Mostoftenoriginates from a deepvenous thrombosis (DUDin thelower extremities or pelvic area . Risk factors include: obesity, pregnancy, cancer, oral contraceptives, hypercoagulabil ity,multiple fractures andpriorDVI . lf youaregiven a que$ion ontheexam where a patient (often bedridden post-surgical) develops sudden shortness of breath, thinkpulmonary embolism. Diagnosis wouldbe confirmed witha V/Q (ventilation/perfusion) scan.
204
a. In primary hypertension, medium-sized muscular arteries develop medial hlpertrophy, intimal thickening and fibrosis with adventitial fibrosis, and internal and external elastic membrane thickening and reduplication. Small arteries and arterioles are most affectedwith medial thickening. A "plexiform lesion" may form, consisting of cellular intraluminal angiomatous tufts. b. Secondarychanges are similar to those in the primary diseasebut may have organized thrombi and diffirse atheroscleroticchangeswithout calcification or ulceration. 4. Clinical course. Patients become symptomatic only after the diseaseis well advanced. They usually presentwith dyspneaand fatigue. Occasionally,syncopeor angina can be the initial manifestation. Respiratory failure or decompensatedcor pulmonale result in death within severalyears of presentation. C. Pulmonary thromboembolism and infarction is an underdiagnosedentity (500,000annually; 10olofatal) resulting in occlusion of a pulmonary artery by an embolic blood clot. Thrombosis on top of a nonocclusiveembolus may lead to complete arterial obstruction. The usual sourcesof emboli are the deep veins of the leg. However, a clot can also develop in the pelvic veins and right heart. 1. Risk factors include bed-bound conditions, obesiry cancer,pregnancy,oral contraceptives, hypercoagulabiliry and prior deep venous thrombosis. a. Large emboli may occludethe main pulmonary artery or its major branchesor lodge in the pulmonary arterybifurcation,leading to a "saddleembolus."Suddendeath can follow from blockageof blood flow out of the right ventricle or from acute right heart failure (acutecor pulmonale). b. Small emboli occlude smaller vessels.Fewerthan 10oloof pulmonary emboli causeinfarction asa result of bronchial artery collateralflow to the lung parenchyma.Under theseconditions, hemorrhage with parenchymal preservation rather than infaraion occurs. If the collateral circulation is compromised, even small emboli can causeinfarction. 2. Pathology. Characteristically,infarctions extend to the lung periph.ry forming a wedgeshaped,pleural-basedinfiltrate. Initially, the infarct is hemorrhagic with ischemicnecrosis ("red infarct") (Figure II-5-8). Fibrinous exudateforms on the apposedpleural surface.RBCslysewithin 48 hours, and eventually fibrous replacementbegins at the margins, leading to scarformation.
Pathology
Figure ll-5-8.Pulmonaryinfarct (gross).
3. Clinical features of a pulmonary embolus depend on its size. a. Small emboli causetransient cough, dyspnea,tachycardia,hyperventilation,and possibly chestpain. Infarction may producefever,worseningchestpain, and hemoptysis in addition to dyspneaand tachypnea. b. Large emboli can produce sudden death with a clinical syndrome similar to an acute myocardialinfarction (chestpain, severedyspnea,shock,fever). D. Fat embolism is characterizedbyprogressiverespiratoryinsufficiency,mental deterioration, and occasionallyrenal insufficiency.Theseemboli usuallydevelop 1-3 daysafter a longbone fracture. 1. Pathogenesisis controversialand probably multifactorial. a. Releaseof fat globules from the marrow may simply occlude vesselsin the lung and brain. Smallerglobulesmay fit through the pulmonary vasculatureand causesystemic emboli. b. Chylomicrons may coalescewith stress,leading to vesselocclusion. c. Disseminatedintravascularcoagulation (DIC) may cause obstructive symptoms, exacerbatedby fat emboli. d. Freefatty acidsmay causemicrovasculartoxic injury, leading to capillary block. 2. Prognosis.Mortaliry is high (10-i5%). E. Amniotic fluid embolism. Releaseof thrombogenic amniotic fluid into the maternal circulation during delivery causeswidespreadthrombosis and occlusion of pulmonary capillaries.DIC may follow. There is a high mortality rate.
205
System Respiratory
MISCELTANEOUS DISORDERS PUTMONARY A. Lipid pneumonia is causedby aspiration of a variety of oils, and it resultsin patchy or diffuse consolidation. The aspirated oil is emulsified upon reaching the alveolus, and oil droplets are phagocytosedby macrophages.In the early stage,the involved alveoli are partially or totally filled with distended,occasionallymultinucleated macrophagescontaining clear cftoplasmic granules.Progressionof diseaseinvolves fibroblast organization of the inflammatory reaction into granulomataand fibrous tissue.
ln a Nutshell Neonatal Respiratory (Hyaline Distress Syndrome Membrane Disease) . Mostcommon cause of deathin premature neonates . Deficiency of surfactant, mainly of composed lecithin dipalmitoyl . Atapproximately the33rd the weekofpregnancy, lecithin concentration increases. Thesphingomyelin remains $able. concentration A lecithin: sphingomyelin ratiogreater orequalto 2:l lunpinthe indicates mature newborn. . Risk factors forneonatal include respiratory distress prematu rean rity,caesa birth,mother with section diabetes mellitus.
B. Neonatal respiratory distress syndrome (hyaline membrane disease)occurs in premature infants asthe result of a deficiency in pulmonary surfactant becauseof inadequatelecithin synthesisby irnmature tnre II pneumocftes. Grossly, the lungs are normal sizedbut solid, airless,and reddish-purple.Alveoli are small and collapsed(atelectasis),whereasproximal alveolar ducts and bronchi are overdistended(emphysema).Necrotic material becomes incorporated into pink fibrin-rich hyaline membranesthat line alveolarducts and alveoli. C. Pneumonia in the immunocompromised host. Pulmonary infiltrates and signsof infection commonly occur in immunosuppressedpatientsundergoing chemotherapy,after transplantation, or with AIDS. A wide arrayof opportunistic infections can causethesepneumonias, many of which rarely causediseasein normal hosts. 1. Cytomegalovirus (CMV) infections acquired postnatally tend to be asymptomatic but can produce seriousillnessin the immunocompromised host, usually involving the lung and intestinal tract. Lung involvementtakesthe form of an interstitial pneumonitis with intracellular inclusions in the alveolarlining cellsand in endothelial cellsof septalcapillaries,as well as in macrophages.Intra-alveolar edema,proteinaceousexudate,and focal hyaline membranesmay appear,depending on the severity of infection. Cellular inclusions occur in enlarged cells (cytomegalo-) with pleomorphic nuclei containing acidophilic nuclear inclusions. The inclusion may be one half the diameter of the nucleus and is surrounded by a clear halo, separating it from the nuclear membrane. Acidophilic inclusions may alsobe seenin the cytoplasm. 2. Pneumocystiscarinii pneumonia (discussedearlier in this chapter) 3. Other infections are caused by fungal (Cryptococcus,Aspergillus) and bacterial (Pneumococcus, S. aureus)agents. D. Atelectasiscan be causedby either a failure of the lungs to expand at birth or by collapseof previously air-filled lungs by processesincluding air obstruction (followed by resorption of air), compression(by blood, fluid, tumor, or air in the pleural cavify), or contraction (by fibrosis). Microscopically, the alveolar spacesare compressedand contain little or no air. Atelectasisis typically a benign condition unless infection supervenesor so much lung tissueis involved as to compromise respiratory function.
LUNGTUMORS Most lung tumors representmetastaticlesions.Of the primary lung neoplasms,most are bronchogenic carcinomas. A. Benign neoplasms 1. Hamartomas are the most common benign pulmonary neoplasm.They affect men more frequentlythan women (3:1) with a peak incidencein the sixth decade.They are uncommon in patientsunder 30 yearsof age.Hamartomas :re mesenchymalneoplasms,composedof a mixture of tissuesusually found in the lung (cartilage,smooth muscle,collagen)in a disorganizedarray.They can becomeextremelylarge despitetheir benign nature and can remain
206
Pathology
clinically silent becauseof their peripheral location. Calcification resemblittg"popped popcorn" occurstn 5-20o/oof hamartomas. 2. Bronchial adenomasarisefrom bronchial mucous glands. 3. Leiomyomas arise from smooth muscle,usually in an endobronchial location. They are usually a diseaseof young women (averageage37)' 4. Hemangiomas are usually peripheral and often subpleural. 5. Lipomas are usually endobronchial and can occur on either side of the bronchial cartilage. 6. Chondromas are derived exclusivelyfrom formed bronchial cartilage. (e.g., 7. Teratomas are r